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Lsm (Sm-Like) protein complexes have been implicated in a large number of RNA 
processing events in every kingdom of life. In Saccharomyces cerevisiae two distinct 
heteroheptameric complexes exist: Lsml -7p in the cytoplasm where it is involved in mRNA 
decapping and Lsm2-8p in the nucleus where it is implicated in a range of processes from 
pre-mRNA splicing and degradation to pre-snoRNA, pre-tRNA and pre-rRNA processing. 
Their involvement in these processes and all that is known about these and other Sm-like 
proteins suggest that they function as RNA chaperones. To investigate this function, 
recombinant yeast Lsm proteins were purified from Escherichia coli and tested for their 
ability to promote annealing of the U4 and U6 snRNAs and to unwind a DNA/RNA duplex 
resembling the 3' stem-loop of U6 snRNA. For comparison, Hfq, the Sm-like protein from 
E. coli, and recombinant human Lsm complexes were used in the same in vitro assays. The 
results are consistent with their ability to promote RNA/RNA annealing and to modulate 
RNA secondary structure, which, in vivo, may also allow them to affect RNA/protein 
interactions. To complement the in vitro analyses, studies were carried out to elucidate the 
contributions made by individual Lsm polypeptides to the function and localisation of these 
complexes in vivo. The function of LSM4 was studied by overexpression and depletion of 
wild-type Lsm4p, and by expression of Lsm4p C-terminal deletion mutants. Results suggest 
that Lsm4p affects cell morphology and that its C-terminus promotes efficient recruitment of 
Lsml-7p to P-bodies. LSM5 was shown to be dispensable for cell viability, and its deletion 
was shown to affect levels of U6 and U41U6 RNAs similar to effects in 1sm64 and ism 74 
strains. A dramatic increase in the level of U4 snRNA in the 1sm54 strain suggests Lsm5p 
may have a task in degradation of this small stable RNA. The involvement of the different 
domains of Lsmlp and Lsm8p in localisation of these proteins to the cytoplasm (to P-bodies 
under stress conditions) and nucleus respectively was investigated by creating (deletion) 
mutants and hybrids of various domains of these proteins. Results suggest that the N-termini 
of both proteins play a central role in targeting them to their respective cellular locations. 
The in vitro studies reveal that the RNA chaperone activities of Sm-like proteins appear to 
have been conserved from bacteria to eukaryotes. Presumably, gene duplication and 
formation of hetero-multimeric complexes in higher organisms has allowed functional 
diversification. The in vivo results begin to distinguish functions specific to individual Lsm 
polypeptides and protein domains, however, undoubtedly others remain to be found. 
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Abbreviations 
A260 absorption at 260 nm 
aa amino acid(s) 
Amp ampicillin 
ARS autonomous replication sequence 
ATP adenosine 5'-triphosphate 
bp base-pair 
BPB bromophenol blue 
BLAST basic local alignment search tool 
BSA bovine serum albumin 
oc degrees Celsius 
cDNA complementary DNA 
CDS coding sequence 




cpm counts per minute 
Cs cold-sensitive 
CTP cytidine 5'-triphosphate 
dATP deoxyadenosine 5'-triphosphate 
dCTP deoxycytidine 5'-triphosphate 
dGTP deoxyguanosine 5'-triphosphate 
dNTP deoxynucleoside 5'-triphosphate 
dTTP deoxythymidine 5'-triphosphate 
DEPC diethylpyrocarbonate 
DMSO dimethyl sulfoxide 




ECL enhanced chemi-luminescence 
EDTA ethylenediaminetetraacetic acid 
EMBL European Molecular Biology Laboratory 
EtBr ethidium bromide 
Fig. figure 




GTP guanosine 5'-triphosphate 
h hour(s) 
HA haemaglutinin HA-i protein epitope 
HEPES N-2-hydroxyethylpiperazine-N ' -2-ethanesulfonic acid 
His histidine 
Hph hygromycin phosphotransferase (hygromycin resistance gene) 
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HRP horse radish peroxidase 
Hyg hygromycin 





kDa kilo Dalton 
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MOPS 3-[N-morpholino]propanesulphonic acid 
mRNA messenger ribonucleic acid 
MW molecular weight 
MWCO molecular weight cut-off 
Nat nourseothrycin 
NCBI National Centre for Biotechnology Information 
ncRNA non-coding RNA 
NES nuclear exclusion or export signal 
ng nanogram(s) 
NLS nuclear localisation signal 
rim nanometre(s) 
NP-40 nonidet P-40 detergent 
nt nucleotide 
NTA nitriloacetic acid 
NTC Prp 19 complex 
0D600 optical density at 600 nm 
ORF open reading frame 
p plasmid designation 
PAGE polyacrylamide gel electrophoresis 
P-bodies (mRNA) processing bodies 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PEG polyethylene glycol 
PI isoelectric point 
pmol picomole(s) 
PNK T4 polynucleotide kinase 
PVDF polyvinylidine difluoride 
RNA ribonucleic acid 
RNase ribonuclease 
RNP ribonucleoprotein particle 
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rNTP ribonucleoside 5'-triphosphate 
rpm revolutions per minute 
rRNA ribosomal ribonucleic acid 
RT room temperature 
s seconds 
SD- synthetic defined or dropout medium minus 
SDS sodium dodecyl sulphate 
SGD Saccharomyces Genome Database 
snRNA small nuclear ribonucleic acid 
snRNP small nuclear ribonucleoprotein particle 
sRNA small (non-coding) RNA 
SSC sodium choride-sodium citrate (buffer) 
ssDNA single stranded DNA or salmon sperm DNA 
SSPE sodium chloride-sodium phosphate-EDTA (buffer) 
Strep streptomycin 
SV40 Simian virus 40 
TAE Tris-acetate (buffer) 
TBE Tris-Borate-EDTA (buffer) 
TBS Tris-buffered saline 
TBST Tris-buffered saline-Tween-20 
TE Tris-EDTA (buffer) 
TEMED N,N,N' ,N' -tetramethyl-ethylenediamine 
Tet tetracycline 








UFO bodies unidentified Lsm4 bodies 
Ura uracyl 
UTP uridine triphosphate 
UTR untranslated region 
UV ultra violet 
V volt(s) 
v/v volume per unit volume 
W Watt(s) 
w/o without 
WT or wt wild type 
w/v weight per unit volume 
XCB xylene cyanol (blue) FF 
YMM yeast minimal medium 
YPDA yeast-peptone-dextrose-adenine (medium) 
YPGa1A yeast-peptone-galactose-adenine (medium) 
12 
Amino acid abbreviations 
Three letter 	 Single letter 
Amino acid 	 abbreviation abbreviation 
Alanine Ala A 
Arginine Arg R 
Asparagine Asn N 
Aspartic acid Asp D 
Cysteine Cys C 
Giutamic acid Glu E 
Glutamine Gin Q 
Giycine Gly G 
Histidine His H 
Isoleucine ISO I 
Leucine Leu L 
Lysine Lys K 
Methionine Met M 
Phenyialanine Phe F 
Proline Pro P 
Serine Ser S 
Threonine Thr I 
Tryptophan Trp W 
Tyrosine Tyr Y 
Valine Val V 
The genetic code 
ii 	 A 
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CUU Lou CCU Pro CAU His CGU Arg 
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AUC lie ACC Thr AAC Asn AGC  Ser 
AUA lie ACA Thr AAA Lys AGA Ary 
AUG Met ACG Thr AAGLYS AGG Arg 
GUU Val GCU Ala GAU 
Asp GGU 	Gly 
GUC Val GCC Ala GAC Asp GGC 	Gly 
GUA Val GCA Ala GAA Glu GGA Gly 
























1.1 RNA, a versatile biomotecule 
Ribonucleic acid (RNA) molecules can be both carriers of information and catalysts. 
Deoxyribonucleic acid (DNA) is an informational molecule with limited catalytic 
capabilities and polypeptides can carry out a wide variety of enzymatic functions, but 
do not usually transfer information. Both functions are needed to allow self-
replication. As RNA molecules have the right characteristics, an early "RNA world" 
may have existed, in which self-replicating RNA molecules were the first life-forms. 
It is unclear whether such a world really existed and, if so, how it would have 
evolved into more complex life-forms that are based on DNA, RNA and proteins 
(Joyce and Orgel, 1999). It is clear however, that RNA is essential for life as we 
know it and central to many processes in the cell, not the least of which is the 
transfer of information encoded by DNA into polypeptide chains. 
1.1.1 Messenger RNA 
Messenger RNAs (mRNAs) contain open reading frames (ORFs) that encode 
proteins. Pre-mRNAs are transcribed by RNA polymerase II and are processed into 
mature translatable mRNAs. Processing takes place on both the 5' and 3' ends. The 
5' end is capped by a guanosine nucleotide connected to the mRNA via an unusual 5' 
to 5' triphosphate linkage. Addition of a methyl group to N 7 of the guanine base 
results in m7 GpppN or cap 0, which is the cap structure of mRNAs in yeast and 
plants. The cap regulates nuclear export, promotes 5' proximal intron removal, 
protects the mRNA from 5' to 3' degradation and is required for translation 
initiation. In eukaryotes a poly(A) tail is added to the 3' end by PAP 1 after 
endonucleolytic cleavage at the polyadenylation site. This tail is 50-250 nucleotides 
long (depending on the organism), protects the mRNA from degradation, plays an 
essential role in translation initiation, and promotes export to the cytoplasm (Wahle 
and Keller, 1997). In contrast, in prokaryotes poly(A) tails usually target the mRNA 
for degradation. In eukaryotes, the mRNA coding sequence is often interrupted by 
non-coding "intronic" sequences that are removed by the spliceosome (see 1.2). 
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1.1.2 Non-coding RNA 
In addition to protein-encoding mRNA a large number of so-called non-coding 
RNAs (ncRNAs) have a wide variety of functions in the cell. 
1.1.2.1 Transfer RNA 
Nucleotide triplets (codons) in the mRNA are recognised by complementary "anti-
codons" in transfer RNA (tRNA) molecules. When "charged", each tRNA carries a 
specific amino acid that gets incorporated into a polypeptide chain by the ribosome. 
The tRNA is transcribed as a precursor sequence by RNA polymerase III with 5' and 
3' extensions, called leader and trailer sequences respectively. The leader sequence is 
removed by endonucleolytic cleavage by the RNase P ribozyme. The trailer sequence 
is removed by endonucleolytic as well as exonucleolytic cleavages catalysed by a 
range of ribonucleases (RNases; Nakanishi and Nureki, 2005). In addition, introns 
need to be removed from tRNA in all three kingdoms of life. In bacteria, introns are 
self-splicing and are removed by a group I splicing mechanism. In other organisms 
removal of intronic sequences involves successive actions of a tRNA splicing 
endonuclease (yeast Sen2p) and ligase (yeast Rlglp; Trotta and Abelson, 1999). 
1.1.2.2 Ribosomal RNA 
Ribosomal RNA (rRNA) molecules play both structural and catalytic roles in the 
ribosome, a multi megadalton ribonucleoprotein (RNP) complex that carries out 
translation. Each ribosome contains four different rRNA molecules and a large 
number (>75) of ribosomal proteins. Three of these rRNAs (5.8S, 18S and 25-28S) 
are transcribed by RNA polymerase I as a large polycystronic precursor. The fourth, 
5S rRNA, is transcribed separately by RNA polymerase III. Processing of the pre-
rRNA into mature rRNAs involves a large number of endo- and exonucleolytic 
cleavage steps, including those carried out by the 5' to 3' exonuclease Rat ip and the 
exosome, a 3' to 5' exonuclease complex. In addition, numerous sites undergo 
chemical modifications, mostly ribose 2' -0-methylation and pseudouridylation. Most 
of these processing steps take place in the nucleolus. Proteins that carry out the 
chemical modifications are guided to the correct sites by complementary small 
nucleolar RNAs (Venema and Tollervey, 1999; Granneman and Baserga, 2004). 
16 
1.1.2.3 Small nucle(ol)ar RNA 
A large number of small nucleolar RNAs (snoRNAs) carry out a variety of functions. 
Some are involved in nucleolytic processing of rRNAs, but the majority play a role 
in ribose 2'-O-methylation and pseudouridylation, not only of rRNA but also of 
small nuclear RNAs (snRNA), tRNAs and possibly even mRNAs. There are two 
classes of snoRNAs each with specific structural features and functions: the box C/D 
snoRNAs function in 2'-O-methylation and the box HJACA snoRNAs in 
pseudouridylation. These so-called guide snoRNAs contain sequences 
complementary to the target sequence. Although some snoRNAs are individually 
transcribed by RNA polymerase II or III, in metazoa the majority is encoded within 
intronic sequences of protein encoding genes, whereas in yeast and plants they are 
mostly synthesised in the form of polycystronic transcripts. Maturation of snoRNAs 
involves endonucleolytic and exonucleolytic processing, with roles for Rntlp 
endonuclease, Ratip and the exosome (Tollervey and Kiss, 1997; Kiss, 2002; 
Filipowicz and Pogacic, 2002). 
Yeast also has five small nuclear RNAs, Ui, U2, U4, U5 and U6 snRNA that play a 
crucial role in pre-mRNA splicing (see 1.3). Other snRNAs exist, including Ui 1, 
U12, U4ATAC and U6ATAC in higher eukaryotes that function in the minor U12-
dependent spliceosome. These won't be discussed here, but for a recent review see 
Will and LUhrmann (2005). 
1.1.2.4 Catalytic RNA 
Small RNAs with catalytic activity are called ribozymes. One of the most well-
known examples is RNase P, a ribonucleoprotein complex required for the 5' 
processing of tRNA, in which the RNA component carries out the endonucleolytic 
cleavage. Other examples of catalytic RNAs include small ribozymes, like 
hammerhead, hairpin, hepatitis delta virus and Neurospora VS ribozymes that 
naturally function without proteins. Others are larger and can function in vitro in the 
absence of proteins, but function in vivo with the help of protein cofactors. These 
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include RNase P, and group I and II self-splicing introns (Jacquier, 1997; Altman and 
Kirsebom, 1999; Kazantsev and Pace, 2006). 
1.1.2.5 Regulatory RNA 
Over the past decade or so a vast array of small regulatory RNAs has been found in 
eukaryotes as well as prokaryotes. In higher eukaryotes these are micro RNAs 
(miRNAs) and small interfering RNAs (siRNAs). They can downregulate gene 
expression by promoting mRNA cleavage or by translational repression. They do this 
by annealing to complementary sequences often, but not always, in untranslated 
regions (UTRs) of the mRNA. Whether degradation or translational repression takes 
place usually depends on the extent of complementarity. miRNAs and siRNAs are 
derived from larger precursor RNAs by endo- and exonucleolytic processing and 
eventually get incorporated into an RNP complex called RISC, for RNA-induced 
silencing complex (Bartel, 2004). In bacteria regulatory ncRNAs are usually called 
sRNAs (for small RNAs). They can function in translational repression or 
stimulation, and RNA protection or degradation (Gottesman et al., 2001; Storz et al., 
2004; Majdalani et al., 2005). Their interaction with target mRNAs is often 
modulated by the Sm-like protein Hfq (Valentin-Hansen et al., 2004). 
Saccharomyces cerevisiae does not have a recognised RISC complex and no known 
sRNA equivalents. 
1.1.2.6 Other non-coding RNAs 
Examples of other non-coding RNAs that fall outside the types of ncRNA described 
above include the RNA component of telomerase RNP (yeast TLC]) which is used as 
a template for reverse transcription to extend the end of the chromosomal DNA 
(Blackburn, 1999; Evans, 2001). Another is the RNA component (yeast scRi) of the 
signal recognition particle (SRP) RNP which is involved in targeting signal sequence 
containing proteins to the endoplasmic reticulum (Halic and Beckmann, 2005). 
Recently RNA was shown to associate with the mitotic spindle and play a direct 
translation-independent role in spindle assembly in Xenopus (Blower et al., 2005). 
Other ncRNAs exist that are not discussed here, and undoubtedly other functions for 
ncRNAs remain to be discovered. 
1.1.3 RNA processing and ribonucleoprotein particles 
It will be clear from the above that RNA has a wide variety of functions. Many 
different RNAs are synthesised, with the overwhelming majority needing extensive 
processing before they can properly carry out their function. With very few 
exceptions, these RNAs are associated with proteins from the moment they are 
transcribed, throughout their biogenesis and lifetime as a mature functional RNA 
until the moment they are targeted for degradation. The protein composition of these 
ribonucleoprotein or RNP particles is often variable throughout their life cycle, but 
specific RNAs often (stably) associate with specific "core" proteins. 
1.2 Pre-mRNA splicing and the spliceosome 
Since the discovery in the late seventies that non-coding sequences can interrupt 
mRNA in eukaryotes (Berget et al., 1977; Chow et al., 1977a; Chow et al., 1977b) 
much effort has been put into elucidating the mechanism of removal of these so-
called introns. The two phosphoryl transfer steps of pre-mRNA splicing (Fig. 1.1) are 
catalysed by the spliceosome. In yeast, this large RNP complex consists of more than 
70 proteins (Stevens et al., 2002) and five small nuclear RNAs (U I, U2, U41U6 and 
U5 snRNA). A multitude of dynamic RNA-RNA, RNA-protein and protein-protein 
interactions navigate the spliceosome through the different steps that ensure the 
precision that is needed to excise only those sequences that need to be removed to 
yield properly coding mRNA. It is widely accepted that the chemical steps that 
remove the intronic sequences and yield a mature mRNA molecule are in effect 
catalysed by the spliceosomal snRNAs (with a central role for U6 snRNA). The 
many associated proteins have tasks in assuring specificity and accuracy, in guiding 
and promoting changing interactions throughout the different stages involved in 
splicing, and ultimately enable these small RNAs to perform catalysis (Staley and 
Guthrie, 1998; Will and Lührmann, 2001). 
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1.2.1 The splicing reaction 
In the first step of splicing a nucleophylic attack by the 2'-OH of the branchpoint 
adenosine on the 5' splice site phosphate cleaves the phosphodiester bond between 
exon- 1 and the intron. This creates a free OH on the 3' end of exon- 1, which in the 
second step attacks the phosphate of the 3' splice site. The products of these two 
transesterification reactions are the mature mRNA and the excised intron in the form 
of a lariate structure (Fig. 1.1). The lariate is subsequently debranched and degraded, 
whereas the mature mRNA is exported to the cytoplasm where it is used for 
translation by the ribosome. 
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Fig. 1.1 The two chemical steps of splicing. Step 1: nucleophylic attack of 
the 2'-OH of the branchpoint adenosine on the 5' splice site phosphate. Step 2: 
the free OH on the 3' end of exon-1 attacks the phosphate of the 3' splice site. 
The end products are the mature mRNA and the excised intron. Reprinted 
from Jurica and Moore (2002) 
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1.2.2 Spliceosome assembly 
There is evidence that at least in some cases, splicing occurs co-transcriptionally. 
Although some splicing factors have been shown to interact with the C-terminal 
domain (CTD) of RNA polymerase II, it is as yet unclear whether spliceosomal 
snRNPs interact with RNA Polymerase II or whether they are recruited to the newly 
synthesised RNA through an alternative mechanism (Maniatis and Reed, 2002; 
Bentley, 2005). Nonetheless, the moment the 5' splice site appears from the exit 
groove of the RNA polymerase the Ui snRNP associates with it. Similarly, the 
branchpoint sequence is recognised by U2AF (yeast Mud2p), which is involved in 
bringing together both parts of the pre-mRNA in the commitment complex. The U2 
snRNP is recruited to the branchpoint and associates with Ui. U4, U5 and U6 enter 
as a pre-assembled U4/U6-U5 tri-snRNP particle to form a complete spliceosome 
(Fig. 1.2). Soon after this U4 and Ui leave the complex or become less strongly 
associated, and new RNA-RNA interactions are formed between U2 and U6, 
between U6 and the 5' splice site, and between U5 and the 5' splice site. These 
conformational re-arrangements create the right conditions for splicing to take place, 
with U2 and U6 as the most likely candidates to form the catalytic centre and a role 
for U5 in aligning the two splice sites (Staley et al., 1998; Collins and Guthrie, 2000; 
Will et al., 2001; Villa etal., 2002; Valadkhan, 2005). 
A spliceosome complex containing all five snRNAs was affinity purified from yeast 
cell extracts, suggesting that a stable penta-snRNPs exists (Stevens et al., 2002; 
Nilsen, 2002), but it seems that the normal state of affairs is that there is a number of 
ordered steps, as described above, in which the spliceosome assembles (see Fig. 
1 .2)(Brow, 2002). Recent studies examined spliceosome assembly in vivo using 
chromatin immunoprecipitation (ChiP). Ui and U2 snRNP were shown to bind co-
transcriptionally to the nascent pre-mRNA, prior to the U4/U6-U5 tri-snRNP 
(Lacadie and Rosbash, 2005; Gömemann et al., 2005; Tardiff and Rosbash, 2006). 
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Fig. 1.2 Spliceosome assembly and U6 snRNP recycling. The UI 
snRNP binds to the 5' splice site (E complex). The U2 snRNP binds to 
the branchpoint to form the commitment or A complex. Pre-formed 
U4/U6-U5 tri-snRNP associates with the A complex, to form the B 
complex. The spliceosome is activated after dissociation of Ui and U4 
forming the catalytically active B*  complex. After splicing has occured, 
the mature mRNA is released and spliceosome components are recycled. 
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1.3 The spliceosomal snRNAs 
1.3.1 Biogenesis of non-U6 spliceosomal snRNPs 
The spliceosomal small nuclear RNAs (snRNAs), also termed U (for uridine-rich) 
snRNAs, have been shown to play a central role in aligning splice sites and are 
considered the most likely candidates to form the actual catalytic core. Following 
transcription by RNA polymerase II and export from the nucleus to the cytoplasm 
Ui, U2, U4 and U5 snRNAs stably associate with seven Sm proteins (SmBIB', Dl, 
D2, D3, E, F and G) that form a heteroheptameric core complex on each of these 
snRNAs. Sm proteins were named after Stephanie Smith, a patient suffering from 
systemic lupus erythematosus in whom the first autoantibodies against the Sm-
antigen, the first known non-histone antigen causing this disease, were found (Tan 
and Kunkel, 1966; Tan and Kunkel, 2006). These antibodies were later used to 
identify the Sm antigen as small nuclear ribonucleoprotein particles (snRNPs), 
consisting of snRNAs and the Sm core proteins (Lerner and Steitz, 1979). Formation 
of the Sm core RNP is essential for snRNA metabolic stability, hypermethylation of 
the 5' cap, 3' end processing, import of the particle into the nucleus, and recruitment 
of at least some particle specific proteins (Will et al., 2001). It has also been 
suggested that the Sm complex has a function in aiding weak interactions, e.g. those 
between the U  snRNP and the 5' splice site, in which the charged C-terminal tails of 
5mB, Dl and D3 would play a central role (Zhang et al., 2001). 
Following transcription by RNA polymerase II the snRNAs acquire a 
monomethylated m 7-GpppG cap and are exported to the cytoplasm in a 
Crmlp/RanGTP dependent fashion. U snRNA export requires additional factors 
including the cap-binding complex (CBC) and PHAX (phosphorylated adaptor for 
RNA export). In the cytoplasm the Sm proteins assemble on the conserved Sm site 
(consensus PuAU4-6GPu with two flanking stem-loop structures). Initially the 
SmD1/D2 and SmEIF/G subcomplexes interact with this sequence and the doughnut-
shaped ring is completed by binding of SmBID3. snRNP assembly and maturation 
require the SMN complex, which is discussed in more detail in section 1.3.3. The cap 
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Fig. 1.3 	U snRNP assembly in higher eukaryotes. Newly 
transcribed U snRNA acquires a methyl guanosine (m7G) cap in 
the nucleus, to which the cap binding complex (CBC) binds. This 
then associates with phosphorylated PHAX which in turn binds to 
CRM1/Xpol which associates with Ran-GTP. This complex is 
exported to the cytoplasm where the complex dissociates after 
PHAX desphosphorylation and GTP hydrolysis by Ran. Assisted by 
SMN, the Sm proteins assemble around the Sm site of the U 
snRNA, which leads to the hypermethylation of the m7G cap, 
forming an ml , 2 ' 7G cap. This enables snRNP reimport into the 
nucleus via Importin-3 and Snurportini. Back in the nucleus the U 
snRNP associates with snRNP-specific proteins, probably in Cajal 
bodies, forming a mature U snRNP particle. 
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U6 is the most highly conserved of the snRNAs (Brow and Guthrie, 1988), and 
certain conserved residues in U6 are thought to contribute to the catalytic centre of 
the spliceosome (reviewed by Valadkhan, 2005). Support for a ribozyme type role 
for U6 snRNA in the splicing reaction comes from experiments showing protein-free 
catalysis of a reaction resembling the first step of splicing by U2 and U6 fragments 
(Valadkhan and Manley, 2001; Valadkhan and Manley, 2003). U6 snRNA exists 
both in a free U6 snRNP and base-paired with U4 in a U4/U6 di-snRNP and U4fU6-
U5 tri-snRNP. In each of these snRNPs U6 RNA is associated with Lsm2-8p via its 
uridine-rich 3' end (Achsel et al., 1999; Mayes et al., 1999; Gottschalk et al., 1999; 
Stevens and Abelson, 1999), but additional interactions with the flanking stem-loop 
structure may exist (Vidal et al., 1999). U4 snRNA has been proposed to have a 
chaperone-like role in masking catalytically important residues in U6 snRNA until 
they are required for catalysis in the spliceosome (Nilsen, 1994). The U4/U6 di-
snRNP must associate with the US snRNP to form a U41U6-U5 tri-snRNP for 
assembly into spliceosomes, after which U6 forms basepairing interactions with U2 
and part of the 5' splice site sequence, and U4 leaves the spliceosome. The U6 3' 
stem-loop structure plays a central role in regulation of U6 interactions with other 
RNAs. Involvement of the same nucleotides in the formation of this intramolecular 
structure and basepairing to U4, and on the other hand the ability of U6 to basepair 
with the 5' splice site in the presence of the 3' stem-loop indicate that a delicate 
balance exists between intra- and intermolecular RNA-RNA interactions (Brow and 
Vidaver, 1995; Ryan and Abelson, 2002). For an overview of some RNA-RNA 
interactions involving U6 snRNA see Fig. 1.4. Thus the U6 snRNA is involved in 
many dynamic interactions during the assembly and activation of spliceosomes, and 
recycling of spliceosome components. 
1.3.3 snRNP assembly and the SMN complex 
In higher eukaryotes RNP assembly is aided by the survival of motor neuron (SMN) 
complex (reviewed by Yong et al., 2004). The SMN complex locates both to the 
cytoplasm and to the nucleus, where it concentrates in nuclear bodies termed gems. It 
consists of the SMN protein and the Gemin2-7 proteins. Interestingly, Gemin6 and 
Gemin 7 form a heterodimer with an Sm-like structure, in spite of limited sequence 
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Model of Yeast Spliceosome 
Fig. 1.4 (A) Proposed secondary structure of U6 snRNA in S. cerevisiae. 
Recent evidence suggests that nt 40-43 are present in single stranded form 
(Karaduman et al., 2006). (B) Duplex interaction between yeast U4 and U6 
snRNAs in U4/U6 snRNP complexes. (C) Working model for U2 and U6 
snRNA interactions in fully assembled spliceosomes. Mutationally sensitive 
nucleotides and essential phosphoryl oxygens are highlighted. Sites of 
previously crosslinked interactions between U6 snRNA and the 5' splice site 
region are indicated. Reprinted from Ryan and Abelson (2002). 
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homology, and may bind and organise the (L)Sm proteins' in preparation for snRNP 
assembly (Ma et al., 2005). SMN interacts with the snRNP core proteins SmB, -Dl 
and -133, as well as Lsm4 via unique carboxy-terminal arginine- and glycine-rich 
domains. This interaction is enhanced greatly by a posttranslational, symmetric 
dimethylarginine modification that occurs at specific arginines in these RG domains, 
a reaction carried out by the 20S methylosome that contains an arginine 
methyltransferase called PRMT5 (yeast Hsl7p). The snRNAs are recognised by SMN 
through specific stem-loop structures. The main function of the SMIN complex seems 
to be to increase efficiency and specificity of snRNP assembly, by preventing 
incorrect protein-protein and protein-RNA interactions. These would be likely to 
occur in the absence of a snRNP chaperone, because (L)Sm proteins by themselves 
can form stable heptameric rings with minimal RNA sequence specificity. Such 
promiscuous interactions could be dangerous to the cell. This may not be restricted to 
snRNPs, as SMN has also been implicated in formation of other types of RNPs, 
including snoRNPs and micro RNPs (Yong et al., 2004). 
In light of this, it is surprising that yeast does not seem to have an SMN homologue 
and is therefore presumed not to have an SMN-type complex. Interestingly however, 
Gemin2 (SIP1) has a yeast homologue called BRRJ (Liu et al., 1997). This protein 
interacts with a number of Sm proteins (Krogan et al., 2006) and its deletion seems 
to affect snRNP assembly, as newly transcribed snRNAs are destabilised, whereas 
mature particles are not affected (Noble and Guthrie, 1996a; Noble and Guthrie, 
1996b). Brrlp may have a function in snRNP biogenesis in yeast equivalent to that of 
the SMN-complex in higher eukaryotes. Lhplp (yeast La protein) has also been 
implicated in U snRNP assembly as it interacts with and stabilises 3' extended pre-U 
snRNAs, thus facilitating binding by Sm proteins (Xue etal., 2000). 
1.3.4 U6 snRNA recycling 
A yeast penta-snRNP particle was isolated which was suggested to go through 
several rounds of splicing without any of the snRNPs leaving the spliceosome 
(Stevens et al., 2002). The biological significance of this penta-snRNP particle is 
1 (L)Sm or Sm(-like) is used when referring to both Sm and Lsm proteins 
unclear and it is generally assumed that the spliceosome is dismantled after 
completion of the splicing reaction. The U4/U6-U5 tri-snRNP particle is re-formed 
and takes part in a new round of splicing. Thus, formation of the U41U6 di-snRNP 
and the U4/U6-U5 tri-snRNP are important steps in both initial spliceosome 
assembly and recycling of spliceosome components. The underlying mechanism for 
this has not yet been fully clarified. Proteins that have been shown to be involved in 
U4/U6 duplex formation are Prp24p (Ghetti et al., 1995; Raghunathan and Guthrie, 
1998a), its human orthologue p1 l0nrb/SART3 (Bell et al., 2002; Medenbach et al., 
2004), and the Lsm2-8 complex (Achsel et al., 1999; Verdone et al., 2004). Verdone 
et al. (2004) proposed specific involvement of Lsm6p and Lsm7p in di-snRNP and 
tri-snRNP assembly respectively. Prp24p (Ghetti etal., 1995; Vidaver etal., 1999) as 
well as the U5 snRNP associated RNA unwindase Brr2p (Raghunathan and Guthrie, 
1998b; van Nues and Beggs, 2001) have also been implicated in subsequent 
rearrangements of the U6 snRNA interactions with U4 snRNA, U2 snRNA and the 
pre-mRNA 5' splice site. In higher eukaryotes U4 and U6 snRNA and p110 are 
enriched in nuclear foci, called Cajal bodies (Stanek et al., 2003; Stanek and 
Neugebauer, 2004). This localised increase in concentration contributes to U4/U6 di-
snRNP assembly (Klingauf et al., 2006). In humans, U4/U6-U5 tri-snRNP formation 
also takes place in Cajal bodies and requires Prp3l and Prp6 (Schaffert et al., 2004). 
1.4 The U6 snRNP proteins 
1.4.1 Lsm proteins form the core of the U6 snRNP 
U6 snRNA interacts with seven Lsm (Like Sm) proteins that are structurally related 
to the highly conserved Sm proteins (reviewed by Beggs, 2005). Eight Lsm proteins 
were initially identified in S. cerevisiae, but only seven of these, Lsm2p to Lsm8p 
(Lsm2-8p) associate with U6 (Mayes et al., 1999; Salgado-Garrido et al., 1999; 
Beggs, 2005), whereas a second Lsm complex consisting of the Lsml to Lsm7 
proteins (Lsml-7p) plays a role in mRNA turnover in the cytoplasm (He and Parker, 
2000; Tharun et al., 2000; Bouveret et al., 2000)(see section 1.6 and Fig. 1.5/1.6). 
Most of these proteins are essential for viability, but deletion strains of LSMJ, LSM6 
and LSM7 are temperature-sensitive, whereas viability of 1sm5iJ seems to depend on 
the strain background (Mayes et al., 1999; Salgado-Garrido et al., 1999; Pannone et 
al., 2001). Decreased levels of U6 snRNA in lsm5z'i, lsm6zi and 1sm7zi and after 
switch off of PG-regulated LSM2, 3, 4, 5 and 8, but not LSMJ showed the 
importance of the Lsm2 to 8 proteins for U6 stability (Mayes et al., 1999; Salgado-
Garrido et al., 1999). Also, overexpression of U6 snRNA makes these proteins 
dispensable for growth (Mayes et al., 1999). Co-immunoprecipitation experiments 
showed stable association of the Lsm2-8 proteins with U6 snRNA in free U6 
snRNPs, as well as in U41U6 di-snRNPs and U411J6.U5 tri-snRNPs (Mayes et al., 
1999; Salgado-Garrido et al., 1999). Lsm2-8p leave U6 snRNA after U4/U6 
unwinding and Prp 1 9p-complex (NTC) binding to the spliceosome, which coincides 
with a change in basepairing interactions between U6 and the 5' splice site. It was 
suggested that NTC-dependent Lsm2-8p dissociation may be required for this change 
in RNA-RNA interactions (Chan et al., 2003). 
The human LSm2-8 complex (hLSm2-8 2) was purified and shown to be stable in the 
absence of RNA. Electron micrographs of these complexes revealed a doughnut 
shaped ring with a diameter of about 80A and a 20A central stain, similar to that of 
the Sin heptamer. The 3'-terminal residues (uuCCAUAUUUUu) of human U6 
snRNA were shown to be essential and sufficient for LSm2-8 binding, but 
dissociation of the RNA oligonucleotide at relatively low salt concentrations 
suggests that additional contacts may be needed to stabilise the interaction (Achsel et 
al., 1999). Interactions between the yeast Lsm proteins and U6 snRNA were 
investigated by photo-crosslinking and immunoprecipitation experiments. Lsm4p, 
Lsm6p and Lsm7p showed strong crosslinking to U6 RNA precipitated by Lsm4p, 
Prp24p or Prp8p antibodies indicating that the Lsm proteins are associated with U6 
in the single, di- and tri-snRNP particles. Others showed no (Lsm3p and Lsm5p) or 
only weak (Lsm2p and Lsm8p) crosslinking. In contrast to the results for human U6 
snRNA, the 3' end of yeast U6 was shown to be essential for Lsm2-8p binding, but 
not sufficient by itself (Vidal et al., 1999). A 3' truncated U6 (U6i3') still gets 
incorporated into U4/1J6 di-snRNP and U41U6.U5 tri-snRNP particles (Fabrizio et 
al., 1989) and in vitro splicing still occurs when wildtype U6 is replaced by U63' 
2 In metazoa LSm is used, as opposed to Lsm for the yeast orthologues 
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(Fabrizio et al., 1989; Ryan et al., 2002). This suggests that interactions outside the 
single stranded U-rich track are sufficient for U6 snRNA incorporation into snRNPs 
in vitro, in spite of weakened binding to the Lsm2-8 complex. Binding of Lsm2-8p to 
the 3' stem-loop would have functional significance as the Lsm proteins are 
implicated in destabilisation of this structure which favours U4/U6 duplex formation. 
Indeed, in vitro assembly of the U4/U6 di-snRNP was promoted in the presence of 
human LSm2-8 affinity purified from HeLa cell extracts (Achsel et al., 1999). 
However, whether U4 and U6 were part of a stable duplex within this particle was 
not confirmed. 
1.4.2 Lhplp is a U6 snRNP chaperone 
Lhplp is only transiently associated with the 3' terminal uridine residues of newly 
transcribed U6 snRNA. LHPJ is non-essential, but becomes essential in strains with 
mutations in or deletion of LSM genes (1sm8-1, lsm8-2, 1sm54, lsm6A and lsm7A). 
This requirement disappears upon SNR6 (the U6 gene) overexpression. In an lhplA 
strain levels of U6-containing snRNPs are almost normal, but U6 RNA is sensitive to 
3' trimming. Lhplp has therefore been proposed to be a chaperone promoting U6 
snRNP assembly by stabilising newly transcribed U6 and handing it on to Lsm2-8p 
(Pannone et al., 1998; Pannone et al., 2001). 
1.4.3 Prp24p promotes U4/U6 annealing 
The S. cerevisiae Prp24 splicing protein was initially identified as a suppressor of a 
cold-sensitive mutation in U4 snRNA (Shannon and Guthrie, 1991). The authors' 
suggestion that Prp24p may be stably associated with U6 snRNA and involved in 
U4/U6 association was subsequently proven by gel shift and in vitro U4/U6 
annealing assays (Ghetti et al., 1995). Prp24p contains 4 RNA recognition motifs 
(RRMs; Rader and Guthrie, 2002) and was shown to bind preferentially to a U4/U6 
duplex in vitro, but under normal conditions only precipitates U6 snRNA in vivo 
(Shannon and Guthrie, 1991). It was therefore proposed that the U4/U6-Prp24p 
complex is only a transient intermediate in the annealing of U4 and U6 in vivo 
(Jandrositz and Guthrie, 1995). Regions of interaction were narrowed down by 
hydroxyradical footprinting using recombinant Prp24p bound to U6 RNA alone or 
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U4/U6. These data suggest that Prp24p preferentially binds an incomplete U4/U6 
duplex (Ghetti et al., 1995). The importance of Prp24p U4/U6 annealing activity in 
vivo was confirmed by Prp24p immunodepletion experiments in splicing extracts 
(Raghunathan et al., 1998a). Prp24p depletion from these extracts lead to reduced 
U4/U6 di-snRNP formation and splicing efficiency. However, annealing activity of 
recombinant Prp24p was heavily reduced in deproteinised snRNPs, suggesting that 
additional proteins are involved in U4/U6 annealing. Attempts to show in vitro 
U4/U6 annealing activity of the human Prp24p homologue, p11  0, failed altogether 
(Bell et al., 2002). 
1.4.4 Interactions between Prp24p and Lsm2-8p 
Lsm2-8p is likely to contribute to more efficient U4/U6 annealing. Purified human 
LSm2-8 was shown to promote U41U6 di-snRNP formation (Achsel et al., 1999), 
and the structure of the yeast native U6 snRNP, containing both Lsm2-8p and 
Prp24p, was recently shown to be more favourable for U4/U6 annealing than that of 
a U6-Prp24p complex (Karaduman et al., 2006). Yeast two-hybrid interactions exist 
between the Lsm proteins and Prp24p (Fromont-Racine et al., 2000; Rader et al., 
2002) and a conserved C-terminal motif in Prp24p, which is essential for this 
interaction, was identified (Rader et al., 2002). Deletion of the 3' uridine-rich track of 
U6 snRNA not only affects Lsm binding, but also Prp24p association with U6 
although no direct interactions between Prp24p and the U6 3' end exist. This 
suggests that Prp24p binding is enhanced by binding of Lsm2-8p to U6. In contrast, 
binding of Lsm2-8p does not appear to depend on U6 binding to Prp24p, as U6 
mutations that affect Prp24p binding do not affect the U6-Lsm2-8p association (Ryan 
et al., 2002). Both Rader and Guthrie (2002) and Ryan et al. (2002) suggested that 
Lsm2-8p initially binds U6 snRNA. Prp24p binding then becomes more favourable 
because of direct Prp24p-Lsm2-8p interactions and/or an Lsm2-8p induced change in 
U6 RNA structure that promotes the interaction with Prp24p. Prp24p could then 
recruit U4 snRNA and promote U41U6 annealing. The proposed function of Prp24p 
in this mechanism is that of a tethering factor. Biochemical dissection of Prp24p 
showed that RRM1 and RRM2 are important for high affinity binding to U6 snRNA. 
RRM3 and RRM4 were suggested to promote U4/U6 association, possibly by 
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binding to U4 snRNA (Kwan and Brow, 2005). More structural studies of U6 snRNP 
complexes, like that of Karaduman et al. (2006) would be of great help in 
determining the potential U4/U6 annealing mechanism. A recent paper reported on 
the structure of the N-terminal RRM1 and RRM2 domains of Prp24p by NMR 
(Reiter et al., 2006). More may follow. A potential mechanism for U4/U6 annealing 
involving both Prp24p and Lsm2-8p is discussed in detail in Chapter 6. 
1.5 Additional nuclear functions of the Lsm proteins 
1.5.1 Lsm proteins in tRNA, rRNA and snoRNA processing 
Several of the Lsm proteins are also involved in a number of functions in the nucleus 
non-related to pre-mRNA splicing (Fig. 1.5). In budding yeast, depletion of Lsm2p 
to Lsm5p or Lsm8p leads to strong accumulation of unspliced, 5' and 3' unprocessed 
pre-tRNA species, whereas the absence of Lsmlp, Lsm6p or Lsm7p results in much 
weaker phenotypes. Co-precipitation of pre-tRNA5 with TAP-Lsm3p and reduced 
association of Lhplp with pre-tRNAs in Lsm depleted strains suggest a chaperone 
function for a nuclear Lsm complex facilitating interactions between pre-tRNA and 
other (processing) proteins. This may also be the case for other RNA polymerase III 
transcripts as Lhplp binding to scRi and pre-P RNA was strongly reduced in Lsm 
depleted strains (Kufel et al., 2002). In addition, strains depleted of any of the same 
five essential nuclear Lsm proteins accumulated high levels of (aberrant) rRNA 
processing intermediates as well as mature rRNAs. This is consistent with a role for 
the Lsm proteins in promoting 5' and 3' exonuclease activity (Kufel et al., 2003a). 
Depletion of these same Lsm proteins also affected U3 snoRNA processing, with 
accumulation of mature and truncated fragments of pre-U3. Binding of Lsm proteins 
and Lhplp to pre-U3 was shown to be interdependent (Kufel et al., 2003b). hLSm4 
was also shown to interact with human pre-U3 snoRNA and hLSm8 was shown to be 
essential for U3 accumulation (Watkins et al., 2004), suggesting a conserved role for 
LSm proteins in U3 snoRNP biogenesis. Involvement of Lsm proteins in these RNA 
processing pathways is consistent with their proposed role as RNA chaperones. As 
suggested, an additional function for the nuclear Lsm complex may be in stimulating 
degradation and/or processing by exonucleases. As polyadenylation of the TRAMP 
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complex was recently shown to stimulate degradation of highly structured RNAs by 
the exosome (LaCava et al., 2005; Vanacova et al., 2005; Wyers et al., 2005; 
Houseley et al., 2006) the Lsm proteins may stimulate the TRAMP complex and/or 
exosome. Multiple yeast two-hybrid interactions between these complexes exist 
(Fromont-Racine et al., 2000). Intruigingly, the Escherichia coli Sm-like protein Hfq 
stimulates polyadenylation of mRNA by PAP1 (Hajnsdorf and Régnier, 2000; Le 
Derout et al., 2003; Folichon et al., 2005) and promotes degradation by PNPase, and 
can even be found in a complex with these two enzymes (Mohanty et al., 2004). 
Nuclear Lsm proteins were also shown to interact with snoRNAs seemingly without 
being involved in their processing. In Xenopus, LSm2 to 8 proteins (excluding 
LSm5) were shown to bind specifically to U8 snoRNA, which is essential for 
maturation of the large ribosomal subunit RNAs, 5.8S and 28S. These LSm proteins 
bind to a conserved element within mature U8 snoRNA and were suggested to be 
involved in stabilisation of U8 and possibly in promoting its interaction with the 
rRNA (Tomasevic and Peculis, 2002). More recently it was suggested that an Lsm2-
7p complex exists in S. cerevisiae as these proteins but not Lsm8p were shown to 
associate with mature snR5 snoRNA This box H/ACA snoRNA functions in guiding 
site-specific pseudouridylation of rRNA (Fernandez etal., 2004). It is uncertain what 
the function of the interaction with snR5 is and whether Lsm2-7p really exist as a 
separate complex, or whether Lsm8p failed to co-precipitate snR5 because its epitope 
is masked in the snR5 RNP. 
1.5.2 Lsm proteins in nuclear pre-mRNA turnover 
Analysis of nuclear mRNA degradation in ism mutants revealed a role for Lsm2-8p 
in decapping and 5' to 3' degradation of nuclear (pre-)mRNAs. To distinguish 
between nuclear and cytoplasmic degradation, inducible MET and heat shock 
transcripts were analysed in a nupI45N temperature-sensitive strain, that fails to 
export poly(A)+ RNA when incubated at nonpermissive temperature. 5'-Capped and 
polyadenylated transcripts accumulate in strains lacking any of the Lsm2-8p proteins, 
but not Lsmlp. Analysis of pre-mRNAs containing intronic snoRNAs show similar 
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accumulation of capped 5' fragments. In addition, Lsm8p interacts directly with the 
poly(A) tail, as the two were shown to crosslink. It was concluded that the nuclear 
Lsm2-8 complex normally targets nuclear RNA substrates for decapping, 
independent of deadenylation (Kufel et al., 2004) 
1.6 Lsm proteins in cytoplasmic mRNA turnover 
1.6.1 Two general mRNA degradation pathways 
Mature mRNA molecules are transported to the cytoplasm where they are generally 
used in several rounds of translation. The lifetime of different mRNAs can vary 
widely and the speed in which they are targeted for degradation is a potential 
regulatory point to influence resulting levels of protein. Two general decay pathways 
have been characterised in yeast by which mRNA is degraded in the cytoplasm 
(reviewed in Tucker and Parker, 2000; Wilusz et al., 2001). Both pathways have the 
initial step in common: shortening of the poly(A) tail to 10-12 nucleotides by the 
Pan2pfPan3p and Ccr4p/Pop2p containing deadenylase complexes. The major 
pathway consists of 5' to 3' degradation by exonuclease Xrnlp (also known as 
Kemip or Skilp), whereas 3' to 5' degradation by the exosome, a multiprotein 
complex of 3' to 5' exonucleases, provides an alternative mRNA turnover 
mechanism. The exosome consists of a large number of protein factors, which in 
yeast includes Rrp4lp, Rrp46p, Mtr3p, Rrp42p, Rrp43p, Rrp45p, Csl4p, Rrp4p, 
Rrp40p, Rrp44p and Ski7p. Ski7p is only part of the cytoplasmic exosome, whereas 
Rrp6p and Rrp47p are unique to the nuclear exosome (Houseley et al., 2006). Xrnlp 
will only act after the 5' cap structure has been removed by the Dcplp decapping 
enzyme (Beelman et al., 1996; LaGrandeur and Parker, 1998), a step which in turn is 
activated by deadenylation. In the alternative pathway, that is independent of 
decapping, the exonucleolytic activity of the cytoplasmic form of the exosome is 
required for degradation following the removal of the remaining adenosine residues 
in a process called terminal deadenylation. Binding of the poly(A) tail by Pabip 
(poly(A) binding protein) plays a vital role in controlling deadenylation. It seems to 
be a negative regulator of deadenylation in metazoa, but at the same time is required 
for optimal shortening of the poly(A) tail in yeast. Loss of Pabip binding when the 
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poly(A) tail reaches a certain minimal length has been suggested to be central to the 
initiation of decapping. Circularisation of the mRNA transcript through interactions 
between the 3' (Pabip) and 5' ends (eIF4E/G translation initiation factors) may 
prevent access of the decapping complex (Tucker and Parker, 2000; Wilusz et al., 
2001). 
1.6.2 mRNA decapping 
Regulation of decapping is complex and involves proteins with functions in 
translation initiation and deadenylation (Tucker et al., 2000; Mitchell and Tollervey, 
2001; Wilusz et al., 2001). Competition for binding to the cap structure between the 
decapping complex and other cytoplasmic cap binding factors, including initiation 
factor eIF4E (Schwartz and Parker, 2000), and deadenylation complexes, plays a 
pivotal role in this regulation (Fig. 1.6). Decapping by Dcplp is also influenced by 
the presence of certain sequences in the RNA. It was found that decapping was 
stimulated by the presence of AU-rich elements (AREs) and that this was dependent 
on ARE-binding proteins (Gao et al., 2001). These sequence elements often occur in 
the 3' UTR and can promote as well as inhibit mRNA decay (reviewed by Wilusz et 
al., 2001). In addition, a number of decapping cofactors, Dcp2p, Patip (Mtrlp), 
Edclp, Edc2p, Edc3p (Dcp3p/Lsml6p) and Dhhlp (Hatfield et al., 1996; Dunckley 
and Parker, 1999; Bonnerot et al., 2000; Coller et al., 2001; Dunckley et al., 2001; 
Fischer and Weis, 2002), and potentially the phophorylation status of Dcplp itself 
(LaGrandeur et al., 1998) regulate its decapping activity. The Lsml-7 complex was 
also shown to be required for efficient decapping (Tharun et al., 2000; Bouveret et 
al., 2000). 
1.6.3 The cytoplasmic Lsm1-7 complex functions in mRNA 
decapping 
Involvement of Lsmlp in mRNA decapping was initially discovered because an 
spb8-2 (!sml) mutation that allows growth of a pabl4 strain, was shown to 
accumulate capped, poly(A)-deficient mRNAs (Boeck et al., 1998). Later, a 
cytoplasmic Lsm heptamer, Lsml-7p, in which Lsmlp interacts with Lsm2 to 7p, 
was shown to exist. The full Lsml-7 complex was shown to be required for mRNA 
36 
decapping, as capped mRNAs accumulated in strains with ism mutations. Direct 
interactions were shown to exist between Lsml-7p, Patip and Xrnlp, whereas an 
interaction with Dcplp was RNA dependent (Tharun et al., 2000; Bouveret et al., 
2000). Patip is not only required for efficient decapping but also for translation 
initiation by promoting stable association of the 40S ribosomal subunit with the 
mRNP (Wyers et al., 2000). Whereas mutations in eIF4E can suppress certain 
mutations in Dcplp, they do not alleviate decapping defects in ismiA or patlA 
strains (Schwartz et al., 2000). These data suggest that Patip may make the cap 
structure available to both the translation machinery and the decapping complex (He 
et al., 2000). As Lsm i-7p mainly seems to interact with deadenylated mRNAs the 
Lsm proteins are more likely to act at a step distinct and most likely downstream 
from the competition between Dcplp and eIF4E. Binding of Lsml-7p may only 
occur after deadenylation, which may in turn stimulate Dcplp binding and/or 
activity. Lsml-7p may mediate this by changing the mRNP structure (Tharun and 
Parker, 2001). 
1.6.4 Lsm1-7p protects shortened mRNA Tends 
In addition to an important role in mRNA decapping the Lsml-7p/Patlp complex 
seems to protect mRNA 3' ends from degradation. Pat] and 1sm1-7 mutant strains 
were shown to accumulate mRNA transcripts that had been trimmed, i.e. shortened 
by 10-20 nucleotides at their 3' ends. Trimming was independent of decapping or 
exosome activity, but trimmed mRNAs did seem to get degraded by the exosome. 
Loss of mRNA 3' end protection and subsequent degradation by the exosome was 
proposed to cause temperature-sensitive (Ts) growth of lms]-7 and pat] mutants, as 
Ts growth was suppressed by mutations in exosome components (He and Parker, 
2001). Protection by Lsml-7p of deadenylated 3' ends from degradation may or may 
not normally have a biologically significant function. It does however suggest that 
Lsml-7p interacts with elements in the 3' UTR after deadenylation. This is 
consistent with a role for this complex in 5' to 3' degradation at a step in between 
deadenylation and decapping. 
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Figure 1.5 Overview of the wide range of functions of the Lsm 
proteins. The Lsm2 to 7 proteins either associate with Lsm8p to form 
Lsm2-8p, which functions in the nucleus, or with Lsmlp to form Lsml-
7p, which functions in the cytoplasm. There may be alternative Lsm 
complexes, e.g. an Lsm2-7p complex may exist with a potential 
function in snR5 snoRNA processing, function and/or stability. 
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Figure 1.6 Schematic diagram of the deadenylation-dependent 5' to 3' 
mRNA degradation pathway in yeast. The poly(A) tail at the 3' of the 
mRNA is first degraded, causing the loss of Pabip binding. This allows 
removal of the m 7G cap at the 5' end of the mRNA by Dcplp, a step 
which requires a number of protein cofactors, including Dcp2p, Dhh ip, 
Pat ip and LsmI-7p. After the cap has been removed, exonuclease Xrnlp 
degrades the mRNA in a 5' to 3' direction. 
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1.6.5 Cytoplasmic 5' to 3' mRNA decay occurs in P-bodies 
In contrast to the exclusively nuclear Lsm8p, Lsmlp was shown to localise to the 
cytoplasm (Tharun et al., 2000; Spiller, 2005). This is in line with its involvement in 
cytoplasmic mRNA decapping and decay. Human LSml-7 (hLSml-7), Dcpl/2 and 
Xml were shown to colocalise in distinct cytoplasmic foci in HeLa cells (Ingelfinger 
et al., 2002). These were later named processing or P-bodies, and in humans are also 
called GW bodies after one of its other protein components, GW 182 (Eystathioy et 
al., 2003). Other proteins involved in cytoplasmic mRNA decapping and degradation 
were found in the same foci, including hCcr4, rck/p54 (hDhhl) and eIF4E (van Dijk 
et al., 2002; Cougot et al., 2004; Andrei et al., 2005). In yeast Lsmlp, Pat ip, Dcplp, 
Dcp2p, Xrnlp and Dhhlp were shown to localise to similar cytoplasmic foci, with 
weak, possibly transient, focal localisation of Crr4p. Decapping and 5' to 3' mRNA 
degradation were shown to occur in these P-bodies, as inhibition of mRNA turnover 
at steps before decapping (ccr4zl) lead to loss of visible foci. In contrast, inhibition of 
steps at or after decapping (dcplA or xrnl4) lead to increased P-body numbers and 
size (Sheth and Parker, 2003). LSm complex formation was shown to be essential for 
localisation of hLSm 1-7 to P-bodies as hLSm4 that carries mutations in residues that 
are proposed to be required for interactions between LSm subunits failed to localise 
to foci. Deletion of the RG-rich C-terminus of hLSm4 however, did not prevent its 
focal accumulation (Ingelfinger etal., 2002). 
In yeast, accumulation of mRNA in P-bodies was shown to occur in response to a 
variety of stress conditions, including glucose deprivation, osmotic stress and 
exposure to ultraviolet light, but not heat or oxidative stress. Additionally, P-bodies 
grew in number and size during late stages of cell growth. Inhibition of translation 
initiation promotes formation of P-bodies, whereas inhibition of translation 
elongation leads to the loss of P-body formation. P-body formation depends on 
mRNA and transcripts that accumulate in P-bodies are translationally repressed 
(Teixeira et al., 2005). RNA that accumulates in P-bodies is therefore not necessarily 
targeted for degradation, but can be stored there in a translationally repressed state. 
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In summary, the Lsml-7p/Patlp/Dhhlp complex is involved in maintaining a proper 
balance between translating and non-translating pools of mRNA, and can act as a 
switch to target these mRNAs for degradation (Tharun et al., 2001; Noueiry et al., 
2003; Brengues et al., 2005; Teixeira et al., 2005). Dhhlp and Patip were in fact 
shown to be required for a general mechanism of translational repression under stress 
conditions (Teixeira et al., 2005; Coller and Parker, 2005). Retrograde movement 
between P-bodies and polysomes shows that this repression is reversible (Brengues 
et al., 2005). In addition, specific sequences, like AREs, in certain cellular transcripts 
may affect posttranscriptional regulation by affecting the switch from translation to 
translationally repressed storage to degradation in response to intracellular or 
environmental cues. Translational repression and degradation of certain transcripts in 
response to miRNAs have also been shown to take place in P-bodies and RNA 
binding protein factors are involved in regulating, and potentially reversing this 
(Bruno and Wilkinson, 2006; Bhattacharyya et al., 2006; reviewed by Parker and 
Sheth, 2007)). 
1.7 Two (or more) complexes, many questions 
It is fascinating that the simple difference of one subunit in otherwise identical Lsm 
complexes (Lsml-7p vs. Lsm2-8p) causes them to localise and function differently 
(Fig. 1.5). Intriguingly, the Tiypanosoma brucei genome was shown to encode only 
seven Lsm proteins. Functional characterisation of the Lsm3p and Lsm8p 
homologues showed that they were essential for U6 stability, cis- and trans-splicing 
as well as mRNA decay. This suggests that in trypanosomes only a single Lsm 
complex may exist (Liu et al., 2004). An interesting question is what factors within 
the Lsm 1 and 8 proteins are responsible for the unique subcellular localisation of the 
corresponding heteroheptameric complexes: the cytoplasm (P-bodies) or nucleus 
(Cajal bodies/nucleolus)? Do specific protein- or RNA- interaction domains affect 
their localisation or their function, or are their distinct functions a direct effect of 
discrete localisations? Is there competition in terms of formation of one complex or 
the other? If so, is this regulated simply by changes in expression levels of the Lsml 
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and 8 proteins or do post-translational modifications play a role? This is even further 
complicated by the potential existence of alternative (L)Sm complexes. 
1.8 Structural and functional studies of Sm(-like) complexes 
1.8.1 The Sm heteroheptameric ring 
Seven Sm proteins assemble around the U-rich Sm site present in the Ui, U2, U4 and 
U5 spliceosomal snRNAs. The 5mB/B' (5mB' is a splicing variant of SmB specific 
to humans), Dl, D2, D3, E, F and G proteins each have two homologous sequence 
motifs, Sml and 5m2, separated by a short variable linker (Hermann et al., 1995; 
Cooper et al., 1995; Séraphin, 1995). These Sm motifs were shown to be essential 
and sufficient for the formation of the SmB/D3 dimer, which suggested the existence 
of a stable Sm domain that mediates protein-protein interactions (Hermann et al., 
1995). Stable subcomplexes SmB/D3, SmD1/D2 and SmE/F/G exist. SmD1/D2 and 
SmE/F/G can associate together on the snRNAs, with binding of SmB/D3 
completing the snRNP core domain (Raker et al., 1996). The crystal structures of the 
SmDl/D2 and SmB/D3 dimers reveal a common fold containing an N-terminal cc-
helix followed by a strongly bent five-stranded antiparallel 13-sheet made of the Smi 
and Sm2 motifs (Fig. 1.7). Intermolecular interactions are mainly hydrophobic in 
nature. Pairing of 134 of one protein and 135 of its neighbour is stabilised by 
hydrophobic clustering and the angle between these strands in each protein 
determines the geometrical relationship between adjacent subunits. In addition to 
extensive clustering of hydrophobic residues on helices and 13-sheets of binding 
partners a small number of salt bridges and hydrogen bonds are involved in 
stabilising multimerisation. Computer modelling, using these crystal structures 
together with data from yeast two-hybrid and immunoprecipitation experiments 
predicts the order of subunits in the ring: Dl, D2, F, E, G, D3 and B. The resulting 
doughnut shaped ring (Fig. 1.7A) has an outer diameter of 70A and a diameter of the 
central hole of 20A (Kambach et al., 1999). 
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Fig. 1.7 Proposed higher-order structure of the human U snRNP core 
proteins. (A) Top left: Ribbon diagram of the heptamer model. The seven 
Sm subunits are arranged within the ring structure based on the crystal 
structures of the SmD1/D2 and SmB/D3 sub-complexes and pairwise 
interactions deduced from biochemical and genetic experiments. Others, 
moving in clockwise direction: Surface representation of the heptameric 
ring model with electrostatic potential (blue, positive; red, negative) 
viewed as in ribbon diagram, side view, and bottom view. Note that the 
central hole is highly basic and the surface of the assembly is asymmetric 
both in shape and charge. (B) Ribbon representations of the crystal 
structure of the SmD3 and B Proteins. Top: SmD3 protein (front view and 
side view) with the hydrogen bonding network involving Tyr-62 and 
highly conserved residues Glu-36, Asn-40, Arg-64, and Gly-65. Bottom: 
B protein (front view) including highly conserved residues Asp-35, Asn-
39, Arg-73, and Gly-74. Reprinted from Kambach et al. (1999). 
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Based on these same structural studies it was suggested that the loops of each of the 
Sm proteins that protrude into the central hole of the ring may interact with the U-
rich Sm site sequence through a number of highly conserved residues. The central 
hole is highly basic and large enough to accommodate single-stranded RNA 
(Kambach et al., 1999). Electron micrographs of U2 snRNP (Kastner et al., 1991) 
and Ui snRNP (Stark et al., 2001) show that the 5' and 3' ends of these snRNAs are 
present on opposite sides of the core domain, supporting the view that RNA passes 
through the centre of the ring. Cross-linking of loop L3 residues of the Sm I motif of 
G and B/B' to the first and third U-residues respectively of an Sm site RNA 
oligonucleotide confirm the importance of the central hole in RNA binding (Urlaub 
et al., 2001). The uridine tract in the consensus Sm site sequence (PuAU 4 . 6GPu) 
provides one of the main recognition determinants for the Sm protein interactions, 
but is usually flanked by stem-loop structures, which may also contribute to Sm 
protein binding (Raker et al., 1999). Mutagenesis of the U-rich tract leads to severely 
reduced binding in most cases, but does not have the same effect on all U snRNAs, 
e.g. yeast U5 snRNA (Jones and Guthrie, 1990) is more tolerant to point mutations in 
the Sm site than U4 snRNA (Hu et al., 1995). Also, additional non-exchangeable 
snRNA elements were found to contribute to the assembly of U 1 and US snRNP 
particles in Xenopus oocytes (Jarmolowski and Mattaj, 1993). Finally, the 
importance of the Sm site flanking stem-loop structures was confirmed by nucleotide 
analogue interference mapping in the UI snRNP. The stem loops are therefore 
suggested to act as a clamp to hold the Sm ring in place (McConnell et al., 2003). 
1.8.2 The Lsm heptamers 
Most functional studies that were done on the eukaryotic Lsml-7 and Lsm2-8 
complexes are discussed in sections 1.4 - 1.6. Comparatively little progress has been 
made in terms of structural studies of these Lsm complexes. Most of what is known 
about them comes from yeast two-hybrid analyses (Fromont-Racine et al., 2000; 
Lehner and Sanderson, 2004) and sequence comparison to the canonical Sm proteins 
(Fig. 1.8). The order of the proteins in the ring has never been confirmed, but is 
assumed to be Lsmlp/8p, Lsm4p, Lsm7p, Lsm5p, Lsm6p, Lsm3p, Lsm2p (Fig. 3.5), 
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Fig. 1.8 	Alignment of amino acid sequences of the yeast and human (L)Sm proteins. (A) The canonical yeast Sm and Lsrn 
proteins were aligned using ClustaiW and adjusted by hand using Jalview; (B) The human LSm proteins were similarly 
aligned. Conserved Sin 	and Sm2 motifs are indicated as well as putative RNA binding residues (*). The most recently 
predicted amino acid sequences for S. cerevisiae Lsm6p, Lsm7p and Lsm8p were used (see Chapter 3). To adjust alignments 
by hand, previously published data were used from Cooper etal. (1995), Séraphin (1995),Achsel etal. (1999), Palfi etal. 
(2000) and Bordonné (2000). 
by analogy to the Sm complex. Yeast two-hybrid data on the human LSm proteins by 
Lehner and Sanderson (2004), who analysed the stringency of all pair-wise 
interactions, convincingly support this order. Sequence analysis indicates the 
presence of Sm domains in all Lsm proteins (Fig. 1.8) and electron microscopy on 
the purified human LSm2-8 complex revealed a doughnut shape (Achsel et al., 
1999). Recent attempts to assemble the human LSm1-7 and LSm2-8 complexes in 
vitro using recombinant subcomplexes were successful, showing a similar shape for 
the LSm1-7 complex. Attempts to crystalise these complexes were however, 
unsuccessful (Zaric et al., 2005). 
1.8.3 Archaeal homomultimeric rings 
Since the discovery of the Sm domain and its involvement in oligomerisation of 
proteins into ring structures with RNA binding capacity, a range of Sm-like proteins 
from archaea has been identified and studied (Collins et al., 2001; Törö et al., 2001; 
Achsel et al., 2001; Mura et al., 2001; Thore et al., 2003; Mura et al., 2003 a; Mura et 
al., 2003b). Most archaea only contain one or two different Sm-like proteins and so 
far these have been shown to form homoheptameric or hexameric ring structures 
(Fig. 1.9), although interactions between rings and even polymerisation into polar 
fibres have been shown to occur for some (Mura et al., 2003a; Mura et al., 2003b; 
Arluison et al., 2006). The biological significance of these multimers of multimers is 
unclear. Like their eukaryotic counterparts, archaeal Sm-like complexes have nucleic 
acid binding properties, with a strong preference for oligo(U) RNA (Achsel et al., 
2001). They have been implicated in pre-tRNA processing, through binding with 
RNase P RNA (Törö et al., 2001). Some also bind DNA (Mura et al., 2003a), 
although this may be non-specific and therefore biologically irrelevant. Many of the 
crystal structures have been solved and show highly homologous structural features 
and similar dimensions to the Sm ring. Co-crystalisation of Archaeoglobus fulgidus 
Smi (Törö et al., 200 1) and Pyrococcus abyssi Smi (Thore et al., 2003) with uridine 
oligonucleotides give clues to how these homoheptamers bind single-stranded RNA. 
Uridine specific binding-pockets are present on the inside of the ring, whereas a 
secondary RNA binding site on the surface of the ring is involved in additional 
contacts with the RNA outside the oligo(U) sequence. 
MI 
Fig. 1.9 	Structure of the Archaeoglobus fulgidus Smi heptamer. 
(A) Ribbon representation of the AF-Sm I heptamer (top and side view) and 
electrostatic surface charge potential of the two face of the ring. Shown on 
the left is the side binding the RNA and containing the N-terminal helix (top 
view). On the right is the bottom view showing positively charged grooves 
(blue) emanating from the centre. (B) Subunit contacts in the AF-Smi 
heptamer. The molecules are shown as ribbons of different colours for the 
pairs of interacting molecules. Side chains involved in contacts, mainly 
located on f3-strands 4 and 5 as well as the N-terminal helix, are represented 
in ball-and-stick mode. Reprinted from Törö et al. (2001). 
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These findings neither disprove, nor prove the possibility of the RNA threading 
through the inner hole of the complex. The oligomerisation behaviour of the Sm2 
type protein from Archaeoglobus fulgidus was shown to depend on the pH and 
presence of RNA. This Sm-like protein formed a hexamer at acidic pH in the absence 
of RNA and a heptamer in the presence of U10-RNA over a wide pH range. The 
stability of both the hexamer and the RNA-bound heptamer increased at lower pH 
(Kilic et al., 2006). 
1.8.4 Hfq, a bacterial Lsm complex with RNA chaperone activity 
Important implications for the evolution of Sm-like proteins and their functions came 
from the discovery of the Hfq Sm-like protein from E. co/i and homologues in other 
bacteria. Initially Hfq (also known as HF-I) was identified as an E. co/i host factor 
required for initiation of plus-strand synthesis by the replicase of the QP RNA 
bacteriophage (Franze de Fernandez et al., 1968). Later, it was shown to specifically 
bind the 3' end of the QP RNA and to melt out a secondary structure, thus facilitating 
binding by the replicase protein (Schuppli et al., 1997). Much more recently it was 
shown to be the bacterial equivalent of the eukaryotic (L)Sm proteins. It associates 
with various RNAs, binds to U-rich tracks of sRNAs and an Sm-like motif is present 
in the N-terminal portion of the protein. Electron microscopy studies revealed a 
doughnut-shaped oligomeric molecule (Moller et al., 2002; Zhang et al., 2002) and 
the crystal structure of Staphylococcus aureus Hfq (Schumacher et al., 2002) and a 
C-terminally truncated Hfq from E. coli (Sauter et al., 2003) confirmed its structural 
homology to (L)Sm proteins (Fig. 1.10). It is not clear what makes Hfq form 
hexamers, whereas most other Sm-like proteins form heptamers, but the result is a 
similarly doughnut shaped ring. S. aureus Hfq was also co-crystalised with an AU 5G 
oligonucleotide giving insight into Hfq RNA binding. Neighbouring Hfq monomers 
form nucleotide binding pockets with specificity for adenosine and uridine residues 
located around the central cavity on one face of the ring (Schumacher et al., 2002). 
In agreement with this Hfq generally recognises a minimal RNA domain consisting 
of an A/U-rich track and, analogous to the Sm proteins, one or more flanking 
hairpins. Additional RNA-binding sites have been shown to exist on the opposite 
face of the ring (Mikulecky et al., 2004). Hfq has a long hydrophilic N-terminal tail, 
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which may be involved in binding to the hairpins or in binding to the mRNA targets. 
Alternatively, it could provide a platform for other cellular binding partners like the 
ribosome with which the majority of Hfq is associated (Kajitani et al., 1994; Sauter 
etal., 2003). 
A 
Fig. 1.10 Structure of the Staphylococcus aureus Hfq hexamer bound to 
an RNA oligonucleotide. (A) Ball-and-stick representation of the Hfq 
hexamer (top view). Each Hfq monomer is painted a different colour; the 
RNA oligonucleotide is shown in orange; (B) Ribbon representation of a 
Hfq monomer. The N-terminal helix is shown in red, 0 -strands I to 5 in 
blue and loops in black. Coordinates from PDB (lkq2) were used in 
Rasmol to produce these images. The crystal structure was solved by 
Schumacher et al. (2002). 
As has been proposed for other Lsm complexes, Hfq acts as an RNA chaperone, 
promoting RNA-RNA interactions, often, but not always by modulating secondary 
structure of its target RNA molecules (reviewed by Storz et al., 2004; Valentin-
Hansen et al., 2004). It acts on a range of non-coding sRNAs and their target 
mRNAs. Some sRNAs are involved in translational control, e.g. OxyS sRNA 
basepairs with and represses translation of JiziA mRNA, whereas DsrA sRNA 
promotes translation of rpoS mRNA by preventing the formation of an inhibitory 
secondary structure. A striking example of its involvement in mRNA stability is the 
regulation of degradation of sodB mRNA which encodes an iron superoxide 
dismutase. Under conditions of limiting iron, RhyB sRNA is expressed and promotes 
the degradation of sodB by making it more sensitive to RNase E digestion. Under 
conditions of high iron the transcriptional regulator protein Fur represses RhyB 
expression, thus downregulating sodB degradation and that of at least five other 
mRNAs encoding proteins involved in the iron metabolism. Storz et al. (2004) 
suggested that sRNAs may also protect certain mRNAs from degradation by binding 
to them. Binding of Hfq itself to the poly(A) tail of rpsO mRNA has already been 
shown to protect it from RNase degradation in vitro (Folichon et al., 2003). 
In summary, Hfq has been shown to alter RNA-RNA and RNA-protein interactions 
by changing RNA secondary structures in some cases (Schuppli et al., 1997; Moller 
et al., 2002; Zhang et al., 2002; Moll et al., 2003; Geissmann and Touati, 2004), but 
has been shown to be able to promote RNA-RNA interactions without affecting 
RNA secondary structures in others (Brescia et al., 2003; Mikulecky et al., 2004). 
This RNA chaperone function may be conserved between all Sm-like protein 
complexes. Apart from this, multiple other parallels exist between Hfq and other Sm-
like proteins, indicating that lessons about the more intricate eukaryotic Lsm 
complexes may be learnt from its relatively simple bacterial counterpart (Wilusz and 
Wilusz, 2005). 
1.8.5 (L)Sm RNA binding activity 
Comparison of available crystal structures of Sm(-like) complexes with and without 
RNA, and alignment of known Sm(-like) proteins has provided insight into the way 
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these complexes bind RNA (Khusial et al., 2005). Bases of the bound nucleotides are 
held in a pocket created by two three amino acid motifs in loops between strands 32 
and 33, and between 04 and 05. Khusial et al. (2005) named these motifs Knuckle I 
and Knuckle II respectively. Differences in residues used to form these nucleotide 
binding pockets were suggested to be the cause of more promiscuous RNA binding 
by the Lsm complexes, compared to the Sm complexes (also see Chapter 9). 
1.8.6 Alternative (L)Sm complexes 
1.8.6.1 U7 snRNP 
In metazoa, processing of the non-polyadenylated 3' end of replication-dependent 
histone mRNA is cell-cycle regulated. An essential factor for endonucleolytic 
cleavage of the 3' UTR is the U7 snRNP. This RNP consists of U7 snRNA and an 
unusual (L)Sm core complex. It has a combination of Sm (SmB, D3, E, F and G) and 
LSm proteins (LSm1O and 11). The latter two effectively replace SmD1 and D2. U7 
snRNA has a degenerate Sm binding site and a free 5' end that is complementary to 
the histone mRNA 3' UTR. Basepairing between U7 snRNA and histone mRNA 
helps to position the endonucleolytic cleavage activity close to the appropriate site. 
Interactions between N-terminal extension of LSm1 ip and other protein factors 
involved in the processing stabilise the RNA-RNA interaction and provide additional 
binding specificity (reviewed by SchUmperli and Pillai, 2004). 
1.8.6.2 snRNP-specific Sm complexes in trypanosomes 
The composition of the Sm core complex of the Trypanosoma brucei U2 and U4 
snRNPs was recently shown to be different than that usually seen for the 
spliceosomal U snRNPs. In the T. brucei U2 snRNP 5mB and D3 proteins are 
replaced with homologous proteins SSm2-1 (Sm16.5K) and SSm2-2 (Sm15K). This 
exchange of two of the Sm subunits seems to contribute to RNA binding specificity 
of the U2 snRNA Sm binding site. In addition to specific RNA binding the 
alternative Sm subunits may contribute to U2 snRNP specific functions, possibly 
through unique protein-protein interactions (Wang et al., 2006; Tkacz et al., 2006). 
Surprisingly, in the U4 snRNP only SmD3 is replaced by a snRNP specific Sm 
protein designated 55m4 (Tkacz et al., 2006). 
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1.8.6.3 Telomerase 
The RNA component of both yeast and human telomerase was shown to associate 
with Sm proteins. In yeast this occurs via a canonical Sm site, identical to that of U4 
snRNA, at the 3' end of TLC] RNA. Tagged SmDlp and SmD3p precipitated TLC] 
RNA, but no other (L)Sm proteins were tested (Seto et al., 1999). In humans tagged 
SmB and SmD3, but none of the other Sm proteins co-immunoprecipitated hTR 
RNA. This human telomerase RNA does not contain an Sm site, but the interaction 
was instead shown to require the CAB box sequence, that targets RNA to Cajal 
bodies. 5mB and D3 were also shown to interact with other CAB box containing 
small Cajal body RNAs (scaRNAs; Fu and Collins, 2006). The precise mode of 
interaction and composition of the telomerase associated Sm complex, particularly in 
humans, is unclear and it may consist of yet another combination of (L)Sm proteins. 
1.8.6.4 Hexameric Lsm complexes? 
Multiple Lsm complexes have been proposed to exist in which one or two Lsm 
proteins may be missing. LSm5 was not found associated with U8 snoRNA in 
Xenopus; Lsm8p did not co-immunoprecipitate yeast snR5; and defects in tRNA, 
rRNA and U3 snoRNA processing were strong in yeast strains depleted of any of the 
essential Lsm proteins, but minimal in the absence of Lsmlp, Lsm6p or Lsm7p (see 
1.5). This may suggest existence of alternative Lsm complexes. Importantly, none of 
these studies conclusively demonstrated the actual composition of any of these 
complexes. However, existence of functional hexameric complexes or heptamers 
with alternative subunits can not be ruled out. 
1.8.6.5 Other S. cerevisiae Sm-like proteins 
In addition to seven canonical Sm proteins and eight Sm-like proteins, the S. 
cerevisiae genome encodes a number of other proteins that contain Sm domains. One 
of these, LSM9 is also called MAK31 (maintenance of killer). It is non-essential, but a 
deletion mutant strain displays elongated telomere length (Askree et al., 2004) and 
exhibits defects in the structural stability of L-A family of dsRNA-containing viral 
particles (Wickner and Leibowitz, 1976). In addition, its deletion leads to a synthetic 
52 
phenotype with csm3 and tofi (Pan et al., 2006), both of which are required for 
mitotic sister chromatid cohesion. LSM9 was also found as a high copy suppressor of 
a temperature-sensitive mutation affecting the RSC (remodels the structure of 
hromatin) complex, the yeast SWVSNF chromatin remodelling complex (Treich et 
al., 1998). It is most closely related to Lsm7p and SmBp (Fig. 1.11A), but has no 
direct structural relatives in other organisms (Salgado-Garrido et al., 1999). It has 
yeast two-hybrid interactions with Lsm2p and Lsm8p (Fromont-Racine et al., 2000), 
but has a poorly conserved Sm2 motif. A usually highly conserved glycine or 
cysteine residue in the putative RNA binding motif of Sm2 is absent (Séraphin, 
1995) and the motif seems to be disrupted by a proline residue (Fig. 1.1 1A). It is 
therefore unclear whether it could be part of an alternative Lsm complex or whether 
it can bind RNA. Its genetic interactions strongly suggest that it may have a function 
in chromatin remodelling and/or telomere maintenance. However, lack of L-A viral 
particle assembly was associated with loss of NatC N-terminal acetyl transferase 
activity of a Mak3 ip containing complex (Polevoda and Sherman, 2001). Its effects 
on chromatin remodelling and telomere maintenance may involve this activity and 
may be indirect. 
Various bioinformatic approaches found a number of other yeast proteins that 
contain divergent Sm domains (Albrecht and Lengauer, 2004; Anantharaman and 
Aravind, 2004). Lsml2p is a protein of unknown function that localises to the 
nucleus and the cytoplasm, interacts with Pbplp (oly(A) binding protein binding 
protein) and Pbp4p (Pbplp binding protein), and associates with ribosomes 
(Fleischer et al., 2006). Pbplp and Pbp4p are involved in regulation of 
polyadenylation (Mangus et al., 1998; Mangus et al., 2004). Interestingly, Pbplp 
itself also contains an Sm domain (Fig. 1.11 B).  Lsml2p and Pbplp may therefore 
interact via their Sm domains and may be part of the same RNA processing 
machinery. Lsml3p is also called Scd6p (suppressor of clathrin deficiency) and 
localises to the cytoplasm. Its overproduction suppresses a null mutation in CHCJ, 
which encodes the heavy chain of clathrin (Lemmon, unpublished; see SGD). It is a 
P-body component and orthologues (Drosophila trailer hitch, C. elegans CAR-1 and 
human RAP55) have links to various cellular processes including spindle pole 
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regulation and endoplasmic reticulum dynamics (Barbee et al., 2006; Decker and 
Parker, 2006 and references therein). C. elegans CAR-i was shown to bind poly(U) 
RNA (Audhya et al., 2005) and the Lsm domain of Xenopus RAP55 was shown to 
be important for translational repression and P-body localisation (Tanaka et al., 
2006). Another Sm-like gene, LSM16 (EDC31DCP3) also encodes a cytoplasmic 
protein that localises to P-bodies. It is an enhancer of deadenylation-independent 
mRNA decapping by DcplpfDcp2p (Kshirsagar and Parker, 2004; Badis et al., 
2004). Interactors found by affinity capture include Dcplp, Dcp2p, Lsmip, Lsm3p 
and Xrnlp (Gavin et al., 2006; Krogan et al., 2006). Others, found by yeast two-
hybrid analysis include Dhhlp (Uetz et al., 2000), Edc3p, Lsm2p and Lsm8p 
(Fromont-Racine etal., 2000). 
Lsml2p (LSm12), Lsml3p (LSm14aIRAP55 and b), Lsml6p (Edc3) and Pbpl 
(Ataxin-2) all have homologues in human (indicated between brackets). Both Sm 
motifs for these proteins are weakly conserved, with no significant conservation of 
the putative RNA binding motifs. This does not necessarily mean that these proteins 
are not able to bind RNA. E. coli Hfq is included in the alignment for comparison 
(Fig. 1.11 B).  Proposed RNA binding residues are poorly conserved between Lsm6p 
and Hfq, but Hfq does bind RNA and Hfq residues (YKH) that line up with Lsm6p 
(RGT) in Sm motif 2 are required for RNA binding (Mikulecky et al., 2004). Also, 
the Sm-like domain of CAR-1 was already shown to bind RNA (Audhya et al., 
2005). It is unclear whether these proteins are able to form complexes with other 
(L)Sm proteins. The nature of the Sm-fold makes it likely that they at least form 
homomultimeric complexes. 
1.8.7 Evolutionary considerations 
It appears that bacteria have retained a unique RNA chaperone involved in many 
stages of RNA metabolism. Most archaeal genomes contain one or two Sm-like 
genes, which may be the result of gene duplication. In eukaryotes further gene and/or 
genome duplications may have lead to structural and functional divergence of a large 
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Fig. 1.11 Alignment of amino acid sequences of putative S. cerevisiae Lsm proteins. (A) The yeast SmB, Lsm7 and Lsni9 
proteins were aligned using ClustaIW and adjusted by hand using Jalview. Previously published data were used from 
Séraphin (1995); (B) S. cerevisiae Lsm6p, Lsml2p. Lsml3p, Lsml6p and Pbplp were similarly aligned with E. co/i Hfq. 
Conserved Sm 1 and Sm2 motifs are indicated as well as putative RNA binding residues (*). To adjust alignments by hand 
previously published data were used from Albrecht and Lengauer (2004) and Anantharaman and Aravind (2004). 
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polypeptides allows a much higher level of complexity. Thus, heteromers with a 
variety of specialised functions could evolve (reviewed by Beggs, 2005). 
1.9 Lsm proteins in disease 
1.9.1 Systemic lupus erythematosus 
Patients with the auto-immune disorder systemic lupus erythematosus (SLE) often 
have autoantibodies to Sm-protein antigens (Lerner et al., 1979). The majority of 
anti-Sm sera from patients with SLE also recognise hLSm4, while a small percentage 
shows exclusive reactivity to the hLSm complex in the absence of reactivity to Sm 
core proteins. Additionally, the finding of anti-hLSm4 antibodies in infectious 
mononucleosis suggests that infection with Eppstein-Bar Virus may play a role in 
initiating the production of autoantibodies (Eystathioy et al., 2002). 
1.9.2 Lsm proteins and spinal muscular atrophy 
The spinal muscular atrophy (SMA) disease gene product, SMN, is crucial for 
snRNP biogenesis. A complex containing SMN interacts with the snRNP core 
proteins, both Sm and LSm (Friesen and Dreyfuss, 2000). A direct correlation exists 
between reduced levels of SMN polypeptide in SMN patient cell extracts and their 
ability to promote snRNP assembly (Wan et al., 2005). However, recent evidence 
suggests that SMN has a novel function in motor axon outgrowth that is relevant to 
SMA but independent of snRNP biosynthesis. Mutations in SMN were identified that 
failed to rescue motor axon defects, but retained the ability to oligomerise and bind 
Sm proteins, functions required for snRNP biogenesis (Carrel et al., 2006). 
Interestingly, a modified U7 snRNP has recently been shown to have potential as a 
form of gene therapy for the treatment of SMA. Wild-type U7 snRNA associates 
with an unusual (L)Sm core complex (reviewed by SchUmperli and Pillai, 2004; see 
1.8.6.1). SMA, a usually fatal, hereditary disease is caused by absence of SMNI 
expression and differential splicing of a second gene copy, SMN2. Exon 7 skipping 
in SMN2 leads to production of a biologically inactive protein isoform. To increase 
exon 7 inclusion of SMN2, vectors expressing modified U7 snRNAs containing 
antisense sequences complementary to the 3' splice site of SMN exon 8 were 
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transiently expressed in HeLa cells. Increased exon 7 inclusion in SMN2 resulted in 
an increase in the concentration of SMN protein (Madocsai et al., 2005). A similar 
approach was shown to have potential for the treatment of 3-thalassemias 
(SchUmperli and Pillai, 2004). 
1.9.3 Lsm proteins and cancer 
Human LSm1 is also called CaSm (cancer-associated Sm protein) as its expression is 
upregulated in cancers of the pancreas (Schweinfest et al., 1997; Gumbs et al., 
2002), breast (Streicher et al., 2006) prostate (Fraser et al., 2005) and various cell 
lines from cancers originating in liver, ovary, lung, and kidney (Schweinfest et al., 
1997). LSM1 overproduction has been directly linked to a transformed cell 
phenotype (Schweinfest et al., 1997; Yan et al., 2005). Delivery of antisense LSM1 
RNA using adenovirus inhibits growth of prostate cancer cell lines by altering cell 
cycle progression (Kelley et al., 2003), and is associated with altered expression of 
cyclin B1, CDK1, NEK2 and nucleophosmin/B23 proteins. Elevated LSM1 
expression in cancers may therefore involve (de)stabilisation of multiple gene 
transcripts (Fraser et al., 2005). In a mouse model of pancreatic cancer (Yan et al., 
2005), tumor growth was shown to be inhibited by intratumoral administration of an 
adenoviral vector encoding LSM 1 antisense RNA and systemic administration lead 
to decreased metastasis and increased survival time (Kelley et al., 2000a; Kelley et 
al., 2001; Yan et al., 2006). Surprisingly, others found that LSM1 was 
downregulated in advanced human prostate cancers (Takahashi et al., 2002), 
suggesting that not only LSM 1 overexpression is associated with cancer, but 
emphasising the importance of correct levels of LSm1. Interestingly, increased 
copynumber of other LSM genes has recently been linked to cancer. Increased copy 
number and expression of LSM3 were shown to be associated with metastatic 
phenotypes of cervical cancers (Lyng et al., 2006). In addition, LSM7 expression 
was shown to be increased in malignant thyroid tumours (Rosen et al., 2005). The 
latter was suggested to involve an interaction between LSM7 and TAM, which 
itself is downregulated in various carcinomas. The function of TACC proteins is 
poorly understood, but orthologues from Xenopus (Maskin) and Drosophila (D-
TACC) are involved in translational regulation and dynamics of spindle pole 
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microtubules during cell division (Conte et al., 2002; Conte et al., 2003). It seems 
that the LSm proteins, most likely LSm 1-7, are involved in cell cycle regulation and 
changes in their levels can result in carcinogenesis. The underlying mechanism is 
likely to involve regulated degradation of cell cycle specific transcripts, but may 
include as yet unknown functions for LSm I -containing Sm-like complexes. 
1.9.4 Other links between Sm-like proteins and disease 
1.9.4.1 Hfq and bacterial virulence 
The bacterial Sm-like protein Hfq has been implicated in the regulation of virulence 
factors in a wide range of pathogenic bacteria, including Yersinia enterocolitica, 
Brucella abortus, Pseudomonas aeruginosa, Legionella pneumophila, Vibrio 
cholerae and Listeria monocytogenes. Experiments with hfq deletion strains have 
shown a direct effect of the deletion on the production of virulence factors through 
the actions of small regulatory RNAs (Christiansen et al., 2006 and references 
therein). 
1.9.4.2 Lsml-7p in viral replication and translation 
The Lsm 1 -7p/Pat 1 pfDhh ip deadenylation dependent decapping activator complex 
was shown to be essential for Brome Mosaic Virus (BMV) replication in yeast. On 
the other hand, there was no apparent involvement of other decapping factors or 
deadenylation independent degradation factors (Diéz et al., 2000; Mas et al., 2006). 
The same complex was shown to be needed for efficient translation of the viral RNA 
(Noueiry et al., 2003). Polysome profiles showed that, while mutations in the Lsml-
7p/Patlp complex completely inhibited viral RNA translation, the levels of viral 
RNA associated with ribosomes were only slightly reduced in mutant yeast. 
Inhibition of BMV RNA translation was selective, with no effect on general cellular 
translation. Thus a defective Lsml-7pfPatlp complex specifically inhibits BMV 
RNA translation at the level of translation elongation. A switch between translation 
and recruitment of BMV RNAs to viral RNA replication seems to be regulated by a 
pathway that usually transfers mRNAs from translation to degradation (see section 
1.6.5). As any (+)strand RNA virus needs to make this switch during its life cycle 
Lsm l-'7p is likely to be involved in replication of other such viruses (Noueiry et al., 
2003; Mas et al., 2006). 
1.10 Aims of this thesis 
To investigate a role for S. cerevisiae Lsm2-8p in U4/U6 annealing, attempts were 
made to assemble this heteroheptameric complex in vitro from its purified 
recombinant constituents. To determine specificity of RNA binding and U4/U6 
annealing activity, the Lsml-7 complex was similarly produced. For comparison E. 
coli Hfq and in vitro assembled human complexes were used. In Chapter 3, I 
describe the development of the methods used to purify, assemble and analyse these 
complexes. In Chapter 4, I analyse RNA-binding and U4/U6 annealing activities for 
the different complexes. In Chapter 5, I investigate in more detail a potential 
mechanism for the suggested U4/U6 annealing activity. This includes the design of a 
strand displacement assay to examine the ability of Sm-like proteins to unwind a 
duplex structure. In summary, Chapters 4 and 5 examine the putative RNA 
chaperone function of Sm-like protein complexes. 
Prp24p and Lsm2-8p are both part of the U6 snRNP and have both been implicated 
in U4/1J6 annealing. In Chapter 6, I investigate genetic interactions between ism and 
prp24 mutations and attempt to clarify direct Lsm-Prp24p interactions by 
immunoprecipitation of purified recombinant proteins. Using these data and the 
available literature I propose a model for the involvement of these proteins in U4/U6 
di-snRNP assembly. 
Previous members of this lab found specific phenotypes associated with Lsm4p 
overproduction. In Chapter 7, I describe experiments that investigate toxicity 
associated with Lsm4p overproduction, aggregation of Lsm4p into foci and a 
potential role for the Lsm4 C-terminal extension in Lsml-7p localisation to P-bodies. 
In addition, I investigate a potential role for Lsm4p in cell morphology and 
cytokinesis. 
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Deletion of LSMJ, LSM6 or LSM7 leads to temperature-sensitive growth and the 
effects of these deletions are known in some detail. In Chapter 8, I investigate 
effects of mutation and deletion of LSM5 on growth and on the levels of 
spliceosomal snRNAs, and compare these to effects of Ism 14, 1sm64 and ism 74. 
Lsml-7p and Lsm2-8p only differ by one subunit, but localise to different subcellular 
sites where they carry out distinct functions. In Chapter 9, I describe experiments 
with Lsmlp and Lsm8p mutant proteins as well as hybrids that combine domains of 
both polypeptides. I investigate their ability to support viability; I analyse in vivo 
localisation of fluorescently tagged mutant and hybrid proteins; and show the 
importance of specific domains for localisation to nuclei and P-bodies. 
In summary, this thesis attempts to elucidate functions of Sm-like proteins, yeast 
Lsml-7p and Lsm2-8p in particular, and the underlying mechanisms. In addition, 
specific functions associated with individual Lsm polypeptides and protein domains 
are investigated. 
CHAPTER 2 
Materials and Methods 
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2.1 General reagents 
2.1.1 Sources of reagents 
2.1.1.1 Chemicals 
Chemicals were purchased from the following sources, except where stated 
otherwise: Sigma, BDH Laboratory Supplies (AnalaR, VWR), Fisher Chemicals, 
Melford Labs, Scotlab and Amersham Biosciences (GE Healthcare). Water used to 
make aqueous solutions was deionised using a Purite Prestige Deioniser to 1-10 PS 
(with C750 carbon pre-treatment and HP700 deioniser columns). 
2.1.1.2 Enzymes 
Restriction enzymes, DNA and RNA polymerases and other enzymes were 
purchased from the following sources unless otherwise stated: Epicentre 
Technologies, Gibco BRL, New England Biolabs, Pharmacia, Promega and Roche. 
2.1.1.3 Growth reagents 
Reagents for all growth media were purchased from the following sources: BD 
Biosciences, Difco Laboratories, Fisher Scientific, Formedium, Gibco BRL, Oxoid 
and Sigma. 
2.1.1.4 Antibiotics 
Ampicillin was purchased from Beecham Research and GlaxoSmithKiine, 
kanamycin from Merck, hygromycin from Calbiochem, G418 from Melford, 
tetracycline from Duchefa and chloramphenicol and streptomycin were purchased 
from Sigma. Nourseothricin was purchased from HKJ, Werner BioAgents (Jena, 
Germany) under the trade name clonNAT. 
2.1.2 Bacterial and yeast growth media 
2.1.2.1 General information 
All liquid growth media were autoclaved (Thermo Denley, Diamond 36, 10 min at 
121 AC), stored at room temperature and warmed to the appropriate temperature 
immediately prior to use. For solid media, 2% (w/v) agar (Oxoid) was added prior to 
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autoclaving. Plates of 15-25 ml each were poured in 9 cm triple-vented petridishes 
(Greiner Bio-One), allowed to set at room temperature and stored at 4°C. 
2.1.2.2 Bacterial media 
Escherichia coli were grown in Luria Broth (LB; also known as Luria-Bertani or 
Lennox Broth, but originally intended to mean Lysogeny Broth (Bertani, 2004)). Its 
composition is as follows: 1% (w/v) bacto-tryptone, 0.5% (wlv) yeast extract and 
0.5% (w/v) NaCl with the pH adjusted to 7.2 with sodium hydroxide. Rich SOC 
medium was used after transformation by electroporation (2.2.3.4) and contains 2% 
(w/v) bacto-tryptone, 0.5% (w/v) yeast extract, 0.06% (w/v) NaCl, 0.02% (w/v) KC1, 
0.1% (w/v) M902, 0.12% (w/v) MgSO4, 0.4% (wlv) glucose. 
2.1.2.3 Yeast media 
Table 2.1.2.3 Yeast media 
Medium 	 Components 
YPDA 	 1% (w/v) Yeast extract, 2% (w/v) Bacto-peptone, 
2% (w/v) Glucose, 0.003% (w/v) Adenine sulphate 
YPGa1A 	 As YPDA, but 2% (w/v) galactose instead of glucose 
YMM 	 0.67% (w/v) Yeast nitrogen base without amino acids, 
2% (w/v) Glucose or 2% (w/v) galactose 
SD- or SDGa1- 	YMIVI with 2 g/l of dropout powder (2.1.2.4) 
5-FOA (*) 	 0.67% (w/v) Yeast nitrogen base without amino acids, 
2% (w/v) Glucose or 2% (w/v) galactose, 
0.2% (w/v) iJra drop-out powder, 0.005% (w/v) Uracil, 
0.1% (w/v) 5-Fluoroorotic acid (Toronto Research Chemicals) 
Pre-sporulation 	10% glucose or galactose, 0.2% appropriate dropout powder, 
(minimal) 	 0.67 % nitrogen base without amino acids 
Sporulation 	 1% Potassium acetate, 0.005% Zinc acetate, 
(minimal) 	 0.05% dropout powder or simply 2% Potassium acetate 
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(*) For each 100 ml of 5-FOA medium: 0.67 g of yeast nitrogen base without amino acids, 
0.2 g of-Ura drop out powder, 5 mg of uracil, 0.1 g of 5-FOA and 10 ml of 20% glucose (or 
galactose) were dissolved in a total volume of 50 ml by gently heating (microwave) till about 
37°C. This mixture was filter sterilised using a 0.2 pm filter (Minisart Cellulose acetate, 
Sartorius) and pre-heated to 55°C, mixed with a 55°C solution of autoclaved 2g agar in 50 ml 
of water. Resulting plates were stored at 4°C protected from the light. 
2.1.2.4 Drop-out powder 
Drop-out powder was prepared by adding and mixing 2 g of each of the following 
nutrients; adenine, alanine, arginine, asparagine, aspartic acid, cysteine, glutamic 
acid, glutamine, glycine, histidine, isoleucine, lysine, methionine, phenylalanine, 
proline, serine, threonine, tyrosine, tryptophan, uracil and valine. In addition, 4 g of 
leucine was added to the drop-out powder when required. For a specific drop-out 
powder, the relevant nutrients were omitted. This mix was then ground with a mortar 
and pestle to ensure complete mixing and was added to yeast media to a final 
concentration of 0.2% (w/v) prior to autoclaving. To adjust the pH, one pellet of 
NaOH was added to each 500 ml of media containing drop-out powder. 
2.1.2.5 Antibiotics 
Antibiotics were added to liquid media immediately prior to use. Solid media were 
autoclaved and cooled down to approximately 50°C before adding the appropriate 
antibiotics. Ampicillin, kanamycin, streptomycin, chioramphenicol, tetracycline and 
nourseothrycin stock solutions (all at 1,000 times that of the required working 
concentration) were stored at -20°C, G418 was stored at room temperature as a 
powder and hygromycin stock solution was stored at 4°C. Those stock solutions 
made in water were filter sterilised using 0.2 tm filters (Minisart Cellulose acetate, 
Sartorius) before aliquoting and storing them at -20°C. 
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Table 2.1.2.5 Antibiotics 
Antibiotic Abbreviation Solvent Final concentration 
4g/ml) 
Ainpicilhin Amp water 100 
Chloramphemcol Cm ethanol 34 
Hygromycm Hyg PBSt 300 
Kanamycin Kan water 30 
G418 (Geneticin) G418 N/A 200 
Nourseothrycin Nat water 100 
Streptomycin Strep water 50 
Tetracycline Tet ethanol 5 
Dissolved in PBS (at 50 mg/ml) when purchased; 3 ml of this stock was added per 500 ml 
of medium. 
2.1.3 Commonly used buffers 
All commonly used buffers were made using autoclaved deionised water. Their 
compositions are indicated in Table 2.1.3 below. 
Table 2.1.3 Commonly used buffers 
Buffer 	 Components 
50x TAE 	 2 M Tris-base, 5.71% (v/v) acetic acid, 50 mM EDTA 
lOx TE 	 100 mM Tris-HC1, 10 mM EDTA pH 8.0 
lOx TBE 	 0.89 M Tris base, 0.89 M boric acid, 20 mM EDTA 
lOx TBST 	 0.5 M Tns-HC1 pH 7.5, 1.5 M NaCl, 
1% (v/v) Tween-20 (USB Corporation) 
20x MOPS SDS-PAGE 	1 M MOPS, 1 M Tris base, 2% (w/v) SDS, 
running buffer 	 20 mM EDTA 
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Table 2.1.3 Commonly used buffers (continued) 
Buffer 	 Components 
lOx Tris-Glycine SDS-PAGE 250 m Tris base, 1.9 M Glycine, 1% (w/v) SDS 
running buffer 
1 Ox Western transfer buffer 	200 mM Tris base, 1.5 M Glycine 
lOx BPTE 	 100 mM PIPES, 200 mM Bis-Tris, 10 mM EDTA pH 8.0, DEPC 
treated or filtered 
20x SSC 	 3 M NaCl, 0.3 M Sodium citrate 
(pH adjusted to 7.0 with 1 M HC1) 
20x SSPE 	 3.6 M NaCl, 0.2 M NaH 2PO4, 20 mM EDTA 
(pH adjusted to 7.4 with NaOH) 
Buffer B 	 0.1 M Potassium phosphate pH 7.4, 1.2 M Sorbitol 
SES1 	 0.5 M Sodium phosphate pH 7.2, 7% (w/v) SDS, 
1 mM EDTA 
NT and NTN 	 50 mM Tris-HC1 pH7.5, 150 mM NaCl 
For NTN only: 0.1% (v/v) NP-40 (Roche) 
2x 1P 150 	 12 mM HEPES-KOH pH 7.9, 300 mM NaCl, 5 MM M902 and 0.1% 
(v/v) NP-40 (Roche) 
2.1.4 Sterilising solutions and making solutions RNase free 
To sterilise solutions they were commonly autoclaved (Thermo Denley, Diamond 36, 
10 min at 121 °C). For those that could not be autoclaved but for which sterility was 
required solutions were filter-sterilised using disposable filter units with PES filters 
(Polyethersulphone, Nalgene). For those solutions that needed to be RNase free 
similar disposable filter units were used with CN filters (Cellulose nitrate, Nalgene). 
Alternatively aqueous solutions were made RNase free by DEPC treatment. DEPC 
(Diethylpyrocarbonate) was added to a concentration of 0.1% (vlv), the solution was 
incubated for a minimum of 1 h at 37°C and autoclaved to hydrolyse the DEPC. 
2.1.5 Escherichia co/i strains 
The bacterial strains used throughout this work are listed in Table 2.1.5 below. 
DH5a and TOP 10 cells were used for cloning and transformation of plasmid DNA, 
and subsequent propagation. All other strains were used for production of 
recombinant proteins and/or were used in making hfq deletion strains (2.2.4). 
Table 2.1.5 Escherichia coil strains 
Strain 	Genotype 	 Source 
DH5a 	F, ço80dlac7-AMl5, 4(1acZYA-argF)U169, deoR, recAl, GIBCO BRL 
endAl, hsdRl7(rk, mk), phoA, supE44, ,%, thi-1, gyrA96, 
re/Al 
TOP 10 	F mcrA 41 (mrr-hsdRMS-mcrB C) ço80lac7-JMl5 4lacX74 	Jnvitrogen 
deoR nupG recAl araD139 4(ara-leu) 7697 ga/U ga/K 
rpsL(Str') endAl 2 
BL21(DE3) 	F ompT gal dcm ion hsdS B (rj MB)  2(DE3) 
	
Novagen 
BL21- 	F ompT gal dcm ion hsdS8(rj m8) 1(DE3) endA Hte [argU Novagen 
CodonPius 	ileYleuW C amR] 
(DE3)-RIL 
C41(DE3) 	F ompT gal dcm ion hsdSB(rj MB)  A(DE3) and an 	 Avidis 
uncharacterised mutation (Miroux and Walker, 1996) 
ER2566 	F); JhuA2 [ion] ompTlacZ::T7 gene] gal sulAll zi('mcrC- NEB 
mrr)114::IS1O R(mcr-73::miniTnlOTetS)2 R(zgb-210::TnlO 
)(TetS) endAl [dcm] 
MG1655 	F); iivG- rjb-50 rph-1 	 David Leach 
MC41 00 	F araDl39 4('argF-lac) Ui 69 rspLl50 re/A] flbBS3Ol 	n/a 
fru425 deoCl ptsF25 e14 
MRE1 	 F); ilvG- rJb-50 rph-1 zlhfq 	 This thesis 
(MG1655 zlhfq) 
MRE2 	F). jhuA2 [ion] ompT lacZ:.T7 gene] gal sulA 11 D(mcrC- Poul Valentin- 
(ER2566 hfq-l) mrr)114..1S10 R(mcr-73::miniTnlOTetS)2 R(zgb-210::TnlO Hansen 
)(TetS) endAl [dcm] hfq-]::.(2(Kan' Bc/I) 
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Table 2.1.5 Escherichia coil strains (continued) 
Strain 	Genotype 	 Source 
MRE3 	F ompT gal dcm ion hsdSB (rB MB)  A(M) hfq-1:: £2 (Kan*, 	Valentin- 
(C41 hfq-1) 	BclI) and an uncharacterised mutation (Miroux etal., 1996) Hansen 
MRE4 	F); JhuA2 [ion] ompT lacZ::T7 gene) gal sulAll D(mcrC- This thesis 
(ER2566 zliifq) mrr)114::ISJO R(mcr-73::miniTnlOTetS)2 R(zgb-210::TnlO 
)(TetS) endAl [dcm] &zfq 
MRE5 	F ompT gal dcm ion hsdS8(rj MB)  2(DE3) Ahfq and an 	This thesis 
(C41 zlhfq) 	uncharacterised mutation (Miroux et al., 1996) 
MRE6 	F araDl39 D(argF-!ac) UI 69 rspLl5O relA I flbB5301 	Gisella Storz 
(GS081) 	fruA25 deoClptsF25 e14 hfq-]::.(2(Cm' I  BclI) 
2.1.6 Saccharomyces cerevisiae strains 
The strains used in and created for this study are listed below in Tables 2.1.6.1 and 
2.1.6.2. The parent strains of those that were created for this thesis are indicated. A 
source and/or references are given for all other strains. 
Table 2.1.6.1 Saccharomyces cerevislae strains created for this thesis 
Strain 	Genotype 	 Derived from 
MRYI 	MATa ade2 arg4 leu2-3,-112 trpl-289 ura3-52 SNR6::ADE2 lsm6,i::KANMX4 [pBS]I9I] BSY557 
MRY2 	MATa ade2 arg4 leu2-3,-112 trpl-289 ura3-52 SNR6:.ADE2 lsm7,i:.KANMX4 [pBS]I91] BSY557 
MRY3 	MATa ade2 arg4 Ieu2-3,-112 trpl-289 ura3-52 SNR6::ADE2 [pSX6] 	 B5Y557 
MRY4 	MATa ade2 arg4 leu2-3,-112 trpl-289 ura3-52 SNR6::ADE2 lsm6,i::K4NMX4 [pSX6] 	MRY1 
MRYS 	MATa ade2 arg4 leu2-3,-112 trpI-289 ura3-52 SNR6::ADE2 lsm7,J::KANMX4 [pSX6] 	MRY2 
MRY6 	MATa ade2-I his3-11,45 leu2-3, -112 tp1i ura3-1 lsmSzj::TRPI 	 AEMY48 
MRY7 	MATh ade2-1 his3 -11.-IS leu2-3, -112 trphl ura3-I lsm5,i::TRPI [pMR91 	 AEMY48 
Table 2.1.6.1 Saccharomyces cerevisiae strains created for this thesis 
(continued) 
Strain Genotype Derived from 
MRY8 MATa ade2-1 his3-11,-15 leu2-3, -112 t,p1i ura3-1 lsm5I::TRP1 [pMRJO] AEMY48 
MRY9 MA Ta his3zll leu2iOlys2t1O metlSAO ura34l prp24zl::KA]'J[pSR53J GLS6 18 
MRY1O MATa his361 leu2iIO lys2ilO metl5LlO ura3Ll] prp24zl::KAN[pSR70] GLS6 18 
MRY1 1 MATa his3A] leu2AOlys2iio metI5AO ura3,iI prp24,i:KAN[pSR86] GLS61 8 
MRY1 2 MATa his3Al 1eu240 lys2iiO met15AO ura3zll prp241::KAN[pSR93] GLS61 8 
MRY1 3 MATa his3,il leu2iO lys2zlO mel]S,iO ura3,i] prp24A::K4N[pMR60] GLS61 8 
MRY14 MA Ta his3,il leu2AO 1ys240 met]54O ura3i1 prp24zl::KAN[pSR]5IJ GLS6 18 
MRYI 5 MATa his3zll leu2AO lys2LlO met15ilO ura311 prp24il::KAN lsm6il::HpHMX3 [pPR097] GLS6 18 
MRY16 MATa his3i1 leu2iiO lys21O metl5zlO ura3ill prp24ii::KAN Ism 7zl::NATMX6 [pPR097] GLS6 18 
MRY17 MATa his3Al leu2LiO me115ilO ura311 lsm6J::HpHMX6 BY4741 
MRY18 MATa his34l Ieu2LlO me:15A0 ura3i1 lsm7zl::HpHMX6 BY4741 
MRY21 MA 	ade2 arg4 leu2-3,-112 trpl -289 ura3-52 SNR6::ADE2 [pMR6]] BSY557 
MRY22 MA 	ade2 arg4 leu2-3,-112 trpl -289 ura3-52 SNR6::ADE2 [pMR62] BSY557 
MRY23 	MATa ade2 arg4 leu2-3,-112 trpl -289 ura3-52 SNR6::ADE2 lsm6zI::KANMX4 [pMR61] 	MRY1 
MRY24 	MA  ade2 arg4 leu2-3,-112 trpl-289 ura3-52 SNR6::ADE2 1sm61::K4NMX4 [pMR62] 	MRY1 
MRY25 	MA  ade2 arg4 leu2-3,-112 trpl-289 ura3-52 SNR6::ADE2 lsm7ii::KANMX4 [pMR61] 	MRY2 
MRY26 	MATa ade2 arg4 leu2-3.-112 trpl-289 ura3-52 SNR6::ADE2 lsm7Ll:.KANMX4 [pMR62J 	MRY2 
MRY27 	MATa his311 leu2LlO metl5zlO ura3iil lsm5A::HpJIMX6 	 BY4741 
MRY28 MATa his311 leu2iiO 1ys240 metISJO ura3Lll prp24ii.:KAN lsm6zi:HpHMX3 [pMR63] MRY1 5 
MRY29 MATa his311 leu21Olys2z1O metI54O ura3 Lii prp24ii:KAN lsm6A:HpHMX3 [pSR86] MRY15 
MRY30 MATa his3Lil Ieu2LiO lys2LiO melI5LiO ura3zli prp24ii.:KAN lsm6J::HpHMX3 [pSR]51] MRY15 
MRY3 1 MA Ta his3ill leu2zlO lys2ilO metI5LiO ura3iil prp24zt:K4N Ism 7Li::NATMX6 [pMR63] MRY16 
MRY32 MATa his3zll Ieu2LiO lys2LiO metl5ilO ura3ili pip24i:KAN Ism 7il::NATMX6 [pSR86] MRY16 
ME 
Table 2.1.6.1 Saccharomyces cerevisiae strains created for this thesis 
(continued) 
Strain 	Genotype 	 Derived from 
MRY33 MATa his3zll leu2LI0 lys2LI0 met1510 ura3zll pip24ii::KAN lsm7LI::NATMX6 [pSRI5I] MRY16 
MRY34 MA Ta his3LII !eu2LI0 Iys2zI0 metI5LIO ura3zll pip24il::KAN lsm6LI::HpHMX3 [pMR59] MRY1 5 
MRY35 MATa his3LIl !eu2zI0 lys2LI0 metl5LIO ura3 LI) p?p24i1::K4N lsm7zI::NA TMX6 [pMR59] MRY16 
MRY36 MA Ta hLc3LI] leu2,i0 !ys2LI0 metI5A0 ura3.61 prp24LI::KAN[pMR65J GLS618 
MRY37 MATa hi3iI] leu2A0lys2LI0 metliLIO ura3zll prp24A::K4[pMR66] GLS6 18 
MRY61 MATa ade2 arg4 leu2-3,-112 trpl-289 ura3-52 SNR6::ADE2 [pMRI09] BSY557 
MRY62 MATa ade2 arg4 leu2-3.-112 trpl-289 ura3-52 SNR6::ADE2 [pMR64] BSY557 
MRY63 MATa ade2 arg4 leu2-3,-112 trpl-289 ura3-52 SNR6::ADE2 lsm6A::K4NMX4 [pMRI09] MRY1 
MRY64 MATa ade2 arg4 leu2-3,-112 trpl -289 ura3-52 SNR6::ADE2 lsm6A::KANMX4 [pMR64] MRY2 
MRY65 MATa adel -101 his3LII trpl-289 ura3-52 LEU2-GALJ-LSM4 lsm8A::HIS3 GAL [pMR63] MCY4 
MRY68 MATa adel-101 his3-1 leu2-3. 112 trpl-289 ura3-52 !sm4A::LEU2 GAL [pMR]57] MCY5 
MRY71 MATa adel-101 his3-1 leu2-3,112 trpl-289 ura3-52 lsm4A::LEU2 GAL [pUSSJ] MRY68 
MRY72 MATa adel-101 his3-1 leu2-3, 112 trpl-289 ura3-52 !sm44::LEU2 GAL [pMCIJJ MRY68 
MRY73 MATa adel-101 his3-1 leu2-3. 112 trpl-289 ura3-52 !sm4A::LEU2 GAL*  [pMCJ2] MRY68 
Table 2.1.6.2 Other Saccharomyces cerevisiae strains 
Strain Genotype 	 Origin 
BMA38a MATa ade2-1 his3,i200 leu2-3,-112 trplill ura3-1 can]-100 	 Albers, 1999 
BMA38a MATa ade2-1 his3A200 leu2-3,-112 trpliil ura3-1 can]-100 	 Albers, 1999 
AEMY25 	MATa ade2-1 his3-11,-15 leu2-3,-112 trpli.II ura3-1 !smILI::TRPI 	 Mayes etal., 1999 
AEMY48 	M4Ta ade2-1 his3-11.-15 leu2-3,-112 trpILII ura3-1 !sm5LI::TRPJ [pBM]25- 	Andrew Mayes, this lab 
GAL 1-HA -LSM5J 
MCY4 	MATa adel-101 his3-I leu2-3,112 trpl-289 ura3-52 LEU2-GALI-LSM4 GAL 	Cooper etal., 1995 
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Table 2.1.6.2 Other Saccharomyces cerevisiae strains (continued) 
Strain 	Genotype 	 Origin 
MCY5 	MATaJa ADE/adel -101 HIS31his3-1 TRPJ/trpl-289 ura3-521ura3-52 leu2- 	Cooper, 1995 
3, 112/leu2-3,112 LSM411sm44::LEU2. GAL 
LMA4 	MAT a/a ade2-11ad2l his3-11,-15/hLS3-11.-15 trpIAI1irpl4I ura3-11ura3-1 	Mayes, 1998 
leu2-3,-11217eu2-3,4 12 LSM81 !sm8A::TRPJ 
BSY557 MATa ade2 arg4 !eu2-3, 112 trpl-289 ura3-52 snr61::ADE2pBSII91 (CEN- Luukkonen and Séraphin, 
URA3-SNR6) 1998 
BY4741 MATa his3 LI] !eu2A0 metISLI ura3ii0 Euroscarf, Brachmann et 
al., 1998 
BY4742 MA Ta his3ill leu2,i0 !ys2ii ura3.60 Euroscarf Brachmann et 
al., 1998 
BY4743 MAT a/a his3Lll/his3Iil leu2J0/leu2,J0 lys2LIO/LYS2 METI51metI5LI0 Euroscarf; Brachmann et 
ura3LlO/ura3LIO al., 1998 
GLS6 18 MATa his3j !eu2,iO lys2zI0 metliii ura3,i0l prp24ii::K4N[pPRO97J Rader etal., 2002 
GLS6 19 MA Ta his34 leu2Ll0 lys2zl0 me115Ll ura3L101 prp24LI::KAN[pPRI131 Rader etal., 2002 
GLS620 MATa his3zI leu2iI0 1ys240 met]5.d ura3AOl prp24zl::KAN[pSR039] Rader etal., 2002 
Y01301 MATa his3,i1 !eu2iIO lys2LIO ura3LIO !smli.I::kanMX4 Euroscarf 
MPS1 I MATa ade2-1 his3-11,-15 !eu2-3,-112 trpMl ura3-1 canl-100 lsm8::TRPI Michael Spiller, this lab 
[pHIS-GALJ-HA-LSM8] LSIvI7:]3myc-HphMX6 
MPS26 MATa ade2-1 his3-11,-15 !eu2-3,-112 trpMl ura3-1 canl-100 lsm8::TRPJ Michael Spiller, this lab 
[pYXJ 72] ISM7:l3myc-HphMX6 
Ll 19-71) MATa ura3-52 trpl/2 adel dbJ2-1 Parkes and Johnston, 1992 
AMy1292 MATa ura3 leu2 ade2 hzs3 trpl dbf2-2 Adele Marston 
AMy1277 MATa ura3 leu2-3 adel trpl-1 omns cdcl5-2 Adele Marston 
CY3 MATa ura3 lys2 ade2 trpl his3 leu2 Yoo and Wolin, 1997 
BP4 lvfATa Lrm8-1 LHPI ura3 lys2 ade2 trpl his3 leu2 Pannone etal., 1998 
KY1 17 MATa his3zl200 lys2-801 ade2 trpliil ura3-52 GAL Chen and Struhl, 1985 
KY1 18 MATa his3,i200 lys2-801 ade2 trpIiJI ura3-52 GAL Chen etal., 1985 
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2.1.7 Plasmids 
Plasmids used throughout this study are listed in Tables 2.1.7.1 - 2.1.7.5 below. 
Those that were created for this work were constructed using standard cloning 
techniques and oligonucleotides described in Tables 2.1.8.1 a and b. 
Table 2.1.7.1 E. coil expression vectors 
Plasmid 	 Description 	 Source 
pET19b 	 AmpR E. coli expression vector with lOx EK-cleavable N-terminal 	Novagen 
His-tag from Ti promoter 
pET28b 	 AmpR E. coli expression vector with N-terminally 6xHis tagging 	Novagen 
MCS controlled by Ti promoter 
pCDFDuet-1 StrepR E. co/i expression vector with two MCS, one with 6x N- Novagen 
terminal His-tag, second with C-terminal S-tag both from Ti 
promoter 
pETDuet-1 AnipR E. coli expression vector with two MCS, one with 6x N- Novagen 
terminal His-tag, second with C-terminal S-tag both from Ti 
promoter 
pCOLADuet-1 KanR E. coli expression vector with two MCS, one with 6x N- Novagen 
terminal His-tag, second with C-terminal S-tag both from 17 
promoter 
pACYCDuet-1 CmR E. coli expression vector with two MCS, one with 6x N- Novagen 
terminal His-tag, second with C-terminal S-tag both from Ti 
promoter 
plP24 AmpR E. co/i expression vector with N-terminally óxHis tagged Vidal etal., 1999 
PRP24 under the lac promoter 
pET28b Hfq Y55A E. co/i hfq Y55A in frame with C-terminal 6xHis tag in pET28b Mikulecky etal., 2004 
expression vector, gift from A.Feig 
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Table 2.1.7.2 E. coil expression vectors created for this thesis 
Plasmid Alias Description 
pMR81 pETI9 HA single HA sequence introduced into NdeI site of pETl9b, NdeI site 
remains only downstream of HA-tagging sequence 
pMR82 pET19 Myc single c-Myc sequence introduced into NdeI site of pET19b, NdeI site 
remains only downstream of HA-tagging sequence 
pMR2 pET 19b Lsm2 LSM2 (intronless) cloned in frame with N-terminal lOxHis tag of 
pET 19b expression vector; Ndel-BamHI 
pMR3 pET19b Lsm3 LSM3 cloned in frame with N-terminal lOxHis tag ofpETl9b expression 
vector; NdeI-BamHI 
pMR4 pETl9b Lsm4 LSM4 cloned in frame with N-terminal lOxHis tag ofpETl9b expression 
vector; NdeI-BamHI 
pMR5 pET19b LsmS LSM5 cloned in frame with N-terminal lOxHis tag ofpETl9b expression 
vector; NdeI-BamHI 
pMR6 pET19b Lsm6 LSM6 cloned in frame with N-terminal lOxHis tag ofpETl9b expression 
vector; NdeI-BamHI 
pMR7 pET19b Lsm7 LSM7 (intronless) cloned in frame with N-terminal lOxHis tag of 
pET l9b expression vector; NdeI-BamHI 
pMR18 pET19 HA Lsm8 LSM8 (correct, shorter ORF) cloned in frame with N-terminal 
lOxHis+HA tag ofpETl9 HA expression vector; NdeI-BamHI 
pMR19 pET19 HA Prp24 PRP24 cloned in frame with N-terminal lOxHis+HA tag ofpETl9 HA 
expression vector; NdeI-BamHI 
pMR20 pET19 HA Prp24Al0 Prp24 with 1OAA C-terminal deletion cloned in frame with N-terminal 
lOxHis+HA tag ofpETl9 HA expression vector; Ndel-BamHI 
pMR21 pET19 Myc Lsml LSMI cloned in frame with N-terminal lOxHis+Myc tag ofpETl9 Myc 
expression vector; NdeI-BamHI 
pMR29 pET 19 Myc Prp24 PRP24 cloned in frame with N-terminal lOxHis+Myc tag ofpETl9 Myc 
expression vector; NdeI-BamHI 
pMR30 	pETl9 Myc Prp24A10 	 Prp24 with 1OAA C-terminal deletion cloned in frame with N-terminal 
lOxHis+Myc tag of pET19 Myc expression vector; NdeI-BamHI 
pMR33 	pET19 HA Lsm8 (old) 	 LSM8 (incorrect, longer ORF) cloned in frame with N-terminal 
lOxHis+HA tag ofpETl9 HA expression vector; NdeI-BamHJ 
pMR39 	pCDFDuet LsmlILsm4 	 LSMI cloned in frame with N-terminal 6xHis-tag ofpMR35; BamHI-PstI 
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Table 2.1.7.2 E. coil expression vectors created for this thesis 
(continued) 
Plasmid 	Alias 	 Description 
pMIR40 	pETDuet L.sm7(His) 	 LSM7 (intronless) cloned in frame with N-terminal 6xHis-tag of 
pETDuet- 1 expression vector; BamHI-PstI 
pMR41 	pETDuet Lsm7(S) 	 LSM7 (intronless) cloned in frame with C-terminal S-tag of pETDuet-1 
expression vector; NdeI-XhoI 
pMR46 	pCOLADuet Lsm3/Lsm2 	LSM3 cloned in frame with N-terminal 6xHis-tag of pMR45; BamHI-PstI 
pMR47 	pACYCDuet Lsm5fLsm6 	LSM5 cloned in frame with N-terminal 6xHis-tag of pMR42; BamHI-PstI 
pMR48 pCDFDuet Lsm8fLsm4 (new) LSM8 (correct, shorter ORF) cloned in frame with N-terminal 6xHis-tag 
of pMR35; BamHI-PstI 
pMR52 pET 19 HA Hfq E. coil hfq cloned in frame with N-terminallOxHis+HA tag ofpETl9 HA 
expression vector; NdeI-BamHI 
pMR53 pET19 Myc Hfq E. coli hfq cloned in frame with N-terminal lOxHis+Myc tag ofpETl9 
Myc expression vector; NdeI-BamHI 
pMR 107 pET 19 Myc HfqiC83 E. coli hfq (up to aa83) cloned in frame with N-terminal lOxHis+Myc tag 
ofpEll9 Myc expression vector; NdeI-BamHI 
Table 2.1.7.3 Yeast shuttle vectors 
Plasmid Description Source 
pBM 125 Yeast E. coil shuttle vector: CEN4, ARSJ, URA3, AnipR, GAL] Johnston and Davis, 1984 
promoter 
pGFP-N-FUS CEN6, URA3 shuttle vector with MCS for N-terminal GFP tagging Niedenthal etal., 1996 
under control of MET25 promoter 
pGFP-C-FUS CEN6, URA3 shuttle vector with MCS for C-terminal GFP tagging Niedenthal etal., 1996 
under control of MET25 promoter 
pRS3 13 CEN6, HIS3 shuttle vector Sikorski and Hieter, 1989 
pRS3 14 CEN6, TRPI shuttle vector Sikorski and Hieter, 1989 
pRS3 15 	 CEN6, LEU2 shuttle vector 	 Sikorski and Hieter, 1989 
pRS3 16 	 CEN6, URA3 shuttle vector 	 Sikorski and Hieter, 1989 
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Table 2.1.7.3 Yeast shuttle vectors (continued) 
Plasmid 	 Description 	 Source 
pRS423-pMet25 	381bp of pMET25 (2785-2404) in pRS423 (2 ji, HIS3) shuttle 	R. Grainger, this lab 
vector 
YEp24 	 2j, URA3 shuttle vector; routinely used in high-copy screens in 	Parent etal., 1985 
yeast 
pSX6 	 pSE358 (CEN4, TRPJ) with SNR6 and flanking sequences, SphI site Madhani etal., 1990 
and XhoI Sites were created at 5' and 3' ends respectively of the U6 
gene, gift from C. Guthrie 
pBS1 191 	 Contains SNR6 with its own regulatory sequences (CEN, URA3) 	Luukkonen etal., 1998 
pYX 172 2t, LEU2 plasmid with SNR6 and 1kb up and downstream Hu et al., 1994 
pSR53 pSE362 (CEN4, HIS3) with prp24-RRM3sub and its own regulatory Rader etal., 2002 
sequences, gift from S. Rader 
pSR70 pSE362 (CEN4, HIS3) with prp24-R.RM4sub and its own regulatory Rader et aL, 2002 
sequences, gift from S. Rader 
pSR86 pSE362 (CEN4, FfIS3) with prp24-RRMlsub and its own regulatory Rader etal., 2002 
sequences, gift from S. Rader 
pSR93 pSE362 (CEN4, HIS3) with prp24-RRMlsub1RR.M4sub and its own Rader etal., 2002 
regulatory sequences, gift from S. Rader 
pSRl 51 pSE362 (CEN4, HIS3) with prp2411O1RRJvf1sub and its own Rader etal., 2002 
regulatory sequences, gift from S. Rader 
pGFP-N-LSM1 LSMJ in frame with N-terminal GFP tag in pGFP-N-FUS M. Spitler, this lab 
pGFP-N-LSM8 LSM8 in frame with N-terminal GFP tag in pGFP-N-FUS (pMPS8) Spitler, 2005 
pMPSLsm4 pGFP-N-FUS, with LSM4 coding region inserted in frame with GFP Spitler, 2005 
coding region 
pMPSL5m4D1 pGFP-N-FLJS, with LSM4 domain! coding region (as 1-93) inserted Spitler, 2005 
in frame with GFF coding region (add IDTVDLESCN at C-term.) 
pMPSLsm4D2 pGFP-N-FUS, with LSM4 domain II coding region (as 92-187) Spitler, 2005 
inserted in frame with GFP coding region 
pMPSLsm2 pGFP-N-FUS, with LSM2 coding region inserted in frame with GFP Spitler, 2005 
coding region 
pGFP-N-Lsm6 pGFP-N-FUS, with LSM6 coding region inserted in frame with GFP Michael Spitler, this lab 
coding region 
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Table 2.1.7.3 Yeast shuttle vectors (continued) 
Plasmid Description Source 
pGFP-N-Lsm7 pGFP-N-FUS, with LSM7 coding region inserted in frame with GFP Michael Spiller, this lab 
coding region 
pMPS2 pGFP-N-FUS, with LHPI coding region inserted in frame with GFP Spiller, 2005 
coding region 
PUSS] 1.7 kb Hindffl genomic fragment with LSM4 ORF, promoter and Cooper, 1995 
terminator sequences cloned into pFL39 (CEN6, TRPJ) 
pMC1 1 Modified pFL39 (CEN6, TRPJ) with a 1.49 kb HindIlJSaII fragment Cooper, 1995 
containing truncated LSM4 (aa 1-136 + CRLVS) with own promoter 
pMC12 Modified pFL39 (CEN6, TRPJ) with a 1.36 kb HindIlJSalI fragment Cooper, 1995 
containing truncated LSM4 (aa 1-92 + VD) with its own promoter 
pRP1 155 DCP2 with C-terminal RFP tag in CEN, LEU shuttle vector, gift Teixeira etal., 2005 
from R.Parker 
Table 2.1.7.4 Yeast shuttle vectors created for this thesis 
Plasmid 	Alias 	 Description 
pMR9 	pRS3 13 LSM5 	 LSM5 with flanking genomic DNA cloned into pRS3 13 (CEN6, HIS3) 
pMR1O 	pRS3 13 LSM5 E1OK 	 LSMS with E1OK mutation and flanking genomic DNA cloned into 
pRS313 (CEN6,HI3S) 
pMR55 	pSR 105 = pSR53+RRM4sub 	re-made pSR 105 (RRM3/4sub; S. Rader) by making RRM4sub mutation 
inpSR53 
pMR58 	pPR097 	 pSE360 (CEN4, URA3) with PRP24 rescued from GLS618 (S. Rader) 
pMR59 	pPR1 13 	 pSE362 (CEN4, HIS3) with PRP24 rescued from GLS619 (S. Rader) 
pMR60 	pMR59 F87A 	 F87A mutation in PRP24 in pSE362 
pMR63 	pSR39 	 pSE362 (CEN4, HIS3) with prp24/1O rescued from GLS620 (S. Rader) 
pMR65 	pMR59 R158S 	 R158S mutation inPRP24 inpSE362 
pMR66 	pMR59 F2571 	 F2571 mutation in PRP24 in pSE362 
pMR61 	pSX6 G63A 	 063A mutation made in SNR6 in pSX6 (Guthrie-lab) 
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Table 2.1.7.4 Yeast shuttle vectors created for this thesis (continued) 
Plasmid Alias Description 
pMR62 pSX6 C69A C69A mutation made in SNR6 in pSX6 (Guthrie-lab) 
pMR64 pSX6 G63A/A82G G63A mutation made (and spontaneous A82G mutation introduced) in 
SNR6 in pSX6 (Guthrie-lab) 
pMR109 pSX6 G63A/C69A G63A mutation introduced in SNR6 in pMR58 
pMR69 pGFP-N-Lsml 18 Hybrid of LSMI (N-term&Sm domains; up to D121) and LSM8 (C-term; 
from S74) cloned in frame with N-terminal GFP-tag of pGFP-N-FUS 
under MET25 Promoter; XbaJ/XhoI 
pMR70 pGFP-N-Lsm881 Hybrid of LSM8 (N-term&Sm domains; up to D73) and LSMJ (C-term; 
from Q122) cloned in frame with N-terminal GFP-tag of pGFP-N-FUS 
under ME725 Promoter; XbalLX7zoI 
pMR71 pBM125 Lam! 18 Hybrid of LSMI (N-term&Sm domains; up to 13121) and LSM8 (C-term; 
from S74) cloned in pBM 125 under GAL Promoter; BamHI 
pMR72 pBM125 Lsm881 Hybrid of LSM8 (N-term&Sm domains; up to D73) and LSMI (C-term; 
from Q!22) cloned in pBM!25 under GAL Promoter; BamHI 
pMR73 pGFP-N-Lsm88 1 mal rnal (N28A; D3 1A) mutation introduced into pMR70 
pMR74 pGFP-N-Lsm881 ma2 rna2 (T34A; N35A) mutation introduced into pMR70 
pMR75 pGFP-N-Lsm881 rna3 rna3 (R57A; G58W; S59A) mutation introduced into pMR70 
pMR76 pGFP-N-Lsm8 ma! rnal (N28A; D3 1A) mutation introduced into pGFP-N-Lsm8 
pMR77 pGFP-N-Lsm8 ma2 rna2 (T34A; N35A) mutation introduced into pGFP-N-Lsm8 
pMR78 pGFP-N-Lsm8 ma3 rna3 (R57A; G58W; S59A) mutation introduced into pGFP-N-Lsm8 
pMR79 pGFP-N-LsmhC LSMJ with C-terminal deletion after D121 in frame with N-terminal 
GFP-tag of pGFP-N-FUS under ME725 Promoter; XbaI/XlzoI 
pMR80 pGFP-N-Lsm8C LSM8 with C-terminal deletion after D73 in frame with N-terminal GFP- 
tag of pGFP-N-FUS under MET25 Promoter; XbaltXhol 
pMR83 pGFP-C-Lsm8 LSM8 (correct, shorter ORF) cloned in frame with C-terminal GFP-tag 
under ME725 promoter; XbalIClaI 
pMR84 pGFP-C-Lsm88 1 1sm881 cloned in frame with C-terminal GFP-tag under MET25 
promoter; XbaJIClaI 
pMR85 pGFP-C-Lsm1AC (Clal) LSMI up to internal Cal site (up to 1117) cloned in frame with C- 
terminal GFP-tag under MET25 promoter; Xba 1/C/al 
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Table 2.1.7.4 Yeast shuttle vectors created for this thesis (continued) - 
Plasmid Alias Description 
pMR86 pGFP-C-Lsml LSM1 (partial digest) cloned in frame with C-terminal GFP-tag under 
MET25 promoter; XbalJClaI 
pMR87 pGFP-C-Lsml 18 Ism 118 (partial digest) cloned in frame with C-terminal GFP-tag under 
MET25 promoter; XbalJClaI 
pMR88 pMET25-Lsml LSMI cloned without C-terminal GFP-tag under MET25 promoter into 
pGFP-C-FUS; Xbal/BamHI 
pMR89 pMET25-Lsm1 18 LsmI 18 cloned without C-terminal GFP-tag under MET25 promoter into 
pGFP-C-FUS; XbaIIBamHI 
pMR90 pMET25-Lsm8 LSM8 (correct, shorter ORF) cloned without C-terminal GFP-tag under 
MET25 promoter into pGFP-C-FUS; XbalJBamHI 
pMR91 pMET25-Lsm88 1 1sm881 cloned without C-terminal (1FF-tag under MET25 promoter into 
pGFP-C-FUS; Xbal/BamHI 
pMR92 pGFP-C-Lsm8 mal lsm8 rnal (N28A; D3 1A) cloned in frame with C-terminal GFP-tag 
under ME725 promoter into pGFP-C-FUS; XbaI/ClaI 
pMR93 pGFP-C-Lsm8 ma2 lsm8 rna2 (T34A; N35A) cloned in frame with C-terminal GFP-tag 
under MET25 promoter into pGFP-C-FUS; XbaI/ClaI 
pMR94 pGFP-C-Lsm8 ma3 Ism8 rna3 (R57A; (158W; S59A) cloned in frame with C-terminal GFP- 
tag under MET25 promoter into pGFP-C-FIJS; XbaJICIaI 
pMR95 pGFP-C-Lsm881 mal 1sm881 rnal (N28A; D31A) cloned in frame with C-terminal GFP-tag 
under ME725 promoter into pGFP-C-FUS; XbalIClaI 
pMR96 pGFP-C-Lsm881 ma2 1sm881 rna2 (T34A; N35A) cloned in frame with C-terminal GFP-tag 
under MET25 promoter into pGFP-C-FUS; XbaIJClaI 
pMR97 pGFP-C-Lsm881 rna3 1sm881 rna3 (R57A; G58W; S59A) cloned in frame with C-terminal 
GFP-tag under MET25 promoter into pGFP-C-FLJS; XbaI/ClaI 
pMR98 pMET25-Lsm8 mal lsm8 mal (N28A; D3 1A) cloned without C-terminal GFP-tag under 
MET25 promoter into pGFP-C-FUS; XbalJBamHI 
pMR99 pMET25-Lsm8 rna2 lsm8 rna2 (T34A; N35A) cloned without C-terminal GFP-tag under 
MET25 promoter into pGFP-C-FIJS; Xbal/BamHI 
pMR100 pMET25-Lsm8 ma3 lsm8 rna3 (R57A; G58W; S59A) cloned without C-terminal (1FF-tag 
under ME725 promoter into pGFP-C-FUS; Xbal/BamHI 
pMR1O1 pMET25-Lsm881 mal 1sm881 mal (N28A; D3 IA) cloned without C-terminal (IFP-tag under 
MET25 promoter into pGFP-C-FUS; XbaIIBamHI 
Table 2.1.7.4 Yeast shuttle vectors created for this thesis (continued) 
Plasmid Alias Description 
pMR102 pMET25-Lsm881 rna2 1sm881 rna2 (T34A; N35A) cloned without C-terminal GFP-tag under 
MET25 promoter into pGFP-C-FUS; XbaIIBamHI 
pMR103 pMET25-Lsm881 rna3 1sm881 rna3 (R57A; G58W; S59A) cloned without C-terminal GFP-tag 
under MET25 promoter into pGFP-C-FUS; XbalIBamHI 
pMR104 pGFP-C-Lsm8C lsm8LC (up to D73) cloned in frame with C-terminal (3FP-tag under 
MET25 promoter; XbalJClaI 
pMIR 105 pMET25-Lsm8zC lsm8tsC (up to D73) cloned without C-terminal GFP-tag under MET25 
promoter into pGFP-C-FUS; Xbal/BamHI 
pMR1 10 pGFP-N-Lsm8iC NLS 1sm8LC (up to D73) cloned in frame with N-terminal GFP-tag of pGFP- 
N-FUS under MET25 Promoter with SV40 NLS fused to C-terminus 
(PKKKRKV); XbalLk7ioI 
pMR ill pGFP-C-Lsm8C NLS 1sm8LC (up to D73) cloned in frame with C-terminal GFP-tag under 
MET25 promoter with SV40 NLS in between C-terminus (PKKKRKV); 
Xbal/ClaI 
pMR1 12 	pMET25-Lsm8C NLS 	lsm8EsC (up to D73) cloned without C-terminal GFP-tag under MET25 
promoter into pGFP-C-FUS with SV40 NLS fused to C-terminus 
(PKKKRKV); XbalJBamHI 
pMR1 13 	pMET25-Lsm8 ma3 NLS 	lsm8 ma-3 cloned without C-terminal GFP-tag under MET25 promoter 
into pGFP-C-FIJS with SV40 NLS fused to C-terminus (PKKKRKV); 
fl'aI/BamHI 
pMRI 14 	pGFP-N-Lsml81 	 Hybrid of LSMJ N-terminal extension (aal-51), LSM8 Sm domains 
(aal 1-73) and LSMI C-terminal extension (aa122-172) cloned in frame 
with N-terminal GFP-tag of pGFP-N-FUS under ME725 Promoter; 
A7,aI/A7th1 
pMRll5 	pGFP-N-Lsm8l 1 	 Hybrid of LSM8 N-terminal extension (aal-10) with LSMJ Sm-domains 
and C-terminal (aa52-172) extension cloned in frame with N-terminal 
GFP-tag of pGFP-N-FUS under ME725 Promoter; XbaJIXhoI 
pMRll6 	pGFP-N-Lsm818 	 Hybrid of LSM8 N-terminal extension (aal-10), LSMJ Sm domains 
(aa52-121) and LSM8 C-terminal extension (aa74-109) cloned in frame 
with N-terminal GFP-tag of pGFP-N-FUS under MET25 Promoter; 
XbalIXhoI 
79 
Table 2.1.7.4 Yeast shuttle vectors created for this thesis (continued) 
Plasmid 	Alias Description 
pMRl 17 	pGFP-C-Lsm188 Hybrid of LSMI N-terminal extension (aal-51), LSM8 Sm domains and 
C-terminal extension (aal 1-109) cloned in frame with C-terminal (FP- 
tag of pGFP-C-FUS under MET25 Promoter; XbalJClaI 
pMRll8 	pGFP-C-Lsm81iC (CIa!) Hybrid of LSM8 N-terminal extension (aal-10) with LSMJ Sm-domains 
up to internal Cal site (aa52-1 18) cloned in frame with C-terminal GFP - 
tag of pGFP-C-FUS under MET25 Promoter; XbalJClaI 
pMR1 19 	pMET25-Lsml8l Hybrid of LSMI N-terminal extension (aal-51), LSM8 Sm domains 
(aal 1-73) and LSMI C-terminal extension (aal22-172), LSM8 Sm 
domains and LSMJ C-terminal extension cloned in pGFP-C-FUS without 
GFP-tag under MET25 Promoter; X7a1IBamHI 
pMR120 	pMET25-Lsm8l I Hybrid of LSM8 N-terminal extension (aal-lO) with LSMI Sm-domains 
and C-terminal (aa52-172) cloned in pGFP-C-F(JS without GFP-tag 
under ME725 Promoter; XbalIBamHI 
pMR121 	pMET25-Lsm818 Hybrid of LSM8 N-terminal extension (aal-10), LSMI Sm domains 
(aa52-121) and LSM8 C-terminal extension (aa74-109) cloned in pGFP- 
C-FUS without GFP-tag under MET25 Promoter; Xbal/BaniHI 
pMR 122 	pMET25-Lsml 88 Hybrid of LSMI N-terminal extension (aal -51), LSM8 Sm domains and 
C-terminal extension (aal 1-109) cloned in pGFP-C-FUS without GFP- 
tag under MET25 Promoter; XbaIJBamHI 
pMR 123 	pGFP-C-Lsml 81 Hybrid of LSMJ N-terminal extension(aal-5 1), LSM8 Sm domains 
(aal 1-73) and LSMI C-terminal extension (aa122-172) cloned in frame 
with C-terminal GFP-tag of pGFP-C-FUS under MET25 Promoter; 
XbaTJClaI 
pMR124 	pGFP-C-Lsm8l 1 Hybrid of LSM8 N-terminal extension (aal-10) with LSMJ Sm-domains 
and C-terminal (aa52-172) cloned in frame with C-terminal GFP-tag of 
pGFP-C-FUS under MET25 Promoter; XbaI/BamHI 
pMR125 	pCiFP-C-Lsm818 Hybrid of LSM8 N-terminal extension (aal-10), LSMI Sm domains 
(aa52-121) and LSM8 C-terminal extension (aa74-109) cloned in frame 
with C-terminal GFP-tag of pGFP-C-FUS under ME725 Promoter; 
XbaIJBamHI 
pMR 126 	pGFP-N-Lsm 188 Hybrid of LSMJ N-terminal extension (aal-5 1), LSM8 Sm domains and 
C-terminal extension (aal 1-109) cloned in frame with N-terminal GFP- 
tag of pGFP-N-FUS under MET25 Promoter; XbaI/XhoI 
Table 2.1.7.4 Yeast shuttle vectors created for this thesis (continued) 
Plasmid 	Alias 	 Description 
pMR129 	pGFP-N-lsm81zC 	 Hybrid of LSM8 N-terminal extension (aal-10) and ISM] Sm domains 
(aa52-121) cloned in frame with N-terminal GFP-tag of pGFP-N-FUS 
under ME725 Promoter; Xbal/XhoI 
pMR 130 	pGFP-C-lsm8 1iC 	 Hybrid of LSM8 N-terminal extension (aal -10) with LSMI Sm-domains 
cloned in frame with C-terminal CIFP-tag of pGFP-C-FUS under MET25 
Promoter; XbalJBamHI 
pMR131 	pMET25-lsm81C 	 Hybrid of LSM8 N-terminal extension (aal- 10) with LSMI Sm-domains 
loned in pGFP-C-FUS without GFP-tag under MET25 Promoter; 
XbalJBamHI 
pMR132 	pGFP-C-lsm8N LSM8 N-terminal extension (aal-10) cloned in frame with C-terminal 
GFP-tag of pGFP-C-FUS under MET25 Promoter; XbalJClaI 
pMR133 	pGFP-N-lsmlC LSMJ N-terminal extension (aal-51)cloned in frame with N-terminal 
GFP-tag of pGFP-N-FUS under MET25 Promoter; XbalIXhoI 
pMR134 	pGFP-N-lsmANl 1 LSMI Sm-domains and C-terminal (aa52-172) extension cloned in frame 
with N-terminal GFP-tag of pGFP-N-FIJS under ME725 Promoter; 
Xbal/XhoI 
pMR135 	pGFP-C-lsmANl 1 LSMJ Sm-domains and C-terminal (aa52-172) extension cloned in frame 
with C-terminal GFP-tag of pGFP-C-FUS under ME725 Promoter; 
Xbal/BamHI 
pMR 136 	pMET25-lsmiN1 1 LSMJ Sm-domains and C-terminal (aa52-172) extension cloned in 
pGFP-C-FUS without GFP-tag under MET25 Promoter; Xbal/BamHI 
pMR1 37 	pGFP-N-lsml 8C Hybrid of LSMJ N-terminal extension (aal-5 1), LSM8 Sm domains 
(aal 1-73) cloned in frame with N-terminal GFP-tag of pGFP-N-FUS 
under MET25 Promoter; Jtl,al/)t7iol 
pMR138 	pGFP-C-lsml8C Hybrid of LSMI N-terminal extension (aal-51), LSM8 Sm domains 
cloned in frame with C-terminal (iFP-tag of pGFP-C-FUS under ME725 
Promoter; Xbal/ClaI 
pMR139 	pMET25-lsml8zC Hybrid of LSMI N-terminal extension (aal-51), LSM8 Sm domains 
cloned in pGFP-C-FUS without GFP-tag under ME725 Promoter; 
Xbal/BamHI 
pMR140 	pGFP-N-lsmN88 LSM8 Sm domains and C-terminal extension (aal 1-109) cloned in frame 
with N-terminal GFP-tag of pGFP-N-FUS under MET25 Promoter; 
Xbal/XhoI 
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Table 2.1.7.4 Yeast shuttle vectors created for this thesis (continued) 
Plasmid 	Alias 	 Description 
pMR141 	pGFP-C-lsmN88 	 LSM8 Sm domains and C-terminal extension (aal 1-109) cloned in frame 
with C-terminal GFP-tag of pGFP-C-FUS under ME725 Promoter; 
XbalIClaI 
pMR142 	pMET25-1smN88 	 LSM8 Sm domains and C-terminal extension (aal 1-109) cloned in 
pGFP-C-FUS without GFP-tag under MET25 Promoter; Xbal/BamHI 
pMR143 pGFP-N-lsmN18 Hybrid of LSMJ Sm domains (aa52-D121) and LSM8 (C-term; from S74) 
cloned in frame with N-terminal GFP-tag of pGFP-N-FUS under MET25 
Promoter; Xba1IJ7wI 
pMR144 	pGFP-C-lsmlN 	 LSMJ N-terminal extension(aal-51) cloned in frame with C-terminal 
GFP-tag of pGFP-C-FUS under MET25 Promoter; Xbal/ClaI 
pMR145 pGFP-C-lsmN18 Hybrid of LSMJ Sm domains (aa52-13121) and LSM8 (C-term; from S74) 
cloned in frame with C-terminal GFP-tag of pCIFP-C-FIJS under MET25 
Promoter; XbaIJBaniHI 
pMR146 	pMET25-lsmAN18 Hybrid of LSMJ Sm domains (aa52-13121) and LSM8 (C-term; from S74) 
cloned in pGFP-C-FUS without GFP-tag under MET25 Promoter; 
Xbal/BamHI 
pMR147 	pGFP-N-lsmiN81 Hybrid of LSM8 Sm domains (aal 1-73) and LSMI C-terminal extension 
(aa122-172) cloned in frame with N-terminal GFP-tag of pGFP-N-FUS 
under MET25 Promoter; XbalL.ThoI 
pMR148 	pGFP-C-lsmAN81 Hybrid of LSM8 Sm domains (as! 1-73) and LSM1 C-terminal extension 
(aa122-172) cloned in frame with C-terminal GFP-tag of pGFP-C-FUS 
under MET25 Promoter; XbalIClaI 
pMR149 	pMET25-lsmN81 Hybrid of LSM8 Sm domains (aal 1-73) and LSMJ C-terminal extension 
(aal22-172) cloned in pGFP-C-FUS without GFP-tag under MET25 
Promoter; XbaI/BamHI 
pMR150 	pGFP-N-lsmAN1C LSMJ Sm-domains (aa52-121) cloned in frame with N-terminal GFP-tag 
of pGFP-N-FUS under MET25 Promoter; XbalLThoI 
pMR151 	pGFP-C-lsmANhC LSMI Sm-domains (aa52-121) cloned in frame with C-terminal GFP-tag 
of pGFP-C-FIJS under MET25 Promoter; XbalIBamHI 
pMR152 	pMET25-lsmN1AC LSMI Sm-domains (aa52-121) cloned in pGFP-C-FUS without GFP-tag 
under MET25 Promoter; Xbal/BamHI 
pMR 153 	pGFP-N-lsmN8AC LSM8 Sm domains (aal 1-73) cloned in frame with N-terminal GFP-tag 
of pGFP-N-FUS under MET25 Promoter; XballXhoI 
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Table 2.1.7.4 Yeast shuttle vectors created for this thesis (continued) 
Plasmid Alias Description 
pMR154 pGFP-C-lsmN8C LSM8 Sm domains (as! 1-73) cloned in frame with C-terminal GFP-tag 
of pGFP-C-FUS under MET25 Promoter; XbaIJClaI 
pMR155 pMET25-1smN8C LSM8 Sm domains (as! 1-73) cloned in pGFP-C-FUS without GFP-tag 
under ME725 Promoter; XbaIIBamHI 
pMR156 pGFP-N-lsm8C LSM8 C-terminus (aa65-end) cloned with 140bp of 3'UTR in pGFP-N- 
FUS with N-terminal GFP-tag under MET25 Promoter; XbalL.WwI; made 
by Michael Spiller, rescued by me 
pMRl 27 pRS423-pMet25-Hfq E. coli hfq cloned behind MET25 promoter in this 2t HIS plasmid made 
by Richard Grainger; NdeI-Jt7joI (into BamHI-X7w1 sites) 
pMR128 pGFP-N-Hfq E. coli hfq cloned in frame with N-terminal CiFP behind MET25 
promoter in pGFP-N-FUSXbaI-X7ioI 
pMR157 pBMI25-Lsm4 LSM4 ORF and terminator sequence cloned into pBM125; BamHJiSphI 
pMIU58 pBMI25-Lsm4D2 LSM4 C-terminal domain (aa92-187 ) and terminator sequence cloned 
into pBM 125; BamHT/SphI 
pMR159 pRS314 DCP2-RFP DCP2-RFP with promoter and terminator cloned from pRPl 155 into 
pRS3 14; SaIl/Sad 
pMR 160 pRS3 13 P0-HA-Lsm8 HA-LSM8 cloned from pAEMY76 into pRS3 13 by Michael Spiller; 
CIalJXhoI; rescued from MPS 11 
pMR161 pMET25-Lsm4 LSM4 ORF cloned without C-terminal GFP-tag under ME725 promoter 
into pGFP-C-FUS; XbalIBamHI 
pMR163 	pRS3 15 PMet-Lsm8-RFP 	PMET25-LSM8 amplified by PCR from pMR90 cloned into pRPll55 
(without DCP2+promoter); SaIl/BamHI 
pMR 165 	YEp24-SDB23 	 3.2kb BamHI genomic SDB23 fragment re-cloned into YEp24; BamHI 
pMR168 	YEp24-sdb23 lsm4ATG-stop 	Site-directed mutagenesis of LSM4 start ATG to TAG in pMR165 
pMR171 	pRS3 13 DCP2-RFP 	 Promoter-DCP2-RFP-PGK1 terminator from pRPl 155 cloned into 
pRS3 13; SaIl/Sac! 
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Table 2.1.7.5 Other vectors 
Plasmid Description Source 
pBR322 one of the most commonly used E. co/i cloning vectors, here used to Watson, 1988 
make radio labeled marker 
pTOF24 KanR, CmR plasmid with SacB (gives sucrose sensitive growth) and D. Leach 
temperature-sensitive replication (grow at 30C), gift from D. Leach 
pMR54 pTOF24 Ahfq = deletion construct with hfq flanking regions cloned This thesis 
into pTOF24; Pstl/SalI 
pU4 Plasmid containing the U4 snRNA coding sequence (SNRJ4); used This lab 
for PCR amplification of T7U4 for in vitro transcription 
pT7U6 Modified pUC9 containing the 17 promoter followed by U6 snRNA Peter Hodges, this lab 
coding sequence (SNR6) with a Dra! Site at the 3' end; used for PCR 
amplification of T7U6 for in vitro transcription 
pU2M 07 pRS3 16 containing the U2 snRNA coding sequence (SNR20; on a A. Newman 
SaIl/EcoRI fragment) with internal 892nt deletion (McPheeters et 
al., 1989); PCR amplification of T7U2A107 for in vitro transcription 
pIVEX2.5d E. co/i HA-tagging expression vector; HA tag from pMR81 is based Roche 
on this sequence 
pPROTet.E E. co/i Myc-tagging expression vector, Myc tag from pMR82 is Clontech 
based on this sequence 
pAG34 (hphMX3) AinpR vector with TEF regulated Hygromycin B resistance gene; Goldstein and McCusker, 
used as template for PCR products in yeast genomic deletions 1999 
pFA6a-kanMX6 AmpR vector with TEF regulated G418 resistance gene; used as Longtine etal., 1998 
template for PCR products in yeast genomic deletions 
pFA6a-natMX6 AmpR vector with TEF regulated Nourseothricin (clonNAT) Hentges etal., 2005 
resistance gene; used as template for PCR products in yeast genomic 
deletions 
pFA6a-hphMX6 AmpR vector with TEF regulated Hygromycin B resistance gene; Hentges et al., 2005 
used as template for PCR products in yeast genomic deletions 
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2.1.8 Oligonucleotides 
Oligonucleotides that were used in this study are listed in the tables below (2.1.8. la - 
2.1.8.5b). All oligonucleotides were synthesised by and purchased from MWG 
Biotech or Sigma-Genosys Ltd., unless otherwise stated. For oligonucleotides that 
were a gift from from others inside or outside this lab the source is given. 
Table 2.1.8.1a Oligonucleotides used for cloning, sequencing and 
colony PCR 
Oligo Name 	Alias 	Sequence 	 Description 
T7F 	 mrol 	TAATACGACTCACTATAGGG 	 Forward primer in the T7 promoter region 
Lsm2-BamHI 	mro4 	AAGGATCCTTATTTTCTTTCAGTCA 
NdeI-Lsm3 	mro5 	AAAAAAACATATGGAGACACCTTTG 
Lsm3-BamHI 	mro6 	AAGGATCCTTATATCTCCACTGCGC 
NdeI-Lsm4 	mro7 	AAAAAAACATATGCTACCTTTATAT 
Lsm4-BamHI 	mro8 	AAGGATCCTTAAAATTCGACCTTTT 
NdeI-Lsm5 	mro9 	AAAAAAACATATGAGTCTACCGGAG 
LsmS-BamHI 	mrol 0 AAGGATCCTTACAACGCCTCCGTAG 
NdeI-Lsm6 	mrol 1 AAAAAAACATATGTCCGGAAAAGCT 
Lsm6-BamHI 	mro12 AAGGATCCCTATATTTTTTGTTCAC 
NdeL-Lsm7 	mro13 AAAAAAACATATGCATCAGCAACAC 
Reverse primer in the 17 terminator region 
LSM2 reverse primer introducing a 3' BamHI site 
for pETl9b, pMR81 and pMR82 
LSM2 forward primer introducing a 5' NdeI site for 
pET19b, pMR8I and pMR82 
LSM3 reverse primer introducing a 3' BamHI site 
for pETl9b, pMR81 and pMR82 
LSM3 forward primer introducing a 5' NdeI site for 
pET19b, pMR81 and pMR82 
LSM4 reverse primer introducing a 3' BamHI Site 
for pETl9b, pMR81 and pMR82 
LSM4 forward primer introducing aS' NdeI Site for 
pET19b, pMR81 and pMR82 
LSM5 reverse primer introducing a 3' BamHI Site 
for pETl9b, pMR81 and pMR82 
LSM5 forward primer introducing aS' NdeI site for 
pET19b, pMR81 and pMR82 
LSM6 reverse primer introducing a 3' BamHI site 
for pET 19b, pMR81 and pMR82 
LSM6 forward primer introducing aS' NdeI site for 
pETl9b, pMR81 and pMR82 
LSM7 reverse primer introducing a 3' BamHI Site 
for pETl9b, pMR81 and pMR82 
T7R 	 mro2 	GCTAGTTATTGCTCAGCGG 
NdeI-Lsm2 	mro3 	AAAAAAACATATGCTTTTCTTCTCC 
Table 2.1.8.1a Oligonucleotides used for cloning, sequencing and 
colony PCR (continued) 
Oligo Name 	Alias 	Sequence 	 Description 
Lsm7-BamHI 	mro14 	AAGGATCCCTATTTTTGCATATATA LSM7 forward primer introducing a 5' NdeI site for 
pET 19b, pMR81 and pMR82 
HA-F 	 mrol5 	TACCAGCTACCCATACGATGTTCCAGA can be cloned with HA-R directly into NdeI site 
TTACGCTCA introducing a single HA tag with a 3' NdeI site for 
cloning, used to make pMR8 1 
HA-R 	 mrol6 	TATGAGCGTAATCTGGAACATCGTATG can be cloned with HA-F directly into NdeI site 
GGTAGCTGG introducing a single HA tag with a 3' NdeI site for 
cloning, used to make pMR8 I 
Myc-F 	 mroll 	TATCGGTGAACAGAAACTGATCAGCGA can be cloned with Myc-R directly into NdeI site 
AGAGGATCTGCA introducing a single c-Myc tag with a 3' NdeI site 
for cloning, used to make pMR82 
Myc-R 	 mrol8 	TATGCAGATCCTCTTCGCTGATCAGTT can be cloned with Myc-F directly into Ndet site 
TCTGTTCACCGA introducing a single c-Myc tag with a 3' NdeI site 
for cloning, used to make pMR82 
Lsml-BamHI 	mrol9 	AAGGATCCTTAGTACATGTCAGAT LSMJ reverse primer introducing a 3' BamHI site 
for pETl9b, pMR81 and pMR82 
NdeI-LSM1 	mro20 	AAAAAAACATATGTCTGCAAATAGC LSMI forward primer introducing aS' NdeI site for 
pET 19b, pMR81 and pMR82 
LSM8-BamHI 	mro2 1 	AAGGATCCTTATTTTGTCTTTGATTC LSM8 reverse primer introducing a 3' BamHI site 
for pET1 9b, pMR81 and pMR82 
NdeI-LSM8 	mro22 	AAAAAAACATATGGACCAGCAAGC LSM8 forward primer introducing a 5' NdeI site for 
pET 19b, pMR81 and pMR82 
pIP24delFC 	mro25 	TGGCGCCATTATTATATTTAG Forward primer ( nt1058-1079 of PRP24) to check 
for MO deletion in prp24 together with pLPdelRC 
pIPdelRC 	mro26 	CATTTTAGCTTCCTTAGCTCC Reverse primer in pIP24 plasmid to check for MO 
deletion in PRP24 together with pIP24delFC 
NdeI-Prp24 	mro30 	AAAAAAACATATGGAGTATGGACATC PRP24 forward primer introducing a 5' NdeI site 
for pETl9b, pMR81 and pMR82 
Prp24-BainHI 	mro3 1 	AAGGATCCCTACTCACCTAGAAAC PRP24 reverse primer introducing a 3' BamHI site 
for pET1 9b, pMR8 1 and pMR82 
Lsm4-XhoI 	mro32 	AAAACTCGAGAAATTCGACCTTTTG LSM4 reverse primer introducing a 3' XhoI site for 
pETDuet vectors MCS2 
Table 2.1.8.1a Oligonucleotides used for cloning, sequencing and 
colony PCR (continued) 
Oligo Name Alias Sequence Description 
BamHl-Lsm8 mro33 AAGGATCCGATGGACCAGCAAGC LSM8 (incorrect) forward primer introducing a 5' 
BamHI Site for pETDuet vectors MCS 1 
Lsm8-PstI mro34 ACTGCAGTTATTTTGTCTTTGATTC LSM8 reverse primer introducing a 3' PstI site for 
pETDuet vectors MCS 1 
ACYCDuetUP1 mro35 GGATCTCGACGCTCTCCCT sequencing primer for Novagen Duet series MCS1 
forward 














TTGTACACGGCCGCATAATC sequencing primer Novagen Duet series MCS2 
forward 
AAAACTCGAGTTTTCTTTCAGTCATTA LSM2 reverse primer introducing a 3' X7ioI site for 
CC pETDuet vectors MCS2 
AAGGATCCGATGGAGACACCTTTGG LSM3 forward primer introducing a 5' BamHI site 
for pETDuet vectors MCS 1 
ACTGCAGTTATATCTCCACTGCGC LSM3 reverse primer introducing a 3' PstI site for 
pETDuet vectors MCS I 
AAGGATCCGATGTCTGCAAATAGC LSMI forward primer introducing a 5' BamHI site 
for pETDuet vectors MCS 1 
AACTGCAGTTAGTACATGTCAGAT LSMJ reverse primer introducing a 3' PstI site for 
pETDuet vectors MCS 1 
AAGGATCCGATGCTTTTCTTCTCC LSM2 forward primer introducing aS BamHI site 
for pETDuet vectors MCS1 
AACTGCAGTTATTTTCTTTCAGTC LSM2 reverse primer introducing a 3 PstJ site for 
pETDuet vectors MCS1 
AAAACTCGAGTATTTTTTGTTCACTG LSM6 reverse primer introducing a 3' k7ioI site for 
pETDuet vectors MCS2 
AAAACTCGAGTTTTTGCATATATAGTA LSM7 reverse primer introducing a 3'J7zo1 site for 
C pETDuet vectors MCS2 
AAGGATCCGATGCATCAGCAACAC LSM7 forward primer introducing aS' BamHT site 
for pETDuet vectors MCS 1 
AACTGCAGTTATTTTTGCATATATAG LSM7 reverse primer introducing a 3' PstI site for 
pETDuet vectors MCSI 
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Table 2.1.8.1a Oligonucleotides used for cloning, sequencing and 
colony PCR (continued) 
Oligo Name 	Alias 	Sequence Description 
BamHI-Lsm5 	mro49 	APGGATCCGATGAGTCTACCGG LSM5 forward primer introducing a 5' BamH! site 
for pETDuet vectors MCS I 
Lsm5-PstI 	mro50 	AACTGCAGTTACAACGCCTCC LSM5 reverse primer introducing a 3' Ps:! site for 
pETDuet vectors MCS I 
Lsm8Rpe2 	mro56 	ATTGGTTATGAATAGATTAG reverse primer anneals to 10 1-120 of LSM8 
(used for primer extension) 
BamH!- 	mro58 	AAGGATCCGATGTCAGCCACCTTG LSM8 (correct) forward primer introducing a 5' 
Lsm8new BamHI site for pETDuet vectors MCS 1 
NdeI-Lsm8new 	mro59 	AAAAAAACAThTGTCAGCCACCTTG LSM8 (correct) forward primer introducing a 5' 
NdeI site for pETl9b 
Prp24dlO-BamH! 	mro62 	AAGGATCCCTACTCACCCATCTGC prp2 4410 reverse primer introducing a 3' BamHI 
site for pET 19b, pMR8 1 and pMR82 
BamHI- 	mro83 	AAGGATCCAGAACGTATACGTATATTG Forward primer introducing BamHI site at 5' end of 
327LSM5-F —327 position of LSM5 start 
XhoI+127LSM5- mro84 	AAAACTCGAGAGCAATCACCAGTGTC 	Reverse primer introducing AlioI site at 3' end of 
R 	 +127 position of LSM5 stop 
U6—check mro98 CAATATTCACATTCATAAAGC Reverse complement to downstream sequence of 
SNR6 
Ptef-R mro99 ATGTATGGGCTAAATGTAC Reverse complement to TEF promoter (HpH, NAT 
and KANpFA6 based cassettes) 
NdeI-Hfq-F mro 100 AAAAAAACATATGGCTAAGGGGCAATC hfq forward primer introducing aS' NdeI site for 
pET 19b, pMR81 and pMR82 
BamHI-Hfq-R mro 101 AAGGATCCTTATTCGGTTTCTTCGCT hfq reverse primer introducing a 3' BamHI site for 
pET 19b, pMR81 and pMR82 
Hfq-del-F1 mrol02 AAAAACTGCAGTGCATCAGTTCGCCAT Ps:l site at 5' end of nt449 to 432 of E. coil Hfq 
CG 
Hfq-del.R1 mrol03 GAAACCTTATTCATTCTCTCTTTTCCT Reverse complement of E. coli hfq nt+302 to +313 
TATATG followed by reverse complement of nt-19 to +2 
Hfq-del-F2 mrolO4 AAAAGAGAGAATGAATAAGGTTTCGGG nt-10 to +2 of E. coil hfq followed by nt+302 to 
CTG +320 
Hfq-del-R2 mrolOS AAAAAGTCGACCTGCAACTTACCCTCA Reverse complement of Sail site at 3' end ofnt+741 
TG to +758 of E. coil hfq 
Table 2.1.8.1a Oligonucleotides used for cloning, sequencing and 
colony PCR (continued) 
Oligo Name Alias Sequence Description 
U617_check mrol08 CCTGGCATGAACAGTGG Covers nt-78 to -62 of SNR6, used for sequencing 
and colony PCRs 
LsmlN-8C-F mro122 GACATCGATAAAGAAGATAGTCTAGCT LSMJ nt.+346 to +363 followed by LSM8 nt.+220 
CCTATAGAC to +237 
LsmlN-8C-R mro 123 GTCTATAGGAGCTAGACTATCTTCTTT Reverse complement of LSMI nt.+346 to +363 and 
ATCGATGTC LSM8 nt.+220 to +237 
Lsm8N-1C-F mrol24 GATGCAGAAAATGATGACCAACCCCTT LSM8 nt.+202 to +219 followed by LSMI nt.+364 
GAGGCC to +378 
Lsm8N- 1 C-R mro 125 GGCCTCAAGGGGTTGGTCATCATTTTC Reverse complement of LSM8 nt.+202 to +219 and 
TGCATC LSMI nt.+364 to +378 
Lsm8-XhoI mrol26 APJACTCGAGTTATTTTGTCTTTGATT LSM8 reverse primer introducing a 3' XhoI site for 
C pGFP-N-FUS 
LsmldC-XhoI-R mro129 AAAACTCGAGTTAATCTTCTTTATCGA LSMI reverse primer introducing a 3' k7oI site to 
TGTC ismiAC (behind nt.363) for pGFP-N-FUS 
Lsm8dC-XhoI-R mrol36 AAAACTCGAGTTAGTCATCATTTTCTG LSM8 reverse primer introducing a 3'Ji7th1 site and 
CATC stop codon to lsm84C (behind nt.219) for pGFP-N- 
FUS 
ClaI-Lsml-R mro137 AAATCGATGTACATGTCAGATTTATGG LSMJ reverse primer introducing a 3' ClaI site for 
pGFP-C-FUS 
ClaI-Lsm8-R mrol38 AAATCGATTTTTGTCTTTGATTCGTAC LSM8 reverse primer introducing a 3' ClaI site for 
pGFP-C-FUS 
PMet25F mro 139 GTCAGATACATAGATAC Forward primer at 3' end of MET25 promoter used 
for sequencing of inserts of pGFP-C-FUS 
Lsm8dC-ClaI-R mro 140 AAATCGATGTCATCATTTTCTGCATC LSM8 reverse primer introducing a 3' ClaI site to 
lsm84C (behind nt.219) for pGFP-C-FUS 
Lsm8dC-BamHI- mrol4l AAGGATCCTTAGTCATCATTTTCTGCA LSM8 reverse primer introducing a 3' BamHI site to 
R TC lsm8AC (behind nt.2 19) for pGFP-C-FUS 
BamHT-HfqdC83 mro 143 AAGGATCCTTAGTAGTTACTGCTGGTA Reverse primer introducing a BamHl site and stop 
C 	 codon to the 3' end of E. coil hfq deleted after aa83 
Xhol-NLS- 	mro 146 AAAACTCGAGTTAGACCTTTCTCTTCT 	Reverse primer introducing Jt7,ol site, SV40 NLS 
Lsm8dC-R 	 TCTTTGGGTCATCATTTTCTGCATC 	and stop codon at 3' end of lsm8AC (behind nt.219) 
for pGFP-N-FUS 
WE 
Table 2.1.8.1a Oligonucleotides used for cloning, sequencing and 
colony PCR (continued) 
Oligo Name Alias 	Sequence Description 
ClaI-NLS- mrol47 	AAATCGATGACCTTTCTCTTCTTCTTT Reverse primer introducing Cal site and SV40 
Lsm8dC-R GGGTCATCATTTTCTGCATC NLS at 3' end of lsm84C (behind nt.219) for pGFP- 
C-FUS 
BamHl-NLS- mro 148 	AAGGATCCTTAGACCTTTCTCTTCTTC Reverse primer introducing BamHI site and SV40 
Lsm8dC-R TTTGGGTCATCATTTTCTGCATC NT S at 3' end of 1sm84C (behind nt.2 19) for pGFP- 
C-FUS 
Lsm1NN8CN-F mrol49 	CTATTGTAAGCTCAGTAGACAAAAGAG LSMJ nt.+134 to +153 followed by LSM8 nt.+3 ito 
TTGTTATAATCAAAGT +53 
Lsm1NN8CN-R mrol5O 	ACTTTGATTATAACAACTCTTTTGTCT Reverse complement of LSMI nt.+134 to +153 and 
ACTGAGCTTACAATAG LSM8 nt.+3 1 to +53 
Lsm8NN1CN-F mrol5l 	CACCTTGAAAGACTACTTAAATCGTAA LSM8 nt.+9 to +30 followed by LSMJ nt.+154 to 
AATCTTCGTTCTTTTG +174 
Lsm8NN1CN-R mrol52 	CAAAAGAACGAAGATTTTACGATTTAA Reverse complement of LSM8 nt.+9 to +30 and 
GTAGTCTTTCAAGGTG LSMJ nt.+154 to +174 
BamHl-Lsmins- mrol53 	AAGGATCCGTACATGTCAGATTTATGG Reverse complement introducing BamHI site to 3' 
R end of LSMI without stop codon for pGFP-C-FUS 
BamHl-Lsm8ns- mro 154 AGGATCCTTTTGTCTTTGATTCGTAC 	Reverse complement introducing BamHI site to 3' 
















Introduces BamHI site at 5' end of E. coli hfq 
Introduces XbaI site at 5' end of E. coli hfq for 
pGFP-N-FUS 
Reverse primer introducing )t7iol site at 3' end of E. 
coli hfq for pGFP-N-FUS 
Reverse primer introducing Cal site at 3' end of 
LSM8 N-terminal extension (behind nt.+30) 
Introduces XbaL site at 5' end of LSMIAN (from 
nt.+154) 
Introduces XbaI site at 5' end of LSM C-terminal 
extension (from nt.+364) 
Introduces XbaL site at 5' end of LSM84N ( from 
nt.+3 1) 
XbaI-lsm8dN-F 	mrol6l AAATCTAGAAAAAGAGTTGTTATAATC 
AAAG 
Table 2.1.8.1a Oligonucleotides used for cloning, sequencing and 
colony PCR (continued) 
Oligo Name 	Alias 	Sequence 	 Description 
Bam}{I-LmldC- 	mrol62 AAGGATCCTTA.ATCTTCTTTATCGATG 	Reverse primer introducing BamHl site and stop 
R 	 TC 	 codon at 3' end of LSMJ4C (behind nt.+363) 
BamHI- 	mro 163 AAGGATCCATCTTCTTTATCGATGTCT 	Reverse primer introducing BamHI site at 3' end of 
LsmldCns-R 	 AC 	 LSMJAC (behind nt.+363) 
XbaI- 	 mro 164 AA.ATCTAGAATGCGTAAAATCTTCGTT 
Ism1dNATG-F 	 CTTTTG 
Xbal- 	 mro 165 AAATCTAGAATGATGAAAAGAGTTGTT 
Ism8dNATG-F 	 ATAATCAAAG 
ClaI-lsmlN-R 	mro166 AAATCGATGTCTACTGAGCTTACAATA 
G  
Introduces XbaI site and start codon at 5' end of 
LSMJ4N (from nt.+1 54) 
Introduces Xbal site and start codon at 5' end of 
LSM8AN (from nt.+3 1) 
Reverse primer introducing ClaI site at 3' end of 
LSMJ N-terminal extension (behind nt.+153) 
Table 2.1.8.1 b Oligonucleotides used for cloning, sequencing and 
colony PCR 
Oligo name Sequence Discnption Source 
S8949. CCCGGATCCATGGAGTATGGACATCACGC Introduces BamHI site at 5' end of PRP24 Vidal, 1998 
(used for PRP24 sequencing) 
S8949 CCACTCTAGAGTCTACTCACCTAGAAAC Reverse primer introducing XbaI site at 3' Vidal, 1998 
end of PRP24 (used for PRP24 sequencing) 
JMB1 1 GGTGTCACCAAGCTTAATC PRP24 nt. +966 to +983; used for Vidal, 1998 
sequencing (used for PRP24 sequencing) 
N6089 GTATACGGCTTCCCAG PRP24 nt. +437 to +451; used for Vidal, 1998 
sequencing (used for PRP24 sequencing) 
Oligo-1 GCTTCGTTCGCCTTC Reverse complement of PRP24 nt. +83 to Vidal, 1998 
+98 (used for PRP24 sequencing) 
Oligo-2 GCGAATCCGCAACATC Reverse complement of PRP24 nt. +210 to Vidal, 1998 
+226 (used for PRP24 sequencing) 
Oligo-3 TCGCCCCTCTAGTGTG Reverse complement of PRP24 nt. +615 to Vidal, 1998 
+630 (used for PRP24 sequencing) 
!J1 
Table 2.1.8.1b Oligonucleotides used for cloning, sequencing and 
colony PCR (continued) 
Oligo name 	Sequence Discription 	 Source 
P5117 	GGCGCCATTGAAGTC Reverse complement of PRP24 nt. +1050 to 	Vidal, 1998 
+ 1065 (used for PRP24 sequencing) 
P5118 	GAAGGCGAACGAAGC PRP24 nt. +83 to +98 (used for PRP24 	Vidal, 1998 
sequencing) 
M13-F 	GTAAAACGACGGCCAG M13 forward sequencing primer 
M13-R CAGGAAACAGCTATGAC M13 reverse sequencing primer 
pQE-F CGTATCACGAGGCCCTTTCG Sequencing primer for pQE vectors, Markus Bohnsack 
approximately 1 OOnt from BamHI site Tollervey lab 
pQE-R GTTCTGAGGTCATTACTGG Sequencing primer for pQE vectors, Markus Bohnsack 
approximately lOOnt from BamHI site Tollervey lab 
S680 GGGGACAAGTTTGTACAAA.AAAGCAGGCT Forward primer used to check genomic Liz Thompson, 
ctGGCTAATTAACTGGGTTATGTG lsmd deletion this lab 
S681 GGGGACCACTTTGTACAAGAAAGCTGGGT Reverse primer used to check genomic 1sm6 Liz Thompson, 
tCTCCGTCACTTTCTGGCTCT deletion this lab 
S674 GGGGACAAGTTTGTACAAAAAAGCAGGCT Forward primer used to check genomic Liz Thompson, 
CTGTCTTCTTCAACTGCCGTTTC lsm7 deletion this lab 
S677 GGGGACCACTTTGTACAGAAPGCTGGGT Reverse primer used to check genomic lsm7 Liz Thompson, 
tCAGTTTGTTTCGTTTTTCCTCA deletion this lab 
Lsm8genF CCCATTCCAGTATCTGCTTGTC Anneals 443 bp upstream of start of LSM8 Marian Thomson, 
(MT042) ORF; used to check for lsm8 deletion this lab 
R-lsm8-485 GGGGAAGAGAAGAAGCAT Anneals 485 bp downstream of LSM8 ORF; Kum Loong 
used to check for lsm8 deletion Boon, this lab 
rpTEF GGATGTATGGGCTAAATGTAC Reverse primer in the TEF promoter region; Marian Thomson, 
used to check for presence of this lab 
deletion/tagging cassette on the genome 
pKO.F AGGGCAGGGTCGTTAAATAGC pTOF24 sequencing primer forward David Leach 
pKO.R2 AGGGAAGAAAGCGAAAGGAG pTOF24 sequencing primer reverse David Leach 
XBALSM 1 GCTCTAGAATGTCTGCAAATAGCAAGGAC Introduces XbaI site at 5' end of LSMJ, for Michael Spiller, 
F cloning into pGFP-N-FUS this lab 
Table 2.1.8.1b Oligonucleotides used for cloning, sequencing and 
colony PCR (continued) 
Oligo name Sequence 	 Discription 	 Source 
XHOLSM 1 	CCGCTCGAGTTAGTACATGTCAGATTTAT Introduces XhoI site at 3' end of LSMJ, for 	Michael Spiller, 
R 	 GG 	 cloning into pGFP-N-FUS 	 this lab 
XBALSM8 	CGTCTAGAATGTCAGCCACCTTGAAAGAC Introduces XbaI site at 5' end of LSM8, for 	Michael Spiller, 
F 	 TACTTAAATAAA 	 cloning into pGFP-N-FUS 	 this lab 
XBAGFPF 	GCTCTAGAGTGGATCCCCCCGCTGAATTC Introduces XbaI site at Send of GFP ORF 	Michael Spiller, 
ATGAGT 	 from pCIFP-N-FUS 	 this lab 
Table 2.1.8.2 Oligonucleotides used in site directed mutagenesis 
Oligo Name Alias Sequence Description 
U6-G63A-F mrol I 1 CAGAGATGATCAGCAATTCCCCTGCAT U6-G63A primers can be used to introduce the 
AAGGATG C69A mutation in SNR6 using the Quik Change 
method 
U6-G63A-R mrol 12 CATCCTTATGCAGGGGAATTGCTGATC U6-C163A primers can be used to introduce the 
ATCTCTG C69A mutation in SNR6 using the Quik Change 
method 
U6-C69A-F mrol09 GATGATCAGCAGTTCCCATGCATAGG U6-C69A primers can be used to introduce the 
ATGAACCG C69A mutation in SNR6 using the Quik Change 
method 
U6-C69A-R mrol 10 CGGTTCATCCTTATGCATGGGAACTGC U6-C69A primers can be used to introduce the 
TGATCATC C69A mutation in SNR6 using the Quik Change 
method 
U6-G63AJC69A- mro 144 CAGAGATGATCAGCAATTCCCATGCAT U6-G63A1C69A primers can be used to introduce 
F AAGGATG G63A and C69A mutations into SNR6 using the 
Quik Change method 
U6-C163A/C69A- mm l45 CATCCTTATGCATGGGAATTGCTGATC U6-G63A/C69A primers can be used to introduce 
R ATCTCTG G63A and C69A mutations into SNR6 using the 
Quik Change method 
PIP24Fb mro23 CCTGACAACAGAGCAGATGGGTGAG Used with PIP24rB to introduce prp24A10  in pIP24 
TAGACTC by Quik change method 
93 
Table 2.1.8.2 Oligonucleotides used in site directed mutagenesis 
(continued) 
Oligo Name Alias 	Sequence Description 
PIP24rB mro24 	AGGTCGCCACTCTAGAGTCTACTCACC Used with PIP2417b to introduce prp24410 in pIP24 
CATCTGCTC by Quik change method 
RRM4sub-F mro 106 	CTTCTCGTTAGCGACGCCAATGCCGCC RRM4sub primers can be used to introduce the 
GCTATTATATTTAGAGATAG RRM4sub mutation in PRP24 using the Quik 
Change method 
RRM4sub-R mrol07 	CTATCTCTAAATATAATAGCGGCGGCA RRM4sub primers can be used to introduce the 
TTGGCGTCGCTAACGAGAAG RRM4sub mutation in PRP24 using the Quik 
Change method 
Prp24-F87A-F mrol 13 	CGTTTTGCACGTATTGAAGCTGCCAGG Prp24-F87A primers can be used to introduce the 
TATGATGGAGC F87A mutation in PRJ'24 using the Quik Change 
method 
Prp24-F87A-R mrol 14 	GCTCCATCATACCTGGCAGCTTCAATA Prp24-F87A primers can be used to introduce the 
CGTGCAAAACG F87A mutation in PRP24 using the Quik Change 
method 
Prp24-R158S-F mrol 18 	CGATTCAATACAAGCAGTAGGTTCGCT Prp24-R158S primers can be used to introduce the 
TACATCGATG R158S mutation in PRP24 using the Quilc Change 
method 
Prp24-R158S-R mrol 19 	CATCGATGTAAGCGAACCTACTGCTTG Prp24-RI58S primers can be used to introduce the 
TATTGAATCG R158S mutation in PRP24 using the Quik Change 
method 
Prp24-F2571-F mro 120 	GCACAGTTTCAATAACTGTTGTGCAAT Prp24-F2571 primers can be used to introduce the 
TATGGTTTTTGAAAATAAAGATTC F2571 mutation in PRP24 using the Quik Change 
method 
Prp24-F2571-R mrol2l 	GAATCTTTATTTTCAAAAACCATAATT Prp24-F2571 primers can be used to introduce the 
GCACAACAGTTATTGAAACTGTGC F2571 mutation in PRP24 using the Quik Change 
method 
LsmS-E 10K-F mro85 	GTCTACCGGAGATTTTGCCTTTAAAAG Add E 10K mutation and Dral site to LSM5 using 
TCATAGATAAAACAP.TTAACCAG the Quik Change method 
LsmS-EIOK-R mro86 	CTGGTTAATTGTTTTATCTATGACTTT Add E1OK mutation and Dral site to LSM5 using 
TAAAGGCAAAATCTCCGGTAGAC the Quik Change method 
Lsm8- mro130 	CCTCATAGCAAGCCTAGCCGGCTTCGC Lsm8-N28A/D31A primers can be used to 
N28A/D3 lA-F CAAAAATACTAATCTATTC introduce N28A and D3 1A mutations into LSM8 
MI 
Table 2.1.8.2 Oligonucleotides used in site directed mutagenesis 
(continued) 
Oligo Name 	Alias 	Sequence 	 Description 
Lsm8- 	 mrol31 GAATAGATTAGTATTTTTGGCGAAGCC Lsm8-N28AID31A primers can be used to 
N28A/D3 1A-R 	 GGCTAGGCTTGCTATGAGG 	 introduce N28A and D3 IA mutations into LSM8 
using the Quik Change method 
Lsm8- mrol32 CTAAACGGCTTCGACAAAAPiTGCTGCT Lsm8-T34A/N35A primers can be used to 
T34A/N35A-F CTATTCATAACCAATGTTTTC introduce T34A and N35A mutations into LSM8 
using the Quik Change method 
Lsm8- mro 133 GAAAACATTGGTTATGAATAGAGCAGC Lsm8-T34A/N35A primers can be used to 
T34A/N35A-R ATTTTTGTCGAAGCCGTTTAG introduce T34A and N35A mutations into LSM8 
using the Quik Change method 
Lsm8- mrol34 CTGCAAGGCACAGTTACTTGCATGGGC Lsm8-RGS57AWA primers can be used to 
RGS57AWA-F CGAGATTGCTCTTGTTGGCCTC introduce R57A, G58W and S59A mutations into 
LSM8 using the Quik Change method 
Lsm8- mroI35 GAGGCCAACAAGAGCAATCTCGGCCCA Lsm8-RGS57AWA primers can be used to 
RGS57AWA-R TGCAAGTAACTGTGCCTTGCAG introduce R57A, G58W and S59A mutations into 
LSM8 using the Quik Change method 
Table 2.1.8.3a Oligonucleotides used for in vitro transcription and strand 
displacement assays 
Oligo Name Alias Sequence Description 
T717new mro27 CCTAATACGACTCACTATAGG for PCR on 11 promoter on pT7U6 (minimal T7 
promoter followed by first G of U6) 
T7U417new mro28 CCTAATACGACTCACTATAGGATCCTT for PCR on pU4 with addition of minimal T7 
ATGCACGGG promoter (anneals to first 15 bp of U4 gene) 
U6-FokI-R mro29 AAACGGTTCATCCTTATGCAG Reverse primer on U6 gene (69-89) to create in 
vitro transcription template with T7Fnew for U63' 
T7U6rc mro5 I CCTAATACGACTCACTATAGGAAAACG Introduces a minimal 11 promoter at the 3' end of 
AAATAAATCTCTTTG U6 to produce a reverse complement template with 
U61' for U6_rc RNA 
95 
Table 2.1.8.3a Oligonucleotides used for in vitro transcription and strand 
displacement assays (continued) 
Oligo Name Alias Sequence Description 
U6F mro52 GTTCGCGAAGTAACCC 5' end of U6 gene used to produce reverse 
complement template in combination with T7U6rc 
for U6_rc RNA 
T7U2F mro54 CCTAATACGACTCACTATAGGATCTCT introduces a minimal 17 promoter to the 5' end of 
TTGCCTTTTGG the U2 gene 
U2R mro55 ATAAAAGAGCGAACGGG reverse primer anneals to 3' end of U2 gene 
T7U6(71-86)F 	mro60 	CCTAATACGACTCACTATAGGCATAAG Introduces a minimal 17 promoter 5' of U6 
GATGAACCG 	 sequence 71-86 
U6(55-70)rc 	mro6l 	AGGGGAACTGCTGATC 	 reverse primer anneals to 55-70 of U6 gene 
U6(76-91)rc 	mro63 	TAAAACGGTTCATCCT 	 anneals to 76-91 of U6 gene (or U6 RNA) 
U6(77-92)rc 	mro64 	GTAAAACGGTTCATCC 	 anneals to 77-92 of U6 gene (or U6 RNA) 
16nt 	 mro65 	TTGCTTTACGGTGCTA 	 random 16nt (taken from unwinding substrate in 
(Cordm etal., 2004)) 
T7F2 	 mro66 	TAATACGACTCACTATAGG 	 T7 promoter for small RNA in vitro transcriptions 
T7U6(77-1 12)rc 	mro67 	AAAACGAAATAAATCTCTTTGTAAAAC 	Template when annealed with T7F2 for in vitro 
GGTTCATCCTATAGTGAGTCGTATTA 	transcription of U6(77-112) RNA 
T7U6(77-108)rc 	mro68 	CGAAATAAATCTCTTTGTAAAACGGTT 	Template when annealed with T71 72 for in vitro 
CATCCTATAGTGAGTCGTATTA 	 transcription of U6(77-108) RNA 
T7U6(77-103)rc 	mro69 	TAAATCTCTTTGTAAAACGGTTCATCC 	Template when annealed with T7F2 for in Vitro 
TATAGTGAGTCGTATTA 	 transcription of U6(77-103) RNA 
T7U6(77-98)rc 	mro70 	CTCTTTGTAAAACGGTTCATCCTATAG 	Template when annealed with T71 72 for in vitro 
TGAGTCGTATTA 	 transcription of 16nt-U6(92-1 12) RNA 
T7-16nt-U6(92- 	mro7l 	AAAACGAAATAAATCTCTTTGTTGCTT 	Template when annealed with T7F2 for in vitro 
1 12)rc 	 TACGGTGCTACCTATAGTGAGTCGTAT 	transcription of U6(77-112) RNA 
TA 
U6(77-98)rc 	mro72 	CTCTTTGTAAAACGGTTCATCC 	 anneals to 77-98 of U6 gene (or U6 RNA) 
U6(71-86)rc 	mro73 	CGGTTCATCCTTATGC 	 anneals to 71-86 of U6 gene (or U6 RNA) 
U6(83-98)rc 	mro74 	CTCTTTGTAAAACGGT 	 anneals to 83-98 of U6 gene (or U6 RNA) 
U6(26-35)rc 	mro75 	TTGACCAAATTT 	 anneals to 26-3 5 of U6 gene (or U6 RNA) 
Table 2.1.8.3a Oligonucleotides used for in vitro transcription and strand 
displacement assays (continued) 
Oligo Name Alias Sequence Description 
T7U6(36-70)rc mro76 AGGGGAACTGCTGATCATCTCTGTATT Template when annealed with T7172 for in vitro 
GTTTCAAACCTATAGTGAGTCGTATTA transcription of U6(36-70) RNA 
T7U6(40-70)rc mro77 AGGGGAACTGCTGATCATCTCTGTATT Template when annealed with T7172 for in vitro 
GTTTCCTATAGTGAGTCGTATTA transcription of U6(40-70) RNA 
T7-16nt-U6(92- mro78 CTCTTTGTTGCTTTACGGTGCTACCTA Template when annealed with T7172 for in vitro 
98)rc TAGTGAGTCGTATTA transcription of 16nt+U6(92-98) RNA 
T7U6(77-92)rc mro79 GTAAAACGGTTCATCCTATAGTGAGTC Template when annealed with T7172 for in vitro 
GTATTA transcription of U6(77-92) RNA 
T7-16nt-rc mro8O TTGCTTTACGGTGCTACCTATAGTGAG Template when annealed with 1'7F2 for in vitro 
TCGTATTA transcription of 16nt RNA 
T7U6(77- mro8l AGCTTGCTTTACGGTGCTAGGTAAAAC Template when annealed with T7F2 for in vitro 
92)20nt-rc GGTTCATCCTATAGTGAGTCGTATTA transcription of U6(77-92)+20nt RNA 
T7rcU6(77-92) mro82 GGATGAACCGTTTTACCTATAGTGAGT Template when annealed with T7172 for in vitro 
CGTATTA transcription of U6(77-92)rc RNA 
T7U6(71-1 12) mro87 AAAACGAAATAAATCTCTTTGTAAAAC Should be T7U6(71.1 12)rc; Template when 
GGTTCATCCTTATGCCTATAGTGAGTC annealed with T7F2 for in vitro transcription of 
GTATTA U6(71-112)RNA 
T7U6(93- mro88 GTAAAACGGTTCATCCAAP.ACGAAATA Template when annealed with T7F2 for in vitro 
1 12)(77-92)rc AATCTCTTTCCTATAGTGAGTCGTATT transcription of U6(93-112)+(77-92) RNA 
A 
T7U6(1 12- mro89 GTAAAACGGTTCATCCTTTCTCTAAAT Template when annealed with T7172 for in vitro 
93)(77-92)rc AAAGCAAAACCTATAGTGAGTCGTATT transcription of U6(112-93)+(77-92) RNA 
A 
T7U6F mrol 17 CCTAATACGACTCACTATAGGTTCGCG for PCR adding T7 promoter to U6 5'end 
AAGTAACCC 
97 
Table 2.1.8.3b Oligonucleotides used for in vitro transcription and strand 
displacement assays 
Oligo name 	Sequence Discnption Source 
T7U4F 	CGTAATACGACTCACTATAGGGAGAATCC Introduces a 11 promoter to the 5' end of Page, 2002 
TTATGCACGGG SNRI4 
U4R 	AAAGGTATTCCAAAAATTCCC Reverse primer from 3' end of U4 snRNA Page, 2002 
coding sequence 
LORY1 	CGTAATACGACTCACTATAGGGAGAGTTC Introduces a T7 promoter to the 5' end of Page, 2002 
GCGAAGTAACCC SNR6 
S5761 	AAAACGAAATAAATCTCTTTGTAAAAC Reverse primer from 3' end of U6 snRNA Page, 2002 
coding sequence 
Table 2.1.8.4 Oligonucleotides used as probes in Northern hybridisation 
Oligo name Sequence Discription Source 
G8102 CACGCCTTCCGCGCCGT Ui snRNA Northern probe Boon, 2005 
08103 	 CTACACTTGATCTAAGCCAAAAG 	U2 snRNA Northern probe 	 Boon, 2005 
06568 	 AGGTATTCCAAAAATTCCC 	 U4 snRNA Northern probe 
	
Boon, 2005 




(V4528) 	 AA 
U6_knockout_rc TTGGTCAATTTGAPACAATACAGAG 
(mro53) 	 AT 
TSA1 probe 	GGAGTATTCGGAGTCAGTGGAGGCG 
(#1455) 	 AAAAGAACT 
SCR  probe 	ATCCCGGCCGCCTCCATCAC 
(#250)  
U6 snRNA Northern probe 	 Boon, 2005 
reverse complement of U6 —knockout primer This thesis 
(29-54), used as a probe for hybridisation to 
U6 reverse complement RNA 
Used as probe in Northern blotting 	Tollervey lab 
hybridisation of ThAi mRNA 
Used as probe in Northern blotting 	Tollervey lab 
hybridisation of scRi RNA 
Table 2.1.8.5a Oligonucleotides used for yeast genomic deletion and 
tagging 
Oligo Name 	Alias 	Sequence 	 Description 
Lsm5-HpH-F mrol 15 	ATAGCGTATACACGTGCACTCACAAGC Forward primer covering 146nt of ISM5 followed 
ATACACAGAAGCGCGCAAACGGATCCC by pFA6a forward sequence (Fl deletion primer, 
CGGGTTAATTAAG Longtine etal., 1998) 
Lsm5-HpH-R mrol 16 	ATTTTTTTTAGATGCACTATACAAATT Reverse primer covering the last 46nt of LSM5 
CGCGTTAATTTTTGCCTTTGAATTCGA followed by pFA6a reverse sequence (Ri deletion 
GCTCGTTTAAAC primer, Longtine etal., 1998) 
Lsm6-HpH-F mro90 	TTCTATTATTAAAACATTTTACCCGGG Forward primer covering 45nt of LSM6 followed by 
GGCAGCTGTTCGTGTACACGGATCCCC pFA6a forward sequence (Fl deletion primer, 
GGGTTAATTAAG Longtine etal., 1998) 
Lsm6-HpH-R mro9l 	ACCAACTTGCTCATTCCTACATATTAA Reverse primer covering 46nt of LSM6 followed by 
TCCATTAGAGGAGATAAGTGAATTCGA pFA6a reverse sequence (Ri deletion primer, 
GCTCGTTTAAAC Longtine etal., 1998) 
Lsm7-HpH-F mro92 	TGAGAGCAGCACTTTGTTTACTACACA Forward primer covering 46nt of LSM7 followed by 
GAACATTAACCAAAAAAACCGGATCCC pFA6a forward sequence (Fl deletion primer, 
CGGGTTAATTAAG Longtine etal., 1998) 
Lsm7-HpH-R mro93 	CGTTTTTAGAAATCAGTTCAGTGTTGT Reverse primer covering 45nt of LSM7 followed by 
TTTCATCATCAGGATTAGGAATTCGAG pFA6a reverse sequence (RI deletion primer, 
CTCGTTTAAAC Longtine etal., 1998) 
Table 2.1.8.5b Oligonucleotides used for yeast genomic deletion and 
tagging 
Oligo name Sequence Discription Source 
S682 TTCTATTATTAAAACATTTTACCCGGG Forward primer for LSM6 genomic deletion Liz Thompson, 
GGCAGCTGTTCGTGTACACGCGCCAGA using the KANMX4 cassette this lab 
TCTGTTTAGC 
S686 ACCAACTTGCTCATTCCTACATATTAA Reverse primer for LSM6 genomic deletion Liz Thompson, 
TCCATTAGAGGAGATAAGTAATTCGAG using the KANMX4 cassette this lab 
CTCGTTTAAACTGG 
Table 2.1.8.5b Oligonucleotides used for yeast genomic deletion and 
tagging (continued) 
Oligo name 	Sequence 	 Discriplion 	 Source 
S678 	 TGAGAGCAGCACTTTGTTTACTACACA Forward primer for LSM7 genomic deletion Liz Thompson, 
GAACATTAACCAAAAAAACCGCGCCAG using the KANMX4 cassette 	 this lab 
ATCTGTTTAGC 
S687 	 CGTTTTTAGAAATCAGTTCAGTGTTGT 	Reverse primer for LSM7 genomic deletion Liz Thompson, 
TTTCATCATCAGGATTAGAATTCGAGC 	using the KANMX4 cassette; deletes Exonl this lab 
TCGTTTAAACTGG 	 and Exon2 to end of Sm domain (no 
disruption of putative YNLI47C-A 3'UTR) 
2.1.9 Antisera 
The antisera used in this study are listed in Table 2.1.9 below. Santa Cruz antibodies 
were also used for Western blotting in horseradish peroxidase (HRP) conjugated 
form, making the use of a secondary antibody superfluous. For non-HRP conjugated 
primary antibodies the appropriate secondary HRP-conjugated antibody was used. 
The same Santa Cruz antibodies were also used for immunoprecipitation in agarose 
conjugated form. S-protein HRP conjugate was used according to the manufacturer's 
instructions. 
Table 2.1.9 Antisera 
Antibody 	Description 	 Reference 
Anti-HA 	Mouse monoclonal antibody (F-7; IgG 2a) raised against the 	Santa Cruz 
(F-7) 
	
	 influenza hemaglutinin HA-i protein epitope; 1:1,000 dilution Biotechnology 
for Western blotting 
Anti-His 	Mouse monoclonal antibody (H-3; IgG 1) raised against the 	Santa Cruz 
(H-3) 	 polyhistidine domain of expression vectors containing the 	Biotechnology 
polyhistidine sequence; 
1:1,000 dilution for Western blotting 
100 
Table 2.1.9 Antisera (continued) 
Antibody 	Description 	 Reference 
Anti-His 	Rabbit polyclonal antibodies (H- 15) raised against a peptide 	Santa Cruz 
(H- 15) 
	
	corresponding to the polyhistidine domains of pET and Xpress Biotechnology 
polyhistidine expression vectors; 
1:1,000 dilution for Western blotting 
Anti-GFP 	Mouse monoclonal antibody (IgG 2a) raised against full length BD Biosciences 
A. Victoria GFP; 1:1,000 dilution for Western blotting 
Anti-c-Myc 	Mouse monoclonal antibody (9E 10; IgG 1 ) raised against the 	Santa Cruz 
(9E10) 	C-terminus of human c-Myc; 	 Biotechnology 
1:1,000 dilution for Western blotting 
Anti-Mouse Sheep anti-rabbit IgG covalently linked to horseradish Amersham 
IgG-HRP peroxidase; 1:10,000 dilution for Western blotting Biosciences 
Anti-Rabbit Donkey anti-rabbit IgG covalently linked to horseradish Amersham 
IgG-HRP peroxidase; 1:10,000 dilution for Western blotting Biosciences 
S-protein HRP 	Ribonuclease S-protein covalently linked to HRP has high 	Novagen 
conjugate 	affinity to the 1 5aa S-tag; 1:5,000 dilution for Western 
blotting 
2.2 Microbiological methods 
2.2.1 Growth of strains 
2.2.1.1 Growth of bacteria 
Strains of E. coli were grown in/on rich LB medium at 37CC, unless otherwise stated. 
To select for or maintain the incorporation of a plasmid, the transformed bacteria 
were grown in/on rich LB medium containing the appropriate antibiotic(s) (2.1.2.5). 
2.2.1.2 Growth of yeast 
Unless otherwise stated, yeast strains were grown at 30°C in/on the appropriate 
medium (2.1.2.3). To maintain selection for plasmid DNA and/or for a nutritional 
reporter gene inserted into the genome, cells were grown in/on YMM (2.1.2.3) 
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complemented with the appropriate dropout powder (2.1.2.4), i.e. synthetic defined 
(SD) medium. To maintain selection for an antibiotic resistance gene inserted into 
the genome, cells were grown in/on the appropriate medium with the relevant 
antibiotic(s) added at the required concentration (2.1.2.5) 
2.2.2 Preservation of strains 
2.2.2.1 Preservation of bacteria 
For storage of E. co/i for time periods up to four weeks, bacteria were stored on solid 
medium at 4°C. In order to preserve strains indefinitely, E. coli were grown 
overnight to stationary phase. 1.5 ml of this culture was added to 150 j.il of 87% 
(w/v) glycerol, resulting in the cells being suspended in 8% (w/v) glycerol, in 2 ml 
Cryo-s screw capped tubes (Greiner). This was subsequently snap-frozen on dry ice 
and stored at —70°C. 
2.2.2.2 Preservation of S. cerevisiae 
Yeast strains were preserved on solid medium for up to eight weeks at 4°C. In order 
to preserve strains indefinitely, yeast cells were grown overnight into late log phase 
or early stationary phase. 1.5 ml of this culture was added to 300 pA of 87% (w/v) 
glycerol, resulting in the cells being suspended in 15% (w/v) glycerol, in 2 ml Cryo-s 
screw capped tubes (Greiner). This was subsequently snap-frozen on dry ice and 
stored at —70°C. 
2.2.3 Transformation of E. co/i 
2.2.3.1 Preparation of chemically-competent cells for cloning 
Preparation of chemically-competent E. co/i was performed according to Inoue et al., 
1990 (Inoue etal., 1990). E. coli DH5a or TOP 10 cells (2.1.5) were grown overnight 
on LB-agar. The next day, a single colony was taken and 5 ml of rich LB with 20 
MM MgSO4 was inoculated and grown overnight to stationary phase. Following this, 
250 ml of LB with 20 MM MgSO4 was inoculated with 2 ml of the stationary-phase 
culture and incubated at 23°C in a shaking incubator at a minimum of 200 rpm until 
0D600 reached 0.4-0.6 (usually 8-10 h). The culture was then cooled on ice for about 
15 min and cells were kept on ice for all subsequent steps. Cells were sedimented (10 
102 
mm, 3,000 rpm, 4°C; Beckman 10,500 rotor) and gently resuspended in 80 ml of ice-
cold sterilised TB buffer (10 mM Pipes-HC1 pH 6.7, 15 mM CaC12, 0.25 M KC1, 55 
mM MnC12). Cells were left on ice for 10 minutes, centrifuged for 10 minutes at 
3,000 rpm at 4°C, and gently resuspended in 20 ml of ice-cold TB buffer. After 
adding 1.5 ml of DMSO followed by a final 10 minutes incubation on ice, cells were 
dispensed into 200 j.il aliquots in cold, sterile tubes and snap-frozen in liquid 
nitrogen. Aliquots were stored at —70°C until required for transformation (2.2.3.2). 
2.2.3.2 Transformation of chemically-competent cells 
For transformation of chemically-competent E. coil (2.2.3.1), aliquots were thawed 
on ice and either up to 10 il of plasmid DNA, or 1-15 p.1 of a ligation reaction 
(2.3.2.14) was added to 50-200 p.l of competent cells and gently mixed. Cells and 
DNA were incubated on ice for 30 min before a 45 seconds heat-shock in a 42°C 
waterbath, after which they were allowed to cool on ice for a further 2 mm. Cells 
were pelleted (5 sec, 14,000 rpm at RT), resuspended in 150 p.1 of LB, pre-warmed at 
3 7°C, before spreading them on LB-agar plates (100 p.g/ml ampicillin; pre-warmed at 
37°C) using the 'Copacabana' method (Worthington et ai., 2001). For antibiotics 
selection other than ampicillin 1 ml of LB (37°C) was added to the cells after the 2 
min incubation on ice and the cells were incubated at 37°C for a further 30-60 mm. 
Cells were then pelleted and resuspended in 150 p.1 of LB before spreading them on 
LB-agar plates containing the appropriate antibiotics. These were incubated 
overnight at 37°C to give cells transformed with the required plasmid time to produce 
visible colonies. 
2.2.3.3 Preparation of electro-competent cells 
A single fresh colony of E. coil DH5a or TOP 10 cells (2.1.5) was used to inoculate 5 
ml of LB and grown overnight to stationary phase. This culture was used to inoculate 
500 ml of LB, which was grown at 37°C till an 0D 600 of 0.6-0.8 was reached. Cells 
were then cooled on ice for 15 min and sedimented by centrifugation for 15 min at 
4,000 rpm, 4°C in a Beckman 10,500 rotor. From this point onwards care was taken 
to keep the cells ice-cold at all times. Cells were then washed twice in 500m1 of ice-
cold sterile water and sedimented as before, each time removing as much of the 
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supernate as possible. Cells were then washed twice in 50 ml of ice-cold 10% (w/v) 
glycerol and sedimented as before. Finally, cells were resuspended in 2 ml of ice-
cold 10% (w/v) glycerol and 40 il aliquots were snap-frozen in liquid nitrogen and 
stored at -70°C. 
2.2.3.4 Transformation of electro-competent cells 
Electro-competent E. coli cells were thawed on ice and 1-15 P1 of DNA @lasmid 
rescued from yeast (2.3.2.3) or ligation mix (2.3.2.14)) was added. This mix was then 
transferred to a pre-chilled electroporation cuvette (2 mm electrode gap; Equibio or 
Eurogentec). The cuvette was dried and electroporation was performed using a Bio-
Rad Gene Pulser II using the following settings: 200 K, 25 gF, 2.5 kV. Immediately 
after electroporation 1 ml of room temperature SOC or LB (2.1.2.2) was added. Cells 
were incubated for 30 min to 1 h at 37°C with agitation. Cells were then sedimented 
by centrifugation (30 s, 14,000 rpm), resuspended in 150 j.il of medium and spread 
using the 'Copacabana' method (Worthington et al., 2001) on LB plates containing 
the appropriate antibiotics (2.1.1.4). 
2.2.3.5 Preparation of calcium-competent cells for transformation with 
plasmid DNA 
For transformation of E. coli with purified plasmid DNA (2.3.2.1), e.g. in preparation 
for expression of recombinant protein (2.4.7), calcium-competent cells were prepared 
as follows. A single fresh colony was used to inoculate 5 ml of LB, which was 
incubated overnight in a shaking incubator. The following day 200 j.il of this 
stationary phase culture was used to inoculate 20 ml of LB. This culture was grown 
for 90 min to 2 h with good aeration until OD600 reached 0.4-0.8. The cells were 
sedimented by centrifugation for 1 min at 10,000 rpm in a Beckman 10,500 rotor, 
resuspended in 10 ml of ice-cold sterilised 50 mM CaCl2 and incubated on ice for 30 
min to 2 h before repeat sedimentation (the presence of a hole in the cell pellet 
indicates competence). The cells were then resuspended gently in 1 ml of ice-cold 50 
mM CaC12 and incubated on ice for a maximum of 24 h or until required for 
transformation. For long-term storage a half volume of ice-cold sterilised 30% 
glycerol was added to the cell suspension, before dispensing into 200 .tl aliquots in 
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cold, sterile tubes. Aliquots were snap-frozen in liquid nitrogen and stored at —70°C 
until required for transformation. 
2.2.3.6 Transformation of calcium-competent cells 
For transformation of calcium-competent E. coli, aliquots were thawed on ice or 
freshly prepared competent cells were dispensed and 0.5 il of plasmid DNA was 
added to 50-100 p1 of competent cells. After gentle mixing the suspension was 
incubated on ice for 30 min and then 1 min in a 42 °C water bath. The cells were 
immediately transferred to ice and left there for 2 min to recover. 1 ml of LB (37°C) 
was then added to the cells followed by incubation at 37°C for a further 30-60 mm. 
Cells were then sedimented, resuspended in 150 .tl of LB and spread using the 
'Copacabana' method (Worthington et al., 2001) on LB-agar plates containing the 
appropriate antibiotics (2.1.1.4). 
2.2.4 Creation of E. co/i genomic deletion 
The method used to make a genomic deletion of the hfq gene was based on that of 
Merlin et al. (Merlin et al., 2002) using the pTOF24 plasmid (2.1.7). The cassette for 
integration into the bacterial chromosome was cloned using the Sal! and PstI sites of 
pTOF24. The cassette was created by PCR with Hfq-del-F 1, Hfq-del-R1, Hfq-del-F2 
and Hfq-del-R2 primers (2.1.8) on BL21 (DE3) (2.1.5) genomic DNA (30 p1 of 
water was boiled for 20 min with one BL21 (DE3) colony; use 1 p1 for a 50 p1 PCR). 
For design of the cassette see 3.6.2. Selection for the newly created plasmid was on 
LB-Cm plates (2.1.1.4) at 30°C (pTOF24 replication is temperature sensitive). 
Colonies were first checked for the absence of Kan resistance to ensure the presence 
of an insert in place of the Kan resistance gene. The insertion was then sequenced 
using pKO.F and pKO.R2 (2.1.8) to check for the presence of the correct sequence. 
The resulting plasmid (pMR54) was transformed using the CaC12 method into the 
strain in which the deletion was to be made (2.2.3.6). Transformed cells were 
selected on LB-Cm plates at 30°C. Single colonies were streaked to LB-Cm plates 
and incubated overnight at 42°C to induce integration of the plasmid into the 
genome. Large colonies representing clones that have the integration were re-
streaked on LB-Cm plates and grown overnight at 42°C to purify the large colony 
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away from small ones. At this stage single large colonies were selected and used to 
inoculate 5 ml LB cultures which were incubated overnight at 200 rpm and 30°C. 
Serial dilutions of each of these cultures (usually 100 .d of 10 -' and 10-6  dilutions) 
were plated on LB ± 5% sucrose and incubated overnight at 30°C. pTOF24 carries 
the SacB gene which makes cells sensitive to sucrose. Growth in the presence of 
sucrose therefore induces excision by recombination of the integrated cassette and 
loss of the excised plasmid. Since sucrose is not 100% effective as a selectable 
marker, 100 colonies (or more if necessary) were replica-plated onto LB with 5% 
sucrose and LB-Cm with 5% sucrose and grown overnight at 30°C. Colonies that 
grow on LB-sucrose but not on LB-Cm-sucrose are ones that have lost the genomic 
insertion and the plasmid. These were then tested by colony PCR using Hfq-del-F1 
and Hfq-del-R2 primers (2.1.8) to check for the presence of the genomic deletion. 
2.2.5 Transformation of S. cerevisiae 
Yeast cells were transformed using the method of Gietz et al. or slight adaptations 
thereof (Gietz et al., 1992). Different versions of this method were used for the 
transformation of plasmid DNA and for the transformation with linear DNA for 
integration into the genome. 
2.2.5.1 Yeast transformation with plasmid DNA 
Method 1, standard transformation with plasmid DNA - 
A single colony was taken and inoculated into 5 ml of appropriate liquid medium 
(Table 2.1.2). This was incubated overnight at 30°C until the cells had grown into 
stationary phase. The cells were sedimented in a Mistral 1000 centrifuge (3 mm, 
3,500 rpm, RT). Cells were then washed two times with 1 ml of deionised water and 
sedimënted in an Eppendorfmicrofuge (1 mm, 3,500 rpm) and finally resuspended in 
1 ml of deionised water. SOLd of cell suspension was mixed with 240 LLl of 40% 
PEG3350, 36 p.1 of 1 M LiAc, 200-800 ng of plasmid DNA (1 p.1 from a plasmid prep; 
2.3.2.1) in 29 p.1 of deionised water and 50 p.g (5 p.1 of 10 mg/ml) of denatured 
salmon sperm carrier DNA (Gibco BRL). This was vortexed briefly to mix and 
incubated at room temperature for 30 min on a rotating wheel. Following this, cells - 
were heat-shocked at 42°C for 15 mm, then sedimented (14,000 rpm, 5 s, Eppendorf 
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microfuge). The pelleted cells were then resuspended in 150 tl of deionised water 
and plated onto the appropriate solid medium to select for transformants. Plates were 
incubated at 30°C for 2-3 days, or longer if required for slow growing strains. 
Method 2, Lazy Bones ' plasmid transformation ofyeast colonies 
This method (Elbie, 1992) was used when in hurry or when the appropriate selective 
liquid medium to grow the strain to be transformed was not available. One fresh 
colony (2-3 mm in diameter) was picked from a plate with a sterile pipette tip and 
transferred directly into the transformation mixture containing the plasmid DNA 
(360 jil total volume as for standard method; see above). The cells were resuspended 
by vortexing and incubated at room temperature for 5 mm. They were then heat 
shocked for 15 min at 42°C, pelleted and plated as above. 
2.2.5.2. Yeast transformation for genomic integration of DNA 
Preparing DNA for genomic integration 
In order to prepare DNA for transformation and integration into the yeast genome, a 
linear DNA fragment was produced by PCR (2.3.2.7). The PCR template was chosen 
to contain the relevant DNA sequence required following the integration. The 
primers were designed so that the final PCR product (the integration cassette) would 
be flanked at both ends by approximately 45 bp of sequence identical to the DNA 
immediately 5' and 3' to the sequence to be replaced or to the site of integration. At 
least one 50 j.il PCR (but up to five depending on the yield) was ethanol precipitated 
(2.3.1.3) and used to transform the relevant strain (2.1.6). 
High efficiency yeast transformation 
A high efficiency transformation protocol based on that of Gietz and Woods was 
used for the transformation with DNA for genomic integration (Gietz and Woods, 
2002). A single colony was taken and inoculated into 10 ml of appropriate liquid 
medium (Table 2.1.2). This was incubated overnight until the cells had entered 
stationary phase. This culture was used to inoculate 50 ml of fresh medium to an 
0D600 of approximately 0.1. This was then incubated at 30°C until the 0D60 0 of the 
culture was 0.8-1.0. The cells were sedimented in a Mistral 1000 centrifuge (3 mm, 
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3,500 rpm, RT), washed once with 20 ml, once with 10 ml of deionised water and 
sedimented as before. Cells were finally resuspended in 0.5 ml of deionised water. 50 
.tl of cell suspension was mixed with ice-cold transformation mixture (240 .t1 of 40% 
PEG3350, 36 .il of 1 M LiAc, DNA in 29 jil deionised water (generally 1-5 j.tg; see 
below) and 100 p.g (10 .ti of 10 mg/ml) of denatured salmon sperm carrier DNA 
(Gibco BRL). This was vortexed briefly to mix and incubated at 42°C for 40 mm, 
then sedimented (14,000 rpm, 5 s, Eppendorf microfuge). The cells were 
resuspended in 150 tl of lx TE (Table 2.1.4) and plated onto the appropriate solid 
medium to select for transformants in case of the use of a nutritional marker. For 
antibiotics markers (HpH, NAT, KAN) cells were resuspended in YPDA and 
incubated for 3 h at room temperature before spreading onto selective medium or 
spread directly on YPDA-agar plates, incubated overnight at 30°C and replica-plated 
onto plates containing the appropriate antibiotics. Plates were incubated at 30°C (or 
the appropriate temperature where temperature-sensitive strains were used or being 
created) for up to two weeks. 
Screening colonies for genomic integration 
Colonies growing on the appropriate selective medium were re-streaked onto fresh 
solid medium and the integration was investigated using colony PCR (2.3.2.8) and, 
where relevant, Western blotting (2.4.1 and 2.4.5). Positive colonies were streaked 
twice onto selective medium taking a single colony each time to ensure a pure 
recombinant strain before use in experiments. 
2.2.6 Yeast sporulation and tetrad dissection 
Fresh colonies of the diploid strain were streaked thickly onto pre-sporulation 
medium (2.1.2.3) and grown for 1-2 days at 30°C. Cells were scraped off the surface 
using a streaking loop and streaked thinly onto sporulation medium (2.1.2.3). These 
were incubated for 3-7 days at 30°C to allow the cells to sporulate. The efficiency of 
sporulation was investigated microscopically by looking for the presence of tetrads. 
When a satisfactory number of tetrads was observed (25% or more) one loopful of 
cells was scraped off the plate and resuspended in a 0.2 mg/ml cytohelicase solution 
(Biosepra) and incubated overnight on ice to digest tetrad sporewalls. The next day 2 
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.tl of this suspension was spotted onto a selective plate and a sterile toothpick was 
used to spread the cells and spores from this point in a straight line down the middle 
of the plate. The Singer MSM series 100 micromanipulator was now used to look for 
tetrads with properly digested sporewalls. These were picked up with the needle and 
dissected, positioning each of the four spores on the plate at set coordinates. The 
plate was subsequently incubated at the appropriate temperature to allow for spores 
to form single colonies. Single colonies were then tested on appropriate selective 
media for the presence or absence of markers, e.g. those corresponding to a deletion. 
2.2.8 Mating type determination 
Following tetrad dissection, haploid progeny (usually Leu-, Lys+) were streaked in 
lines on the appropriate solid medium (2.1.2.3). KY 117 and KY 118 cells (Leu+, 
Lys-) (2.1.6) were simultaneously grown on YPDA medium by streaking in lines. 
Plates were incubated overnight at 30°C and replica-plated to SD-Leu-Lys with the 
lines of the strains to be tested perpendicular to those of the KY117 and KY1 18 
strains. Plates were incubated at 30°C. Only those cells which had undergone 
successful mating (at the intersection point of two lines) were able to grow. The 
mating type of the haploid progeny could thus be determined since only MATa cells 
can mate with KY1 18 (MATa), and only MATa cells can mate with KY1 17 (MATa). 
2.2.9 Growth curves 
Growth curve analysis was performed to compare growth rates of different yeast 
strains and in case of temperature-sensitive strains to test their reaction to a shift in 
temperature. Cells were grown in liquid media to mid-logarithmic phase under 
permissive conditions. Cultures were maintained in logarithmic growth by diluting 
with pre-warmed growth medium to ensure that 0D600 readings were below 0.8. The 
growth rate was measured by recording the 0D60 0 at regular intervals, typically every 
1 or 2 hours. To test temperature-sensitive strains logarithmic cultures were shifted to 
non-permissive temperature by diluting the culture with pre-heated medium giving 
the resulting culture the required temperature whilst keeping the culture within the 
logarithmic phase. They were then incubated at the appropriate temperature and the 
growth rate was measured as described. 
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2.2.10 Spot assays 
To compare growth of different yeast strains under a variety of conditions spot 
assays were used. Small cultures (5 - 10 ml) were grown overnight. The 0D600 was 
measured for each and serial dilutions were made in the appropriate medium, 
corresponding to 0D600 readings of 0.0003, 0.003, 0.03, 0.3 (and 3). These dilutions 
(200 j.il each) were made in sterile 96-well flat bottom plates (Bibby Sterilin, Ltd.) 
and a metal "hedgehog" was used to spot these on the appropriate solid medium. 
This could be repeated on various media and plates could be incubated at various 
temperatures to allow for growth of these virtual replicas to be compared. 
2.2.11 Plasmid shuffle on 5-FOA 
Plasmids containing a URA3 marker were replaced with plasmids containing a 
different nutritional marker by streaking a colony containing both plasmids on 5-
FOA containing plates (2.1.2.3). Strains that grew on 5-FOA plates were put through 
a second round of selection by streaking one colony on 5-FOA again. Resulting 
colonies were tested for the absence of the URA3 marker and the presence of the 
other marker by streaking them on SD-Ura and the appropriate SD droupout plates. 
2.3 Nucleic acid methods 
Unless otherwise stated, all DNA and RNA manipulations were based on those 
described by Ausubel etal. (Ausubel etal., 1994). 
2.3.1 General methods 
2.3.1.1 Spectrophotometric quantification of nucleic acids 
The concentration of DNA or RNA solutions was determined by measuring the 
absorption of diluted solutions at 260 nm using a Cecil CE 2040 spectrophotometer, 
and a quartz cuvette (10 mm light path, Sigma). Dilutions were made in 80 gl of 
deionised water aiming for a reading of 0.1-1.0. For double-stranded DNA, an A260 
value of 1.0 represents a DNA concentration of approximately 50 ng/tl. For single-
stranded RNA an A260 value of 1.0 represents an RNA concentration of 
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approximately 40 ng/j.il. The purity of the nucleic acid sample was determined by 
measuring the absorption at both 260 and 280 nm. Protein-free preparations of DNA 
and RNA give an A260:A280 ratio between 1.8 and 2.2. The A260:A230 ratio should be 
higher than 1.7 indicating the absence of carbohydrate, lipid and phenol. 
2.3.1.2 Phenol/chloroform extraction 
Nucleic acids were purified away from proteins in aqueous solutions by extraction 
with phenol and chloroform. For DNA this was done by adding an equal volume of 
phenol: chloroform: isoamyl alcohol in a 25:24:1 ratio (equilibrated with 10mM Tris, 
1 mM EDTA, pH8.0). For RNA an equal volume of phenol:chloroform in a 5:1 ratio 
(acid equilibrated, pH 4.7) was added. The mixture was vortexed thoroughly and 
centrifuged (14,000 rpm, 3 mm). The upper, aqueous, phase containing nucleic acids 
was moved to a fresh container, being careful not to transfer any of the lower phase. 
2.3.1.3 Precipitation of nucleic acids 
Nucleic acids were precipitated from aqueous solution by adding 0.1 volumes of 3 M 
sodium acetate (pH 5.2) and 2-2.5 volumes of ethanol for DNA or 2.5-3 volumes of 
ethanol for RNA. After thorough mixing these were incubated at -70°C for a 
minimum of 60 mm. Precipitated nucleic acids were then sedimented by 
centrifugation (14,000 rpm, 15-30 min,4°C) and the resulting pellet was washed with 
70% (v/v) ethanol. The pellet was then air-dried and dissolved in an appropriate 
volume of deionised water or TE. 
2.3.2 DNA methods 
2.3.2.1 Small scale preparation of plasmid DNA 
Plasmid DNA was prepared using the QiAprep Spin Miniprep Kit (Qiagen), 
following the manufacturer's instructions. DNA was extracted from 3 ml of 
stationary phase E. coli culture, eluted in 50 tl of deionised water or TE and stored 
indefinitely at —20°C. 
111 
2.3.2.2 Large scale preparation of plasmid DNA 
Plasmid DNA was prepared using the HiSpeed Plasmid Maxi Kit (Qiagen), 
following the manufacturer's instructions. DNA was extracted from 150 ml of 
stationary phase E. co/i culture for high-copy plasmids or 250 ml for low-copy 
plasmids. The volumes of buffers P1, P2 and P3 were doubled for low-copy 
plasmids. Plasmid DNA was finally eluted in 500 p1 of deionised water or TE and 
stored indefinitely at —20°C. 
2.3.2.3 Plasmid rescue from yeast 
To rescue plasmid DNA from yeast the Zymoprep kit (Zymo Research) was used 
according to the manufacturer's instructions. Plasmid DNA was extracted from imi 
of full-grown yeast culture. The isopropanol precipitated DNA was finally dissolved 
in 20 p.1 TE. Between 1 and 5 p.1 of this preparation was used to transform E. coli 
(2.2.3.2). 
2.3.2.4 DNA restriction digests 
DNA was digested by restriction endonucleases (mostly NEB) in the appropriate 
buffer (supplied and recommended by the manufacturer). To perform restriction 
analysis on a plasmid the digest was usually performed in 10 p.1 with 0.5-1 p.g of 
DNA and 2-10 units of the appropriate restriction enzyme(s), ensuring that the total 
enzyme volume did not exceed 10% of the total reaction volume. The digest was 
incubated at the appropriate temperature, typically for 1-2 hours. To digest plasmids 
or PCR products to be used in later cloning steps, the digest was usually performed 
in 50 p.1 with 2 - 5 p.g of DNA and 1 p.1 of the appropriate enzyme(s) and incubated 
overnight at the appropriate temperature. For double digests the manufacturers' 
guidelines were followed with regards to the optimal buffer conditions for both 
enzymes (NEB catalogue). Where necessary, sequential digests were performed, 
cleaning up the DNA in between. After digestion DNA was gel (2.3.2.13) or column 
(2.3.2.11) purified. 
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2.3.2.5 Removal of phosphates from DNA ends 
Plasmid DNA digested with a single restriction endonuclease to be used for cloning 
was dephosphorylated to prevent recircularisation during ligation. To this end 5 U of 
Calf Intestinal Alkaline Phosphatase (CIP, NEB) were added directly after digestion 
(2.3.2.4). This was incubated for 30 min at 37°C to remove terminal phosphate 
groups from the DNA. DNA was then gel (2.3.2.13) or column (2.3.2.11) purified. 
2.3.2.6 Yeast genomic DNA preparation for PCR 
Yeast genomic DNA was prepared using one of the following two methods. The first 
method is quicker and easier; the second is more likely to give successful results for 
difficult PCRs (e.g. amplification in the centromeric region). 
Method 1 
Cells from a 10 ml stationary phase culture were sedimented in 1.5 ml portions in 
microfuge tubes (3,500 rpm, 1 mm, RT). Cells in each tube were resuspended in 100 
j.tl of freshly prepared lysis solution (10 mM Tris-HC1 pH 7.5, 1 mM EDTA, 10% 
SDS, 1.4 M —Mercaptoethano1) and vortexed for 15 minutes. 500 .tl of TE was 
added and the mixture was extracted with 500 l of phenol (pH 8.0). The aqueous 
phase was transferred to fresh microfuge tubes, 50 .tl of 3 M sodium acetate (pH 5.2) 
was added and DNA was precipated by mixing with 600 tl of isopropanol and 1 
hour incubation at -20°C. After centrifugation for 20 min at 14,000 rpm at 4°C the 
resulting pellet was washed twice with 70% ethanol. The pellets were then air-dried 
and each pellet was dissolved in 20 .tl of TE with 0.2 mg/ml RNase A (DNase free, 
Roche). Routinely 0.5-1 j.tl of this solution was used as a template in a 50 p.1 PCR. 
Method 2 
Five ml of stationary phase culture was sedimented by centrifugation and washed 
with one ml of deionised water. The cells were resuspended in 360 p.! of 
spheroplasting solution (0.9 M sorbitol, 0.1 M EDTA pH 8.0) and 15 p.1 of 1 M DTT 
was added together with 15 p.1 of zyrnolase (15 mg/ml; Seikagaku Corporation, 
Tokyo, Japan). This was incubated at 37°C for 30 - 60 min to break down the cell 
walls. The cells were centrifuged and resuspended in 300 p.1 of lysis solution (50 mM 
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Tns-HC1, 50 mM EDTA pH 8.0) and mixed with 60 j.il of 10% SDS. This was 
incubated at 65CC for 5 min before adding 100 .ti of 5 M potassium acetate. This 
mixture was incubated on ice for 5 min to allow proteins to precipitate. Proteins were 
sedimented by centrifugation for 2 min at 14,000 rpm. The supemate was transferred 
to fresh microfuge tubes and centrifugation was repeated if necessary to lose all 
precipitated proteins. To precipitate the DNA 300 j.il of isopropanol was added. After 
thorough mixing the DNA was sedimented by centrifugation for 2 min at 14,000 
rpm. The pellet was washed with 500 jtl of 70% ethanol and left to air dry. The dried 
DNA pellet was finally resuspended in 50 p1 of TE and 0.5 - 1 p.1 of this was used as 
a template in a 50 p.1 PCR. 
2.3.2.7 Amplification of DNA by Polymerase Chain Reaction 
Specific regions of DNA were amplified using the polymerase chain reaction (PCR). 
Specifically designed oligonucleotide primers (2.1.8 and 2.3.2.10) were annealed to 
denatured template DNA (1-10 ng of plasmid DNA or genomic DNA (2.3.2.6)) and 
extended by a thermostable DNA polymerase. A typical PCR was assembled as 
follows: 
5 p.1 1 Ox DNA Polymerase Buffer with M902 
5 p.1 2.5 mM dNTPs (dATP, dCTP, dGTP, dTTP; Roche) 
1 p.1 Forward oligonucleotide primer (10-50 [LM) 
1 p.1 Reverse oligonucleotide primer (10-50 p.M) 
1 p.1 Template DNA 
1 .il Thermostable DNA polymerase 
36 p.1 Sterile deionised water 
Depending on the type and purpose of PCR different DNA polymerases were used: 
Taq (Roche, 2 U/p.l) and TaKaRa LA Taq (Takara Bio Inc., 5 U/p.l) for highly 
efficient amplification (at 72°C) but with relatively high error rates; Pfu or Pfu Turbo 
(Promega, 3 U/p.l) and Expand Long Template (Roche, 5 U/p.l) for amplification (at 
68°C) with low error rates. For amplification of DNA with a high GC content (e.g. 
the NAT cassette) 5% DMSO was added to the PCR. All PCRs were performed in a 
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Biometra UNO II Thermoblock or an MJ Research PTC-200 Peltier Thermal Cycler 
programmed according to the length of the desired product and the annealing 
temperature of the oligonucleotide primers being usedt.  A typical PCR cycle was as 
follows and repeated 25-35 times: 
Denaturation 




1 min per kb at 72°C or 
1 min per 500 bp at 68°C 
For oligonucleotides up to 25 nt in length: Tm (°C) = 4(G+C) + 2(A+T) 
2.3.2.8 Colony PCR 
To check E. coli colonies for plasmids with a specific insert (in a specific orientation) 
or for the presence of a genomic deletion (2.2.4) PCR was performed directly using 
the colony as a source of template. Yeast colonies were similarly checked for the 
presence of genomic insertions or deletions. To this end a 10 tl tip was used to lift 
(part of) a colony from a plate. Each colony was resuspended in 20 tl PCR mix and 
run using the standard PCR protocol (2.3.2.7), instead starting with a 6 min heating 
step at 96°C (to break the cells) and denaturing at 96°C for each cycle thereafter. The 
PCR mix was made by mixing 15 j.tl of water, 2 j.tl of 1 Ox PCR buffer with MgCl2, 2 
j.tl of 2.5 mM dNTP mix, 0.4 t1 of 10 IiM forward primer, 0.4 j.tl of 10 IIM reverse 
primer, 0.2 jil of Taq DNA Polymerase (Roche, 2 U/pi; or Fast Start Taq DNA 
Polymerase, Roche, 5 U/pi; the latter works particularly well for colony PCR 
because of the initial heat activation step) or multiples thereof for each colony to be 
checked. 
2.3.2.9 Site directed mutagenesis 
Site directed mutagenesis was performed based on the QuikChange method 
(Stratagene). 50 ng of plasmid (usually 1 p.1 of a 1 in 10 dilution of plasmid 
miniprep) was used for a PCR in which the entire plasmid was amplified by primers 
with imperfect complementarity to the region of the gene to be mutated. These 
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primers typically contained around 40 bp of sequence complementary to the target 
gene, as well as nucleotide changes giving the desired mutation (usually located 
close to the middle of the primers). The forward and reverse primers were perfectly 
complementary to each other, with a minimum annealing temperature of 78°C 
(2.3.2. 10). Another strategy can be used (particularly useful for creating deletions) in 
which the forward and reverse primers only overlap partially (15 —20 nt in the region 
to be mutated; see (Boon, 2005). The product of this type of PCR is a nicked circle, 
with the nicks occurring at the end of each synthesised strand. 
A typical reaction mix was as follows: 
5 tl 1 Ox DNA Polymerase Buffer with MgC12 
5 p1 2.5 mM dNTPs (Roche) 
1 p1 Plasmid (50 ng) 
1 p.1 Forward primer (10 p.M) 
1 p.1 Reverse primer (10 p.M) 
1 p.1 DNA polymerase 
36 j.tl Water 
Pfu polymerase (Promega, 3 UIp.l) was used routinely. If this was not successful Pfu 
Turbo (Stratagene, 2.5 U/p.l; more efficient amplification, especially for long (>10 
kb) products) or Expand Long Template Enzyme Mix (Roche, 5 U/p.l; buffer 2 with 
2.75 MM  MgCl2; more efficient amplification, but higher error rate) was used. A 
typical PCR cycle would be as follows: 
Denaturation 	95°C 1 mm 
n* Denaturation 	95°C 30 sec 
00 I 	Annealing 	55 *C 1 mm (but sometimes as low as 50 C) L_ Extension 	68°C 2 min per kb 
Extension 	68°C 10-20 mm 
The PCR product was incubated with 1 p.1 of DpnI (NEB, 20 U/p.l) at 37°C for a 
minimum of 2 h. DpnI digests dam-methylated DNA, so that parental plasmid is 
digested, but not non-methylated PCR-product. At this stage 10 p.1 of the DpnI 
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treated sample could be run on an agarose gel (2.3.2.12) to see if any correctly sized 
product was present. Depending on the amount visible on the gel, 1-10 gl of the 
DpnI treated DNA was used to transform E. co/i (2.2.3.2 or 2.2.3.4). Resulting 
colonies were screened for presence of the desired mutation by restriction digest 
(2.3.2.4), colony PCR (2.3.2.8) and/or by sequencing (2.3.2.15). 
2.3.2.10 Primer design 
Primers to amplify DNA for cloning 
Primers were designed by eye, aiming for a T. of around 50°C (40-60°C) taking care 
that the melting temperatures of two primers to be used in the same PCR did not 
differ by more than 5°C. The formula Tm (°C) = 4(G+C) + 2(A+T) was used for 
primers up to 25 nt in length. Where possible, primers were designed to terminate in 
at least one G or C base at the 3' end. Restriction enzyme cleavage sites were 
included at the 5' end of primers with an additional number of random nucleotides 
(usually A) added to the 5' end to allow for efficient digestion of the PCR product. 
For this, the NEB catalogue (2002-2003; p.242-243) was used as a reference. 
Primers for site-directed mutagenesis 
Mutagenic primers for use in site-directed mutagenesis were designed according to 
the desired mutation. The following considerations were made for their design. First, 
both mutagenic primers contain the desired mutation and anneal to the same 
sequence on opposite strands of the plasmid. Second, primers should be between 25 
and 45 bases in length, with a melting temperature (Tm) of ~:78°C (see below), 
although primers longer than 45 bases were also used successfully. Third, the desired 
mutation (deletion or insertion) should be near the middle of the primer with a 
minimum of 10-15 bases of correct sequence on either side. Fourth, the primers 
optimally should have a minimum GC content of 40% and should terminate in one or 
more C or G bases. The following formula was used to estimate the Tm of mutagenic 
primers: 
Tm = 81.5 + 0.41(%GC) - 675/N - % mismatch 
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in which N is the primer length in bases and the values for %GC and % mismatch are 
whole numbers. To calculate Tm for primers intended to introduce insertions or 
deletions, a modified version of the above formula was used: 
Tm = 81.5 + 0.41(%GC) - 675/N 
in which N does not include the bases which are being inserted or deleted. 
Alternatively the QuikChange T m calculator was used (available online at 
hltp://www.stratagene.com/QPCR/tmCalc.aspx).  
2.3.2.11 Purification of PCR products and restriction digests 
To purify PCR products and endonuclease digested DNA away from salts, dNTPs, 
oligonucleotides and/or other DNA fragments shorter than 100 bp the QiaQuick PCR 
Purification kit (Qiagen) was used according to the manufacturer's instructions. 
DNA was eluted in 30-50 21 of water or TE buffer and stored indefinitely at -20°C. 
Alternatively PCR reaction mixes or digests were phenol/chloroform extracted 
(2.3.1.2) and/or ethanol precipitated (2.3.1.3) or separated by size by agarose gel 
electrophoresis (2.3.2.12) and gel purified (2.3.2.13). 
2.3.2.12 Agarose gel electrophoresis 
Plasmid DNA and DNA fragments produced by restriction endonuclease digestion 
(2.3.2.4) or generated by PCR (2.3.2.7) were analysed in 0.8-2% (w/v) agarose gels. 
Gels were prepared by dissolving agarose (SeaKem LE Agarose, Cambrex) in 100 
ml of lx TAE buffer (2.1.3) by boiling and adding ethidium bromide to a final 
concentration of 0.5 p.g/ml before pouring the mixture into a horizontal gel tray 
(BRL, Horizontal System for Submerged Gel Electrophoresis, Model H5) and 
allowing it to set. Ficoll loading buffer (6x Ficoll loading buffer: 15% (wlv) Ficoll 
400, 0.025% (w/v) Bromophenol Blue (BPB), 0.025% (w/v) Xylene Cyanole FF 
(XCB) and 50 mM EDTA pH 8.0) was added to samples to be analysed. The samples 
were loaded in the gel and 100-150 V were applied across the gel separating the 
DNA fragments by size. The DNA was subsequently visualised using a 
ChemiGenius 2 liv transilluminator (Syngene, Cambridge, UK) and Genesnap 6.03 
118 
software to process the image. DNA markers (1kb PLUS DNA Ladder (Invitrogen) 
or 1 OObp DNA Ladder (NEB)) with fragments of known sizes were separated 
simultaneously, allowing fragment sizes to be estimated. 
2.3.2.13 Purification of DNA from agarose gels 
DNA fragments produced by endonuclease digestion (2.3.2.4) or generated by PCR 
(2.3.2.7) were separated according to size by agarose gel electrophoresis (2.3.2.12). 
Fragments were visualised on a UV transilluminator (Herolab IJVT-28M at low 
intensity setting) and the desired band was cut from the gel using a clean surgical 
blade. The DNA was then isolated from the agarose gel using the QiaQuick Gel 
Extraction kit (Qiagen) according to the manufacturer's instructions. DNA was eluted 
in 30-50 p1 of sterile deionised water or TE and stored indefinitely at -20°C. 
2.3.2.14 Ligation of DNA molecules 
Ligations were performed using the Fast-Link DNA Ligation Kit (Epicentre 
Biotechnologies) according to the manufacturer's instructions. Briefly, 100-200 ng of 
vector DNA, 2 to 5 times this molar amount of insert DNA, 1 mM ATP and 2 U of 
Fast-Link DNA Ligase were incubated in lx Ligation Buffer in a final volume of 15 
.tl (30 min to 16 h, RT). Some or all of this ligation mixture was then used for 
transformation into E. coli (2.2.3.2 or 2.2.3.4). Oligonucleotide linkers (e.g. HA and 
Myc tag inserts for pMR8 1 and pMR82) were cloned using ?100:1 molar ratio of 
linker to plasmid (with approximately 0.1 pmol of linker) and incubating for 16 h at 
16°C. Complementary linker oligonucleotides were mixed at a 1:1 molar ratio (50.tM 
each) in TE buffer, heated to 95°C and slowly cooled to room temperature to allow 
duplex to form, before using them for ligation. 
2.3.2.15 De-salting small amounts of DNA 
In preparation for transformation by electroporation ligation mixes (2.3.2.14) were 
de-salted by floating a Millipore 0.025 pm Type VS membrane on a petridish filled 
with deionised water (shiny side up) with the ligation mix spotted on top and 
incubating them for a minimum of 30 min at room temperature. 
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2.3.2.15 DNA sequencing 
Plasmid DNA to be sequenced was purified (2.3.2.1) and quantified by 
spectrophotometry (2.3.1.1) and/or comparison to a marker by visualisation on an 
agarose gel (2.3.2.12). Sequencing reactions were performed using the BigDye 
Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems). A typical reaction mix 
was as follows: 
Template DNA (200-500 ng) 	2 p.1 
BigDye Terminator mix 	 2 p.1 
Better Buffer (Web Scientific Ltd.) 3.3 p.1 
Primer (1.6 p.M) 	 1 p.1 
Water 	 1.7p.l 
Reactions were performed in a Biometra UNO II Thermoblock or an MJ Research 
PTC-200 Peltier Thermal Cycler for a minimum of 25 cycles: 
Denaturation 	3mm 96°C 
Denaturation 	15s 	96°C 
L Annealing lOs 50°C Extension 4 min 60°C 
Samples were processed and run at the School of Biological Sciences Sequencing 
Service (SBSSS) on an Applied Biosystems 3730 DNA Analyzer. Sequence data 
were analysed using Sequencher 4.2 or 4.5 (Gene Codes Corp.), and later using 
ContigExpress (Invitrogen, Vector NTI Advance 10). 
2.3.2.16 End-labelling of oligonucleotides 
Oligonucleotides were 5'-end radiolabelled with [y- 32P] ATP (Redivue, lOp.CiIp.l; 
-6,000 Ci/mmol; Amersham Biosciences) using T4 Polynucleotide Kinase (PNK, 
NEB) and the provided 1 Ox PNK buffer. Variations of the recommended protocol 
were used depending on the downstream application: Northern analysis (2.3.3.7), 
primer extension (2.3.3.8) or strand displacement assays (2.5.3). To label an 
oligonucleotide probe for Northern analysis a 20 p.l reaction was performed in lx T4 
PNK buffer with 10 pmol of oligonucleotide, 2 p.1 of [y- 32P] ATP and 5 U of T4 
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PNK (NEB). To label primers for primer extension reactions were performed in 10 
.t1 in lx T4 PNK buffer with 10 pmol of oligonucleotide, 1 .ti of 100mM DTT and 2 
tl of ['y-32P] ATP. To prepare substrate for strand displacement assays 
oligonucleotides were labelled in 20 jil reactions: 2 tl of 33 .tM oligo, 2 il of lOx 
PNK buffer (NEB), 13 tl of water, 1 j.il of PNK (10 U/j.il, NEB) and 2 p1 of [7- 32P] 
ATP. All labelling reactions were incubated at 37 °C for 45 min to 1 h. For use in 
Northern probing the labelled oligonucleotide was passed through a 0.45 .tm filter in 
2 - 3 ml of hybridisation buffer to remove any particulate matter. For use in primer 
extension and strand displacement assays the labelled oligonucleotides were purified 
by gel filtration (2.3.2.19) in a total volume of 20 pl. Labelling efficiency was 
estimated and generally between 30 and 60%. 
2.3.2.17 Making DNA probes for Northern analysis 
Method 1 1  DNA oligomer end-labelling 
Ten pmol of oligonucleotide was end-labelled in a 20 p1 PNK reaction (2.3.2.16) and 
passed through a 0.45 jim filter (Minisart Cellulose acetate, Sartorius) in 2 - 3 ml of 
SES 1 hybridisation buffer (2.1.3) to remove any particulate matter. 
Method 2 1  Single stranded DNA labelling by PCR 
A 50 p1 reaction was assembled in lx Taq DNA polymerase buffer with 20 ng of 
template DNA (purified, double stranded PCR product (2.3.2.7) of the target 
sequence), 0.2 mM each of dATP, dGTP and dTTP, 1.2 tM dCTP, 10 pmol of 
primer (reverse complement to the sequence to be probed), 5 p1 of [a-32P] dCTP 
(Amersham) and 2.5 U of Taq DNA polymerase (Roche). This was incubated for 35 
cycles (30 s 94°C, 30 s 40 - 60°C (2.3.2.10), 1 mm/kb 72°C) in a Biometra UNO II 
Thermoblock. The labelled single stranded DNA probe was purified by gel filtration 
(2.3.2.19) and heated at 95°C for 2 min before adding it to the Northern blot for 
hybridisation (2.3.3.7). 
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2.3.2.18 Radioactive labelling of DNA size marker 
Labelled pBR322 DNA- MspI digest (NEB) and lOObp DNA ladder (NEB) were 
used as size markers. A 10 p.1 reaction was assembled and incubated for 15 - 30 mm 
at room temperature: 
1 p.! marker DNA (1 p.g /1.11) 
1 p.1 1 Ox Filling buffer (Roche) 
1 p.1 3 dNTPs mix (2.5 mM each of dATP, dGTP and dTTP; Roche) 
3 111 [a-32P] dCTP (Redivue, 10 p.Ci/p.l; -'6,000 Cilmmol, Amersham) 
3.5 p.1 water 
0.5 p.1 Klenow (Roche, 2 U/.il) 
The reaction was stopped by adding 1 p.1 of 0.5 M EDTA pH 8.0 and 40 p.1 of TE. 
The labelled ladder was purified by gel filtration (2.3.2.19). A small volume (2 p.1) of 
a large dilution equivalent to about 50 cps/p.l was usually enough to give a good 
picture after denaturing PAGE (2.3.3.3). 
2.3.2.19 Purification of labelled DNA from unincorporated nucleotides 
Radioactively labelled DNA molecules were separated from unincorporated 
nucleotides by gel filtration using Mini Quick Spin Oligo columns (Roche) following 
the manufacturer's instructions. In brief, the column matrix was resuspended by 
gentle flicking. The column was packed by centrifugation for 1 min at 1,000 g. The 
column was transferred to a clean microfuge tube and the labelling reaction (20-50 
p.1) was applied to the centre of the column. After 4 min centrifugation at 1,000 g the 
flow-through contained labelled nucleic acids whereas unincorporated nucleotides 
were stuck on the column. Efficiency of labelling could be estimated by comparing 
the number of counts in both. 
2.3.3 RNA methods 
2.3.3.1 Three methods for total RNA isolation from yeast 
Method 1, RNA isolation for primer extension 
122 
Total yeast RNA was prepared using the method of Schmitt et al. (Schmitt et al., 
1990). A 20 ml culture was grown in YPDA (2.1.2.3) to 0D6 00 0.5 - 1.0. Cells were 
sedimented by centrifugation for 3 min at 3,500 rpm (Mistral 1000 centrifuge). The 
pellet was washed with 400 p.1 of AE buffer (50 mM Na acetate pH 5.2, 10 MM 
EDTA), sedimented and resuspended in 400 p.! of AE buffer. Then 40 p.1 of 10% 
SDS was added together with 500 p.1 of phenol (equilibrated with AE buffer). This 
was vortexed two times for 10 s at a time, followed by 4 min incubation at 65°C and 
snapfreezing on dry ice. After thawing and 2 min centrifugation at 20,800 g in a 
microfuge at 4°C the aqueous phase was phenol/chloroform extracted (2.3.1.2). 
Finally one tenth of a volume of 3 M Na acetate (pH 5.2) was added together with 
2.5 volumes of 100% ethanol. The RNA was precipitated at -70°C overnight, 
sedimented by centrifugation, washed with 70% ethanol, air-dried and finally 
dissolved in 50 p.1 RNase-free TE. 
Method 2 1  for Northern analysis 
A 50 ml yeast culture was grown in the appropriate medium (2.1.2.3) and at the 
appropriate temperature to an 0D600 of 0.5. The cells were sedimented by 
centrifugation for 5 min at 1,000 g at 4°C. The pellet was washed with 20 ml of ice-
cold water and centrifuged again. In a 4°C room the following were added ice-cold: 
0.5 ml of GTC mix, 0.5 ml of phenol and 1 ml of glass beads (acid-washed, Sigma). 
This was vortexed for 5 mm (2 times 2 min and 1 time 1 min with 2 min cooling on 
ice in between) after which another 7.5 ml of ice-cold GTC mix and 7.5 ml of phenol 
were added. The mixture was incubated for 5 min at 65°C and subsequently allowed 
to cool on ice for 5 mm. Then, 4 ml of NaAc mix (0.1 M Na acetate, 1 mM EDTA 
and 10 mM Tns-HC! pH8.0) and 7.5 ml of chloroform were added, vortexed briefly 
and centrifuged for 5 min at 4,600 rpm at 4°C (4,570 g; Sorvall Legend RT). Ten ml 
of the aqueous phase was removed and added to 10 ml of cold PCI (25:24:1 pH 4.7), 
vortexed and centrifuged for five min at 4,600 rpm at 4°C. This was repeated with 8 
ml of the aqueous phase (plus an equal volume of PCI) and finally 6m1 of the 
aqueous phase was mixed with 20 ml of ice-cold 100% ethanol. After mixing by 
inversion this was incubated for a minimum of 30 min at -70°C. The precipitated 
RNA was sedimented by centrifugation for 30 min at 4,600 rpm at 4°C, washed with 
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5 ml ice-cold 70% ethanol, air-dried and finally dissolved in 100 - 200 p.1 of DEPC-
treated water. 
GTC mix: 100 g of Guanidine thiocyanate, 100 ml of DEPC-treated water, 
10.6 ml of 1 M Tris-HC1 pH8.0 and 4.24 ml of 0.5 M EDTA pH8.0 were 
mixed and left to dissolve overnight with agitation. This mixture was then 
heated for 10 min at 60 -70°C and finally 21.2 ml of 20% L.Lauroylsarcosine 
and 2.1 ml of J-Mercaptoethanol were added 
Method 3, for Northern analysis of non-denatured RNA 
To look at levels of U4/U6 duplex by Northern anaylsis, total RNA was isolated 
under non-denaturing conditions using the method described by Lygerou et al. 
(1999). Cells were grown in the appropriate medium to 0D600 0.5 - 1.0. 
Approximately 108  cells (10 units at 0D60 0) were then collected, washed with ice-
cold deionised water and resuspended in ice-cold 250 p.1 of RNA extraction buffer 
(100 mM LiC1, 1 mM EDTA, 100 mM Tris-Cl pH 7.5, 0.2% (w/v) SDS). Cells were 
broken in a cooled Thermomixer Comfort (Eppendorf) for 15 min at 4°C with 250 p.1 
of phenol-chloroform (5:1, pH 4.7) and 100 p.1 of Zirconia beads (Ambion). The 
aqueous phase was mixed with an equal volume of 2x native RNA loading buffer or 
2x formamide loading buffer for native (2.3.3.4) or denaturing PAGE respectively 
(2.3.3.3) 
2.3.3.2 In vitro transcription and RNA purification 
Template preparation 
Three different kinds of templates were used for in vitro transcription. For in vitro 
transcription of ACT] pre-mRNA p283 plasmid DNA (2.1.7) was digested (2.3.2.4) 
and purified (2.3.2.13). For in vitro transcription of snRNAs or parts of snRNAs 
templates were created by PCR (2.3.2.7) or by annealing two oligonucleotides (Table 
2.1 .8.3a,b). In each case a minimal T7 promoter sequence 
(TAATACGACTCACTATAGG) was fused upstream of the sequence to be transcribed. 
By PCR this was accomplished with a forward primer which contained the T7 
promoter sequence followed by the first nucleotides of the sequence (giving an 
annealing temperature between 48 - 56°C) and a reverse primer complementary to 
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the last nucleotides of the sequence (with the same annealing temperature). The PCR 
product was purified (2.3.2.11), taking care to keep it RNase free. In case of an 
oligonucleotides template, a DNA oligomer was designed by taking the reverse 
complement of the sequence that covered the T7 promoter sequence and the desired 
sequence (Milligan and Uhienbeck, 1989). This oligomer (12.5 tl of 100 PM) was 
mixed with an equal amount of DNA oligomer covering the full T7 promoter 
sequence (T7F2, Table 2.1.3.7a). The mixture was heated at 90°C for 3 minutes and 
snap-chilled on ice. The resulting duplex was diluted in 225 tl TE to a final 
concentration of 5 pM and used directly in the in vitro transcription reaction or 
stored at -20°C until required. 
The in vitro transcription reaction 
For each 100 p.1 reaction the following were mixed according to the NEB T7 
polymerase product information: 
10 p.1 1 Ox T7 RNA polymerase reaction buffer (NEB) 
10 p.! 100mM DTT 
10 p.! DNA template 
10 p.120 mM NTPs mix (10mM ATP, CTP, GTP and UTP; Amersham) 
I p.1 BSA (lOmg/ml) 
2.5 p.1 RNasin (Promega, 40 U/p.1) 
2 j.il T7 RNA polymerase (NEB, 50 U/p.l) 
54.5 p.1 RNase free water 
The reaction was incubated at 37°C for a minimum of 2 h (overnight incubation may 
increase yield). The reaction was stopped by adding 2 p.! of 0.5 M EDTA pH 8.0 and 
10 p.1 of 3 M Na acetate pH 5.2. This was extracted with an equal volume of 
phenol/chloroform (2.3.1.2) and the RNA was ethanol precipitated (2.3.1.3). 
Purification  of in vitro transcribed RNA 
The RNA was pelleted by centrifugation at 14,000 rpm at 4°C for 30 mm, washed 
with 500 p.1 70% ethanol and finally air dried. The pellet was dissolved in 20 p.1 of lx 
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formamide loading dye (48% deionised formamide, 10 mM EDTA pH 8.0, some 
BPB and XCB) and heated at 95°C for 2 minutes before running it on a lx TBE 8% 
denaturing polyacrylamide (19:1) gel for 30 - 90 min at 25 W (2.3.3.3). The RNA 
was visualised by UV shadowing using a hand-held UV lamp (254 nm; UVItec Ltd.) 
and cut out with a clean RNase-free surgical blade. The RNA was eluted from the gel 
by electro-elution in a Schleicher and Schuell Biotrap (according to the 
manufacturer's instructions; using BT1 and BT2 Elutrap-Membranes, Whatman) in 
0.25x TBE at 4°C for 30 mm - 1 h at 200 V or by diffusion in two times 200 j.tl of 
RNA elution buffer (10 mM Tris-HC1 pH 7.6, 0.1% SDS, 1 mM EDTA, pH 8.0) for 
two times 2 h at 30°C. The RNA was again ethanol precipitated (after electro-elution 
with 0.3 M Na acetate pH5.2; after passive elution with 150 mM NaC1), washed with 
70% ethanol and air-dried before dissolving in 20 jtl of TE. Yields were variable (0.5 
—20 tg). If desired the size and integrity of the purified RNA fragment was tested by 
running 1 tl on a lx TBE 8% denaturing polyacrylamide (19:1) gel for 30 - 90 mm 
at 25 W (2.3.3.3) along side 1 pg of pBM322 MspI digest (NEB). The RNA was then 
visualised using Stains-All (Sigma). Ten millilitres of a 0.1% (w/v) Stains-All 
solution in formamide was mixed with 20 ml of isopropanol and 70 ml of deionised 
water. The gel was incubated in this mixture in the dark for 30 minutes and then 
destained in deionised water by exposure to light until bands were visible against a 
clear background. 
2.3.3.3 Denaturing PAGE of RNA 
For separation of small to medium sized single stranded RNA fragments samples 
were mixed with an equal volume of 2x formamide loading dye (96% (vlv) 
formamide, 20mM EDTA pH 8.0, some BPB and XCB) heated for 2 min at 95°C 
and loaded on a pre-run denaturing polyacrylamide gel in a vertical gel tank 
(Cambridge Electrophoresis, Model No. EV200). Denaturing polyacrylamide-urea 
gels (0.2 - 1.0 mm thick) were prepared using Sequagel 6 or 8 (National 
Diagnostics) for 6% or 8% (19:1) gels according to the manufacturer's instructions. 
The polymerised gel was pre-run in lx TBE (2.1.3) for 30 mm - 1 h at 25 W with a 
metal plate to distribute heat evenly. Wells were rinsed thoroughly before loading the 
samples. The gel was run for the required length of time (usually 45 - 120 mm) 
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depending on the size of the fragments and the desired separation. Bromophenol 
Blue and Xylene Cyanol FF were used as a reference (BPB corresponds to 19 nt and 
26 nt fragments on 8% and 6% gels respectively, XCB corresponds to 75 nt and 106 
nt fragments). 
2.3.3.4 Native PAGE of RNA 
For separation of native RNA, RNA-RNA duplexes (annealing assay; 2.5.2) or RNA 
protein complexes (bandshift assay; 2.5. 1) samples were mixed with native RNA 
loading buffer (2x native loading buffer: 30% glycerol, 80 mM HEPES-KOH pH7.9, 
100 mM KC1, 2 mM Mg acetate, some BPB and XCB) before loading on a pre-run 
native polyacrylamide gel. Native polyacrylamide gels (6%, 20:1, 1.0 mm thick) 
were prepared by mixing 25.4 ml of water with 6 ml of 40% (w/v) acrylamide 6 ml 
of 2% (w/v) bis-acrylamide (Bio-Rad), 2 ml of lOx TBE, 0.4 ml of 10% APS and 40 
.tl of TEMED. After polymerisation the comb was removed and wells were rinsed 
thoroughly with 0.5x TBE. The gel was pre-run for 1 h at 5 W, 4C in a vertical gel 
tank (Cambridge Electrophoresis, Model No. EV200) in pre-cooled 0.5x TBE 
running buffer. The gel was run for the required length of time (usually 3 - 4 h) 
depending on the size of the fragments and the desired separation. Bromophenol 
Blue and Xylene Cyanol FF were used as a reference (BPB corresponds to 45 nt and 
60 nt fragments on 8% and 6% gels respectively, XCB corresponds to 160 nt and 
240nt fragments). 
2.3.3.5 Electrophoresis of glyoxylated RNA through agarose gels 
For separation of medium to large sized single stranded RNA, samples were 
glyoxylated and run on agarose gels. Five pg of total RNA in 2 p1 was mixed with 10 
jil of glyoxal reaction mixture (6 ml of DMSO, 2 ml of deionised glyoxal, 1.2 ml of 
lOx BPTE electrophoresis buffer (2.1.3), 0.6 ml of 80% glycerol and 20 j.ti of 10 
mg/ml ethidium bromide, divide into small aliquots and store at -70CC) and heated 
for 1 h at 55 C C. The samples were then snap-chilled in ice water and collected at the 
bottom of the tube by centrifugation. The samples were loaded on a horizontal 1.2% 
agarose gel (24 cm in length) in lx BPTE. The gel was run overnight at 55 V in a 
EMBL H135 gel tank. Lanes not containing RNA were loaded with RNase-free 
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standard DNA loading dye (2.3.2.12) containing Bromophenol Blue and Xylene 
Cyanol FF. These were used as a reference for migration. BPB was run to near the 
bottom of the gel. 
2.3.3.6 Northern blotting 
Method 1, after polyacrylamide gel electrophoresis 
RNA separated by size on polyacrylamide gels, native (2.3.3.4) or denaturing 
(2.3.3.3), was transferred to a membrane to allow for detection of specific RNA 
species with radioactively labelled probes (2.3.2.17). The gel was stacked between 
two layers of Whatman 3MM paper with Hybond-N membrane (Amersham 
Biosciences) directly on top of the gel, all of which were cut to the size of the gel. 
This was sandwiched between sponge pads all of which were submerged in 0.5x 
TBE (2.1.3) taking care not to leave any bubbles between any of the layers. The 
transfer was performed in 0.5x TBE in a water-cooled Bio-Rad Trans-Blot Cell for 1 
h at 60 V after which the RNA was crosslinked to the membrane in a UV Stratalinker 
1800 (Stratagene) using the 'autocrosslink' function. 
Method 2, after electrophoresis of glyoxylated RNAs through agarose gels 
RNA separated by size on agarose gels was transferred to a membrane using passive 
transfer. The gel was washed in deionised water and incubated in 75 mM NaOH for 
20 min to break the RNA molecules into smaller pieces to facilitate transfer. The 
reaction was stopped by incubation in TrisfNaCl (0.5 M Tris-HC1 pH 7.0, 1.5 M 
NaCl) for 15 mm, after which the gel was washed a further two times in 6x SSC 
(2.1.3). The gel was then stacked on top of Whatman 3MM paper on a bridge 
suspended over a container with 6x SSC with the filter paper hanging into the 
solution. A piece of Hybond-N membrane (Amersham Biosciences) was cut to the 
exact size of the gel and after soaking it in 6x SSC was placed on top of the gel 
taking care not to leave any bubbles in between. Three more layers of soaked 3MM 
filter paper cut to size, followed by three layers of dry 3MM paper were added. 
Stacks of hand towels and a weight were placed on top of these to ensure constant 
pressure. Parafilm was used around the gel to ensure the towels only soaked up liquid 
that passed through the gel and the membrane. The transfer was left overnight after 
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which the RNA was crosslinked to the membrane in a UV Stratalinker 1800 
(Stratagene) using the 'autocrosslink' function. 
2.3.3.7 Northern blot hybridisation 
Hybridisation of oligonucleotide probes to membrane immobilised RNA 
End-labelled oligonucleotides (2.3.2.16) were passed through a 0.45 J.tm filter 
(Minisart Cellulose acetate, Sartorius) in 2 - 3 ml of SES1 buffer to remove 
particulate matter and hybridised to RNA on Hybond-N membrane (Amersham 
Biosciences) in 50 ml of SES1 hybridisation buffer (0.5 M Na phosphate pH 7.2, 7% 
(w/v) SDS, 1 mM EDTA) by incubation with agitation overnight at 37°C. Before 
addition of the probe, membranes were pre-hybridised in 50 ml of SES1 buffer at 
37°C for a minimum of 30 mm. After hybridisation, membranes were washed twice 
for 15 minutes in 6x SSPE buffer (2.1.3) at 37°C, followed by two washes of 30 
minutes in 6x SSPE (pre-warmed to 42°C) at 37°C. Following the final wash, 
membranes were wrapped in Saran Wrap and subjected to autoradiography using 
Kodak BioMax MS Film and/or a Phosphor Imaging screen to allow for 
quantification using a STORM 860 scanner and ImageQuant 5.2 software (Molecular 
Dymamics). 
Hybridisation of single stranded DNA probe to membrane immobilised RNA 
Northern blot membranes (2.3.3.6) were pre-hybridised in Neverfail Hyb Solution at 
42°C with agitation for a minimum of 2 h. Neverfail Hyb Solution was prepared as 
follows: 5 ml of 10% SDS, 250 ml of deionised formamide, 125 ml of 20x SSC 
(2.1.3), 12.5 ml of 1 M NaH 2PO4, 12.5 ml of 1 M Na2HPO4, 25 ml of lOOx 
Denhardts (10 g Ficoll 400, 10 g polyvinyipyrrolidone, 10 g BSA (Pentax Fraction 
V, Miles Laboratories) in 500 ml, filter sterilized, aliquots stored at -20°C), 1 ml of 
10 mg/mi salmon sperm DNA and deionised water up to 500 ml. Neverfail Hyb 
Solution was stored at room temperature and passed through a 0.45 pm filter 
immediately prior to use. Purified single stranded DNA probe (2.3.2.17) was heated 
at 95°C for 2 min and added directly to the hybridisation solution. After overnight 
incubation at 42°C the hybridisation solution containing the labelled probe was 
stored in a 50 ml tube at -20°C (for re-use this mixture was heated for 15 min at 
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100°C). The membrane was washed 2 times with 50 ml of 6x SSC while heating the 
incubator to 55°C, then 2 times for 15 min with 50 ml of 0.2x SSC with 0.1% SDS at 
55°C. Following the final wash, membranes were wrapped in Saran Wrap and 
subjected to autoradiography using Kodak BioMax MS Film and/or a Phosphor 
Imaging screen to allow for quantification using a STORM 860 scanner and 
ImageQuant 5.2 software (Molecular Dymamics). 
Membrane stripping for reprobing 
For successful removal of probes, membranes were prevented from drying out after 
hybridisation. To strip, a boiling solution of 0.1% (w/v) SDS was poured on the 
membrane and incubated on a rotating platform for 10 minutes. This was repeated 3 
times, or until all counts were gone. The membrane was then either hybridised with 
another probe, or blotted dry and stored for future use. 
2.3.3.7 Denaturing northern blot analysis of snRNAs 
Yeast total RNA (2.3.3.1) was separated by denaturing PAGE (2.3.3.3; 25 W for 45 
min or until XCB was 2cm from the bottom of the gel). The RNA was then 
transferred to Hybond-N membrane by electrophoretic transfer (2.3.3.6). All five 
spliceosomal snRNAs were detected simultaneously by hybridising the membrane 
with end-labelled RNA specific oligonucleotide probes for Ui, U2, U4, US and U6 
(Table 2.1.8.4) 
2.3.3.8 Primer extension 
The oligonucleotides to be used in primer extension were 5'-end radiolabelled with 
[7-32P] ATP (2.3.2.16) and purified by gel filtration (2.3.2.19). Primer extension 
reactions were set up as follows. I 1 of 10 mM dNTPs, 0.5 gl of total RNA (0.7 j.tg; 
2.3.3.1) and 4.5 tl of labelled primer were mixed, incubated for 5 min at 65°C and 
snap-chilled on ice. To this 4 pd of the following mixture was added: 2 p.1 5x RT 
buffer (Invitrogen), 0.5 p.1 of 100 mM DTT, 0.125 p.1 of SUPERase-In (Ambion, 20 
U/p.!), 0.875 p.1 of water and 0.5 p.1 of SuperScript II Reverse Transcriptase 
(Invitrogen, 200U/p.l). The reverse transcription reaction was then incubated for 1 h 
at 42°C and inactivated for 15 min at 70°C. Ten p.1 of 2x formamide loading dye 
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(96% (v/v) deionised formamide, 20mM EDTA, some BPB and XCB) with 10 mM 
NaOH was added to each reaction. Samples were heated for 5 min at 95°C to degrade 
the RNA and to denature the DNA products. They were then snap-chilled on ice and 
10 j.tl of each was loaded onto a tall pre-run 6% (19:1; 0.2 mm thick) denaturing 
polyacrylamide gel (Sequagel-6, National Diagnostics) in a vertical gel tank 
(Cambridge Electrophoresis, Model EV500) in lx TBE (2.1.3) using a metal plate to 
distribute the heat evenly. The samples were separated by electrophoresis for 2 h at 
30 W until the BPB had just run off the bottom of the gel. The gel was dried onto 
Whatman 3MM filter paper on a Hybaid Gel-Vac drier by heating for 1.5 h at 80°C. 
The gel was exposed overnight to a Phosphor Imaging screen and an image was 
obtained by scanning the screen on a STORM 860 and processing the image using 
ImageQuant 5.2 (Molecular Dymamics). The sizes of fragments were estimated by 
comparing them to a radiolabelled marker (2.3.2.18). 
2.4 Protein methods 
2.4.1 Crude protein preparation from yeast 
To prepare crude protein from yeast a method described by Volland et al. was used 
(Volland et al., 1994). Briefly, 10 ml of the appropriate medium (2.1.2.3) was 
incubated overnight with a single fresh colony of the appropriate yeast strain (2.1.6). 
The optical density of the culture was measured at 600nm and approximately 3 units 
of yeast culture was sedimented by centrifugation. The cells were lysed by 
resuspending and incubation in 0.5 ml of 0.2 M NaOH on ice for 10 minutes. 
Proteins were then precipitated by adding 50 .tl of 50% TCA and incubation on ice 
for a minimum of 10 minutes. Proteins were sedimented by centrifugation for 5 
minutes at 14,000 rpm at 4°C. The pellet was finally resuspended in 35 tl of 
dissociation buffer (0.1 M Tris-HC1 pH 6.8, 4 mM EDTA, 4% SDS, 20% (v/v) 
glycerol, 2% (vlv) 3-mercaptoethanol, 0.02% (w/v) BPB) and the solution 
neutralised by the addition of 15 tl of 1 M Ins base. Samples were heated at 95°C 
for 10 min before SDS-PAGE (2.4.3; 2 - 10 .tl was generally loaded per sample). 
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2.4.2 Preparation of yeast whole cell extract 
2.4.2.1 Preparation of splicing extracts 
100 - 200 ml of the appropriate medium was inoculated with a single colony of the 
yeast strain under investigation and incubated overnight at the appropriate 
temperature. This overnight culture was used to inoculate 2-3 1 of pre-warmed 
medium to 0D600 of approximately 0. 1, and grown to an 0D600 of approximately 0. 8. 
Cells were then centrifuged in a Beckman JLA 10,500 rotor (5,000 rpm, 5 mm, RT) 
and washed in 50 ml of ice-cold AGK buffer. Cells were sedimented (3,500 rpm, 3 
min RT; Mistral 1000 centrifuge), resuspended in 20 ml AGK buffer and centrifuged 
as above. The resulting yeast pellet was weighed (typically 3 - 5 g) and cells were 
resuspended in a volume of AGK buffer (ml), corresponding to 0.4x the cell pellet 
weight (g). DTT was added to a final concentration of 2 mM and the yeast 
suspension was frozen by dropwise addition to liquid nitrogen and stored at -70°C. 
The frozen cell suspension was added to a mortar containing liquid nitrogen and 
ground to a fine powder keeping everything from thawing by occasional addition of 
liquid nitrogen. The frozen powder was then transferred to a pre-chilled 
polycarbonate centrifuge tube, thawed on ice and centrifuged in a JA25.50 rotor 
(17,000 rpm, 30 mm, 4°C). The supernate was transferred to a pre-chilled 
polycarbonate centrifuge tube, taking care to avoid the lipid-containing top layer of 
the supernate, and centrifuged in a 70.1 Ti rotor (40,000 rpm, 60 mm, 4°C; 
Beckman). The resulting supernate was transferred to SnakeSkin dialysis membrane 
(Pierce, MWCO 3.5 kDa) and dialysed against 11 of pre-chilled dialysis buffer for 3 
hours at 4°C, with two changes of dialysis buffer. The dialysed cell extract was 
cleared of insoluble material one last time by centrifugation in pre-chilled microfuge 
tubes (14,000 rpm, 10 mm, 4°C). The resulting supernate was finally aliquoted into 
pre-chilled microfuge tubes and frozen at -70°C until use. 
AGK buffer: 	 10 mM HEPES-KOH, pH 7.9 
1.5 MM  MgC12 
200 mM KC1 
10% (vlv) Glycerol 
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Dialysis buffer: 	 20 mM HEPES-KOH, pH 7.9 
50 mM KC1 
0.4 mM DTT 
2.4.2.2 Preparation of crude extracts for immunoprecipiation 
Cultures of 1 litre were grown to 0D600 of 0.8 - 1.0. Cells were centrifuged, washed 
with 20ml of ice-cold AGK buffer and pelleted again. The wet pellet was weighed 
and 0.4x volume of AGK buffer was used to resuspend the cells. DTT was added to a 
final concentration of 2 mM before freezing the cell suspension in liquid nitrogen in 
a dropwise fashion. The cells were ground using a mortar and pestle, as described 
above. Frozen powder was transferred to a pre-chilled polycarbonate centrifuge tube, 
thawed on ice and centrifuged in a JA25.50 rotor (17,000 rpm, 30 mm, 4°C). The 
supernate was aliquoted and stored at -70°C or used directly for immunoprecipitation 
(2.4.6). 
2.4.3 SIDS Polyacrylamide gel electrophoresis (SIDS-PAGE) 
Samples to be analysed by SDS-PAGE had an equal volume of 2x SDS Loading 
Buffer (see below) added before being heated at 95°C for 5 - 10 minutes. Samples 
were then loaded onto a pre-cast 4-12% polyacrylamide Bis-Tris gel (NuPAGE, 
Invitrogen), 4-20% Tris-Glycine gel (Invitrogen or iGels from Life Gels) or 10-20% 
Tris-Glycine gel (Invitrogen) alongside molecular weight markers of known size 
(SeeBlue Plus2, Invitrogen) for reference. Bis-Tris gels were subjected to 
electrophoresis in an XCell SureLock Mini-Cell gel tank (Invitrogen) with lx MOPS 
SDS-PAGE running buffer (2.1.3); Tris-Glycine gels with lx Tris-Glycine SDS-
PAGE running buffer (2.1.3). Electrophoresis was performed at 150 V until the 
bromophenol blue dye front reached the bottom of the gel or until the pre-stained 
marker had reached the desired level of separation (usually 90 mm). Home-made 
gels (Tris-Glycine) were also used at the appropriate concentration (most commonly 
15% resolving gel with 5% stacking gel), poured and run using the Bio-Rad Mini-
PROTEAN 3 System. Ten ml of 15% resolving gel mix for two 1.0 mm gels was 
made as follows: mix 2.3 ml of water, 5 ml of 30% acrylamide/bis-acrylamide 
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(Design-A-Gel, 37.5:1, Severn Biotech Ltd.), 2.5 ml of 1.5 M Tris-HC1 pH 8.8, 0.1 
ml of 10% SDS, 0.1 ml of 10% APS and 10 j.tl of TEMED. Gels were allowed to set 
covered with isopropanol and subsequently washed with water. Then 5% stacking 
gel mix (for 3 ml mix: 1.66 ml of water, 0.5 ml of 30% acrylamide/bis-acrylamide, 
0.78 ml of 0.5 M Tris-HC1 pH 6.8, 30 j.il of 10% SDS, 30 j.il of 10% APS and 3 111 of 
TEMED) was poured and allowed to set on top. For different percentage gels the 
amount of bis-acrylamide solution and water were adjusted accordingly. 
Alternatively, for better resolution of proteins of low molecular weight the high-
TEMED protocol described by (Lehmeier et al., 1990) was used. For SDS-PAGE of 
mixtures containing multiple Lsm proteins 4-20% Tris-Glycine gels were most 
commonly used (occasionally 10-20%). 
2x SDS Loading Buffer: 	 100 mM Tris-HC1, pH 6.8 
1.25 M J-Mercaptoethanol 
4% (w/v) SDS 
0.2% (wlv) bromophenol blue 
20% glycerol 
2.4.4 Coomassie staining of protein gels 
2.4.4.1 Standard Coomassie staining protocol 
After electrophoresis the gel was stained for 30 mm - 2 h in Coomassie staining 
solution (50% methanol, 10% acetic acid and 0.1% (w/v) Coomassie Brilliant Blue 
R, Sigma B7920) until the gel was completely blue. It was then transferred to 
destaining solution (10% methanol, 10% acetic acid) and incubated with gentle 
mixing for several hours or overnight if necessary with a piece of film to soak up the 
Coomassie until the background was clear compared to the stained protein bands. 
2.4.4.2 GelCode Blue staining for mass spectrometry 
To allow detection of protein bands after SDS-PAGE for isolation and subsequent 
Mass spectrometry (2.4.12) GelCode Blue Stain Reagent (Pierce) was used 
according to the manufacturer's instructions. The gel was handled with clean gloves 
only and stained in a clean container. After electrophoresis the gel was washed three 
134 
times five minutes in 200 ml of deionised water. It was then incubated with gentle 
mixing in 20 ml of the staining solution for a minimum of 1 h, followed by 
destaining for 2 - 3 h with several changes of deionised water. 
2.4.5 Western blotting 
2.4.5.1 Transfer of proteins to PVDF membrane 
Proteins were transferred electrophoretically from the SDS-polyacrylamide gel to 
PVDF membrane (Immobilon-P, Millipore) using the Invitrogen XCe1I II 
Blotmodule system according to the manufacturer's instructions. Electrophoretic 
transfer was performed in lx Western Transfer Buffer (2.1.3) at 25 - 30 V for 1 - 2 
hours. Transfer was confirmed by staining of the membrane with Ponceau S or 
simply by observing the transfer of the pre-stained marker. 
2.4.5.2 Western blot hybridisation 
Non-specific protein interactions to the membrane were prevented by blocking the 
PVDF membrane directly after transfer. To block, the membrane was incubated for a 
minimum of 30 min at room temperature in 20 ml TBST-M (lx TBST (2.1.3) with 
5% (w/v) Marvel dried skimmed milk) with constant shaking. Primary antiserum 
(2.1.9) was diluted to the appropriate concentration in 2.5 - 10 ml TBST-M, added to 
the blocked membrane and incubated (2 h, RT or 0/n, 4°C) with constant shaking. 
The membrane was then washed 5 times 5 minutes in 20 ml of lx TBST. For HRP 
conjugated primary antibodies the Western blot was ready for development (2.4.5.3). 
For non-conjugated primaries, HRP-conjugated secondary antiserum was diluted in 
10 ml of lx TBST-M, applied to the membrane and incubated with constant shaking 
(1 - 2 h, RT). The membrane was then washed as described above and developed as 
described below. 
2.4.5.3 Enhanced Chem iluminescence (ECL) 
1.5 ml of ECL solution (Amersham Biosciences) was prepared according to the 
manufacturer's instructions, added to the protein side of the PVDF membrane and 
incubated (1 mm, RT). Excess liquid was removed, the membrane was placed in 
Saran wrap and exposed to photographic film (Kodak MXB Film). Exposure times 
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varied depending on the strength of the signal, but were typically between 10 
seconds and 5 mm. Film was developed using a Konika SRX-101A Developer. For 
weak signals ECL Plus (Amersham Biosciences) was used according to the 
manufacturer's instructions. 
2.4.5.4 Stripping Western blots 
To remove antibodies from a Western to allow subsequent hybridisation with a 
different antibody Restore Western Blot Stripping Buffer (Pierce) was used. To this 
end the blot was incubated with agitation for 30 min in 20-30 ml of stripping buffer 
at 50°C. The blot was then washed in TBS-T, blocked and hybridised as usual 
(2.4.5.2). The Stripping Buffer was kept at 4°C and reused multiple times. 
2.4.6 Immunoprecipitation of proteins 
Pre-swollen Protein A Sepharose beads (30 p1; Amersham Biosciences) were 
incubated with antiserum (2.1.9) overnight at 4°C. Beads were washed 3 times with 1 
ml of NTN buffer (2.1.3) and blocked with 100 p1 blocking solution (0.1 mg/ml 
tRNA, 0.1 mg/ml BSA and 0.1 mg/ml glycogen) for 45 minutes at room temperature. 
Pre-conjugated agarose beads (30 tl; Santa Cruz Biotechnology; 2.1.9) were washed 
with 1 ml of NTN and blocked the same way. Beads were then washed three times 
with 1 ml of NTN buffer and once with 1 ml of lx 1P 150 buffer (2.1.3). For 
immunoprecipitation of proteins from whole cell extracts 30 p1 of extract (2.4.2) was 
added in a final volume of 200 .tl of lx 1P150 buffer. For co-immunoprecipitation of 
recombinant proteins appropriate amounts (0.2 - 2 p.g) of each of the purified 
proteins were added in 1P 150 buffer. The suspension was incubated for two hours at 
4°C with gentle mixing. Beads were then washed 2 times with 1 ml of NTN and 2 
times with 1 ml of NT buffer. For problematic "sticky" proteins 0.1% Triton X- 100 
was added to the [P150 and NTN buffers. Beads were finally resuspended in 20 .tl lx 
SDS loading buffer (2.4.3). Supernate and pellet samples (and where appropriate 
input samples) were heated in lx SDS loading buffer for 5 - 10 min at 95°C and 
subjected to SDS-PAGE (2.4.3) and Western blotting (2.4.5). 
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2.4.7 Recombinant protein expression in E. co/i 
Two methods of recombinant protein expression in E. co/i were used and many 
variations of both methods to obtain optimal levels of expression and/or optimal 
levels of soluble protein. For optimal levels of expression colonies of the appropriate 
E. co/i strain (2.1.5) freshly transformed with the expression vectors (Tables 2.1.7.1 
and 2.1.7.2) were used to inoculate an appropriate volume of LB in the presence of 
selective antibiotics (2.1.2.5). 
2.4.7.1 Recombinant protein induction with IPTG 
For one method of expression a small culture (usually 5 ml) was grown overnight at 
37°C. The following morning a 1 in 100 dilution was made in fresh LB (100 ml - 1 
L) with antibiotics. This culture was grown at 18°C, 23°C, 25°C, 30°C or 37°C to an 
0D600 of 0.4, at which stage 0.1mM of isopropyl-j-D-thiogalactopyranoside (IPTG) 
was added. The culture was then grown for another lh to overnight before harvesting 
(usually short for expression at 37°C; long for 18°C or 23°C). 
2.4.7.2 Recombinant protein expression using ONEX 
The second method of expression used the Novagen Overnight Expression (ONEX) 
system. For this method 2 - 10 fresh colonies were used to inoculate an appropriate 
volume of LB (1 - 100 ml) with antibiotics and ONEX solutions 1, 2 and 3 (0.01, 
0.05 and 0.001 times the culture volume respectively). This culture was grown at the 
appropriate temperature for the appropriate length of time (14 - 16h for 37°C, 24 - 26 
h for 30°C or 30 - 34 h for 23°C) before harvesting. 
2.4.7.3 Harvesting cultures after recombinant protein expression 
A small volume of each expression culture was taken and mixed with an equal 
volume of 2x SDS-PAGE loading buffer to allow to check for expression by SDS-
PAGE (2.4.3) followed by Coomassie staining (2.4.4) and/or Western analysis 
(2.4.5). Cultures were harvested by pelleting the cells for 5 min at 6,000 rpm, 4°C in 
a Beckman JLA1O,500 rotor. Cell pellets were stored at -70°C until required for lysis 
and recombinant protein purification (2.4.8). Even if the purification was carried out 
the same day, the pellet was frozen at -70°C because this step aids in cell lysis. 
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2.4.7.4 Expression of Lsm proteins and Hfq 
The most successful methods for expression of Lsm proteins and E. co/i Hfq were 
overnight expression at 23°C in the presence of 0.1 mM IPTG (500 ml culture 
volume) and 24 h expression at 30°C using the ONEX system (10 - 50 ml culture 
volume). When performed as described high levels of expression and satisfactory 
levels of soluble protein were obtained, although the latter varied considerably 
between the different Lsm proteins. 
2.4.7.5 Expression of Prp24p 
The most successful method for expression of Prp24 protein was expression at 37°C 
in the presence of 0.1 mM IPTG (500 ml culture volume) for 1 - 2 h. When 
performed as described high levels of expression were obtained. Levels of soluble 
Prp24p were generally high; the main concern was to limit proteolysis. Degradation 
of recombinant Prp24p was minimised by adding IPTG no later than 0D600 0.4, by 
not exceeding 2 h of incubation in the presence of IPTG and by cooling the culture 
quickly after expression. 
2.4.8 His-tagged protein purification 
Two methods of His-tagged protein purification were used, native and denaturing, 
both based on Qiagen Ni-NTA Agarose or Superflow and the manufacturer's 
instructions. Methods were optimised for individual proteins as described below. 
2.4.8.1 Cell lysis for protein purification 
Two methods were used for cell lysis. The first method employed lysozyme and 
Triton X-100 detergent to break the cells and exonucleases to degrade DNA and 
RNA; in the second (preferred) method cells were lysed by sonication while shearing 
DNA and RNA simultaneously. 
Cell lysis for native purification 
Both methods were used for cell lysis in preparation for native purification of 
recombinant proteins. In the first method cells were resuspended in Lysis Buffer (20 
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mlvi Tris-HC1 pH 7.5, 1 M NaCl, 5% (v/v) glycerol, 10 mM imidazole and 5 mM 3-
Mercaptoethanol; 30 ml for 500 ml IPTG expression culture; 5 ml for 10 ml ONEX 
expression culture). Lysozyme was added to a final concentration of 0.2 mg/ml and 
the suspension was incubated for 30 minutes with mixing at 4°C. Triton X-100 was 
then added to a final concentration of 0.2% (v/v) together with DNase and RNase A 
(final 5 p.g/ml for both), and the mixture was incubated a further 15 min at 4°C. To 
lyse cells by sonication a Vibra Cell microtip sonicator (Sonics & Materials Inc., 
Jencons Scientific Ltd.) was used. It was set to amplitude 35% with 5 sec bursts and 
5 sec breaks for 2 mm. To make sure the mixture stayed cold during sonication it was 
kept on watery ice throughout. 
Cell lysis for denaturing purification 
Harvested cell pellets (2.4.7.3) were resuspended in freshly prepared 8 M urea pH 8 
buffer (100 mM NaH 2PO4, 10 mM Tris, 8 M urea, pH 8.0 set with NaOH) and cells 
were lysed by sonication as described above. 
After lysis cell extracts were transferred to polypropylene centrifuge tubes and 
centrifuged (17,000 rpm, 30 mm, 4°C; Beckman JLA 10,500 rotor). Supernates were 
transferred to polycarbonate tubes and used for purification immediately (2.4.8.2 and 
2.4.8.3) or stored at -70°C until required. 
2.4.8.2 His-tagged protein purification under native conditions 
Cleared cell lysate (2.4.8.1) was incubated with Ni-NTA agarose (Qiagen; washed 
with lysis buffer) for 30 mm -1 h at 4°C with rotation. The amount of Ni-NTA 
agarose used depended on the level of soluble recombinant protein present after lysis 
and was chosen for each case. It is preferable to have excess His-tagged protein over 
resin, to avoid high levels of non-specific binding of E. coli proteins. As a rule of 
thumb 0.5 to 2 ml of 50% slurry was used for 100 to 500 ml IPTG induced cultures 
(2.4.7.1) or 10 to 100 ml ONEX induced cultures (2.4.7.2). The agarose beads were 
sedimented by centrifugation for 1 min at 1,000 rpm in a Mistral 1000 centrifuge. 
The beads were washed with 10 ml of lysis buffer, centrifuged, resuspened in 5 ml of 
lysis buffer, applied to a Polyprep Chromatography column (Bio-Rad, 731-1550) and 
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allowed to drain by gravity. Another 10 ml of lysis buffer was applied to the resin 
and left to drain. The resin was washed another three times with 10 ml of wash buffer 
(20 mM Tris-HC1 pH 7.5, 1 M NaCl, 5% (v/v) glycerol, 40 mM imidazole and 5 mM 
-Mercaptoethano1), fully resuspending the resin during one of these steps. Finally 
elution buffer (wash buffer with 250 mM imidazole) was applied to the column 1 ml 
at a time and 0.2 to 0.5 ml fractions were collected and stored at -70°C. Samples 
were taken at each step, including all elution fractions, mixed with equal volumes of 
2x SDS-PAGE loading buffer. All samples were separated by SDS-PAGE (2.4.3) 
followed by Coomassie staining (2.4.4) and/or Western analysis (2.4.5) to determine 
the presence and purity of purified recombinant protein. Elution fractions with good 
amounts and purity of recombinant protein were pooled and dialysed against 3x 330 
ml of BC 100 buffer (20 mM Tris-HC1 pH7.9, 100 mM KC1, 20% (v/v) glycerol) at 
4°C in Spectra/Por (Spectrum, MWCO 12 - 14 kDa) or SnakeSkin (Pierce, MWCO 
3.5 kDa) dialysis tubing to remove all imidazole. For proteins that tended to 
precipitate at low salt (Lsm4 in particular) KC1 or NaC1 in the buffer up to 0.5 M was 
beneficial. After dialysis insoluble material was removed by centrifugation and 
supemate was aliquoted and stored at -70°C. 
2.4.8.3 His-tagged protein purification under denaturing conditions 
Cleared cell lysate (2.4.8.1) was incubated with Ni-TNA agarose (Qiagen; washed 
with 8M urea lysis buffer) for 30 min at 4°C with rotation. The amount of Ni-NTA 
agarose used depended on the level of recombinant protein present after lysis and 
was chosen for each case (see 2.4.8.2). Resin was washed as described under 2.4.8.2, 
but 8 M urea pH 8 lysis buffer (100 mM NaH 2PO4, 10 mM Tris, 8 M urea, pH 8.0 set 
with NaOH) and 8 M urea pH 6.3 wash buffer were used instead. Protein was finally 
eluted with 8 M urea pH 4.5 buffer (pH adjusted with HC1). All buffers were 
prepared freshly each time. Elution fractions with good amounts and purity of 
recombinant protein were pooled and stored at -70°C. 
2.4.9 Protein quantification 
To determine the concentration of proteins in purified samples or in total protein 
extracts the Bradford assay was used in the form of the Bio-Rad Protein Assay, 
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according to the manufacturer's instructions. In brief, a standard curve was made 
using a BSA concentration range of 0.2, 0.4, 0.6, 0.8 and 1.0 mg/mi. 20 p1 of each 
solution was mixed with 1 ml of dye reagent (made by diluting 1 part of 5x Dye 
Reagent Concentrate with 4 parts of deionised water). These were mixed thoroughly 
and their A 595 was measured between 5 min and 1 h of mixing. Absorbance readings 
were plotted against protein concentration and a linear fit was used to estimate 
unknown protein concentrations. To this end A595 was measured for a mix of 20 p1 of 
protein sample with 1 ml of lx Bradford reagent. Where necessary dilutions of 
protein samples were made to ensure readings were between those of the 0.2 and 1.0 
mg/ml BSA standards. 
2.4.10 In vitro assembly of Lsm complexes 
2.4.10.1 Assembly of Lsm complexes in 8M urea 
Individual Lsm proteins were expressed in E. co/i (2.4.7.4) and purified under 
denaturing conditions using Ni-NTA resin (2.4.8.3). Equal amounts of each of the 
members of the Lsm l-'7p or Lsm2-8p complexes as estimated by Coomassie stained 
SDS-PAGE gels (2.4.3) were mixed together and dialysed in Spectra/Por dialysis 
tubing (Spectrum, MWCO 12 - 14 kDa) against BC100 (2.4.8.2) at 4C (3 times 330 
ml, 2 h). Soluble and insoluble proteins were separated by centrifugation for 15 mm 
at 14,000 rpm, and samples of each were separated by SDS-PAGE (2.4.4). 
Coomassie staining of the gel showed the yield of soluble protein and presence of the 
different members of the Lsm complexes. Mass spectrometry of overlapping bands 
(Lsm2 and 5, and Lsm7 and 8; 2.4.12) confirmed the presence of all members of the 
ring (3.5.3). Co-immunoprecipitation (2.4.6) of all Lsm proteins using the epitope tag 
on one of them showed their interaction (3.5.1). Size exclusion chromatography 
(2.4.11) was used to estimate the size of the resulting complexes. 
2.4.10.2 Assembly of Lsm complexes in 4M urea 
Human LSm complexes were assembled in vitro using purified recombinant 
subcomplexes by a method based on the one described by Zaric et al. (Zanc et al., 
2005). In brief, equal molar amounts of each of the subunits were mixed and the urea 
concentration was brought up to 4 M by the addition of the appropriate amount of 
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urea. The mix of proteins was dialysed for 4 h against 20 mM Tris-HC1 pH7.5, 1 M 
NaCl and 4 M urea at 30°C, for 16 h against 20 mM Tris-HC1 pH7.5, 1 M NaCl at 
30°C and finally for 2-4 h against 20 mM Tris-HC1 pH7.5, 0.5 M NaCl at 4°C. 
2.4.10.3 Optimisation of yeast Lsm complex assembly 
Comparison of the 4M and 8M urea methods used for assembly of the yeast and 
human Lsm complexes, their yields and RNA binding, annealing and strand 
displacement activities (described in Chapters 3-5), shows that there is still room for 
improvement, in particular for in vitro assembly of recombinant yeast Lsm 
complexes. Possibilities for improvements are discussed in detail in 3.5.4. 
2.4.11 Size exclusion chromatography of protein complexes 
Protein samples to be analysed by size exclusion chromatography were dialysed into 
gelfiltration buffer (20mM Tris-HC1 pH 7.9, 0.1 - 0.5 M KC1, 10 mlvi - 
Mercaptoethanol) and concentrated by centrifugation in Vivascience Vivaspin 
concentrators (MWCO 30,000; VS0121). Samples were centrifuged directly before 
injection to loose any insoluble matter. For separation of proteins in the range 
between 10 and 600 kDa a SUPERDEX 200 HR1O/30 size exclusion 
chromatography column was used connected to an AKTApurifierl 0 FPLC unit 
(Amersham Biosciences). For better resolution in a higher molecular weight range 
(30 to 2,000 kDa) a SUPEROSE 6 HR10/30 (Amersham Biosciences) size exclusion 
column was used. After a pumpwash purifier run, the column was equilibrated with 
at least one column volume (V a) of gelfiltration buffer (filtered and degassed at 4°C). 
Protein was loaded in a volume of 200 j.il using a 200 j.t1 loop and injected onto the 
column using 300 jil of buffer. During a run with 1.2 column volumes of buffer at 
0.3 - 0.5 ml/min the A260 of flowthrough was measured and collected in 0.5 ml 
fractions. Data were collected using Unicorn 4.10 software. To calculate protein 
molecular weights (Mw) from their corresponding elution volumes (V a) proteins of 
known size were run across the same columns. Proteins with molecular weights of 
15.6, 20.4, 49.1, 67.4, 176, 219, 416 and 699 kDa had previously been used to create 
a calibration curve for the SUPERDEX 200 column. Albumin (67 kDa), aldolase 
(158 kDa), catalase (232 kDa), ferritin (444 kDa) and thyroglobulin (669 kDa) from 
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the Amersham High Molecular Wight Gel Filtration Calibration Kit (17-0441-01) 
were used to calibrate the SUPEROSE 6 column. Blue dextran 2,000 was used to 
estimate the column void volumes (Vo). The Kay = (V e V0)/(Vc V0) was plotted 
against the Log(Mw), the linear fit to these data points was used to calculate the 
molecular weight of detected A 260 peaks. 
2.4.12 Mass spectrometry of proteins 
Proteins were visualised after SDS-PAGE by Coomassie staining (2.4.4). 
Appropriate bands were excised using a clean scalpel. Samples were processed and 
analysed by Sam Clokie and Andrew Cronshaw in the Mass Spectrometry facility of 
The Wellcome Trust Centre for Cell Biology. In brief, gel bands were cut and 
digested with trypsin (Promega). Peptides from the digested bands were then run on 
a MALDI-TOF MS spectrometer (Matrix-assisted Laser Desorptionllonisation, Time 
Of Flight; Voyager DE-STR MALDI-TOF MS, Applied Biosystems) and some on a 
nanoLC-MS mass spectrometer (Liquid Chromatography, Mass Spectromertry; 
Famos autosampler, Switchos column switching unit and Ultimate nanoLC, Dionex). 
Processed spectra were searched against the NCBI non-redundant database using 
Protein Prospector or MASCOT (Matrix Science). 
2.5 Mixed protein/RNA assays 
2.5.1 RNA bandshift assay 
RNA bandshift reactions were carried out in a volume of 7.5 p1. In vitro transcribed 
RNA (2.3.3.2) and purified proteins (2.4.8) were mixed and incubated at room 
temperature before separating bound and unbound RNA by native PAGE (2.3.3.4). 
RNA was denatured at 85CC for 3 min and snap-chilled on ice just before the assay. 
Each reaction was assembled as follows in lx RNA annealing buffer (40 mM 
HEPES-KOH pH 7.9, 50 mM KC1, 10 mM Mg acetate): 
0.75 tl 	lOx RNA annealing buffer 
0.75 p1 10mMDTT 
0.1 p1 	RNasin (Promega, 40 U/j.tl) 
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1 jtl 	 U6 RNA (7.5 ng; 0.2 pmol) or other RNA 
0.5 —5 .ti 	purified protein (complex) 
Bring total volume up to 7.5 j.tl with deionised water 
Reactions were incubated for 10 min at room temperature. They were then 
transferred to ice before separation by native PAGE (2.3.3.4), followed by Northern 
blotting (2.3.2.6) and hybridisation with radioactively labelled RNA specific probes 
(2.3.2.7; Table 2.1.8.4). 
2.5.2 U4/U6 RNA annealing assay 
U4/U6 annealing reactions were carried out in a volume of 7.5 j.tl. In vitro 
transcribed U4 and U6 RNA (2.3.3.2) and purified proteins (2.4.8) were mixed and 
incubated before degrading the protein with Proteinase K (and in some cases 
removing all protein by phenol/chloroform extraction; 2.3.1.2). RNA was denatured 
at 85CC for 3 min and snap-chilled on ice just before the assay. Each reaction was 
assembled as follows in lx RNA annealing buffer (40 mM HEPES-KOH pH 7.9, 50 
mM KC1, 10 mM Mg acetate): 
0.75 p.1 lOx RNA annealing buffer 
0.75 p.1 10mMDTT 
0.1 p.1 RNasin (Promega, 40 U/p.l) 
1 p.1 U6 RNA (7.5 ng; 0.2 pmol) 
0.5 —4 p.1 purified protein (complex) 
Bring total volume up to 6.5 p.1 with deionised water 
Reactions were incubated for 10 min at room temperature before adding 1 p.! U4 
RNA (15 ng, 0.27 pmol), followed by incubation at 30°C for 30 mm - 1 h. 2.5 Al of 
native loading buffer (15% glycerol, 40 mM HEPES-KOH pH7.9, 50 MM KC1, 1 
mM Mg acetate, some BPB and XCB) with 1 p.g/p.l Proteinase K was added to each 
reaction and incubated for a further 5 - 10 min at 30°C. In some cases 
phenol/chloroform extraction was performed with an equal volume of 
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phenol/chloroform (2.3.1.2) and the aqueous phase was loaded directly onto a pre-
run 6% (20:1) native PAGE gel (2.3.3.4) and run for 3 h at 5 W, 4°C in 0.5x TBE. 
RNA was transferred to Hybond-N by Northern blotting (2.3.3.6) and hybridised 
with radioactively labelled probes (2.3.2.16) for U4 or U6 RNA (2.3.2.7; Table 
2.1.8.4). 
2.5.3 Strand displacement assay 
The strand displacement assay was adapted from the helicase assay described by 
Cordin et al. (Cordin et al., 2004). 
2.5.3.1 Strand displacement substrate preparation 
Substrate for the strand displacement assay consisted of a duplex formed between 
non-labelled RNA and a labelled complimentary DNA oligonucleotide. The RNA 
fragment was produced by in vitro transcription and gel purified (2.3.3.2). The DNA 
oligonucleotide was end-labelled (2.3.2.16) and purified by gel filtration (2.3.2.19). 
Duplex was formed by mixing the following: 5 j.tl of 5x annealing buffer (100 mM 
Tris-HC1 pH 8.0, 1 M potassium acetate, 0.5 mM EDTA), 1.25 .t1 of 100 jtM 
unlabeled oligo (final 5 .tM), RNA at a final concentration of 5 JIM, 2.5 .tl of 
labelled oligo (final 0.33 tM), and water up to 25 .tl. This mixture was incubated for 
2 min at 90 °C and snap-chilled on ice, and used directly in the strand displacement 
assay or stored at -20 °C until required. 
2.5.3.2 Strand displacement reactions 
Strand displacement reactions were carried out in a volume of 10 j.tl: 0.5 .tl of duplex 
(25 - 250 nM final), 0.5 .t1 of 100 .tM oligo, 2 tl of 5x helicase assay buffer (100 
mM Tris-HC1 pH 7.5, 250 mM potassium acetate, 25 mM Mg acetate, 0.5 mg/ml 
BSA), 1 j.tl of 10 mM DTT, 0.2 1.il of RNAsin (Promega, 40 U4tl), 0.5 - 4 j.il of 
protein and deionised water up to 10 pl. Duplex was added last and reactions were 
mixed thoroughly (for the Dedip control 1 mM ATP was added last). These were 
then incubated for various times (usually between 1 min and 1 h) at 37 T. Reactions 
were stopped by transferring them to ice and adding 5 .t1 of helicase loading buffer 
(40% glycerol, 10 mM EDTA, some BPB and XCB). Samples were loaded on a 15% 
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native lx TBE PAGE (20:1) (Bio-Rad, MiniPROTEAN gel-kit; 1.0 mm gels) and 
run in pre-cooled lx TBE at 4°C for 30 min at 8 W per gel. Gels were dried onto 
Whatman 3MM paper on a Hybaid Gel-Vac drier by heating for 1.5 h at 80°C. Dried 
gels were exposed to film (Kodak BioMax MS Film) and/or to a Phosphor Imaging 
screen to allow for quantification using a STORM 860 scanner and ImageQuant 5.2 
software (Molecular Dymamics). 
2.6 Microscopy methods 
2.6.1 Live cell imaging 
For live cell imaging, cells were grown in the appropriate liquid medium. For simple 
visualisation, 5 j.tl of (log-phase) culture was spotted on a poly-lysine coated 
microscope slide (Polysine, VWR, 631-0107), a coverslip was placed on top, and 
cells were investigated immediately. 
Live cells were observed by bright field microscopy and expression and localisation 
of fluorescently tagged proteins were detected by fluorescence microscopy using a 
Leica FW4000 microscope. The microscope contained a narrowband filter wheel 
with the capability for detecting fluorescence from GFP (gf; 489 nm excitation, 508 
nm emission), RFP (Cy3; 550 nm excitation, 570 nm emission) and DAPI (A4; 359 
nm excitation, 461 nm emission). Exposure times for GFP and RFP fluorescence 
were typically between 200 and 500 milliseconds, while exposure times for DAPI 
were between 50 and 100 milliseconds. Images were captured with a CoolSnap 
camera (Roper Scientific) using Leica FW4000 Vi. 1.1 software. Only one Z-section 
was taken for each sample, because live cells are constantly in motion. 
2.6.2 Imaging of fixed and DAPI stained cells 
Cells were grown in the appropriate liquid media, fixed for 10 minutes in 4% 
formaldehyde and washed 3 times with buffer B (2.1.3). To detect the localisation of 
nuclei the nuclear marker DM1, which stains DNA, was used. Fixed and washed 
cells were resuspended in a suitable volume of buffer B and 2 gl of cell suspension 
was spread on .a poly-lysine coated microscope slide (Polysine). This was left to 
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airdry for a few minutes, 3 .il of Vectashield (H1200), mounting medium for 
fluorescence with DAPI, (Vector Laboratories Inc., Burlingame, CA, USA) was 
added and a coverslip was placed on top. Cells were observed 1 - 24 h later to allow 
the DAPI to stain the DNA properly. 
2.7 Bioinformatics 
A range of bioinformatics tools was used, most of which are internet-based. The 
Saccharomyces Genome Database (SGD; http://www.yeastgenome.org/)  was used to 
get general information on S. cerevisiae genes of interest. This includes DNA and 
amino acid sequence information, physical and genetic interaction data and 
description of mutant phenoypes. NCBI BLAST (httD://www.ncbi.nlm.nih.gov/ 
blast!) was used to find homologues of proteins (blastp) or to find out the origin of a 
piece of sequenced DNA (blastn or blastx; Altschul et al., 1990). Protein Calculator 
v3.3 (http://www.scripps.edu!—cdputnamlprotcalc.html) was used to get information 
on a protein, such as its molecular weight, p1 and molar absorbance. NEBcutter 
V2.0 (http://tools.neb.com/NEBcutter2/index.php)  was used to get a restriction map 
of a piece of DNA (Vincze et al., 2003). Reverse complement 
(hLtp://bioinfon -natics.org/sms/rev comp.html) was used to get the reverse 
complement of a DNA sequence (usually to make a reverse primer). ExPASy 
translate tool (http://www.expasy.org!tools/dna.html) was used to get all possible 
frames of translation of a DNA or RNA sequence. To calculate the annealing 
temperature of primers for site-directed mutagenesis the Stratagene QuikChange 
Primer Tm calculator was used (http://www.stratagene.com/QPCRI  tmCalc.aspx). 
To order primers and get information on their annealing temperature and likelihood 
of secondary structure formation the Sigma-Genosys website was used 
(https://orders.sigma-genosys.eu.com!). To align multiple amino acid sequences by 
conservation ClustalW was used (http:!/www.ebi.ac.uk!clustalw/) (Thompson et al., 
1994) and Boxshade 3.21 for a clearer graphical output of the results 
(http://www.ch.embnet.org/software/BOXform.html) . Jalview version 2.2 (http :1/ 
www.ialview.org/) was used to make manual adjustements to automatic multiple 
sequence alignments (Clamp et al., 2004). To check for the presence of nuclear 
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localisation signals in proteins of interest PredictNLS (http://cubic.bioc. 
columbia.edul predictNLSf) was used (Cokol et al., 2000). To check for the presence 
of putative phophorylation sites in proteins of interest NetPhos 2.0 
(http://www.cbs.dtu. dklservicesfNetPhos/)  was used (Blom et al., 1999). To predict 
the 2D and 3D structure of proteins of interest based on homology to proteins with 
known (crystal) structures 3D-PSSM (hLtp://www.sbg.bio.ic.ac.uk/-3d])ssm/  
htm1/ffrecogsimpIe. html) was used (Kelley et al., 2000b). For prediction of 
secondary RNA structures mfold version 3.2 (htip://www.bioinfo.ri)i.ed 
 .cgi) was used (Mathews et al., 1999; Zuker, 2003) 
Finally, to check the sequence and trace of a sequenced piece of DNA and to align it 
with a known sequence Sequencher 4.2 or 4.5 (Gene Codes Corp.; Macintosh) or 
ContigExpress (Invitrogen, Vector NTI Advance 10; PC) were used. 
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CHAPTER 3 
Lsm protein expression, purification 
and in vitro complex formation 
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3.1 Introduction 
To investigate the structure and function of the S. cerevisiae Lsml-7 and Lsm2-8 
complexes recombinant Lsm proteins needed to be produced. Initial experiments 
with Lsm proteins produced by in vitro translation in wheat germ extracts (Page, 
2002; Silvia Galardi, this lab, unpublished data) were promising, but the potential 
presence of wheat Lsm proteins and/or other functionally related proteins made 
interpretation of results problematic. A similar approach using E. co/i cell-free 
extracts to produce Lsm proteins by in vitro translation proved unsuccessful. Large 
amounts of most Lsm proteins could be produced, but they were often largely 
insoluble. No specific U6 RNA binding activity of mixtures of Lsm2-8 proteins 
produced this way could be detected (data not shown). An alternative approach was 
therefore taken, in which recombinant Lsm proteins were produced in E. coli, 
purified and used to assemble the appropriate complexes in vitro. Complexes thus 
produced could be used to study their function in isolation of contaminant eukaryotic 
proteins. In addition, the aim was to elucidate the correct order of the Lsm 
polypeptides within the ring-shaped complex using different tags on different 
proteins to allow examination of interactions between individual subunits by co-
immunoprecipitation. Efforts to optimise expression, purification and in vitro 
assembly of Lsm complexes are described in this chapter. Functional and structural 
analyses of these complexes are described in Chapters 4-6. 
3.2 Creating protein expression vectors 
3.2.1 Cloning yeast LSM genes into E. co/i expression vectors 
Coding sequences of S. cerevisiae LSMJ to 8 were cloned into pET 19b (pMR1-8, 32) 
enabling T7 promoter driven expression of N-terminally His-tagged proteins in 
BL2 1 (DE3) cells or other T7 expression systems. Predicted coding sequences were 
taken from the Saccharomyces Genome Database (SGD) and cloned, PCR-amplified 
sequences were inspected to ensure absence of any mutations. Intronless LSM2 and 
LSM7 were amplified by PCR using previously cloned sequences (Mayes, 1998) as 
template. Two new vectors were created with a single HA (pMR81) or Myc tag 
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(pMR82) inserted between the pET19b lOxHis-tag and the multiple cloning site, 
allowing for the production of double tagged proteins. All Lsm coding sequences 
were cloned into these new vectors (pMR1 1-18, 21-28, 33, 34). A different, shorter 
LSM6 open reading frame (ORF) was used than that proposed by Mayes et al. (1999) 
and indicated on SGD. Bouveret et al. (2000) suggested a new start site for LSM6 
because it is consistent with the protein's apparent molecular mass of 9.3 kDa, and is 
supported by comparison of the yeast Lsm6p sequence to homologues from other 
organisms (Bouveret et al., 2000). The size of the protein is therefore 86 amino acids 
(aa) instead of 123 aa. This change was later confirmed by genome-wide mapping of 
yeast transcription start sites (Zhang and Dietrich, 2005) and amended by SOD. 
3.2.2 Confirmation of a change in LSM8 ORF designation 
The LSM8 ORF proposed by SOD was initially used to create expression vectors for 
the production of recombinant Lsm8p. When S. cerevisiae Lsm8p was aligned with 
orthologues from other organisms a discrepancy between the N-terminus of yeast 
Lsm8p (scLsm8p) and other Lsm8 polypeptides became apparent (Fig. 3.1A). 
Further investigation revealed that the LSM8 ORF designation had been changed 
based on the automated comparison of closely related Saccharomyces species (Kellis 
et al., 2003). These authors suggested to move the start site for LSM8 57 nucleotides 
(nt; 19 aa) downstream. This is also the predicted start methionine in the majority of 
Saccharomyces species orthologues (Kellis et al., 2003; Cliften et al., 2003) and 
significant sequence conservation begins abruptly at this methionine (Fig. 3.1B). To 
confirm this new start site primer extension was performed to determine the length of 
the 5' untranslated region (UTR) of LSM8. The main product after primer extension 
with Lsm8Rpe2 was approximately 128 nt long (Fig. 3.2A), suggesting a short 5' 
UTR for LSM8 of only about 8 nt consistent with the new suggested start site. The 
majority of yeast leader sequences are upward of 25 to 30 nt, but 5' UTRS of 8 nt or 
even shorter do occur (Zhang et al., 2005). Unfortunately the LSM8 5' UTR was not 
mapped in the Zhang study. A recent large-scale cDNA analysis using a vector-
capping method to clone the yeast transcriptome reported the LSM8 5' UTR to be 15 
nt long (Miura etal., 2006). The authors of this study 
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Fig. 3.1 The S. cerevisiae LSM8 ORF was initially predicted incorrectly 
as alignments with Lsm8p sequences from different organisms suggest. 
(A) Alignment of Lsm8p sequences from 13 different organisms suggests 
that the predicted S. cerevisiae (sc) sequence may be 19 amino acids too 
long. ki = Kluyveromyces lactis; sp = Schizosaccharomyces pombe; hs = 
Homo sapiens; mm = Mus musculus; xi = Xenopus laevis; dm = Drosophila 
inelanogaster; ce = Caenorhabditis elegans; at = Arabidopsis thaliana; 
pf= Plasmodiumfalciparum; yl =Iarrowia lipolytica; eg = Eremothecium 
gossvpii; tb = Trypanosoma brucei; (B) Alignment of Lsm8p from seven 
different Saccharomyces species shows that these 19 amino acids are not 
conserved amongst related yeasts either, confirming a new start for S. 
cerevisiae LSM8. Sc = Saccharomvces cerevisiae; Sb = S. bavanus; Sp = 
S. paradoxus; Sm = S. rnikatae; Sk = S. kudriavzevii; Sca = S. caste/lu; 
SkI = S. kluvveri 
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LSM8 genomic sequence 
-350 TCTAAAGCGC CTGcATTCGC TACTTTCCCA CTGTGGGAGA ATATAGATCT 
-300 GCGGTGP.T GATGTTTCTG TAATCATCAA CGAG'rGTTCA GATTAGCCT 
- 00 CTGAAACATC TGTAGATATC TCGTCTcTTC TACCTCTAGC GACCATTTT 
- 0 CTAAATGTTT CTACACGTCT GCAGTATCCT TGTTTTGCTT GTTTTCCTTC 
-100 TTTCTGTTCT TGTTGATTTT CCCTTTAAGT CCTGAAAATA CTATCATGGC 
- 0 GTAAAGGGAA AAAAAAAAAC TAATCTTACG TGGTTCrrAT AAGATGGACC 
- AGCAAGCTGC ATACGTACA CCAThCAAGA AGAPCACACT ATCGTGCACC 
ATGTCP.GCCA CCTTGAAAGP. CTACTTAAAT AAAAGAGTTG TTATAATCAA 
AGTTGACGGC GAP.TGCCTCA TAGCAAGCCT PAACGGCTTC GACAP.AAATA 
AA..ç.........çj GTTTTCAPCC GCATAAGCAA GGAATTCATC 
P0! TGCAAGGCAC AGTTCTTCG AGGCAGCGAG ATTGCTCTTG TTGGCCTCAT 
AGATGCPGAA AATGATGACA GTCTAGCTCC TP.TAGACGAP. AAGAAGGTCC 
CAATGCTAAA GGACACCAAG AATAAAATCG AAAATGAGCA TGTAATATGG 
I GAAAAAGTGT ACGAATCAAA GACAAAATAA TATAGTTGCA ATAATAGTAA 
I TAATAATAAT AATAATAATP. ATAATAATAA Th.ATAATAAT AATAATP.CCA 
1 TGTATAGPAG TATATAAATC ATACAATAAA TTTAAGCATT AACCCGTCAC 
Fig. 3.2 Verification of new LSM8 start by primer extension. (A) Primer 
extension with primer Lsm8Rpe2 on yeast total RNA (3), with labelled 
pBR322 Mspl digest (I) and NEB 100 bp ladder (2). The main product 
is estimated to be 128 nt long (see arrow), indicating that the LSM8 5' UTR 
from the new start may only be 8 nt long; (B) LSM8 coding sequence and 
surrounding genomic sequence. Potential TATA-boxes are indicated in blue, 
old and new ATG start codons in red; the predicted coding sequence is 
underlined with the old prediction dashed: the Lsm8Rpe2 annealing site 
is underlined with a dotted line. Numbering starts with +I at the new ATG 
start. The putative TATA box at position -63 is a favourable distance away 
from the new transcription start site. The new start codon is in a sequence 
context favourable for translation intiation. 
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showed variable lengths of 5' UTRs for many transcripts that were cloned multiple 
times. In fact, the vast majority of yeast genes was shown to have two or more 
transcription start sites. As the LSM8 transcript was only cloned once, there may be 
alternative 5' UTRs for LSM8 as well. To further confirm the new start site the 
genomic sequence surrounding the LSM8 start-ATG was examined (Fig. 3.213). 
TATA elements in S. cerevisiae are typically located 40 to 120 nt upstream of the 
transcription initiation site and have a TATAAA consensus. Derivatives of this 
sequence can also confer TATA function, possibly with diminished activity 
(Hampsey, 1998). A TATAAG sequence 63 nt upstream of the new start ATG fits 
these criteria. In addition, the new start codon seems to have a sequence context 
favourable for translation initiation. Protein synthesis is regulated by the sequence 
and structure of the 5' UTR of the mRNA transcript. In mammals, the Kozak 
sequence GCCACCAUGG, which often lies within a short 5' UTR region, directs 
translation of mRNA (Kozak, 1991). In yeast, the preferred sequence context is 
A,AA/AJ uGUCU with a particular preference for A in position -3 and U in 
position +4 (Yoon and Donahue, 1992). 
In summary, the correct LSM8 ORF is 130 nt long and encodes a 109 aa (12.4 kDa) 
polypeptide with a p1 of 7.18. The LSM8 transcript has a short 5' UTR of 8-15 nt. 
This correct LSM8 coding sequence was used throughout the work presented in this 
thesis, unless otherwise stated. 
3.3 Optimisation of expression and purification of individual 
Lsm proteins 
Because of problems with solubility of recombinant Lsm proteins overexpressed in 
E. coli a range of expression conditions were tested to optimise the level of 
expression as well as solubility, whilst minimising degradation. Details are given in 
Materials and Methods (2.4.7). The best conditions for general expression of Lsm 
proteins were 16 h expression at 23°C in the presence of 0.1 mM IPTG or 24 h 
expression at 30°C using the ONEX system (Novagen; see Materials and Methods; 
Fig. 3.3), although further optimisation for individual Lsm proteins may still be 
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Fig. 3.4 Ni-NTA affinity purification of yeast Lsm proteins expressed in 
E. coli. (A) His-Lsm3 purified under native conditions after expression in 
131-2I(DE3) cells; (B) His-HA-Lsm8 purified under native conditions after 
expression in 131-21(DE3) cells; (C) Recombinant Lsm proteins expressed 
in 131-2 I (DE3) cells and purified under native conditions; (D) Purified 
recombinant Lsm proteins after expression in MRE4 cells and purification 
in the presence of 8 M urea. M = SeeBlue Plus2 marker; T = total protein; 
S = soluble proteins; FT = Ni-NTA agarose unbound fraction; WI = 20 mM 
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Table 3.1 	Levels of expression and solubility of co-expressed recombinant Lam proteins 
Expression 	Sulubility 	I.prcsion 	.SoIuFnIiIy 
Proteins  
(ONEX 37C) 	(ONEX 37C) 	UNEX 23C) 	()NEX 23 C) 
I.mI/Lsm4 -- 	 - 
Lsm3/L,m2 4-44 	 +-$-+ 	 4--f-f 	 4-4-f 
LsmII-sm6 4-4-4- 	 +++ 	 -4+4- 
Lsm8/Iun4  
Lsm5'6. Lm7.S*ag +4 	 .-.-- 	 +4+ 
L.im5/6. Ili,-l.sm7 -' 	 + 
LsmI-7. bm7-Stag 
Lxznl-7. llis-Lsm7 -I- 	 + 
bm2-8. L%m7-SIag - 	 *4 	 44. 
I.sm2-8. IIii-Lsm7 1 	 +i- 
Fig. 3.5 Co-expression of Lsm proteins improves solubility. (A) Proposed 
order of Lsm proteins in the ring-shaped complex, based on homology of 
individual proteins to those in the Sm. complex (B) and yeast two-hybrid 
analysis (C) Recombinant Lsm proteins were cloned for co-expression in 
pairs corresponding to the known Sm subcomplexes: SmB/D3 (Lsm 1/4 or 
Lsm8/4), SmDI/D2 (Lsm2/3) and SmF/E/G (Lsm6/5/7). Table 3.1 gives 
scores for levels of expression and solubility for different combinations 
of co-expression. 
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Lsm5 and 6 (pMR47). LSM7 was cloned in pElDuet-1 either with the N-terminal 
His-tag or the C-terminal S-tag (pMR40 and 41). Pairs of Lsm proteins, as well as 
Lsm5-6-7p, Lsml-7p and Lsm2-8p were co-expressed in BL21(DE3) at 23 or 37°C 
using the ONEX system. Expression levels were generally high (Table 3. 1), but not 
always equal for co-expressed proteins. Expression levels seemed to be better for 
expression at 23 than 37°C when more than two proteins were co-expressed at one 
time. The level of solubility was examined by SDS-PAGE of total, soluble and 
insoluble protein after cell lysis. Western analysis with a-His-HRP and S-protein-
HRP allowed for comparison of the levels of recombinant protein in all fractions. 
Solubility of pairs of proteins was significantly improved (>90% soluble; Table 3.1) 
compared to that of individually expressed Lsm proteins (data not shown). 
Surprisingly there was a significant difference between solubility of Lsm5-6-7p, 
Lsml-7p and Lsm2-8p including N-terminally His-tagged or C-terminally S-tagged 
Lsm7p. Reduced solubility with His-Lsm7p suggests that the N-terminal tag may 
interfere with Lsm7p's interaction with its neighbouring subunits, thus making them 
more susceptible to aggregation. 
3.4.1 Co-expressed pairs of Lsm proteins can be co-purified 
Improved solubility is presumed to be the result of formation of hetero-multimeric 
complexes that are less prone to aggregation than monomers or homo-multimenc 
complexes. This was also shown to be the case for the human LSm proteins (hLSm) 
with stable complexes formed for hLSm2/3, hLSm4/8 and hLSm5/6/7 (Zaric et al., 
2005). Surprisingly however, in the Zaric study, improved solubility did not depend 
on co-expression of assumed nearest neighbours as other combinations showed 
similarly improved solubility. This was suggested to be due to a low level of LSm-
LSm interaction specificity. Nonetheless, I decided to test whether co-expressed 
yeast Lsm proteins could be co-purified by affinity chromatography using the His-tag 
on one of the proteins. Lsm2p and Lsm3p (pMR46), as well as Lsm5p and Lsm6p 
(pMR47) were co-expressed in BL21(DE3) cells using the ONEX system at 23°C. 
Soluble protein after cell lysis was used for Ni-NTA affinity chromatography under 
native conditions. Washes were performed with 20 mM and 55 MM imidazole and 
finally proteins were eluted with 250 mM imidazole. Lsm2-Stag was co-purified 
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with His-Lsm3 (Fig. 3.6A) and Lsm6-Stag was co-purified with His-Lsm5 (Fig. 
3.6B), indicating that co-expressed Lsm proteins interact. These interactions may not 
be specific to assumed nearest neighbours, as was shown by Zaric et al. (2005) for 
the human LSm proteins, but lead to decreased aggregation and improved solubility. 
3.4.2 Co-expression and purification of Lsml-7p and Lsm2-8p 
Lsml-7p and Lsm2-8p were co-expressed using S-tagged Lsm7p in BL21(DE3) cells 
and the ONEX system at 23CC. Soluble protein after cell lysis was used for Ni-NTA 
affinity chromatography under native conditions. Washes were performed with 20 
mM and 55 mM imidazole and finally proteins were eluted with 250 mM imidazole. 
Proteins were expressed at similar levels and were mostly soluble. Exceptions were 
His-Lsml and Lsm2-Stag, with His-Lsml expressed at significantly higher levels 
and Lsm2-Stag expressed at extremely low levels. All proteins were purified at 
similar levels, with the same exceptions of Lsmlp and Lsm2p (Fig. 3.6C and D). 
Efficient co-purification of S-tagged Lsm proteins with His-tagged Lsm proteins 
suggest that heteromultimeric complexes are formed during expression in E. co/i. 
The absence of high levels of Lsm2p suggests that the majority of the formed 
complexes may not contain Lsm2p. Alternatively, Lsm2p and/or its C-terminal S-tag 
may be particularly susceptible to proteolytic cleavage leading to reduced levels of 
Lsm2p that are detectable using S-protein-HRP. However, the fact that no such 
problems occurred during co-expression with His-Lsm3p (Fig. 3.6A) argues against 
this. These results show that it should be possible to co-express seven recombinant 
Lsm proteins at once and to co-purify them using affinity tags. Additional 
purification steps will be required to obtain homogenous complexes that contain all 
seven subunits. Use of combinations of dual expression vectors, as was done here, 
may not be optimal. Likely problems include differences in expression levels due to 
variable plasmid copy-numbers and possible interference of the large number of tags 
with Lsm complex formation and functionality. A better approach would be to create 
a heptacistronic expression vector with only one protein carrying a cleavable affinity 
tag. This approach is challenging in terms of devising a successful cloning strategy 
and because of potential problems with instability of such a construct due to 
recombination (Christian Kambach, personal communication). 
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Fig. 3.6 Co-expressed Lsrn proteins can be co-purified. Recombinant 
Lsm proteins were co-expressed using (combinations of) dual expression 
vectors in BL2I(DE3) cells and the ONEX system at 23°C, and purified by 
Ni-NTA chromatography. Samples from various fractions were separated 
by SDS-PAGE and analysed using a-His and S-protein-HRP Westerns. 
His-Lsm3 purified with Ni-NTA agarose co-purifies Lsm2-Stag; 
His-LsmS similarly co-purifies Lsm6-Stag; (C) Co-expression of 
His-Lsml, 3 and 5 with Lsrn2, 4, 6 and 7-Stag allows purification of 
all Lsm proteins by Ni-NTA affinity chromatography, although levels 
of Lsm2-Stag are extremely low; (D) Co-expression of Lsm2 to 8 
proteins similarly allows their co-purification, although levels of Lsm2-
Stag are low here also. T = total protein; S = soluble protein; WI = 20 
mM imidazole wash; W2 = 55 mM imidazole wash; E = elution with 
250 mM imidazole 
161 
3.5 Lsm complex formation in vitro 
3.5.1 Re-naturation of a mixture of denatured Lsm proteins allows 
for complex assembly in vitro 
An alternative strategy to in vivo complex formation by co-expression was in vitro 
assembly of complexes from purified components. Initial attempts to create Lsm 1-7p 
and Lsm2-8p complexes in vitro by mixing together individually purified Lsm 
proteins under native conditions were unsuccessful (data not shown). This is likely to 
be due to formation of homomultimeric complexes of which Lsm3p is a prime 
example. To allow for heteromultimeric complex formation these self-interactions 
need to be disturbed first. His-Lsm2 to -Lsm7p were individually expressed in 
BL21(DE3) cells and affinity purified under denaturing conditions, i.e. in the 
presence of 8 M urea (Fig. 3.7A). Approximately equimolar amounts of each of these 
monomers were then mixed with natively purified His-Myc-Lsmlp or His-HA-
Lsm8p, and dialysed against buffer without urea. Soluble and insoluble proteins were 
separated after dialysis by centrifugation. Samples of each were analysed by SDS-
PAGE and Coomassie staining. Yields of soluble proteins varied from experiment to 
experiment, but generally between 50 and 90% of proteins were soluble after dialysis 
(Fig. 3.7B). Approximately equimolar amounts of each of the Lsm monomers were 
recovered, suggesting that correct heteroheptameric complexes may have formed. To 
show that all proteins were present in the same complex the Myc- and HA-tags of 
Lsmlp and Lsm8p respectively were used to immunoprecipitate these proteins. Both 
Coomassie staining after SDS-PAGE and Western analysis with a-His antibody 
showed that all Lsm proteins were pulled down by Lsmlp and Lsm8p (Fig. 3.7C). 
These results show that it is possible to assemble heteromultimeric Lsm complexes 
in vitro by re-naturation of a mixture of denatured Lsm monomers. The homogeneity 
of the resulting complexes is as yet uncertain. 
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Fig. 3.7 In vitro assembly of yeast Lsm complexes. (A) His-Myc-Lsml, 
His-Lsm2 to 7 and His-HA-Lsm8, affinity purified under denaturing conditions, 
were separated by SDS-PAGE and Coornassie stained; (B) Natively purified 
His-Myc-Lsml or His-HA-Lsm8 were mixed with His-Lsm2 to 7 purified with 
8 M urea and re-natured by dialysis. Soluble (S) and insoluble (1) fractions were 
analysed by SDS-PAGE and Coomassie staining. (C) Soluble fractions of 
Lsm 1-7 and Lsm2-8 were used for immunoprecipitation with a-Myc and a-HA 
antibodies. Pellets and supernates were separated by SDS-PAGE and Coomassie 
stained or Western blotted and hybridised with ct-I-Iis-HRP antibody. M = See 
Blue Plus2 marker (Invitrogen) * Light chain of antibodies used in CoIP. 
163 
3.5.2 Soluble complexes can form in the absence of single 
subunits 
It seems that Lsm proteins are promiscuous in their interactions. Formation of the 
correct heteromultimeric complexes in vivo therefore presumably depends on the fact 
that interactions within the Lsm 1-7 and Lsm2-8 complexes are the most energetically 
favourable. In higher eukaryotes the SMN complex contributes to formation of the 
correct complexes, but in S. cerevisiae no such snRNP assembly chaperone is known 
to exist. The success of these in vitro assembly experiments also depends on 
formation of these most energetically favourable complexes. To test whether 
formation of correct complexes can be measured by the yield of soluble protein after 
dialysis, various combinations of six Lsm proteins were mixed and re-natured. 
Soluble and insoluble proteins were separated after dialysis by centrifugation and 
samples of each were separated by SDS-PAGE. Coomassie stained gels showed that 
yields of six-protein mixtures were not significantly different from those that 
contained all seven Lsm proteins (Fig. 3.8). This suggests that heterohexameric Lsm 
complexes can form in vitro. Whether this is a reflection of the potential existence of 
such hexameric complexes in vivo is unclear, but it does mean that: a) levels of 
soluble protein after re-naturation are not necessarily a measure of correct 
heteroheptameric complexes; b) hexameric complexes may form in mixtures of 
seven proteins with a heterogeneous mixture of complexes as a result. 
3.5.3 Lsm complexes aggregate and/or form higher order 
structures 
To investigate the homogeneity of the in vitro assembled Lsm 1-7 and Lsm2-8 
complexes size exclusion chromatography was performed. In addition to a measure 
of homogeneity (elution in a single peak), size-exclusion chromatography allows an 
estimation of the apparent molecular weight of a protein or protein complex which 
corresponds to the time it takes the complex to leave the column. Lsm 1-7 and Lsm2-
8 complexes were assembled in vitro as described. They were concentrated to 
approximately 1 mg/ml and subjected to size exclusion chromatography on a 
SUPERDEX 200 HR1O/30 column (data not shown) or a SUPEROSE 6 HRIO/30 
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Fig. 3.8 In vitro Lsm complex formation with six subunits. To test if 
soluble complexes can form in the absence of one of the seven Lsrn sub-
units, six of them were mixed under denaturing conditions and re-natured 
as described. Soluble (s) and insoluble (i) proteins after dialysis were 
separated by centrifugation and analysed by SDS-PAGE and Coomassie 
staining. M = SeeBlue Plus2 Protein Marker (Invitrogen) (A) Soluble and 
insoluble fractions of mixtures of Lsm I to 7p and Lsm2 to 8p after dialysis; 
(B) Soluble and insoluble fractions of mixtures of 6 different Lsm proteins 
after dialysis 
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absorbance of the eluate at a wavelength of 280 nm. The extinction coefficients for 
Lsml-7p and Lsm2-8p were estimated at 0.55 (mglml)'cm' and 0.52 (mg/ml) - 'cm' 
respectively using the online Protein Calculator (see section 2.7). Here, extinction 
coefficients are estimated based on the number of tryptophans and tyrosines using an 
absorbance curve of known lyophilized proteins (Gill and von Hippel, 1989). As the 
proteins are strongly diluted between loading onto and eluting off the column, A280 
readings are low, reducing the accuracy and making them sensitive to background 
noise. Nonetheless, both complexes eluted off the column in a single main peak, with 
a shoulder, indicating a major and a minor peak that are not properly resolved (Fig. 
3.9A and Q. Additional peaks were detected corresponding to molecular weights of 
less than 10 kDa. To determine protein content of each of the peaks, the appropriate 
fractions were collected, TCA precipitated and analysed by SDS-PAGE and 
Coomassie staining (Fig. 3.913 and D). All Lsm proteins were detected in fractions 
corresponding to the main peak and shoulder, but no proteins were detected in the 
<10 kDa peaks, suggesting that the latter may have been due to background noise. 
Lsm7p and Lsm8p, and Lsm2p and Lsm5p migrate in single bands during SDS-
PAGE. To confirm the presence of all Lsm polypeptides these bands were submitted 
to mass spectrometry (2.4.12). In the Lsml-7p Lsm2/5 band Lsm2p was covered by 
8 peptides (57% aa) and Lsm5p by 3 peptides (31% aa). In the Lsm2-8p Lsm2/5 
band Lsm2p was covered by 12 peptides (73% aa) and Lsm5p by 2 peptides (19%). 
The Lsm7/8 band produced 2 Lsm8p peptides (13% aa) and 1 Lsm7p peptide (8%). 
In addition most bands produced small numbers of peptides from Lsm6p and some of 
the other smaller Lsm proteins. In conclusion, the main peaks contain all seven Lsm 
polypeptides. The apparent molecular weights corresponding to the main peaks and 
shoulders were calculated. The molecular weight corresponding to the Lsm 1-7p main 
peak was estimated at 530-580 kDa, that of the minor peak at 300-310 kDa, 
corresponding to approximately 5 and 3 Lsm l-'7p heptamers respectively. Calculated 
molecular weights corresponding to the Lsm2-8p peaks were more variable between 
experiments and were 560-730 kDa for the main peak and 250-310 for the minor 
peak, corresponding to 5-7 and 2-3 Lsm2-8p heptamers respectively. Increasing the 
salt concentration from 0.1 M to 0.5 M KC1 did not significantly change the 
outcome. 
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Fig. 3.9 Size exclusion chromatography of in vitro assembled yeast 
Lsm l-7p and Lsm2-8p suggests these complexes aggregate. (A) In vitro 
assembled Lsml-7p was separated on a SUPEROSE 6 size exclusion 
chormatography column into 4 main peaks; (B) Fractions corresponding 
to peaks 1-4 were TCA precipitated, separated by SDS-PAGE and 
Coomassie stained; (C) In vitro assembled Lsm2-8p was separated into 
3 main peaks; (D) Fractions corresponding to peaks 1-3 were TCA 
precipitated, separated by SDS-PAGE and Coomassie stained. 
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In summary, the in vitro assembled Lsm complexes do not resolve like heptameric 
complexes during size exclusion chromatography. This may well reflect 
multimerisation of (heptameric) complexes, in this case into structures containing 
anywhere between 2 and 7 Lsm rings. As it has been shown that Sm-like complexes 
are prone to aggregation, in some cases into well-ordered higher order structures 
(Arluison et al., 2006), this is not unlikely. 
3.5.4 In vitro assembly of human LSm complexes 
Purified human LSm protein (hLSm) subcomplexes (kindly provided by Christian 
Kambach) were used to assemble hLSm complexes in vitro as described in Materials 
and Methods (2.4.10.2). hLSml, hLSm2/3, hLSm4, hLSm5/6/7 and hLSm4/8 (Fig. 
3.10A) were mixed at equimo tar amounts under semi-denaturing conditions and 
dialysed to form hLSml-7 or hLSm2-8. Yields were generally high (>90%) and 
although not all protein bands could be resolved by SDS-PAGE relative intensities of 
Coomassie stained bands and published data (Zaric et al., 2005) suggest that all 
seven hLSm proteins are present in the resulting complexes (Fig. 3.1OB). A number 
of complexes were assembled with less than seven subunits to act as controls in RNA 
bandshift, annealing and strand displacement experiments (Chapter 4 and 5): hLSm2-
7 (hexamer), hLSm23567 (pentamer without hLSm4), hLSm4-8 (pentamer with 
hLSm4), hLSm123567 (hexamer without hLSm4) and hLSm48 (dimer). 
Surprisingly, similar yields were obtained for each of these control complexes (Fig. 
3.10C shows a Coomassie stained SDS-PAGE gel with approximately equimolar 
amounts of each of these complexes). RNA bandshifi experiments with these protein 
mixtures (Chapter 4) suggest that alternative complexes are formed that retain some 
functionality. 
3.5.5 Optimisation of in vitro Lsm complex assembly 
Comparison of the 4M and 8M urea methods used for assembly of the yeast and 
human Lsm complexes and their functional integrity (described in Chapters 4 and 5) 
shows that there is still room for improvement, in particular for in vitro assembly of 
recombinant yeast Lsm complexes. Presence of soluble protein after renaturing 
dialysis is not necessarily a measure of correctly assembled active complexes. 
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Fig. 3.10 In vitro assembly of hLSm complexes. (A) Coomassie 
stained SDS-PAGE gel with purified hLSm proteins and subcomplexes; 
(B) Coomassie stained SDS-PAGE gel with input (in), insoluble (I) and 
soluble (S) samples before and after dialysis; (C) Equimolar amounts 
of heptameric, hexameric and pentameric hLSm complexes assembled 
in vitro. 
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Efficiency of U6 RNA binding may be the best and easiest way to measure this (see 
Chapter 4). Different RNA annealing activities of human LSm complexes assembled 
from subcomplexes in the presence of 4 M and 8 M urea also shows that 8 M urea 
may disrupt a structure needed for this activity (section 4.3.3.1). The best way to 
optimise in vitro assembly of yeast Lsm complexes may therefore be to purify 
subunits under semi-denaturing conditions (e.g. in the presence of 4 M urea), dialysis 
of purified proteins to buffer of physiological pH in the presence of 4 M urea and 
assembly into heteromultimeric complexes under conditions similar to those 
described for the human LSm proteins (2.4.10.2). Strong homomultimerisation by 
some of the Lsm proteins (yLsm3p in particular) may still prevent successful 
complex assembly. A combination of co-expression of predicted sub-complexes and 
their purification under semi-denaturing conditions, analogous to the method used for 
the human LSm proteins (Zaric et al., 2005), may therefore be necessary. Attempts to 
purify recombinant yeast Lsm proteins at lower urea concentrations (<8M) to 
assemble complexes in vitro under semi-denaturing conditions were unsuccessful 
(data not shown). 
3.6 Contamination of recombinant Lsm proteins with E. coil 
Sm-like protein Hfq 
3.6.1 Lsm8p co-purifies E. co/i Hfq 
His-HA-Lsm8p purified from BL21(DE3) cells under native conditions contained a 
10 kDa fragment detectable by Coomassie staining (Fig. 3.4B) but not by a-His 
Western analysis (data not shown). This was initially thought to be an Lsm8p 
degradation fragment without the His-tag, but problems with the interpretation of 
results from functional assays (discussed in Appendix Al) lead me to investigate 
further. The 10 kDa band was taken from a Coomassie stained SDS-PAGE gel and 
analysed by mass spectrometry. No Lsm8p peptides, but E. coli Hfq peptides were 
detected, showing that Hfq protein is co-purified with recombinant Lsm8p at 
significant levels. The nature of the interaction between Lsm8p and Hfq is unclear, 
but there are some indications that they may form a heteromultimeric complex 
(Appendix A2). Results from U6 RNA bandshift assays (compare Fig. 4. 1A to Fig. 
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A1.1) suggest that Lsm5p and Lsm6p may also co-purify Hfq, but at lower levels. No 
additional Coomassie stained bands were observed for these proteins however, as 
Lsm5p, Lsm6p and Hfq migrate at around the same molecular weight. Hfq is the E. 
co/i Sm-like protein, it binds RNA and has been shown to act as an RNA chaperone 
(Moll et al., 2003). Its presence in functional assays of the yeast Lsm proteins is 
therefore undesirable. 
3.6.2 Creation of an hfq deletion strain for Lsm protein production 
To prevent contamination by Hfq an hfq deletion strain was constructed to be used 
for the production of Lsm proteins. The method used to make this deletion was based 
on that of Merlin etal. (2002). This method is described in detail under Materials and 
Methods (2.2.4) and in Fig. 3.11 A-D.  The standard method was successful for the 
MGi 655 control strain (Fig. 3.11G), but for unknown reasons no deletion strains 
were obtained from BL21(DE3) after screening 350 colonies by colony PCR. As an 
alternative, hfq was deleted from hfq-1 mutant strains (kindly provided by Poul 
Valentin-Hansen) that are based on T7 polymerase expression strains ER2566 and 
C41 (DE3) (MRE2 and 3; Table 2.1.5). These are effectively hfq knockout strains and 
were created by P1 transduction of the hfq-1 Q-Kan' insertion mutation in the hfq 
Bc/I site (at nt 117) from strain TX2808 (Tsui et al., 1994). To allow co-expression 
of Lsm proteins (see section 3.4) using the KanR  pCOLADuet-1 plasmid and to 
ensure no fragments of Hfq protein would be produced, the entire Hfq coding 
sequence with the insertion was removed in both strains (MRE4 and 5; Table 2.1.5). 
The same procedure for creating a genomic deletion was followed, but resulting 
colonies were additionally screened for the absence of kanamycin resistance (Fig. 
3.11E). Colonies that were kanamycin sensitive were tested by colony PCR and 
shown to carry the genomic deletion (Fig. 3.11G). In addition hfq deletion strains 
could be detected because of their changed colony morphology, which was described 
previously (Tsui et al., 1994). Colonies of hfq deletion strains generally look more 
transparent and spread out, an example of which can be seen for MG 1655 with and 
without hfq (Fig. 3.11F). The T7-polymerase expressing hfq deletion strains (MRE4 
and 5; Table 2.1.5) were used for expression and purification of the Lsm proteins that 
were used in functional assays described in Chapter 4 and 5. 
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Fig. 3.11 Making a genomic /ifq deletion in E. co/i; (A-D) The strategy; 
(E-G) Verification of the hfq deletion. (A) A 900 bp fragment covering 
450 bp of E. co/i genomic sequence on either side of the Hfq coding 
sequence, with PstI and Sail restriction sites on either end, was created by 
two-step PCR using primers mrolO2-l05; (B) The KanR  gene from 
pTOF24 was removed by PsulISafl digestion and replaced with the 900 bp 
genomic sequence (pMR54); (C) E. co/i was transformed with pMR54. 
Subsequent growth on LB-Cm at 42°C promoted recombination of pMR54 
onto the genome; (D) Growth at 30°C allowed recombination out of the 
genome with two possible outcomes: revert to wild type or deletion of 
hfq. Growth on LB with 5% sucrose is indicative of plasmid loss (SacB 
on pTOF24 makes the cells sensitive to sucrose); (E) Resulting colonies 
were tested for growth on sucrose (growth = no plasmid), Cm (no growth 
= no plasinid) and where appropriate on Kan (no growth = loss of hfq-l); 
(F) For MG 1655 wild-type ()and Ahfi (*) colonies could be distinguished 
by different colony morphology as previously described by Tsui et al. 
(1994); (G) Potentially positive colonies were tested for the hfq  genomic 
deletion by colony PCR with primers mro 102 and 105. 
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3.7 Discussion 
3.7.1 Change to the LSM7 annotation 
Recent evidence from a large-scale cDNA analysis from the yeast transcriptome 
(Miura et al., 2006) suggests that the LSM7 3' splice site may have been annotated 
incorrectly (chromosomal coordinate 351055 instead of 351079) leading to insertion 
of an additional 24 nt in the mRNA and 8 aa (KSENKPQQ) after S6 in the Lsm7 
polypeptide. This insertion eliminates a gap in the alignment between Lsm7p and 
some of its fungal orthologues. In addition, the authors detected many rare splicing 
variants of known introns that often disrupted the ORFs, including an alternative 3' 
splice site in LSM7 and alternative 5' and 3' splice sites in LSM2. The biological 
significance of this is unclear. Mayes (1998) cloned intron-less LSM7 by PCR using 
genomic DNA as a template and a forward primer covering all of the first exon and 
spanning the intron based on the annotated sequence at the time. This explains the 
discrepancy between the intron-less LSM7 cloned by Mayes and the cDNA cloned in 
the Miura study. The LSM7 sequence as described on SGD and in Mayes et al. 
(1999) was used throughout the work presented in this thesis. The consequences of 
the absence of 8 aa in the N-terminus of Lsm7p for this work is uncertain. These 8 
residues were however shown to be non-essential for growth at 37C, as intron-less 
LSM7 cloned by Mayes (1998) and expressed from the GAL] promoter rescued 
temperature-sensitive growth of !sm7A (Mayes, 1998). This suggests that the 
outcome of experiments described here are unlikely to have been affected by the use 
of the incorrect LSM7 sequence. 
3.7.2 Conclusions 
In this chapter I have shown that it is possible to assemble both yeast and human 
Lsm complexes in vitro from purified recombinant Lsm subunits expressed in E. 
coli. These complexes contain all seven Lsm polypeptides, but may aggregate, as 
was shown by size exclusion chromatography. The homogeneity of the resulting 
complexes is unclear, as it seems that not all seven subunits are required to form 
soluble complexes. In addition, Lsm proteins seem to be highly promiscuous in their 
interactions. They are able to form homo-multimeric complexes and seem to be able 
to interact with Lsm proteins other than the proposed nearest neighbours in the ring- 
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shaped complex. Lsm8p even interacts with the E. coli Sm-like protein, Hfq, leading 
to co-purification of this polypeptide in significant amounts during affinity 
chromatography. It is therefore important that Lsm proteins are purified from hfq 
deletion strains to prevent downstream problems due to contamination of Lsm 
complexes with this known RNA chaperone. The challenge in forming the correct 
complex in vitro lies in finding conditions that disrupt pre-existing undesirable Lsm-
Lsm interactions without affecting potentially important structures within each of the 
subunits, and subsequently conditions in which correct Lsm-Lsm interactions are 
most likely to form. No easy failsafe methods exist to test for the formation of 
correctly assembled Lsm complexes. The homogeneity of complexes can be 
characterised by biochemical means such as ion-exchange and size-exclusion 
chromatography, although the propensity to complex aggregation may complicate 
interpretation of results. Due to the unknown level of homogeneity of these in vitro 
assembled complexes, additional purification steps may be desirable in any case. The 
RNA binding efficiency of human LSm2-8 increased with additional purification 
steps after the initial complex formation (Christian Kambach, personal 
communication). Another way of testing for proper complex formation is to see if 
they are functionally active. Lsm2-8p can be tested for its ability to bind U6 snRNA 
and may be tested for its ability to promote U41U6 di-snRNP formation, which was 
shown to be an activity of the native human LSm2-8 complex (Achsel et al., 1999). 
However, no RNA binding target or biological activity is known for Lsml-7p. One 
of the aims of this study was to elucidate biological activities and underlying 
mechanism for the Lsm complexes. This can only be done with functionally active 
complexes, posing a catch-22 situation. Nonetheless, it seems that the methods 
described here can form at least partially functionally active Lsm complexes as will 
be discussed in Chapters 4 and 5. 
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CHAPTER 4 
RNA binding and annealing activities 
of Sm-like Proteins 
176 
4.1 Introduction 
The Lsm2-8 complex forms the core of the U6 snRNP and although the Lsm proteins 
interact with a wide range of other RNAs, U6 snRNA is the only known target with 
which they stably associate. The ability of in vitro assembled Lsm2-8p to bind U6 
RNA is therefore a good test for its functional competence, at least in terms of 
specific RNA binding. No specific binding sequence for Lsml-7p is known, but it is 
expected to be a single-stranded uridine-rich sequence similar to the proposed Lsm2-
8p binding site in U6 snRNA (Achsel et al., 1999; Vidal et al., 1999), as these 
complexes have six out of the seven subunits in common. In addition, a stem-loop 
structure adjacent to the single-stranded sequence may be required for efficient 
binding (Vidal et al., 1999). S. cerevisiae Lsm2-8p has been implicated in U4/U6 di-
snRNP formation in vivo (Verdone et al., 2004) and purified native human LSm2-8 
has been shown to promote U4/U6 di-snRNP formation in vitro (Achsel et al., 1999). 
It is as yet unclear whether Lsm2-8p directly promotes U4/U6 annealing, like Prp24p 
has been shown to do in vitro (Ghetti et al., 1995; Raghunathan et al., 1998a; Rader 
et al., 2002), or whether it acts simply as a co-factor to Prp24p. The E. co/i Sm-like 
protein Hfq has been shown to function both in vivo and in vitro in promoting 
basepairing between non-coding small RNAs and their target mRNAs (reviewed by 
Storz et al., 2004; Valentin-Hansen et al., 2004). This RNA chaperone activity may 
be conserved in some, if not all, Sm-like protein complexes. This chapter describes 
RNA binding and U4/1J6 annealing activities of individual recombinant yeast Lsm 
proteins, Lsm l-7p and Lsm2-8p, and compares these to recombinant Hfq and human 
LSm complexes. 
4.2 RNA binding by recombinant Sm-like proteins 
4.2.1 Individual yeast Lsni proteins and U6 snRNA binding 
During purification of some of the recombinant yeast Lsm proteins E. co/i Hfq was 
co-purified (section 3.6.1 and Appendix A.l). Initial RNA binding and U411J6 
annealing experiments were therefore unknowingly performed with Lsm-Hfq 
mixtures. To put the later experiments that are discussed here in perspective, results 
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of the earlier experiments with protein mixtures are presented in Appendix Al. To 
examine RNA binding activities of individual Lsm proteins in the absence of Hfq, 
recombinant His-tagged yeast Lsm proteins 1 to 8 were expressed in MRE4 or 
MRE5 (Ahfq) cells and purified by Ni-NTA affinity chromatography. These purified 
proteins were used together with in vitro transcribed gel-purified U6 RNA in RNA 
bandshift assays (Fig. 4.1A). Proteins were added in excess over RNA, but none of 
the yeast Lsm proteins showed significant U6 RNA binding with a discreet protein-
RNA complex as a result, like those observed for the Lsm8p (Hfq+) preparation or 
recombinant Hfq. However, some of the Lsm proteins did seem to interact with U6 
RNA. The exception was His-Myc-Lsmlp which caused a discrete U6 RNA mobility 
shift that may be due to binding by an Lsmlp homomultimer. Lsml protein was 
added in large excess over RNA however (more than 100x), indicating low affinity. 
His-Lsm4p and -Lsm7p shifted U6 RNA into the wells, indicative of aggregation of 
proteins with RNA, and His-Lsm5p and His-HA-Lsm8p showed a small shift that 
may be caused by RNA binding of Lsm5p and 8p monomers. In contrast, no U6 
mobility shift was observed for His-Lsm2p, -Lsm3p or -Lsm6p. A shift observed for 
Lsm8p (Hfq+) was due to binding by co-purified Hfq as no such shift was observed 
for Lsm8p (Hfq-) (discussed in detail in Appendix Al). 
In summary, none of the recombinant yeast Lsm proteins seems to form discrete 
homomultimeric complexes with significant U6 RNA binding activity (only weak 
binding by a possible Lsmlp multimer). Lsm4p and Lsm7p bind U6 RNA but 
aggregate simultaneously, whereas small shifts in the presence of Lsm5p and Lsm8p 
suggests that these may interact with U6 RNA as monomers. 
4.2.2 In vitro assembled yeast Lsml-7p and Lsm2-8p bind U4 and 
U6 snRNA 
Recombinant yeast Lsm proteins purified from hfq deletion strains were used to 
assemble Lsml-7p and Lsm2-8p in vitro as described in Chapters 2 and 3. The 
ability of these complexes to bind U6 RNA was investigated in an RNA bandshift 
assay with in vitro transcribed U6 RNA. Both Lsml-7p and Lsm2-8p bind U6 RNA 
(Fig. 4. lB and C). The observed RNA binding by these in vitro assembled 
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Fig. 4.1 RNA binding by individual recombinant yeast Lsm proteins and 
in vitro assembled yLsml-7p and yLsm2-8p. (A) l-Iis-Myc-Hfq, His-Myc-
LsmI, His-HA-Lsm8 and His-Lsm2 to -Lsm7 were purified under native 
conditions from a hfq deletion strain, and His-HA-Lsrn8 was also purified 
from BL2I(DE3) (a hfq+ strain). Proteins were used at concentrations in 
excess over in vitro transcribed gel-purified U6 RNA: 7.5 ng (0.2 pmo!) 
of U6 RNA, 10 pmol of Hfq, 2' ) pmol ofLsml, 2 pniol Lsm2, 26 pmol 
Lsm3, 0.4 pmo! Lsm4, 65 pmol LsrnS, 44 prnol Lsm6, 8 pmol Lsm7, 49 
pmol of Hfq-free Lsm8 and 5 pmol of Lsm8 (monomers; Hfq+); (B)In 
vitro assembled 1-Ifq-free yLsm 1-7p and yLsm2-8p were used at a 
maximum of 10 pmol and 2-fold serial dilutions thereof; (C) As in (B) 
with 2 .tg of tRNA added to the highest protein concentration; (D) As in 
(C), but with 0.2 pniol U4 RNA (10 ng) instead of U6 RNA. 
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complexes in contrast to the absence of significant specific RNA binding of the 
individual Lsm proteins suggests that at least some functional (heteroheptameric) 
complexes may have formed. Smeary shifts for Lsml-7p in particular and failure to 
fully resolve into distinct bands suggests that these RNA-protein complexes may not 
be very stable under the bandshift conditions. The mobility of U6-Lsm l-'7p and U6-
Lsm2-8p bands compared to those observed with recombinant Hfq suggests that 
Lsml-7p binds mainly with two complexes per U6 molecule. Lsm2-8p seems to bind 
with one, two or three complexes per U6 molecule, depending on the protein 
concentration and with a preference for two complexes. The difference in mobility 
between Lsml-7p and Lsm2-8p-bound U6 RNA suggests that correct heptameric 
complexes may have formed as Lsm l-7p has a slightly higher molecular weight than 
Lsm2-8p leading to a less mobile U6-protein complex. Although the homogeneity of 
the in vitro formed complexes is unknown, the level of U6 binding by Lsml-7p and 
Lsm2-8p suggests that Lsm2-8p has a slightly higher affinity for U6 RNA. 
Competition with a large excess of tRNA (270x) reduces U6 binding by both 
complexes significantly, but also seems to reduce smearing a lot (Fig. 4.1 Q. The 
level of protein bound U6 RNA in the presence of competitor RNA suggests that 
Lsm2-8p may also have a higher specificity for U6 RNA than Lsml-7p. Using the 
same proteins in a U4 RNA bandshift assay (Fig. 4.1 D) shows that both complexes 
bind similarly to U4 RNA, with a preference for two rings binding per RNA 
molecule and slightly higher affinity and specificity for Lsm2-8p than for Lsml-7p. 
These conclusions are preliminary, as these experiments need to be repeated with 
complexes of known homogeneity. Binding to U6 as well as U4 RNA may indicate 
promiscuous RNA binding by both Lsm complexes, but may be biologically 
significant for Lsm2-8p if it could bind these RNAs simultaneously. Alternatively 
two complexes may interact with one binding U4 RNA (possibly the Sin heptamer) 
and the other binding U6 RNA thus favouring duplex formation by bringing the 
RNAs into close proximity. Favoured binding of two rings per RNA molecule and 
the tendency to aggregate may be significant in this respect. 
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4.2.3 Recombinant Hfq binds U4 and U6 snRNA 
As E. coli Hfq was co-purified with a number of the yeast Lsm proteins, I wanted to 
investigate the ability of recombinant Hfq to bind U6 RNA to allow comparison with 
the Lsm complexes and interpretation of results of experiments with Lsm-Hfq 
protein mixtures (Appendix Al). His-Myc- and His-HA-tagged Hfq were expressed 
in Ahfq strains and purified under native and denaturing conditions respectively. The 
latter was followed by dialysis to remove all urea identical to the protocol used for in 
vitro yeast Lsm complex assembly. Denaturing purification of Hfq may produce 
more pure protein as more protein and RNA contaminants are likely to be removed. 
The Hfq hexamer has been shown to be extremely stable as many published 
purification methods of native Hfq include heating steps and/or 8 M urea steps which 
may only partially disrupt hexamer formation and may not affect the structure of the 
Hfq monomers. Indeed, recombinant Hfq was shown to still shift some RNA when 
separated by denaturing PAGE after heating in formamide loading buffer (data not 
shown). Recombinant Hfq purified under native and denaturing conditions displayed 
similar levels of U6 RNA binding in bandshift assays (Fig. 4.2A and B), suggesting 
that both methods result in equally functionally competent Hfq complexes. There 
was a slight difference in levels of aggregation (compare Fig. 4.2A and B), but this 
varied between experiments as well as between protein batches (data not shown). 
Increased co-purification of RNA with natively purified Hfq may affect its observed 
RNA binding and aggregation in vitro. RNA binding seemed specific for U6 as a 
large excess of tRNA (270x) did not strongly affect Hfq-U6 binding. The specificity 
may be for a single-stranded U-rich sequence adjacent to a stem-loop structure, as 
recombinant Hfq displayed similar binding to U4 RNA in a bandshift assay (Fig. 
4.2C), although specificity for U4 RNA binding appeared to be slightly lower than 
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Fig. 4.2 RNA binding by purified recombinant Hfq. (A) His-Myc-Hfq was 
purified under native conditions from a hfq deletion strain. 7.5 ng (0.2 pmol) 
of in vitro transcribed gel-purified U6 RNA was incubated with a maximum 
of 10 pmol of Hf'q (monomers) and 2-fold serial dilutions thereof. 1-us-HA-
Lsm8 was used as in Fig. 4.1 A; (B) Dialysed His-I-IA-Hfq purified under 
denaturing conditions was used at a maximum of 10 pmol of l-lfq and 2-fold 
dilutions thereof with 2 jig of tRNA added to the highest Hfq concentration; 
(C) As in (B), but with 0.2 pmol U4 RNA (10 ng) instead of U6 RNA. 
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4.2.4 RNA binding by in vitro assembled human LSm complexes 
Human LSm 1-7 and LSm2-8 were assembled in vitro from purified recombinant 
sub-complexes as described in Chapters 2 and 3. The ability of these complexes to 
bind U6 RNA was investigated in an RNA bandshift assay with in vitro transcribed 
U6 RNA. Both hLSml-7p and hLSm2-8p were shown to bind U6 RNA with similar 
affinities (Fig. 4.3A). Just like the yeast Lsm complexes and Hfq, the human LSm 
complexes seem to aggregate at higher protein concentrations, but not as severely 
and at these concentrations only one or two complexes were seen to bind one RNA 
molecule at one time. A slight difference in mobility between U6-hLSm1-7 and U6-
hLSm2-8 suggests that the correct heptameric complexes may have formed as 
hLSml-7 has a higher molecular weight than hLSm2-8. I was surprised to find that 
both hLSml-7 and hLSm2-8 bind U6 RNA, as Zaric et al. (2005) had found that 
hLSm2-8, but not hLSml-7 binds U6 snRNA. However, Zaric et al. used Xenopus 
tropicalis U6 snRNA for the bandshift assay, whereas the results presented here are 
for S. cerevisiae U6 snRNA. Xenopus tropicalis and Homo sapiens U6 snRNA only 
differ by one nucleotide in the 5' stem-loop, but the difference with yeast U6 is much 
more considerable. Although the secondary structures of these RNAs are very similar 
and both have uridine-rich 3' ends, differences in their primary sequence could 
significantly contribute to a difference in RNA binding by the LSm complexes. To 
test if I could distinguish between RNA binding specificity by the hLSm complexes, 
I used various competitor RNAs in the U6 RNA bandshift assay. However, up to 
four times excess of U6(77-98), U6(77-112) and U2M07 RNA did not significantly 
affect U6 RNA binding by either of the human LSm complexes (data not shown). A 
large excess of competitor RNA was needed to abolish U6 RNA binding (Fig. 4.313). 
To lose half of U6 binding an excess of approximately 2.7 103  times (w/w) of tRNA 
was needed, with all binding abolished at 2.7- 10  times excess. In contrast most U6 
RNA binding by hLSm2-8 and a significant amount of binding by hLSml-7 are 
abolished by addition of 100 times excess (w/w) of U6(77-112) RNA. This suggests 
that U6 RNA binding by both hLSml -7 and hLSm2-8 is highly specific, with the 
single-stranded uridine-rich U6(77-112) RNA as a moderately effective competitor. 
To determine what part of U6 RNA is important for binding by the hLSm complexes 
U6(1-90) and U6(77-112) RNAs were used in bandshift assays (Fig. 4.4A-D). The 
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Fig. 4.3 RNA binding by in vitro assembled hLSml-7 and hLSm2-8. 
(A) Human LSmI-7 and 2-8 complexes were assembled from purified 
recombinant subcomplexes and incubated at a maximum of 10 pmol and 
2-fold serial dilutions thereof with 0.2 pmol of U6 RNA; (B) 5 pmol of 
hLSml-7 and hLSm2-8 was incubated with 0.2 pmol (7.5 ng) of U6 RNA 
and 2.20 or 200 .tg of tRNA, or 7.5, 75 or 750 ng of U6(77-112) com-
petitor RNA. 
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affinity of both complexes was higher for U6(77-112) than for the U6i3' RNA, 
which lacks the U-rich single stranded tail. The affinity of hLsm2-8 was slightly 
higher than that of hLSml-7, particularly for U6(77-112) RNA. This confirms the 
data with this RNA as a more effective competitor for hLSm2-8p than for hLsml-7 
in the U6 bandshift assay (Fig. 43B). Binding to both of these U6 RNA fragments is 
specific as a large excess of tRNA was needed to abolish the majority of binding 
(Fig. 4.4B and D). All binding by hLSml-7 disappears with 8.31O (w/w) for U63' 
RNA and 2- 10  (wlw) for U6(77-112) RNA excess of tRNA, whereas hLSm2-8 still 
binds some of the U6 RNA fragments at these tRNA concentrations. 
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Fig. 4.4 RNA binding requirements of in vitro assembled hLSrn 1-7 
and hLSm2-8. (A) 10 prnol ofhLSml-7 and hLSni2-8 and 2-fold 
dilutions thereof were incubated with 0.2 prnol (2.5 ng) of U6(77-112) 
RNA, or (B) 20 pmol of complexes was incubated with 0.2 pmol of 
RNA and 2, 10 or 50 jig of competitor tRNA; (C) As in (A) but with 
0.2 pmol (6 ng) of U6A3' RNA; (D) As in (B) but with U6A3' RNA. 
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The results of these experiments are summarised in Fig. 4.5. The presented data 
suggest that both hLSml-7p and hLSm2-8p bind yeast U6 snRNA with similar 
affinities and high specificity (possibly slightly higher for hLSm2-8p than for 
hLSm l-7p). Both complexes show preferred binding to full length U6 RNA over U6 
fragments lacking either the 3' undine-rich single stranded tail or the structured 5' 
half. This strongly suggests that, like yeast Lsm2-8p (Vidal et al., 1999), both 
hLSml-7p and hLSm2-8p prefer to bind U-rich single stranded RNA with an 
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Fig. 4.5 Overview of hLSm 1-7 and hLSm2-8 binding to 
yeast U6 snRNA or fragments thereof 
4.3 RNA annealing activity of recombinant Sm-like proteins 
The in vitro U4f1J6 annealing activities of yeast and human Lsm complexes as well 
E. coli Hfq were tested with purified recombinant proteins and in vitro transcribed 
gel-purified U4 and U6 RNA. For these experiments it was important not to use the 
RNAs at too high a concentration as this was shown to significantly increase the 
amount of spontaneous U4/U6 duplex formation in the absence of any protein. In 
addition the RNAs were denatured at 85°C and snap chilled on ice just prior to use. 
10. 
Failure to do so lead to increased amounts of U6 bands of slow mobility, suggestive 
of U6 dimer formation. After incubation RNA was deproteinised by Proteinase K 
digestion and/or phenol-chloroform extraction to allow determination of the level of 








Fig. 4.6 Schematic representation of U4/U6 annealing. The proposed 
secondary structure of U6 snRNA on the left contains a 3' stem-loop 
structure part of which (indicated in red) is directly involved in base-
pairing interactions with U4 snRNA in the U4/U6 duplex on the right. 
4.3.1 Recombinant yeast Lsm complexes do not display U4/U6 
annealing activity 
The in vitro assembled yeast Lsml-7 and Lsm2-8 complexes failed to promote 
annealing between U4 and U6 RNA in vitro (data not shown), in spite of their U6 
(and U4) RNA binding ability (Fig. 4.1). Their failure to do so may mean that yeast 
Lsm2-8p itself does not have U4/U6 annealing activity, at least in vitro. However, it 
could also indicate that the in vitro assembled complexes are not fully functional. 
Annealing experiments with human LSm complexes assembled under different 
conditions suggest that denaturation with 8 M urea may affect a structure within the 
complex that is essential for U4/U6 annealing activity (4.3.3.1). Attempts to 
assemble yeast Lsm complexes using individual, natively purified Lsm proteins and 
the method used for the human LSm complexes (with 4 M urea) failed to produce 
complexes that bind U6 RNA (data not shown), so this hypothesis could not be 
tested. As discussed in Chapter 3, a method analogous to that used for the human 
LSm proteins (i.e. co-expression in pairs and assembly under semi-denaturing 
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conditions) or co-expression of all seven proteins using a heptacistronic construct 
may be more likely to allow formation of recombinant complexes that are fully 
functional. 
4.3.2 Recombinant Hfq promotes U4/U6 annealing 
Hfq has been shown to function as an RNA chaperone both in vivo and in vitro 
(reviewed by Storz et al., 2004; Valentin-Hansen et al., 2004; Arluison et al., 2007). 
This bacterial Sm-like protein promotes basepairing interactions between non-coding 
small RNAs and their target mRNAs. As recombinant yeast Lsm proteins that co-
purified Hfq were shown to be able to promote U4/U6 annealing (Appendix Al) and 
Hfq-free Lsm complexes did not display this activity (4.3.1) it seems that this Hfq 
activity is not restricted to its biological targets. To confirm that Hfq can indeed 
promote U4/U6 duplex formation and to further investigate potential mechanisms for 
this, recombinant Hfq was purified and tested in U4/U6 annealing assays 
4.3.2.1 Hfq RNA binding is essential for its annealing activity 
Recombinant purified Hfq, either natively purified or purified under denaturing 
conditions, displayed U4/U6 annealing activity in vitro (Fig. 4.7 and 4.8). To test if 
Hfq needs to be able to bind RNA to promote U4/'U6 annealing Hfq-Y55A mutant 
protein, which has been shown to have much reduced RNA binding (Mikulecky et 
al., 2004) was purified. In addition, a C-terminal deletion mutant, HfqAC (aa 1-83), 
was purified to test if the C-terminal extension of Hfq plays a role in the RNA-RNA 
annealing process by participating in RNA-binding as was suggested by Sauter et al. 
(2003). The Y55A mutation was indeed shown to abolish binding to U6 RNA at 
concentrations at which wild-type Hfq shifts all U6 RNA. In contrast, the C-terminal 
deletion had only a small effect on U6 RNA binding (Fig. 4.7A). These same 
proteins were used in a U41U6 annealing assay (Fig. 4.713). HfqóC was shown to 
have annealing activity similar to that of wild-type Hfq (only slightly reduced again), 
whereas Hfq-Y55A did not display any annealing activity above background levels. 
These data indicate that Hfq needs to be able to bind stably to RNA to promote 
RNA-RNA duplex formation and that the C-terminal extension does not play a 
significant role in either RNA binding or RNA-RNA annealing, at least under the 
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Fig. 4.7 U6 RNA binding and U4/U6 annealing by recombinant 
Hfq and Hfq mutants. (A) Recombinant His-HA-Hfq, His-Myc- 
HfqAC and Hfq-Y55A-His were incubated at 10 pmol (of monomers) 
or 2-fold dilutions thereof with 0.2 pmol of U6 RNA; (B) The same 
proteins and amounts as in (A) were incubated with 0.2 pmol of U6 
RNA and 0.3 pmol of U4 RNA and treated with Proteinase K before 
separation by native PAGE. 
4.3.2.2 Hfq affects the conformation of the U4/U6 duplex 
Interestingly, U4/U6 duplex formed in the presence of Hfq displayed a different 
(faster) mobility during native PAGE compared to the duplex formed in the absence 
of protein or with recombinant Prp24p (Fig. 4.8 and A1.3). Denaturing PAGE and 
Northern analysis of U4 and U6 RNA after annealing with or without Hfq showed 
that the faster migrating duplex is not caused by partial degradation of the RNA (data 
not shown). U4/U6 duplex formed by recombinant Prp24p, which migrates like 
spontaneously formed duplex, was converted to the more mobile duplex when Hfq 
(co-purified with Lsm8p) was added (Fig. 4.8 and A1.3C). U4 and U6 RNA were 
present in both duplexes (Fig. 4.813). These data suggest that Hfq changes the 
structure of the U4/U6 duplex to a more compact one. Phenol/chloroform extraction 
of the RNA-protein mixture before separating the RNA by native PAGE caused the 
fast-migrating duplex to be converted back into the slow-migrating duplex (Fig. 
4.8A). This is not affected by the pH (4.7 or 8.0) of the phenol/choloroform mixture 
(data not shown). Separation of the two different duplexes on a lx TBM instead of a 
lx TBE gel (1 MM MgCl2 instead of EDTA) made them migrate at the same rate 
(data not shown), suggesting that the MgCl 2 either affects the Hfq-fragment RNA 
interaction, or that Mg 2 favours the structure of the less mobile duplex. The melting 
temperature of the two duplexes is the same as both start melting at 56°C (Fig. 4.8C), 
in agreement with the melting temperature of the native U41U6 duplex of 
approximately 55°C (Brow et al., 1988; Raghunathan et al., 1998a). Interestingly, at 
52 and 54°C some of the "fast" duplex changes to the "slow" duplex suggesting that 
the protein-duplex interaction may be destabilised at these temperatures before the 
U4/U6 duplex itself is destabilised. In summary, these data strongly suggests that 
there is an Hfq fragment that is resistant to degradation by Proteinase K and that is 
stably bound to RNA leading to a U4/U6 duplex with a more compact structure, but 
the same duplex stability, that migrates faster in spite of its presumably larger 
molecular weight. This alternative U4/U6 structure is not maintained in the absence 
of the Hfq fragment. 
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Fig. 4.8 Hfq affects the structure of the U4/U6 duplex (A) Recombinant 
His-Myc-Hfq was incubated at 10 pmol (of monomers) or 2-fold dilutions 
thereof with 0.2 pmol of U6 RNA and 0.27 pmol of U4 RNA. Samples 
were treated with Proteinase K and/or phenol-chloroform extracted before 
separation by native PAGE; (B) 1.3 pmol of U6 and 1.8 pmol of U4 RNA 
were annealed in the presence of increasing amounts of Hfq and Proteinase 
K treated before native PAGE; (C) V6 and U4 RNA were annealed with 
7.5 pmol of Prp24p and/or Hfq, Proteinase K treated and heated for 5 mm 
at various temperatures and snap chillied before separation by native PAGE. 
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4.3.3 Recombinant human LSm complexes promote annealing of 
yeast U4 and U6 snRNA 
4.3.3.1 hLSm1-7 and hLSm2-8 annealing activity is affected by the 
method of complex assembly 
Both the human LSm1-7 and LSm2-8 complexes show U4/U6 annealing activity in 
vitro (Fig. 4.913), when complexes are assembled using the method described by 
Zaric et al. (2005) or a slight adaptation thereof (2.4.10.2). However, when the 
human LSm complexes are assembled in vitro using the method described in 
2.4.10.1, with a denaturing step at 8 M urea followed by one-step dialysis to 0 M 
urea, almost all U4/U6 annealing activity disappears (Fig. 4.913). In contrast, 
complexes assembled with each of these methods show almost identical binding to 
U6 RNA (Fig. 4.9A), suggesting that both methods produce similar complexes that 
are competent in terms of RNA binding. Both hLSml-7 and hLSm2-8 seem to have 
similar U4/U6 annealing as well as U6 RNA binding activity. These data suggest 
that, as for Hfq, the level of RNA binding correlates with the level of U41U6 
annealing, but that there may be an additional requirement for RNA-RNA annealing 
activity, at least in case of the human LSm complexes. 
4.3.3.2 hLSm4 may be essential for annealing activity 
To confirm the necessity of RNA binding for U4/1J6 annealing activity of the LSm 
complexes and to determine what the additional requirement for this activity may be 
a number of controls were prepared. As the LSm complexes are heteroheptameric it 
is difficult to know whether point mutations in putative RNA-binding residues of 
single subunits would affect RNA binding of the complexes in vitro, as is the case 
for Hfq-Y55A. An alternative approach was therefore taken in which single subunits 
were left out of the mixture used for in vitro complex assembly. Soluble complexes 
can be formed this way (see Fig. 3.10). These are presumably complexes containing 
less than seven subunits per ring (5- or 6-mers) or with certain subunits occurring 
twice, with alternative heteroheptameric rings as a result. hLSm2-7 and hLSm23567 
were produced this way and tested for U6 RNA binding and U4/U6 annealing (Fig. 
4.1 OA and B). Both complexes have significantly reduced affinities for U6 RNA 
(>2x for hLSm2-7 and >4x for hLSm23567), but the nature of the complexes is 
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Fig. 4.9 U4/U6 annealing activity of in vitro assembled human LSrn 
complexes is affected by 8 M urea. (A) Both hLSml-7 and hLSm2-8 
assembled either using 4 M urea or 8 M urea bind tJ6 RNA with equal 
affinity; (B) hLSin 1-7 and hLSni2-8 assembled using 4 M urea have 
similar U4/U6 annealing activity, whereas the complexes assembled 
with 8 M urea only display less than one quarter of this activity. U6 
RNA was used at 0.2 pmol for both assays, U4 RNA at 0.3 prnol in the 
annealing assay and proteins at 10 pmol or 2-fold serial dilutions 
thereof. 
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Fig. 4.10 U6 binding and U4/U6 annealing by in vitro assembled human 
LSm complexes with less than seven different subunits. hLSm 1-7, 2-8, 2-7 
and 23567 were assembled in vitro using the 4 M urea protocol. Proteins 
were used at 10 pmol (assuming 7-, 6- and 5-mers respectively) and 2-fold 
serial dilutions thereof (A) RNA bandshift assay with 0.2 pmol of U6 RNA 
and the described complexes; (B) 1J4/U6 annealing assay with the same 
complexes. 
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uncertain as U6-hLSm2-7 migrates similar to hLSml-7 and hLSm2-8, whereas U6-
hLSm23567 migrates significantly faster and could therefore represent an actual 
pentameric complex. In contrast the U4/U6 annealing activity of hLSm2-7 is about 
twice as high as that of hLSml-7 and hLSm2-8 and the activity of hLSm23567 is 
relatively very low (>8x lower). This indicates that there is no direct correlation 
between RNA-binding affinity and U4/U6 annealing activity of these complexes. 
As these complexes were a "hexamer" with hLSm4 (active) and a "pentamer" 
without hLSm4 (inactive) it may be either that a hexameric complex is the minimal 
requirement for efficient U4/1J6 annealing or that hLSm4 is an essential component 
of the LSm complexes in terms of annealing. To test these hypotheses a 
"pentameric" complex with hLSm4 (hLSm4-8) and a "hexameric" complex without 
hLSm4 (hLSm 123567) were assembled and tested for U6 RNA binding and U4/U6 
annealing (Fig. 4.11 A and B). The exact nature of the complexes that were formed 
was again uncertain as mobility of U6-protein complexes may not fit with formation 
of pentameric and heptameric complexes respectively. Nonetheless both displayed 
U6 RNA binding with reduced affinity compared to hLSm2-8 (at least 8 times 
lower). In contrast, hLSm123567 displayed very little U4/U6 annealing, whereas 
hLSm4-8 displayed annealing activity that was slightly higher than that of hLSm2-8. 
This suggests that hLSm4 may be the essential subunit of hLSm complexes in terms 
of U4/U6 annealing. To test if hLSm4 and the hLSm48 subcomplex are able to 
promote annealing both were dialysed to the same buffer without urea. Soluble 
proteins were tested for U6 RNA binding and U4/1J6 annealing. Surprisingly, much 
of the free U6 RNA disappeared in the U6 bandshift assay without showing a shift 
(Fig. 4.12A). This is unlikely to be due to RNA degradation as no significant 
degradation of U6 RNA was observed during the U4/U6 annealing assay (Fig. 
4.1213) even though proteins and RNA are incubated much longer in the latter assay. 
As U4/U6 annealing reactions are Proteinase K treated before native PAGE and U6 
bandshift reactions are loaded directly onto the gel, hLSm4 and hLSm48 may 
aggregate while binding RNA and thus prevent the U6-protein complexes from 
entering the gel. This could be equivalent to what was observed for yeast Lsm4p 
(Fig. 4.IA) but the U6-hLSm4(8) aggregates may not have transferred to the 
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Fig. 4.11 hLSm4 is essential for annealing activity of human LSm 
complexes. hLSm2-8, 123567 and 4-8 were assembled in vitro using 
the 4 M urea protocol. Proteins were used at 10 pmol (assuming 7-, 
6- and 5-mers respectively) or 2-fold dilutions thereof, with 0.2 pmol 
of U6 RNA and/or 0.3 pmol U4 RNA. (A) U6 RNA bandshift assay 
with the hLSm2-8, 123567 and 4-8 complexes; (B) U4/U6 annealing 
assay with the complexes from (A). 
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membrane during Northern transfer. U4 and U6 RNA are annealed efficiently by 
both hLSm4 and hLSm48. As the concentration of hLSm4 (subunits) is the same in 
these reactions as in the reaction performed with other hLSm4 containing complexes 
it seems that the annealing activity depends on the number of hLSm4 monomers 
present. As the annealing activity of hLSm48 is approximately half of that of hLSm4, 
the presence of hLSm8 may inhibit some of the annealing activity. Similarly, 
hLSml-7 and hLSm2-8 both display less annealing activity than hLSm2-7, which 
may indicate that hLSml also inhibits the LSm4-dependent annealing activity. 
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Fig. 4.12 Lsm4 is sufficient for annealing activity. 
(A) hLSm4 and 48 were dialysed into 0 M urea buffer. Proteins were used 
at 10 prnol of hLSm4 monomers or 2-fold dilutions thereof, with 0.2 prnol 
of U6 RNA for bandshift assays, (B) and 0.3 prnol U4 RNA for V4/U6 
annealing assays; (C) U4/U6 annealing assay with 0.4 pmol of hfq-free 
recombinant yeast Lsm4p (as in Fig. 4.1A). 
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4.4 Discussion 
In this chapter I have shown that recombinant yeast and human LSmI-7 and 2-8 
complexes assembled in vitro as well as affinity purified recombinant E. coil Hfq are 
capable of binding U6 and U4 snRNA. The affinity and specificity for binding to U6 
RNA may be slightly higher for yLsm2-8p than for yLsml-7p. The human LSm 
complexes show a similar but subtle difference in RNA binding specificity, but seem 
to prefer a uridine-rich single stranded sequence with an adjacent stem-loop structure 
as was previously proposed for yLsm2-8p (Vidal et al., 1999). The affinity of Hfq for 
both U4 and U6 RNA seems to be considerably higher, but this difference may 
reflect the low efficiency of correct Lsm complex assembly in vitro more than an 
actual difference in affinity for RNA. In addition, it shows the promiscuity of RNA 
binding by Hfq. Hfq has a preference for A/U rich sequences and a nearby stem-loop 
structure, which may be a feature that is conserved between all Sm-like complexes. 
In vitro assembled yeast Lsm complexes failed to show any annealing activity. As 
these complexes were assembled from individual Lsm proteins in the presence of 8M 
urea and the human LSm complexes had much reduced activity when assembled 
under these same conditions, this may be due to the failure to produce fully 
functional complexes this way. However, it can not be ruled out that the yeast Lsm 
complexes do not have U4/U6 annealing activity by themselves, but assist Prp24p 
(p 1  10 in humans) in this process (see also Chapter 6). 
In contrast, hLSm 1-7 and hLSm2-8 showed high levels of U4/U6 annealing. 
Presence of recombinant hLSm4 was shown to be essential and sufficient for this 
activity. Although it is appealing to conclude that the hLSm4 polypeptide itself 
determines the annealing activity of the Lsm complexes, co-purification of an E. coii 
protein that has this activity with hLSm4 can not be ruled out at this stage. In that 
case, reduced annealing for hLSm 1-7 and hLSm2-8 compared to hLSm4 alone may 
indicate inhibition of activity of this factor because of high affinity hLSm-U6 
binding. This potential hLSm4-specific contaminant is unlikely to be Hfq for two 
reasons: firstly, no Hfq-sized band is observed on (Coomassie stained) SDS-PAGE 
gels; secondly, a denaturation step with 8 M urea decreases the hLSm annealing 
activity, whereas increased activity may be expected for Hfq (see Appendix Al for 
results with Hfq-contaminated yLsm complexes). If it is hLSm4 that provides 
annealing activity it poses a number of questions. How does it promote annealing? 
What happens to hLSm4 in the presence of 8 M urea that leads to loss of most of this 
activity? In this respect it is interesting to note that yeast Lsm4p was shown to 
aggregate, both in vivo (see Chapter 7) and in vitro (Fig. 4. IA), and was shown to 
promote U4/U6 annealing in vitro (Fig. 4.12C). Is it possible that hLSm4 does the 
same and that its aggregation while bound to RNA promotes U4/U6 annealing? 
Annealing activity of yeast Lsm4p again emphasises the possibility that the yeast 
Lsm complexes would also have U4/U6 annealing activity if assembled under the 
right conditions. Both hLSml-7 and hLSm2-8 display similar levels of U6 RNA 
binding as well as U4/U6 annealing activity. This suggests that there may only be 
subtle differences between the RNA-binding specificity of these two complexes and 
that a big part of their functional difference in vivo may come from their specific 
subcellular localisations (see also Chapter 9). 
As both Hfq and the human LSm complexes were shown to be able to promote 
annealing between U4 and U6 RNAs, it suggests that RNA chaperone activity may 
be conserved between Sm-like complexes across the different kingdoms of life. It is 
as yet uncertain however, what the mechanism is by which Sm-like complexes 
promote RNA-RNA annealing. Experiments that attempt to elucidate this intriguing 
question will be discussed in Chapter 5. 
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CHAPTER 5 
Investigating a possible mechanism 
for RNA annealing by Sm-like proteins 
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5.1 Introduction 
Sm-like proteins have been shown to promote RNA-RNA interactions (see Chapter 4 
and references therein). Two different mechanisms for this RNA-RNA annealing 
activity have previously been proposed, although they are not mutually exclusive. 
One mechanism involves simultaneous binding of both RNAs, thus bringing them 
into close proximity, effectively increasing their local concentration and chance of 
forming an intermolecular duplex. A second mechanism involves destabilisation of 
inhibitory intramolecular secondary structures (5. 1B). For U4/U6 duplex formation 
this second mechanism is likely to play an important role, as destabilisation of the 3' 
stem-loop and telestem structures in U6 snRNA is required to allow U6 to form 
basepairing interactions with U4 snRNA (Fig. 5.1A). The "bridging" or 
"matchmaker" mechanism may however, be equally important. Although both 
Prp24p and Lsm2-8p are known to be involved in U4/U6 di-snRNP formation, it is 
unclear exactly what parts the individual proteins play in U41U6 duplex formation. 
This chapter describes experiments that try to address this question. The main focus 
is on the potential role of Lsm2-8p in destabilisation of the U6 snRNA 3' stem-loop 
structure. Effects of U6 point mutations predicted to disrupt the 3' stem-loop were 
investigated both in vivo and in vitro. A strand displacement assay using an 
RNA/DNA duplex that resembles the stem-loop was developed and activities of the 
recombinant yeast and human LSm complexes as well as E. coli Hfq were examined. 
5.2 Effects of mutations that destabilise the U6 3' stem-loop 
5.2.1 U6 3' stem-loop destabilising point mutations do not rescue 
Ism6Lt and Ism7L growth phenotypes 
Strains with a deletion of LSM6 or LSM7 are viable, but temperature sensitive, have 
reduced levels of U6 snRNA and are defective in efficient incorporation of U6 
snRNA into U4/U6 di-snRNPs and U4/U6-U5 tri-snRNPs respectively (Mayes et al., 
1999; Verdone et al., 2004). If Lsm2-8p promotes U4/U6 annealing by 
destabilisation of the U6 3' stem-loop, this step is likely to be affected by ism 
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Fig. 5.1 U4/U6 annealing. (A) To allow U4 and U6 snRNA to anneal 
the U6 3' stem-loop (red) needs to be destabilised; (B) Two possible 
mechanisms by which Lsm2-8p could promote U4/U6 annealing: (C) 
G63A and C69A mutations destabilise the 3' stem-loop, but do not 
affect basepairing in the U4/U6 duplex. 
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therefore rescue this defect. This was previously investigated by Page (2000) who 
reported that C69A and G63A1C69A mutations in SNR6, but not a G63A mutation, 
rescued the temperature sensitive growth of an 1sm6A strain, but not of an 1sm7A 
strain. These mutations were inserted into the genomic copy of SNR6 using a PCR-
based snr6-HpH cassette. However, strains created by Page (2000) could not be 
recovered from glycerol stocks and attempts to recreate these strains either using the 
same or other strategies to incorporate these mutations into the genome were 
unsuccessful. Therefore an alternative strategy was used to determine the effect of 
these snr6 mutations on the growth phenotype of wild-type, lsm6A and ism 74 strains. 
The G63A, C69A and G63A1C69A mutations were introduced in a plasmid based 
copy of the SNR6 gene (pSX6) by PCR-based site-directed mutagenesis. Resulting 
plasmids were checked for the presence of the correct mutations and absence of any 
other mutations by sequencing. One other spontaneous double mutation, 
G63A1A82G was found. Just like the G63A and C69A mutations, the A82G 
mutation is not involved in basepairing interactions in the U4/U6 duplex, but may 
destabilise the 3' stem-loop, in this case by disturbing an A-U Watson-Crick 
interaction. All four mutations were introduced into BSY557 (WT), MRY1 (1sm6A) 
and MRY2 (1sm7A) by plasmid shuffle (Fig. 5.2A), resulting in strains that only 
express U6 snRNA from these plasmids: MRY3 to 5, MRY21 to 26 and MRY61 to 
64 (see Table 2.1.6.1). These strains were tested for growth at 30 and 37CC (Fig. 
5.213). The snr6 mutations had no noticeable effect on growth of LSM+, lsm6A and 
ism 74 strains. To confirm the presence of the snr6 mutations, plasmids were rescued 
and re-sequenced. All mutations were present where expected. To confirm that G63A 
and C69A really did not rescue growth defects of the 1sm64 strain, as had been 
reported by Page (2000), growth rates of the appropriate strains (MRY4, 23 and 24) 
were measured at 30°C in liquid YPDA. Growth rates were identical and all strains 
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Fig. 5.2 U6 3' stem-loop destabilising mutations do not rescue temperature-
sensitive growth of/sm6A and lsm7A. (A) snr6 mutations were introduced by 
plasmid shuffle into BSY557 (WT), MRYI (Ism6A) and MRY2 (1srn7L). 
(B) The resulting strains were spotted on YPDA in 10-fold serial dilutions 
and incubated at 30 or 37°C. MRY3, MRY2 I, N'1RY22, MRY61 and MRY62 
(LSM+ with SNR6 (U6), snr6-G63A, C69A, G63A/C69A and G63A/A82G 
respectively) did all display similar amounts of growth; MRY4, MRY23, MRY24, 
MRY63 and MRY64 (Isrn6A with SNR6 (U6), snr6-G63A, C69A, G63A/C69A 
and G63A/A82G respectively) were all similarly temperature-sensitive, as 
were MRY5, NIRY25 and MRY26 (1sm7t with SNR6, snr6-G63A and C69A) 
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In summary, snr6-G63A, —C69A, -G63A/C69A and -G63A/A82G mutations that are 
predicted to destabilise the U6 snRNA 3' stem-loop structure (Fig. 5.1 C) do not 
rescue slow growth of lsm6A at permissive temperature or lethality at non-permissive 
temperature. Nor do the snr6-G63A and —C69A mutations rescue the growth defects 
of ism 74 and, surprisingly, no growth defect was associated with any of the snr6 
mutations in the LSM+ background (at least not at 30 or 37°C). 
5.2.2 Stem-loop destabilising mutations do not increase U4/U6 
levels in vivo 
Temperature-sensitive phenotypes associated with the lsm6 and ism 7 deletions may 
be caused by reduced protection of shortened mRNA 3' ends by the Lsm 1-7 complex 
as was previously proposed for ismiA (He et al., 2001) and not by reduced levels of 
U6 snRNA, U4/U6 di-snRNPs and/or U4/1J6-U5 tri-snRNPs. If this is indeed the 
case the snr6 mutations may still increase U4/U6 levels of lsm6A and/or 1sm7A 
strains, in spite of their failure to rescue their growth phenotypes. To examine this 
possibility the levels of the snRNAs and the U4/U6 duplex were determined in LSM6 
and lsm6A strains with SNR6, snr6-G63A, snr6-C69A or snr6-G63A/C69A (Fig. 5.2). 
Total RNA was isolated from all strains under non-denaturing conditions. Levels of 
all snRNAs were examined by Northern blotting analysis with snRNA-specific 
probes, after denaturing PAGE (Fig. 5.3A and B). Levels of free U4 and U6 as well 
as U4/U6 duplex were determined by Northern blotting analysis after non-denaturing 
PAGE with U6 (Fig. 5.3C and D) and U4-specific probes (Fig. 5.3E and F). Loading 
was not entirely equal between lanes and was corrected for in the quantifications by 
normalising against the level of Ui snRNA in each lane. This was shown to be a 
valid loading control (see Fig. 8.5) 
The snr6 mutations do not significantly affect the levels of any of the other snRNAs 
in an LSM6 strain, but surprisingly cause reduced levels of U6 snRNA (61-68% of 
SNR6; Fig. 5.3A and B). This suggests either that transcription of these mutant RNAs 
is less efficient or that the RNAs themselves are less stable. As expected the levels of 
U6 snRNA are reduced in the lsm6A strain, with slight variations in the exact level 
between U6 mutants (37-53% of LSM61SNR6). Interestingly, all lsm6A strains also 
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show reduced levels of U2 snRNA (62-67% of LSM6ISNR6) and U5-L snRNA (46-
55% of LSM61SNR6). The reason for this is unclear, but this phenomenon is 
consistently observed in lsm5A, lsm6A and lsmM strains and is discussed in more 
detail in Chapter 8. Analysis of levels of free U6 snRNA and U4/U6 by native PAGE 
shows that the U6 mutations in the LSM6 background only affect levels of free U6 
snRNA (41-60% of SNR6) and not the levels of U41U6 (106-116%; Fig. 5.3C and 
D). This suggests, that in spite of overall reduced levels of U6 RNA the mutant 
RNAs are efficiently (possibly even more efficiently) incorporated into U41U6 di-
snRNPs. In contrast, the levels of free U6 snRNA and U4/U6 are similarly reduced 
(to 32-46% and 66-76% of LSM61SNR6 respectively) for wild-type U6 and U6 
mutants in the lsm6A background. The U6 mutations clearly do not correct the 
U4/U6 assembly defect caused by the lsm6 deletion. This is confirmed by analysis of 
the U4/U6 levels using a U4 specific probe (Fig. 5.3E and F). Levels of free U4 are 
significantly increased for all 1sm6A strains (232-369% of LSM61SNR6), but because 
of the reduced U411J6 levels the total level of U4 is only slightly increased (113-
135% of LSM61SNR6; Fig. 5.3A and B). An increase in free U4 levels is consistently 
seen for lsm5A, 1sm6A and 1sm7A strains, with a variable, but significant increase of 
total U4 snRNA levels as well. This seems to be, at least in part, an indirect effect of 
reduced U6 snRNA levels. A possible mechanism is discussed in Chapter 8. 
Fig. 5.3 U6 3' stem-loop destabilising mutations do not rescue U4/U6 levels in 
lsm6iX. RNA was extracted under non-denaturing conditions from MRY3, MRY2 1, 
MRY22, MRY61 (LSM6 (wt) with SNR6 (wt), snr6-G63A, C69A and G63A+C69A), 
MRY4, MRY23, MRY24, MRY63 (1sm6A with SNR6 (wt), snr6-G63A, C69A and 
G63A +C69A). RNA was separated by denaturing and non-denaturing PAGE, 
Northern blotted and probed for the spliceosomal snRNAs. (A) Northern blot after 
denaturing PAGE and (B) quantification of all spliceosomal snRNAs. (C) Northern 
blot after non-denaturing PAGE probed for U6 RNA and (D) quantification of 
U4/U6 duplex and free U6 snRNA. (E) Northern blot after non-denaturing PAGE 
probed for U4 RNA and (F) quantification of U4/U6 duplex and free U4 snRNA. 
Levels were expressed as a percentage of LSM61SNR6 (wt/wt) and were corrected for 
equal loading by comparison to the amount of U  snRNA present in each lane. 
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5.2.3 Stem-loop destabilising mutations increase U4/U6 annealing 
efficiency in vitro 
As the snr6 mutations lead to reduced levels of U6, but not U4/U6 in an LSM+ 
background, it suggests that the stem-loop destabilising mutations may increase 
U4/U6 annealing. Failure to correct U4/U6 levels in the ism 64 background suggests 
that these mutations may only do so in vivo in the presence of a fully functional 
Lsm2-8 complex. Alternatively, the U6 mutants are more susceptible to degradation 
unless they are basepaired to U4. To test if the stem-loop destabilising mutations lead 
to increased annealing in vitro, wild-type U6, U6-G63A and U6-C69A were 
Flo 
wild-type U6 	 mutant U6 
U6 	G63A 	C69A 
- + + - + + - + + 	incubation 
- - + - - + - - + 	Hfq 
U4/U6  
duplex 	 - 
U6/U6 
duplex? 
U6 RNA tt L%Si1PI 
Fig. 5.4 U6 3' stem-loop destabilising mutations make U4/U6 annealing 
in vitro more efficient. (A) Schematic representation of U6 snRNA secon-
dary structure with putative stem-loop destabilising mutations, G63A and 
C69A, indicated; B) In vitro U4/U6 annealing with in vitro transcribed 
and gel-purified U4 RNA and U6, U6-G63A and U6-C69A RNA in the 
absence and presence of recombinant Hfq. Annealing reactions were sepa-
rated by non-denaturing PAGE and the Northern blot was probed for U6 
snRN A. 
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transcribed in vitro and gel-purified. U4/U6 annealing reactions were carried out as 
in Chapters 4, with or without recombinant Hfq present. Both mutations increased 
the amount of U4/U6 duplex significantly, both with and without Hfq there to 
promote annealing, but C69A had a stronger effect than G63A (Fig. 5.413). U4 was 
shown to be present in the band indicated with U41U6 duplex, but not in the 
additional bands of slower mobility (data not shown), that may represent a U61U6 
duplex. These data suggest that the 3' stem-loop structure in U6 RNA inhibits U41U6 
annealing in vitro as well as in vivo, and that when this secondary structure is 
destabilised by point mutations and/or protein binding, formation of a U4/U6 duplex 
is more efficient. 
5.3 Can Lsm complexes change RNA structure? 
One of the functions of the Lsm2-8 complex in addition to protecting the U6 snRNA 
from degradation may be to destabilise the U6 3' stem-loop structure, thus promoting 
U4/1J6 annealing. The Lsml -7 complex may similarly destabilise RNA secondary 
structures and thereby affect RNA-protein interactions. Hfq has been shown to alter 
RNA-RNA and RNA-protein interactions by changing RNA secondary structures in 
some cases (Schuppli etal., 1997; Moller et al., 2002; Zhang et al., 2002; Moll et al., 
2003; Geissmann et al., 2004), but has been shown to be able to promote RNA-RNA 
interactions without affecting RNA secondary structures in others (Brescia et al., 
2003; Mikulecky et al., 2004). This RNA chaperone function may be conserved 
between all Sm-like protein complexes. 
5.3.1 Designing a strand displacement assay 
To investigate the ability of Lsm2-8p to melt out the U6 3' stem-loop structure an in 
vitro strand displacement assay was designed. Initial attempts to create a U6 RNA 
structure in vitro by mixing in vitro transcribed and gel-purified 5' (nt 1-70) and 3' 
(nt 71-112) U6 fragments were unsuccessful. This was thought to be due to the 
formation of stable intramolecular structures within both of these U6 fragments, the 
5' fragment in particular (predicted by mfold (Mathews et al., 1999; Zuker, 2003); 
data not shown). Therefore an alternative strategy was taken in which a duplex was 
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formed between U6(77-112) RNA and a complementary end-labelled DNA oligo, 
U6(77-92)rc (Fig. 5.513). The melting temperature of the RNA/DNA duplex was 
estimated at approximately 54°C (default settings at http://bioweb.pasteur.fr/seqanall  
interfaces/melting.html; Le Novere, 2001). Incubation in the presence of purified 
recombinant proteins at 37°C and subsequent native PAGE allowed detection of 
remaining duplex and DNA oligo freed by strand displacement. Reactions were 
carried out in the presence of a 20-fold excess of unlabeled DNA oligonucleotide to 
quench potential re-formation of the duplex with the displaced labelled 1 6-mer. 
Additionally, absence of significant strand displacement without proteins provided 
evidence that the duplex was thermodynamically stable under the assay conditions. 
A variety of substrates were created, mostly with similar melting temperatures, but 
different sequences in either the 3' single stranded part or in the duplex to allow to 
test for sequence specificity of strand displacement activity (see Appendix Fig. 
A1.5). 
5.3.2 Proof of principle: Dedip helicase unwinds the U6-like 
RNA/DNA duplex structure 
To test the strand displacement assay, S. cerevisiae Dedip helicase was used. 
Recombinant Dedip has been shown to unwind an RNA/DNA duplex of unrelated 
sequence, but of similar design, including a 3' single stranded RNA tail and a duplex 
with a melting temperature of approximately 52°C (Cordin et al., 2004). Here, 25 nM 
of Dedlp (kindly provided by Olivier Cordin) was able to unwind 250 nM of the U6-
like duplex efficiently within minutes in the presence of 1 mM ATP (Fig. 5.5C). In 
contrast, only minimal strand displacement was observed in the absence of Dedip or 
with Dedip in the absence of ATP. This is comparable to what was found by Cordin 
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Fig. 5.5 Design of a strand displacement assay based on the U6 snRNA 
3' stem-loop, and strand displacement activity of Dedip helicase. 
(A) Schematic representation of the U6 snRNA secondary structure and 
U4/U6 structure; B) Schematic representation of the strand displacement 
assay. The substrate is an RNA/DNA duplex, resembling the 3' stem-loop 
structure, made with in vitro transcribed gel-purified U6-3' RNA and a 
complementary end-labelled DNA oligonucleotide; (C) Strand displacement 
over time with 25 nM Ded I  and 250 nM of substrate in the absence and 
presence of 1 mM ATP. Duplexes and oligonucleotides were separated by 
native PAGE. 
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5.4 Yeast Lsm complexes have strand displacement activity 
Initial experiments with in vitro assembled yeast Lsm protein complexes displayed 
high levels of strand displacement activity. However, the discovery of co-purification 
of E. coil Hfq with Lsm8p in particular made interpretation of results problematic 
(see Appendix Al). Hfq-free Lsm complexes were then formed which were able to 
bind RNA (see 4.2.2), but were not able to promote U4/U6 annealing (see 4.3.1). 
These complexes failed to show strand displacement at rates which were seen in the 
earlier experiments. The substrate concentration was therefore decreased (from 250 
nM) to 25 nM, which is approximately the same as the RNA concentrations used in 
the RNA bandshift assays (4.2.2). Both Lsml-7p and Lsm2-8p now displayed strand 
displacement after 30-60 mm (Fig. 5.6A), but a significant part of the substrate RNA 
was shown to be degraded (data not shown). It was unclear however, to what extent 
RNA degradation contributed to strand displacement and to what extent RNA was 
degraded after unwinding by the Lsm proteins. Reactions were therefore incubated 
for shorter periods of time (up to 20 mm) and both Lsml-7p and Lsm2-8p still 
displayed strand displacement activity (Fig. 5.6B), without significant RNA 
degradation (Fig. 5.6C). A higher level of strand displacement by Lsm2-8p than by 
Lsml-7p corresponds to higher affinity RNA binding in the RNA bandshift assays 
(Fig. 4.1). It is uncertain however, whether this reflects a real difference between 
Lsml-7p and Lsm2-8p or different levels of correctly formed complexes. Just like in 
the RNA bandshift assays, a large excess of protein over substrate is needed. This is 
likely to reflect the low level of correct heteroheptameric complexes rather than low 
affinity and/or strand displacement activity of these complexes. Addition of up to 1 
mM ATP did not increase strand displacement activity (data not shown), suggesting 
that unwinding by the Lsm complexes does not require ATP. 
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Fig. 5.6 Strand displacement by in vitro assembled yeast Lsrn 1-7 and 
Lsm2-8 complexes; (A) 25 nM of U6(77-1 12)/(77-92)rc duplex was 
incubated for 30 or 60 min with buffer, I iM ofyLsml-7p or yLsm2-8p; 
(B) Repeat of (A) but shorter incubations of up to 20 nun; (C) Duplicate 
strand displacement reactions of (B) were separated by denaturing PAGE 
and analysed by Northern blotting with U6(77-92)rc probe showing 
absence of RNA degradation. The DNA half of the duplex substrate shows 
equal loading. 
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5.5 RNA-binding by recombinant Hfq is required for its strand 
displacement activity 
Recombinant Hfq was shown to bind U4 and U6 snRNA (Fig. 4.2) and to promote 
annealing between these RNAs in vitro (Fig. 4.7 and 4.8). To investigate whether 
Hfq may promote U41U6 annealing by destabilising the U6 3' stem-loop, 
recombinant Hfq was tested for strand displacement activity in the assay described 
above. As was seen for the hfq-free Lsm complexes, strand displacement activity for 
recombinant Hfq was not as robust as that detected for the Lsm-Hfq mixture 
(Appendix Al). A large excess of Hfq over duplex substrate was needed to detect 
strand displacement. With enough Hfq added however, most substrate was unwound 
within 60 minutes after what seems to be initial binding of the duplex by Hfq (Fig. 
5.7A; compare to Fig. A1.4C). Strand displacement activity did not increase by 
addition of 1 mM ATP (data not shown), suggesting that Hfq does not require ATP 
to unwind the RNA/DNA duplex. As Hfq has been suggested to have ATPase 
activity (Sukhodolets and Garges, 2003) this finding is significant. 
The Hfq C-terminal extension was shown to be non-essential for RNA binding and 
U4/U6 annealing activity. In contrast, RNA binding as well as annealing was 
undetectable for Hfq-Y55A, which carries a point mutation in a residue thought to be 
involved in RNA binding (Fig. 4.7A). Just like RNA-binding and U4/U6 annealing, 
strand displacement activity was similar for Hfq and HfqAC, but almost non-existent 
for Hfq-Y55A (Fig. 5.713. Northern analysis of U6(77-112) RNA after strand 
displacement (Fig. 5.7C) revealed that strand displacement by Hfq and HfqiC was 
not due to RNA degradation, whereas the low level of strand displacement observed 
for the highest amount of Hfq-Y55A seems to be caused, at least in part, by RNA 
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Fig. 5.7 Strand displacement by recombinant Hfq; (A) 25 nM of 
U6(77-112)/(77-92)rc duplex was incubated for up to 60 min with 
buffer or 1 MM of His-l-IA-Hfq (hexamer); (B) 25 nM of substrate 
was incubated with 1, 0.5 or 0.25 MM of His-HA-l-Ifq, His-Myc- 
l-lfqAC or Hfq-Y55A-His for 60 mm; (C) Duplicate strand displace-
ment reactions of of the highest protein concentrations in (B) were 
separated by denaturing PAGE and analysed by Northern blotting 
with U6(77-92)rc probe showing absence of RNA degradation. The 
DNA half of the duplex substrate shows equal loading. 
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5.6 hLSm4 may be essential for strand displacement by the 
human LSm complexes 
In vitro assembled human LSmI-7 and Lsm2-8 were tested in the above strand 
displacement assay and both complexes were shown to unwind the duplex substrate 
(Fig. 5.8A). In contrast to the effect that different assembly methods had on the 
U4/U6 annealing activities of the resulting complexes (4 M urea vs. 8M urea; see 
4.3.3.1), only a minimal difference was observed in their strand displacement 
activities (Fig. 5.8A and B). This correlates with the absence of an effect on RNA 
binding by these complexes and suggests that RNA binding is sufficient for strand 
displacement activity. In contrast, there may be additional requirements for RNA-
RNA annealing activity. The same may be true for the yeast Lsm complexes and 
these complexes may also display in vitro annealing activity when assembled under 
different conditions. 
The same "incomplete" LSm complexes that were used as controls in the U41U6 
annealing assays (4.3.3.2) were used to determine the requirements for strand 
displacement activity. Similar to U4/1J6 annealing activity displayed by the 
hexameric hLSm2-7 and pentameric hL5m23567 control complexes (Fig. 4.10) 
strand displacement activity was higher for hLSm2-7 than for hLSml-7 and 
hLSm23567 only displayed minimal activity (Fig. 5.8C). To determine whether the 
presence of hLSm4 or the formation of a hexameric complex is essential for strand 
displacement activity a hexameric complex lacking hLSm4 (hLSml23567) and a 
pentameric complex with hLSm4 (hLSm4-8) were assembled and tested in the strand 
displacement assay. Minimal activity of the hLSm123567 and efficient strand 
displacement by hLSm4-8 suggest that hLSm4 is required for unwinding activity 
(Fig. 5.9A and B). Again, this is identical to what was found to be essential for 
annealing activity (Fig. 4.IIA and B). To determine whether, like for U4/U6 
annealing, hLSm4 is not only essential but also sufficient for strand displacement 
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Fig. 5.8 Strand displacement activity of in vitro assembled human LSm 
complexes depends on the assembly method and may require hLSm4; 
(A) 25 nM of V6(77- 11 2)/(77-92)rc duplex was incubated for 60 min with 
buffer, 2 tM of hLSrnl-7 or 1 tM of hLSm2-8 (assembled using the 4 M 
urea method) and 2-fold dilutions thereof -,(B) 25 nM of substrate was 
incubated for 60 inin with buffer, I tM. 0.5 tM and 0.25 1tM ofhLSml-7 
or hLSm2-8 (assembled using the 8 M urea method); (C) 25 nM of substrate 
was incubated for 60 miii with buffer, 1 ptM, 0.5 1tM and 0.25 iM of 
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Fig. 5.9 hLSm4 is essential and sufficient for strand displacement activity 
of in vitro assembled human LSm complexes; (A) 25 nM of U6(77-112)/ 
(77-92)rc duplex was incubated for 60 min with 1, 0.5 and 0.25 iM of 
hLSml-7 or hLSm 123567; (B) 25 nM of substrate was similarly incubated 
with 1, 0.5 and 0.25 1iM of hLSm2-8 or hLSm4-8; (C) 25 nM of substrate 
was similarly incubated with hLSm4 or hLSm48 at 1, 0.5 and 0.25 1.tM of 
hLSm4 monomers. 
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Strand displacement activity for these proteins was as high as that of hLSm2-7 per 
mole of hLSm4, indicating that hLSm4 has annealing as well as strand displacement 
activity. The fact that the strand displacement activity of hLSm 1-7 and hLSm2-8 was 
lower at the same molar concentration of hLSm4 suggests that hLSml as well as 
hLSm8 may somehow mask this hLSm4 activity. However, it can not be ruled out 
that the activity comes from a hLSm4-specific E. coli contaminant protein and that 
its activity is inhibited by hLSm 1-7 and hLSm2-8 RNA binding. 
5.7 Discussion 
In this chapter I have shown that, although mutations that disrupt the U6 snRNA 3' 
stem-loop structure lead to more efficient U4/U6 annealing in vitro, the same 
mutations do not increase the level of U4/U6 duplex present in vivo for an lsm6A 
strain, nor do they rescue temperature-sensitive growth of this strain. Interestingly 
C69A had a more pronounced positive effect on U4/U6 annealing in vitro than did 
G63A. This may simply indicate a less stable stem-loop for U6-C69A than for U6-
G63A. Both mutations disrupt a G-C basepair however, suggesting that the position 
of the disruption is important. Karaduman et al. (2006) noted the resemblance of the 
3' stem-loop to a so-called kissing loop. It is likely that this loop and the 
complementary free 5' end of U4 snRNA interact, thus initiating formation of U4/U6 
stem II by helix propagation. As C69 is close to the top of the stem-loop its mutation 
is likely to lower the energy barrier that needs to be overcome to initiate U4/U6 
duplex formation. G63 is further down the stem and may therefore have less of an 
effect. 
In vivo, binding by Prp24p and Lsm2-8p is likely to affect the stability of the U6 3' 
stem-loop. To examine the potential function of Lsm2-8p in destabilising this stem-
loop and to investigate similar RNA chaperone functions of Lsm l-7p and Hfq, a 
strand displacement assay was designed using an RNA/DNA duplex resembling the 
3' end of U6 snRNA. All Sm-like protein complexes that were tested, yeast and 
human Lsml-7 and Lsm2-8, and E. coli Hfq, were able to displace the DNA 
oligonucleotide from the U6-3' RNA fragment. No ATP was required by any of 
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these Sm-like complexes, but results with an Hfq mutant and a variety of hLSm 
complexes indicate that RNA binding is essential for strand displacement activity. As 
an excess of protein over duplex substrate was needed for complete unwinding, it 
seems that it may be the process of RNA-binding itself that leads to strand 
displacement. I propose that binding of the uridine-rich sequence at the 3' end of U6 
RNA along the inside of the doughnut-shaped Lsm complexes bends the RNA 
forcing open the bottom end of the duplex, effectively lowering the melting 
temperature. In addition, binding by extensions of specific Lsm proteins to the RNA 
duplex itself may contribute to duplex unwinding (Fig. 5.10). The results described 
in this Chapter and Chapter 4 suggest that Lsm4p may play an important role in the 
latter. Comparison of the naked U6 RNA structure to that bound by Prp24p and/or 
Lsm2-8p (Karaduman et al., 2006) suggests that both destabilisation of the telestem 
and 3' stem-loop by Lsm2-8p binding occur in vivo, as presence of Lsm2-8p leads to 
reduced protection of nucleotides in the telestem and in the 3' stem-loop. As the 
structure of U6 snRNA with Lsm2-8p alone is not known, it cannot be ruled out 
however, that these effects are indirect effects of Lsm2-8p on Prp24p-U6 binding 
(see also Chapter 6). Preferred binding of the Lsm complexes to a U-rich sequence 
flanked by a stem-loop structure favours a model in which protein-RNA interactions 
extend beyond those between the single stranded RNA and the proposed nucleotide 
binding pockets along the inside of the ring. 
binding 
U6 snRNA 	 Destabilises 
structure 
Fig. 5.10 A model for Lsm2-8p stem-loop destabilisation. 
The single stranded U-rich tail of U6 RNA is bound along 
the inside of the Lsm2-8p ring pulling apart the telestem. 
Additional interactions with other parts of the Lsm complex, 
possibly involving Lsm4p may further destabilise the 3' 
stem-loop structure. 
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Human LSm4 was shown to be essential and sufficient for annealing (Chapter 4) as 
well as strand displacement activity (this Chapter). This suggests that hLSm4 may be 
responsible for binding to and destabilisation of the stem-loop. Initial experiments 
with yeast Lsm4p suggest that this protein also has U4/U6 annealing activity. It 
would be interesting to investigate whether it is also able to perform strand 
displacement. However, no U4/1J6 annealing activity was associated with the same 
yeast Lsm protein complexes that displayed RNA-binding and strand displacement 
activity. This suggests that destabilisation of the U6 3' stem-loop (at least as 
measured by the strand displacement assay) is not sufficient to promote U4/1J6 
annealing. As discussed in Chapter 4 the human LSm complexes lose their annealing 
activity when they are assembled using 8 M urea. This suggests that 8 M urea affects 
the hLSm4 functionality. However, an Lsm4p specific contaminant from E. coli can 
not be ruled out at this stage. Repeating these experiments with hLSm4 mutant 
proteins that are defective in complex formation and/or RNA-binding may shed some 
light on this. Additional experiments with yeast Lsm4p may also be useful. 
In summary, I have shown strand displacement activity for E. coli Hfq as well as for 
the yeast and human Lsm complexes. The ability of Sm-like protein complexes to 
modulate RNA secondary structure may therefore be conserved. It allows these 
complexes to promote or disrupt RNA-RNA and RNA-protein interactions 
influencing a wide variety of RNA metabolic processes. 
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CHAPTER 6 
Interactions between Prp24p 
and Lsm proteins 
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6.1 Introduction 
Prp24p is an essential U6 snRNP protein that is important for U4/U6 di-snRNP 
formation. Recycling of U6 snRNA was shown to be impaired in splicing extracts 
immuno-depleted of Prp24p (Raghunathan et al., 1998a) and recombinant Prp24p 
was shown to have U4/U6 annealing activity in vitro. This process does not require 
ATP, but is more efficient in the presence of Lsm2-8p (Ghetti et al., 1995; 
Raghunathan et al., 1998a; Rader et al., 2002; this thesis). Yeast Prp24p has four 
RNA Recognition Motifs (RR-Ms; Shannon et al., 1991; Rader et al., 2002) and a 
highly conserved C-terminal decapeptide (Rader et al., 2002; Bell et al., 2000; Fig. 
6.1). This C-terminal motif was termed SNNFL box (Kwan et al., 2005), after its 
most conserved residues (SNDDFRKMFL) and was shown to be involved in a direct 
interaction with the Lsm2-8 complex, which was proposed to stabilise the Prp24p-U6 
snRNA interaction (Rader et al., 2002; Ryan et al., 2002). A range of genetic 
interactions between mutations in SNR14 (the U4 snRNA gene) and SNR6 (the U6 
snRNA gene) and PRP24 that map to residues in these RRMs (Shannon et al., 1991; 
Vidaver et al., 1999) lead Rader and Guthrie (2002) to propose that RR-M2 and 
RRM3 favour free U6 over U4/U6 RNA. At the same time, genetic interactions 
between mutations in the different RRMs lead them to propose that RRM 1, RRM4 
and the SNFFL box promote U4/1J6 annealing. Lsm2-8p has been shown to be 
involved in U4/U6 di-snRNP formation, most likely as an RNA chaperone, both in 
yeast (Verdone etal., 2004) and in humans (Achsel etal., 1999; this work). Levels of 
U4/U6 RNA are reduced in lsm64 and lsm7A strains (Mayes et al., 1999; Verdone et 
al., 2004; this work). This may be caused, at least in part, by the reduced U6 snRNA 
levels in these strains. However, loss of efficient Lsm2-8p chaperone activity is 
likely to contribute. The exact roles Prp24p and the Lsm proteins play in the process 
of U4/U6 duplex formation are still unclear. In this chapter I examine interactions 
between these U6 snRNP polypeptides and propose a model for U4/1J6 annealing. 
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Fig. 6.1 Domains and mutations in yeast Prp24p. Prp24p contains four 
RNA recognition motifs (RRM 1-4) and a highly conserved 10 aa motif 
near the C-terminus (SNFFL-box). Triple alanine mutations in each of the 
RRMs (RRM I -4sub; ***) affect residues that are proposed to be essential 
for RNA binding. RI58S and F2571 affect one of these residues in RRM2 
and RRM3 respectively. F87A affects a highly conserved residue in RRM 1. 
The prp24M0 mutation carries a deletion of the 10 residues covering the 
SNFFL-box. Amino acid coordinates are indicated at the bottom. 
6.2 Investigating genetic interactions between PRP24, LSM6 
and LSM7 
If the above proposed roles of the various Prp24p RRMs are correct, it may be 
expected that mutations in RRM2 and RRM3 could rescue slow growth phenotypes 
associated with lsm6 and ism 7 deletions, whereas mutations in RRM 1 and RRM4 
may cause synthetic lethality. To test this LSM6 or LSM7 was deleted in GLS618, a 
strain with a prp24 deletion carrying a plasmid with PRP24 under its own regulatory 
elements (pPR097, CEN-URA3). The resulting MRY15 (lsm6A) and MRYI6 
(ism 7A) strains were transformed with plasmids expressing prp24 mutants (CEN-
HIS3) and growth in the absence of wild-type Prp24p expression was tested for by 
streaking on 5-FOA plates (counter-selection against Ura+ cells; Fig. 6.2). The 
following prp24 mutants were used: RRM1-4sub mutants with triple alanine 
mutations in putative RNA binding residues in each of the RRMs (Fig. 6. 1), mutants 
with single point mutations in the RRMI-3 domains (F87A, R158S and F2571), a 
prp24zlIO mutant with a C-terminal 10 aa deletion of the residues involved in the 
interaction with Lsm2-8p, and various combinations of RRMsub mutations. Prp24 
mutations that were previously shown to be viable in the GLS6 18 (LSM+) 
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Fig. 6.2 Plasmid shuffle (A) in GLS6I8 (LSM+; B), MRY15 (/smóA; C) and 
MRYI6 (ism 7A; D). GLS6I8, MRYI5 and MRYI6 were transformed with 
the plasmids pSR53 (prp24-RJ?M3sub), pSR70 (prp24-RRM4sub), pSR86 
(prp24-RRMlsub), pSR93 (prp24-RRM1sub1RRM4sub), pSR 105 (prp24-
RRM3 sub1RRM4 sub*), pSR 15 1 (prp24L1O-RRMIsub) and pMR59 (PRP24). 
Counterselection against pMR58 (PRP24-CEN-UR.A3) on 5-FOA left cells 
dependent on the mutant prp24 plasmids for survival. * Sequencing revealed 
the absence of the RRM4sub mutation in this plasmid. It was remade (pMR55) 
by site-directed mutagenesis of pSR53 and turned out to be inviable in the 
GLS6I8 background. * Cells for lsm7Et with pSRI05 growing on 5-FOA were 
tested for growth on SD-Ura and grew; on repeat Ism7A pSR 105 was inviable. 
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background, prp24-RRMIsub, prp24-RRM3sub, prp24-RRM4sub, prp24-RRMlsub1 
RRM4sub, prp24-RRM3sub1RRM4sub, prp2 4410, prp24AlO/RRMlsub (Rader et al., 
2002) all supported growth on 5-FOA (Fig. 6.2B). In contrast only three of these 
prp24 mutants allowed growth in the MRY15 (lsm6A) and MRYI6 (1sm74) 
backgrounds: prp24-RRMIsub, prp24AlO and the combined prp244101RRMlsub 
mutation (Fig. 6.2C and D; Fig. 6.3). In all cases growth was reduced for these prp24 
mutants compared to PRP24, with the exception ofprp24AlO in Ism 7A (Fig. 6.3). 
In addition to the triple alanine mutations in each of the RRM domains the effects of 
mutations in single residues in RRM2 and RRM3 were tested. These prp24-R158S 
and prp24-F2571 mutations were shown to suppress cold-sensitive growth of a U6-
A62G mutation, which supposedly causes hyperstabilisation of the U6 RNA 3' stem-
loop structure, thus inhibiting U4/U6 formation (Fortner et al., 1994; Vidaver et al., 
1999). The heat-sensitive phenotype caused by both prp24 mutations as previously 
described (Vidaver et al., 1999) was shown to be more severe for prp24-R158S than 
for prp24-F2571 (Fig. 6.3). Like the prp24-RRM2sub and RRM3sub mutations these 
point mutations were also synthetic lethal with lsm6A and ism 74. Kwan and Brow 
(2005) later showed that the prp24-RRMlsub mutations only affect residues that are 
poorly conserved between Prp24p homologues, suggesting that the residues mutated 
in RRMlsub are not essential for RNA-binding. A point mutation, F87A, in a highly 
conserved residue of RRM I was shown to be heat-sensitive lethal (Kwan et al., 
2005). This mutation also turned out to be synthetic lethal with 1sm6zl and lsm7A 
(this work; data not shown). 
All plasmids were sequenced to confirm the presence of the correct prp24 mutations 
and absence of any others. Contrary to published data, plasmid pSR 105 
(RRM3/4sub) was shown to contain the prp24-RRM3sub mutation only and not the 
prp24-RRM4sub mutation. To test whether the double mutation prp24-RRM3sub1 
RRM4sub is really viable in the GLS6I8 (LSM+) background, pSR53 (RRM3sub) 
was used as a template for site directed mutagenesis creating pMR55 (RRM3/4sub). 
This double mutation was found to be lethal in LSM+, 1snz6A and ism 74 
backgrounds, unlike what was reported by Rader and Guthrie (2002). 
226 
14°C 	 30°C 	 37°C 
PRP24O• 
prp24-R158S • 	4 . 
PRP24 	 f •••. ••• Y 
prp24MO . 	 4141 
prp24-RRMlsub ••• 	•••• 
prp24t1O-RRM1sub •• • ,.. 2 	 2 
PRP24 •.: •••4 
prp24A10 • 	 •• • . 	• 
prp24-RRM1sub • 
prp24MO-RRM1sub , 
PRP24 •*s ...,*: •..i ' 
prp241O 	 •.7. •*3'. 
prp24-RRMlsub • 
prp24MO-RRM1sub • • - 9 I •• 1W 	3l.- ' 
Fig. 6.3 Growth phenotypes of prp24 mutants in LSM+ (GLS6I 8), Ism6A 
(MRYI5) and Ism 7A (MRYI6). The following plasmids were shuffled into 
GLS6I8, MRY15 and MRYI6 as in Fig. 6.IA: pMR59 (PRP24), pMR65 
(prp24-R1588), pMR66 (prp24-F2571), pMR63 (prp24AIO), pSR86 (prp24-
RRMIsub) and pSR 151 (prp24AJO-RRMlsub). Resulting strains were grown 
overnight in YPDA and ten-fold serial dilutions of equal OD units of each 
culture were spotted on YPDA and grown at 14°C, 30°C and 37°C, for 2 days 
(2), for 3 days (3) or for 9 days (9). 
In summary (Table 6. 1), mutations in conserved residues of all four RRMs of Prp24p 
cause synthetic lethality with deletion of LSM6 or LSM7. The only prp24 mutations 
that allow growth in combination with 1sm64 or lsm7A are prp24-RRMIsub, which 
does not affect conserved Prp24p residues, prp24A 10, which affects the Prp24-Lsm2-
8p interaction and the combined prp24zl1O-RRM1sub mutation. Interestingly, 
prp24AlO confers cold-sensitivity on an LSM+ strain, but has no effect on lstn7A at 
any temperature and leads to heat-sensitive instead of cold-sensitive growth in 1sm6A 
(Fig. 6.3). In addition, prp24410 seems to alleviate part of the prp24-RRMIsub slow 




all temperatures and is strongly heat-sensitive, whereas prp24A 1 O-RRMlsub grows 
the same at 14 and 30°C as PRP24 in 1sm7A without significantly rescuing heat-
sensitive growth. 
Table 6.1 Overview of effects of pip24 mutations on growth 
LSM+ 1sm6A ism 74 
PRP24 viable Ts (weak) Ts (weak) 
RRMlsub viable Cs / Ts Cs / Ts 
F87A Ts" t t 
RRM2sub t n.t. n.t. 
R158S Ts   t t 
RRM3sub Ts a/c t t 
F2571 Ts' t t 
RRM4sub is a t t 
RRM1/4sub is a t t 
RRM3/4sub t a f 
MO 	 C S a 	 Ts 	 is 
M0/RRMlsub 	CSITSa** 	 Cs/Ts Cs/Ts*** 
t lethal; n.t. = not tested; Ts = heat sensitive; Cs = cold sensitive 
a Rader and Guthrie (2002); this report 
b  Kwan and Brow (2005); this report 
C  Vidaver et al. (1999); this report 
* Incorrect in Rader and Guthrie (2002); I've shown here that this combination is 
lethal 
As shown here and in Rader and Guthrie (2002), the RRM 1 sub mutation slightly 
alleviates Cs slow growth for the prp24410 mutation (this was not noted by R&G) 
In the Ism 7A background, the prp24A10 mutation alleviates slow growth caused 
by the RRMlsub mutation at all temperatures (see Fig. 6.3) 
6.3 Investigating physical interactions between Prp24p and 
Lsm proteins in vitro 
Interactions between Prp24p and Lsm2p, Lsm5p, Lsm6p, Lsm7p and Lsm8p were 
initially shown to exist by yeast two-hybrid analysis (Fromont-Racine et al., 2000). 
These interactions were confirmed and extended to include Lsm4p by Rader and 
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Guthrie (2002). In addition Rader and Guthrie (2002) showed that deletion of the 
SNFFL box from the C-terminus of Prp24p abolished these interactions with the 
exception of the interaction with Lsm6p. Although Lsm3p showed an interaction 
with wild-type Prp24p that was not above that for the Lsmlp negative control as 
measured in a -galactosidase assay, its interaction did significantly decrease in the 
absence of the SNFFL box. Interactions of Prp24p with Lsm5p, Lsm7p and Lsm8p 
were measured as the strongest in the same assay, suggesting that these may be direct 
interactions with Prp24p. An attempt was made by Page (2002) to investigate 
interactions of individual in vitro translated Lsm proteins with recombinant Prp24p. 
Page showed co-immunoprecipitation of in vitro translated Lsm3p, Lsm4p, Lsm5p, 
Lsm6p and Lsm8p (not Lsmlp, Lsm2p and Lsm7p) with His-Prp24p. However, 
similar repeat experiments by Silvia Galardi (this lab; unpublished data) did not find 
any significant interactions between Prp24p and Lsm polypeptides that were above a 
background of non-specific binding to beads. To attempt to elucidate these 
interactions I used affinity purified recombinant His-Lsm proteins in co-
immunoprecipitation experiments with His-HA or His-Myc tagged Prp24p. 
The level of non-specific pull-down of Lsm proteins was again high and was 
eventually partially resolved by addition of 0.1% Triton-X100 to the 
immunoprecipitation and wash buffers. Almost all Prp24p added was pulled down. 
In contrast, no Lsm6p or Lsm8p was pulled down (Fig. 6.4A, lanes 19-21, 25-27) 
and only small amounts of Lsmlp, Lsm2p, Lsm4p, Lsm5p and Lsm7p (Fig. 6.4A, 
lanes 4-9, 13-18, 22-24). However, background was still high for both Lsmlp and 
Lsm7p (lanes 6, 24). The only protein that is significantly pulled down with no 
background is Lsm3p (lanes 10-12). Lsm3p forms very stable homomultimeric 
complexes (Collins et al., 2003; this work, Fig. 3.4C), which sometimes fail to 
resolve into monomers during SDS-PAGE. Insets in lane 10 indicate a probable 
Lsm3p 6- or 7-mer for the input sample. To test if Prp24p has a general affinity for 
multimeric Sm-like complexes, recombinant E. coli His-Myc-Hfq was used as a 
control (lanes 1-3). Hfq forms a similarly stable homohexameric complex (see inset), 
but does not interact with Prp24p under these conditions. 
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Fig. 6.4 Immunoprecipitation of recombinant Prp24p and Lsm proteins. 
(A) Recombinant His-HA-Prp24p was used in combination with affinity-
purified recombinant His-Myc-Hfq and His-Myc-Lsm 1 p;  His-Myc-Prp24p 
was used in combination with His-Lsm2p, -Lsm3p, -Lsm4p, -Lsm5p, 
-Lsm6p, -Lsm7p and His-HA-Lsm8p; (B) His-Myc-Prp24p or -Prp24A lOp 
was used with His-Lsm3p; (C) His-HA-Prp24p or -Prp24A lOp was used with 
Lsml-7p (Lsml His-Myc tagged, all others His tagged) and His-Myc-Prp24p 
or -Prp24AlOp was used with Lsm2-8p (Lsm8 His-HA tagged, all others His 
tagged). Approximately 0.5 ig of each recombinant protein was used in each 
reaction; HA-Prp24p was immunoprecipitated with a-HA agarose beads 
and Myc-Prp24p was immunoprecipitated with a-Myc agarose beads. Inputs 
(in), pull downs (pellets) and supernates were separated by SDS-PAGE and 
Western blots were probed with a-His-HRP antibody. * insets show bands 
on the same Western blots representing Hfq and Lsm3p multimers 
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Some of the Lsm proteins (e.g. Lsm4p, lanes 13-15) are lost from both pellets and 
supernates, suggesting that they stick to the beads during the initial incubation, but 
are subsequently lost during the washes. To test if the Prp24p-Lsm3p pull-down is 
SNFFL box specific, the pull-down was repeated with Prp24p and Prp24AlOp (Fig. 
6.4B). Lsm3p was specifically pulled down by both Prp24p and Prp24AlOp, 
suggesting that the interaction does not depend on the SNFFL box. To test if Prp24p 
has specificity for Lsm2-8p over Lsml-7p, in vitro assembled recombinant Lsm 
complexes were used in a pull-down with Prp24p (Fig. 6.4C, lanes 1-8). Both 
complexes showed significant background binding to the beads, but were pulled 
down more strongly in the presence of Prp24p. To test if this interaction is SNFFL 
box specific, the pull-down was repeated with Prp24zlOp (lanes 9-16). The pull-
down seemed slightly reduced for Lsm2-8p, but not for Lsm l-'7p. 
In summary, non-specific binding due to stickiness of Lsm proteins under 
immunoprecipitation conditions is a significant problem. Interactions found by yeast 
two-hybrid analysis were not confirmed by pull-down experiments. The strongest 
interaction found by co-immunoprecipitation between Prp24p and Lsm3p was the 
weakest by yeast two-hybrid and was independent of the SNFFL box. Although the 
results presented here are not conclusive, Prp24p may not differentiate between 
Lsml-7p and Lsm2-8p, which would mean that the specificity of the interaction in 
vivo may depend entirely on their different cellular localisations. 
6.4 Discussion 
In this chapter I have shown that all prp24 mutations, with the exception of 
RRMlsub and prp24A10, are synthetic lethal with deletions of LSM6 and LSM7. This 
strongly suggests that both Prp24p and Lsm2-8p work together to anneal the U4 and 
U6 snRNAs. Genetic interactions between mutations in the Prp24p RRMs, mutations 
in U4 and U6 snRNAs, and their (suggested) effects on U41U6 levels were 
previously used to propose distinct roles for the individual RRMs in either annealing 
or unwinding of the U41U6 duplex (Fig. 6.5). The data presented here suggest that, 
although the individual RRMs may have different effects on the U6 structure and 
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thus have different effects on U41U6 association, all four RRMs ultimately work 
together with Lsm2-8p to promote U411J6 di-snRNP assembly. 
The lack of a synthetic phenotype between prp24-RRM3sub and prp24-RRM4sub 
was the basis of the proposal that the functions of RRM3 and RRM4 may be 
antagonistic (Rader et al., 2002). However, I have now shown that this observation 
was due to the absence of the double mutation and therefore incorrect. In fact, the 
double mutation is lethal suggesting that RRM3 and RRM4 instead may have 
partially redundant functions in U411J6 annealing. This fits with the later proposal by 
Kwan and Brow (2005) that RRM3 and RRM4 may primarily promote U4/U6 
association, possibly by binding to U4 RNA and/or U4 snRNP proteins. The Kwan & 
Brow model was based on in vitro RNA binding assays with truncated Prp24p 
mutants that showed that high affinity U6 RNA binding is due to RRM1 and not 
RRM4, and on the existence of synthetic lethal interaction of mutations in RRM 1 
and 2, but not RRM3 with U6 telestem mutations that promote U4/U6 association 
(Kwan et al., 2005). 
Rader and Guthrie (2002) proposed a partially redundant function for RRM1 and the 
SNFFL box in U4/U6 association based on the strong synthetic heat-sensitive 
phenotype between prp24-RRM1sub and prp24A10. The role of RRM1 in U4/U6 
association was however disputed by Kwan and Brow (2005), who instead proposed 
a role for RRM1 in U4/U6 dissociation, based on synthetic lethal interactions 
between the prp24-F87A mutation (in RRM1) and mutations that disrupt the U6 
telestem (and are thus proposed to promote U47U6 annealing). Our finding of 
absence of a synthetic phenotype between prp24-RRIVI1sub and prp24A10 in lsm6A 
and ism 7A backgrounds complicates matters even further, particularly since the 
double mutation even leads to better growth than the single prp24-RRM1sub 
mutation in the ism 74 background. The synthetic effect of prp24-RRM1 sub alone 
with the ism deletions found here (Fig. 6.3) supports a role for RRM1 in U4/U6 
association. This suggests that both Prp24p-RRM1 and Lsm2-8p are needed to 
promote U4/U6 annealing. 
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A number of synthetic or suppressor effects were observed that are hard to explain, 
based on our current knowledge. None of these however, are in contradiction with 
the model proposed below. These effects include: partial suppression of slow growth 
of prp24-RRM1sub 1sm74 by an additional prp24410 mutation; absence of cold-
sensitive growth for prp24AlO with lsm6 or lsm7A compared to prp24AlO LSM+; 
and absence of a synthetic effect of prp2 4410 with 1sm7A compared to a clear effect 
with lsm6A. Most of these involve deletion of the SNFFL-box, suggesting that this 
motif may have a function in U411J6 association that is as yet unknown. 
In addition to the interactions described above, there are many genetic interactions 
between mutations in SNR14, SNR6 and PRP24. So far, these interactions have been 
used by various groups to try to assign specific functions in U41U6 association and 
dissociation to the different motifs present in Prp24p (Fig. 6.5B). However, none of 
the models proposed so far manages to reconcile all known interactions and 
consequences of single mutations for U4/U6 formation. For example, the prp24-
R158S and prp24-F2571 mutation in RRM1 and RRM2 alleviate cold-sensitive 
growth of a U6-A62G mutation, a mutation which reduces U41U6 levels. At the same 
time these prp24 mutations themselves also lead to temperature-sensitive growth and 
a decrease in the level of U4/1J6 (Vidaver et al., 1999). The former is used as an 
argument to suggest that Prp24p-U6 interactions involving RRM2 and RRM3 
stabilise an intramolecular structure in U6 RNA (the telestem) that antagonises 
U4/U6 basepairing. Reduced Prp24p-U6 binding in the U6-A62G mutant would 
therefore lead to a less stable telestem and increased U4/U6 association. No 
satisfactory explanation is given however, for reduced U41U6 annealing in these 
prp24 mutant strains with wild-type U6 RNA. Later, synthetic interactions between 
telestem destabilising mutations and mutations in RRM1 and RRM2, but absence of 
these interactions with mutations in RRM3 were used by Kwan and Brow (2005) to 
argue a role for RRM1 and 2 in telestem stabilisation and U4/U6 dissociation. 
However, Kwan and Brow (2005) did not explain the suppression by prp24-F2571 
(in RRM3) of the cold-sensitive growth caused by the 3' stem-loop stabilising U6-
A62G mutation (Vidaver et al., 1999), thus favouring a model in which RRM3 and 4 
instead promote U4/U6 association. 
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Fig. 6.5 A model for Prp24p and Lsm2-8p in U4/U6 annealing. (A) Schematic 
representation of effects Prp24p's RRM domains and Lsm2-8p have on the structure 
of U6 snRNA; (B) Proposed models about the role of the various Prp24p domains 
(and Lsm2-8p) in U4/U6 association and dissociation. 
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It may be possible to reconcile all known interactions in a model in which Prp24p 
has a role together with Lsm2-8p in U4/U6 di-snRNP formation (Fig. 6.5). Kwan and 
Brow (2005) built a strong case for a central role for RRM1 and 2 in binding of U6 
RNA and a resulting stabilisation of the telestem. A more stable telestem opposes 
complete U41U6 annealing. In addition SELEX (Ghetti et al., 1995) and chemical 
probing experiments (Jandrositz et al., 1995) show that Prp24p prefers to bind to a 
U4/U6 duplex in which stem II is not fully basepaired. Protection of the U6 RNA 3' 
stem-loop structure in a Prp24p-U6 RNA complex during chemical footpnnting 
experiments suggests that Prp24p binds and possibly stabilises this structure. In 
contrast, this stem-loop region is less protected in the native U6 snRNP, i.e. in the 
presence of Lsm2-8p. In addition, the telestem is less protected in the native U6 
snRNP. The overall U6 structure is more open in both the recombinant Prp24p-U6 
complex and the native U6 snRNP in the regions covered by nt 29-33, 40-63 and 85-
91 which are involved in extensive basepairing in the naked U6 RNA (Karaduman et 
al., 2006). These results show that binding of Prp24p opens up the U6 RNA structure 
significantly, but that complete U4/U6 annealing may be inhibited by bound Prp24p, 
which was previously proposed by Ghetti et al. (1995) and Jandrositz and Guthrie 
(1995). Karaduman et al. (2006) has now shown that additional binding by Lsm2-8p 
opens up the U6 structure even further. Both direct effects of Lsm2-8p-U6 
interactions and indirect effects of these interactions on Prp24p-U6 binding are likely 
to contribute. The Lsm2-8 complex could thus promote U4/1J6 association both by 
opening up the U6 RNA structure and by destabilising Prp24p-U4/U6 binding. Kwan 
and Brow (2005) suggested that RRM3 and 4 may interact with U6 sequences 
downstream of the telestem in their in vitro binding experiments and may bind U4 
RNA in vivo. The fact that mutations in RRM3 suppress the U6-A62G 3' stem-loop 
structure stabilising mutation may mean that RRM3 also binds and stabilises this 
stem-loop structure in vivo, but only if it is hyperstabilised by mutations in U6 RNA. 
Alternatively, reduced binding of Prp24p to U4/U6 due to the RRM3 mutation may 
aid annealing by increased Prp24p dissociation from the half-formed duplex. This 
could explain suppression of the U6-A62G cold-sensitive growth by mutations in 
RRM3 and the absence of synthetic interactions between RRM3 and telestem 
destabilising mutations. 
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In conclusion, to reconcile all existing data and explain the synthetic lethal 
interactions between ism deletions and prp24 mutations presented here, I would like 
to propose the following model (Fig. 6.513). Proper and complete U4/1.J6 formation in 
vivo can only occur in the presence of both Prp24p and Lsm2-8p, and Prp24p leaves 
only when the di-snRNP is fully formed. This may be a quality control switch to 
ensure incorporation of only full length U6 RNA (to which Lsm2-8p binds) into a 
properly formed U4/U6 duplex. In this model all four Prp24p RRMs and the C-
terminal SNFFL box cooperate with Lsm2-8p to promote formation of the U4ILJ6 di-
snRNP, with Prp24p acting as a scaffold for proper U4/U6 alignment with the help of 
Lsm2-8p, while both destabilise inhibitory intramolecular structures in U6 RNA. A 
role for Prp24p in U4/U6 dissociation prior to spliceosome activation can not be 
ruled out. If it does function at this step RRM1 and 2 are likely to play a central role 
by stabilising the telestem (Fig. 6.5). 
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CHAPTER 7 
A functional analysis of Lsm4p 
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7.1 Introduction 
LSM4 of S. cerevisiae, also called SDB23 or USSJ, is an essential gene with a 564 bp 
ORF encoding a 187 amino acids long polypeptide (21.3 kDa). The N-terminal 92 
amino acids include the Sm-domain, which is involved in protein-protein and 
protein-RNA interactions within the Lsm complexes. The C-terminal 95 amino acids 
of the protein are unstructured as predicted by 3D-PSSM (data not shown; Kelley et 
al., 2000) and rich in asparagine (36%) and serine (17%), giving it a highly basic 
character (Fig. 7.1). The sequence of this C-terminal extension is poorly conserved 
and its function is as yet unknown. Many Lsm4p homologues from higher organisms 
have an abundance of arginine and glycine residues, often in the form of RG repeats, 
shown to be important for interactions with the SMN complex and believed to 
regulate snRNP assembly through symmetrical dimethylation of the arginine residues 
(Brahms et al., 2001; Paushkin et al., 2002). S. cerevisiae does not have a known 
SMN complex equivalent, providing a possible explanation for the absence of RG 
repeats in yeast Lsm4p. SDB23 (suppressor of dumbbell phenotype 2, no. 3) was 
initially isolated in a high copy-number suppressor screen of a mutation in DBF2, 
which encodes a cell cycle protein kinase (Parkes et al., 1992). The mechanistic basis 
of this suppressor activity is unknown. 5DB23 sequence homology to the Sm (snRNP 
core) proteins and subsequent demonstration of its requirement for U6 snRNA 
stability and pre-mRNA splicing established Ussip (U-Six snRNP) as the first of 
seven U6 snRNP core proteins (Cooper et al., 1995; Mayes et al., 1999; Salgado-
Garrido et al., 1999). LSM4 was later also found in other screens: one looking for 
essential genes involved in cell morphology (Chun and Goebl, 1996), one looking for 
genes that promote de novo prion formation when present at high copy-number 
(Derkatch et al., 2001), and one looking for synthetic lethality with actl-120Ts 
(Davierwala et al., 2005). This poses a number of interesting questions: Does Lsm4p 
have functions in addition to those known for Lsml-7p and Lsm2-8p in RNA 
processing? If so, does it perform these functions within the context of these Lsm 
complexes? What is the function of the unusual carboxy-terminal domain of yeast 
Lsm4p? In this chapter, I try to answer some of these questions by investigating 
phenotypes caused by overproduction or depletion of Lsm4p, and expression of 
Lsm4 C-terminal deletion mutants. 
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7.2 Investigating LSM4 overexpression phenotypes 
7.2.1 Overproduced Lsm4p and its C-terminus accumulate in foci 
Spiller (2005; unpublished data) showed that both GFP-tagged full length Lsm4p 
(GFP-Lsm4; pMPSLsm4) and it C-terminus (GFP-Lsm4C; pMPSLsm4D2; Fig. 7.1) 
accumulate in foci when overexpressed from the MET25 promoter. In contrast, the 
GFP-tagged N-terminal domain of Lsm4p (GFP-Lsm4C2; pMPSLsm4DI; Fig. 7.1) 
failed to accumulate in foci. A repeat of these experiments confirmed these initial 
findings (Fig. 7.2). Extremely bright foci are present in a variable percentage of cells 
(10-60%) expressing GFP-Lsm4 and GFP-Lsm4C, whereas GFP-Lsm4AC2 localises 
throughout the cells, with occasional weak nuclear accumulation. This is the case 
both in the presence (BY4741; Fig. 7.2) and absence (MCY4-PGAL-LSM4 grown on 
glucose; Fig. 7.613) of native Lsm4p. The size and number of foci increases after 
hypo-osmotic shock for both Lsm4p and Lsm4C, suggesting that at least some of 
them may be P-bodies. After osmotic shock GFP-Lsm4AC2 still localises throughout 
the cell, although very rarely (< 1% of cells) weak foci can be seen (data not shown). 
Sm-domain 	N-rich C-terminus 
	
Lsm4 1 	 1187 
Lsm4C1 1 	 1136 
Lsm4\c2 1 	 92 
Lsm4C 	 921 	 1187 
Fig. 7.1 Schematic overview of Lsm4p structure. The N-terminal domain 
of Lsm4p (aa 1-92) contains the Sm-domain (Sm I and Sm2 motifs). The 
C-terminal extension (aa 92-187) is rich in Asn and Ser, and is predicted 
to be unstructured. Various Lsm4p fragments were used in this study. These 
includes a partial C-terminal deletion in pMCI I (covers aa 1-136, Uss1ip; 
Cooper, 1995) which will be referred to as Lsm4AC I; a full C-terminal de-
letion mutant in pMCl2 (covers aa 1-92, Uss1p*;  Cooper, 1995) and 
pMPS4D I (covers aa 1-93, Lsm4Dl; Spiller, 2005) which will be referred 
to as Lsm4AC2; and the C-terminus alone in pMPS4D2 (aa 92-187, 
Lsm4D2; Spiller, 2005) which will be referred to as Lsm4C. 
239 
It is unclear whether the Lsm4p foci are P-bodies, as suggested by Spiller (2005), as 
they are present throughout the log phase under normal growth conditions and they 
are often many times brighter (and bigger) than the P-bodies that are usually 
observed. I'd therefore like to name these foci UFO bodies, for Unidentified Lsm 
FOur bodies. In summary, these results indicate that the Lsm4 carboxy-terminal 
domain is essential as well as sufficient for aggregation in UFO bodies and possibly 








Fig. 7.2 Cellular localisation of overproduced full length Lsm4p and its N-
and C-terminal domains tagged with fluorescent proteins. (A) GFP-Lsm4 
(pMPSLsm4) and GFP-Lsm4C (pMPS1sm4D2), but not GFP-Lsrn4AC2 
(pMPSLsm4D1) accumulate in foci when overexpressed from the MET25 
promoter. GFP-Lsm4Dl shows weak nuclear accumulation in some cells. 
Plasmids were transformed into BY4741 and cells were grown in SD-Ura 
-Met. Localisation was examined in live cells during log phase growth. 
7.2.2 Toxic effects of LSM4 overexpression 
Lsm4p overproduction was shown to have a negative effect on cell growth and 
viability (Cooper et al., 1995; Cooper, 1995). This effect is enhanced when 
combined with other mutations affecting U6 snRNP-related proteins. Cooper (1995; 
unpublished data) showed that overexpression of LSM4 from the GAL] promoter 
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enhanced the temperature-sensitive phenotypes of prp3-1, prp4-1 and prp24-7 (U6 
snRN P-related) splicing mutants, but not of a prp2-1 splicing mutant (not U6 snRNP 
related). To extend this study, I examined the effects of LSM4 overexpression on ism 
mutant and deletion strains. LSM4 overexpression (from PMRI57-PGAL-LSM4) had a 
negative effect on growth of all the strains that were tested. It aggravated slow 
growth of lsm5A (MRY27), lsm6A (MRY17) and 1sm7A (MRYI8) at permissive 
temperature and lead to slow growth of BMA38a wild-type cells at 36°C (Fig. 7.3). 
In addition, LSM4 overexpression aggravated slow growth of lsm8-1 (BP4), but only 
affected growth of 1sm14 (AEMY25) at 14°C (data not shown). Overproduction of 
the C-terminal extension (Lsm4C from pMR158-PGAL-1sm4C) had no noticeable 
effect on growth of any of these strains at any of the temperatures tested (Fig. 7.3; 
data not shown). 
Thus it appears that LSM4 overexpression is toxic to cells, in particular to those with 
defects in U6 snRNP-related proteins. In contrast, overproduction of the C-terminus 
of Lsm4p alone does not have a noticeable effect on growth. The latter indicates that 
aggregation of Lsm4p and Lsm4C in UFO bodies per se does not have a significant 
toxic effect on yeast, as has previously been seen for certain GFP aggregates in C. 
elegans (Link et al., 2006). 
7.2.3 Other Lsm proteins accumulate in UFO bodies upon Lsm4p 
overproduction 
When LSM4 is overexpressed from the GAL 1/10 promoter, in strain MCY4, GFP-
Lsml (pGFP-N-Lsml), -Lsm2 (pMPSLsm2), -Lsm6 (pGFP-N-Lsm6), -Lsm7 
(pGFP-N-Lsm7) and even Lsm8-GFP (pGFP-C-Lsm8) localise to similar foci that 
are present during log phase growth (Fig. 7.4; data not shown). In contrast these 
GFP-tagged proteins show normal localisation (i.e. throughout the cell under normal 
growth conditions for Lsm2, -6 and -7p, to P-bodies under stress conditions for 
Lsmlp and to the nucleus for Lsm8p) when LSM4 is expressed from its native 
promoter (Fig. 7.4A; data not shown). Strikingly, no nuclear concentration of GFP-
Lsm8 is observed at all when MCY4 (PGA L-LSM4) cells are grown in galactose-based 
medium, even when LSM8 is deleted from the MCY4 genome (strain MRY65; Fig. 
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Fig. 7.3 Effects of Lsm4p or Lsm4C overproduction from the GAL] promoter 
on growth of lsm5A (MRY27), 1sm6 (MRYI7), Ism7A (MRY18) and wild-type 
(BMA-')8a) strains. Overexpression of LSM4 (pMR 157) aggravates slow growth 
of Ism5, 6 and 7 deletion strains at 30°C, and causes slow growth in a BMA38a 
wild-type strain at 36°C. Overexpression of /srn4C(pMR158) does not affect 
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Fig. 7.4 Lsm8p aggregates when LSM4 is overexpressed. (A) pMR83 
(Lsm8-GFP), pMPS2 (GFP-Lhpl) or pGFP-N-FUS were transformed 
into MCY4 cells (PG4L-LSM4) and grown in SDGaI-Ura or in SD-tJra 
in the presence ofpUSSI (LSM4 under its native promoter). Localisation 
of GFP-tagged proteins was investigated in live cells during log phase 
growth. (B) MRY65 (PGtL-LSM4, ls,n8L, pGFP-C-LSM8) was grown 
in SDGaI-Ura. Log phase cells were fixed and DAPI stained; and Lsm8-
GFP aggregates were shown to be cytoplasmic and in some cases to be 
closely associated with DAPI-stained nuclear DNA. 
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7.413), so that cell viability depends on plasmid-based expression of Lsm8-GFP. As 
there is only a mild effect on cell viability (Fig. 7.3; data not shown), it suggests that 
only very low levels of Lsm8p are needed in the nucleus to support viability. This 
was previously shown for the lsm8-1 mutant, which displays only a mild cold-
sensitive phenotype, whereas the Lsm8 mutant protein level is strongly reduced 
(Pannone et al., 2001). Accumulation into foci as a result of Lsm4p overproduction 
is specific to the Lsm proteins, as GFP alone localises throughout the cells as normal 
when expressed in MCY4 (PGAL-LSM4) cells grown on galactose. Also, the 
exclusively nuclear Lhpl protein tagged with GFP remains nuclear under these 
conditions and does not localise to foci (Fig. 7.4A). Co-localisation of Lsm8-GFP 
foci with DAPI-stained nuclear DNA showed that UFO bodies are mostly 
cytoplasmic, although regular close association with the DNA suggests possible 
nucleolar localisation (Fig. 7.413). Co-localisation of overexpressed GFP-Lsm4 with 
tagged Noplp and Popip (nucleolar proteins) confirmed localisation of some foci to 
the nucleolus (data not shown). 
7.2.4 Lsm8p co-localises with Lsm4p, but not Lsm4C aggregates 
It is likely that the negative effect of Lsm4p on growth is caused by aggregation of 
Lsm proteins in UFO bodies, leading to a decrease in soluble Lsm protein levels and 
decreased availability for essential processes. In contrast to the effect of 
overproduction of full length Lsm4p, overproduction of the C-terminus of Lsm4p 
alone does not have a noticeable effect on growth (Fig. 7.3). Indeed, Lsm8-RFP does 
not accumulate in foci when the Lsm4C is overproduced and still shows (weak) 
nuclear accumulation (Fig. 7.5A). Nor does Lsm8-RFP co-localise with GFP-Lsm4C 
aggregates that form upon overexpression from the MET25 promoter, although 
Lsm8-RFP does fail to accumulate in the nucleus under these conditions (Fig. 7.513). 
The significance of the latter is unclear, particularly as these experiments were 
performed in the presence of native Lsm8p, making it likely that Lsm8p is present in 
excess over the other Lsm proteins. In contrast, Lsm8-RFP co-localises with GFP-
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Fig. 7.5 Lsm8p localises in aggregates together with GFP-Lsm4, but not with 
GFP-Lsm4C. (A) pMR83 (Lsm8-GFP) and pMR 163 (Lsm8-RFP) were 
transformed into MCY4 (P(;4L-LSM4) and BY4741 pMR 158 (PG. IL-Ism4c) 
respectively. Cells were grown in SD-Ura-Met (MCY4 with pUSS!), SDGaI 
-Ura-Met (MCY4), SD-Leu-Ura-Met or SDGaI-Leu-Ura-Met (BY4741 pMR 
158); (B) BY4741 was transformed with pMPSLsm4 (LSM4), -4D1 (lsm4AC2) 
and -4D2 (Ism4C) as well as pMR 163 (Lsm8-RFP). Cells were grown in SD-
Leu-Ura-Met. Localisation of fluorescently tagged proteins was examined in 
live cells during log phase growth. Note that all strains also express native 
LSM8. 
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7.2.5 Reduced U6 snRNA levels may be the cause of Lsm4 
toxicity 
Cooper et al., (1995) showed that MCY4 (Pcj-LSM4) cells accumulate RP28 pre-
mRNA when grown on galactose. When shifted to glucose splicing improved at early 
time points (5-10 h after shift) before deteriorating as a result of Lsm4p depletion (20 
h after shift). This corresponded with an increase and subsequent decrease of U6 
snRNA levels at the same time points compared to time point zero, i.e. just before 
shifting the cells from galactose to glucose (Cooper et al., 1995). It is likely that the 
weak splicing defect displayed by MCY4 (PGAL-LSM4) cells grown on galactose is 
caused by reduced levels of U6 snRNA due to Lsm protein aggregation with 
overproduced Lsm4p in UFO bodies. 
In conclusion, it seems likely that overexpression of LSM4 leads to aggregation of 
Lsm4p and other Lsm proteins into foci (UFO bodies). The resulting decrease in 
nuclear Lsm2-8p levels leads to reduced levels of U6 snRNA, which in turn affects 
splicing efficiency. This also explains why toxic effects of LSM4 overexpression are 
more noticeable in strains that have other mutations affecting U6 snRNP proteins, as 
accumulative effects on U6 snRNA stability will enhance the mutant phenotypes. As 
the nuclear Lsm proteins play a role in many other RNA processing events, effects of 
their aggregation on these processes may contribute to Lsm4p toxicity as well. UFO 
bodies may not have biological significance and may simply be a result of pnon-like 
aggregation of Lsm4p and associated proteins. Intriguingly, Derkatch et al. (2001) 
isolated LSM4 in a high-copy screen for factors that are able to induce yeast prion 
[PSI] formation. All nine novel candidate prion genes isolated in this screen carry 
prion-like domains, i.e. Q-, N- or Q/N-rich domains and are themselves prone to 
aggregation (Derkatch et al., 2004). This explains the requirement of the Lsm4p C-
terminal asparagine-rich extension for aggregation of Lsm4p and aggregation of the 
C-terminal domain itself. 
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7.3 Investigating a role for Lsm4p in Lsm1-7p recruitment to 
P-bodies 
The fact that GFP-Lsm4 as well as GFP-Lsm4C accumulate in foci when 
overexpressed, whereas GFP-Lsm4iC2 fails to aggregate even under stress 
conditions is suggestive of a role for the Lsm4p C-terminus in targeting Lsm l-7p to 
P-bodies. 
7.3.1 UFO bodies are not P-bodies 
As Lsm4p and Lsm4Cp aggregate in foci independent of growth conditions it is 
unlikely, but not impossible that UFO bodies are in fact P-bodies. To address this 
question Dcp2-RFP, a decapping enzyme subunit and P-body component, was 
expressed in the same cells that overproduced GFP-tagged Lsm4p or Lsm4C2. 
Most foci that are present during log phase growth did not contain Dcp2-RFP, or 
only very small amounts (Fig. 7.6A). After hypo-osmotic shock however, the number 
and size of foci increased and Dcp2-RFP was seen to co-localise with most, but not 
all of these. This shows that Lsm4p localises to P-bodies under stress conditions, and 
that some UFO-bodies may even recruit decapping enzymes under these conditions. 
However, as not all foci contain Dcp2-RFP, in particular those present during log 
phase growth, there seems to be a non-P-body population of Lsm protein aggregates. 
Dcp2-RFP localised to foci after osmotic shock in the lsm4AC2 mutant (Fig. 7.6B), 
showing that P-body localisation of Dcp2p does not depend on the Lsm4 C-terminus. 
This is in agreement with the observation by Sheth and Parker (2003) that 
localisation of Dhhlp to P-bodies was not noticeably affected in an ismiA strain. 
7.3.2 The Lsm4p carboxy-terminal domain is not essential for 
localisation to P-bodies 
The above results show that deletion of the Lsm4p C-terminus prevents Lsm4AC2 
from localising to P-bodies. As it is generally assumed that a complete Lsml-7p 
complex is needed for it to localise to P-bodies (Ingelfinger et al., 2002; Tharun et 
al., 2005) the C-terminal deletion is likely to affect localisation of the entire Lsm 1-7p 
complex. To study the effects of a C-terminal deletion of Lsm4p on 
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Fig. 7.6 Lsm4p forms UFO bodies during log phase growth when over 
produced. but also localise to P-bodies after osmotic shock. (A) Over-
expressed GFP-Lsm4 forms strong aggregates during log phase growth 
that do not contain Dcp2-RFP, after osmotic shock the number of foci 
increases and many of these contain Dcp2-RFP; (B) GFP-Lsm4C2 
localises throughout the cell even after osmotic shock, whereas Dcp2-RFP 
localises to foci. BY4741 was transformed with pMPSLsm4 (GFP-Lsm4) 
and pRPI 155 (Dcp2-RFP), MCY4 (P(;,, / -LSM4) was transformed with 
pMPSLsrn4DI (GFP-Lsm4AC2) and pMR 159 (Dcp2-RFP). Cells were 
grown in SD-Ura-Leu-Met and live cells were examined during log phase 
growth or 10-30 min after hypo-osmotic shock. 
localisation of Lsmlp to P-bodies, MCY4 (Paij-LSM4 strain) was transformed with 
pUSSI (LSM4), pMC1I (lsm4ACl) or pMCI2 (Ism4AC2) allowing growth on 
glucose with Lsm4 wild-type or mutant proteins expressed from the native LSM4 
promoter (Fig. 7.7A). These strains were in turn transformed with pGFP-N-Lsml. 
Cells were grown in SD-Ura-Met and localisation of GFP-Lsml was examined 
during log phase growth and after hypo-osmotic shock. GFP-Lsml localised 
throughout the cytoplasm under normal growth conditions and concentrated in P -
bodies when cells were subjected to hypo-osmotic stress (10 - 60 min incubation in 
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Fig. 7.7 The Lsm4 C-terminus is not essential for localisation of Lsmlp 
to P-bodies, but its absence leads to reduced localisation to P-bodies. 
(A) Schematic representation of Lsm4 deletion mutants; (B) GFP-Lsm I 
localises to P-bodies after osmotic shock, but this localisation is reduced 
in the deletion mutants; (C) Quantification of the number of cells that 
show foci after osmotic shock. MCY4 (PG ,-LSM4) was transformed 
with pUSS I (LSM4), pMC 11 (lsrn4ACI) or pMC 12 (1sm4iC2) and pGFP-
N-Lsml. Cells were grown in SD-Ura-Met and live cells were examined 
after hypo-osmotic shock. The percentage of cells in which foci were 
observed was calculated based on counts in three biological replicas 
(n = 200 per count). 
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water; Fig. 7.7B). Accumulation of Lsmlp in P-bodies in lsm4AC2 shows that the 
Lsm4p carboxy-terminal domain is not essential as a P-body targeting signal for the 
Lsml-7 complex. There did, however, seem to be a significant reduction in the 
intensity of the foci in the lsm4ziC2 strain compared to the LSM4 strain. In addition 
the number of cells showing P-bodies seemed reduced. To quantify this, the number 
of cells showing P-bodies after hypo-osmotic shock was counted for all three strains. 
This was done in triplicate, counting 200 cells per strain per experiment. The 
majority of LSM4 cells displayed foci (89 ± 1%), as did the lsm4ACI cells (81 ± 7%). 
In contrast, the number of lsm4.4C2 cells showing foci was significantly reduced (61 
± 18%; Fig. 7.7C). 
7.3.3 Efficiency of Lsm protein recruitment to P-bodies is reduced 
in the absence of the Lsm4p C-terminus 
The effect of the Lsm4p C-terminal deletion was more severe on P-body localisation 
of GFP-Lsm4AC2 (Fig. 7.2) than on GFP-Lsml (Fig. 7.7B). To rule out possible 
leaky LSM4 expression from the genomic GALl/JO promoter an lsm4 deletion strain 
with a CEN-URA3-PGAL-LSM4 plasmid (pMR157) was created (pMR68). This strain 
was transformed with pUSS1 (LSM4), pMC11 (lsm4ACl) or pMC12 (1sm4AC2; all 
three with the LSM4 promoter). Counter-selection against pMR157 on 5-FOA 
medium left these centromenc plasmids as the only source of Lsm4 expression. The 
resulting strains (MRY71, 72 and 73) were transformed with pGFP-N-Lsml and 
GFP-Lsml localisation was investigated asunder 7.3.2. 
The effects on GFP-Lsml localisation were identical to those seen in MCY4 (PGAL -
LSM4; compare Fig. 7.7B and 7.8A). Upon closer investigation, there seemed to be a 
delay in the lsm4AC mutants in terms of GFP-Lsml localising to foci after hypo-
osmotic shock. To quantify this effect, the number of cells that displayed P-bodies 5 
min and I h after hypo-osmotic shock was counted in the LSM4 and lsm4AC2 strains. 
There was indeed a significant effect of the Lsm4p C-terminal deletion on the time 
after which GFP-Lsml could be seen to localise to P-bodies. Most LSM4 cells 
displayed foci after 5 mm (85%), with only a minor increase (to 90%) after I h. In 
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Fig. 7.8 GFP-Lsm 1 is delayed in its localisation to P-bodies after 
osmotic shock in the absence of the Lsm4 C-terminal domain. 
(A) GFP-Lsml localises throughout the cell during log phase growth 
and localises to P-bodies I h after osmotic shock, although at reduced 
levels for lsm4C2; (B) The percentage of cells showing foci almost 
reaches its maximum 5 min after osmotic shock for LSM4, whereas 
less than 5% of lsm4AC2 cells show foci. (C) Not all lsm4AC2 cells 
show weaker foci than LSM4, but images in (A) are representative of 
the whole population. MRY7I (LSM4), MRY72 (lsm44CI) and MRY73 
(lsm4AC2) were transformed with pGFP-N-Lsml; cells were grown in 
SD-Ura-Met and localisation was examined during log phase growth or 
5 min or 60 min after osmotic shock. Counts were performed once 
(n = 100). 
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contrast, only 4% of lsm4AC2 cells displayed foci after 5 mm, with an increase to 
73% after I h. 
To investigate whether the Lsm4p C-terminal deletion has the same effect on other 
Lsml-7 complex members, similar experiments were carried out with GFP-Lsm2 
and GFP-Lsm6. During log phase growth both localised throughout the cell, with 
some nuclear accumulation apparent for GFP-Lsm6 in both MRY7 I (LSM4) and 
MRY73 (lsm4AC2; Fig. 7.9A). Under stress conditions (hypo-osmotic shock) both 
GFP-Lsm2 and GFP-Lsm6 accumulated in cytoplasmic foci, with a reduction in 
intensity for both in MRY73 (Fig. 7.9A). The GFP-Lsm2 foci were less pronounced 
than those for GFP-Lsm6, which together with the absence of nuclear accumulation 
for GFP-Lsm2 may indicate reduced complex formation for this tagged Lsm2p. In 
addition, there was a similar delay in the observed appearance of foci after hypo-
osmotic shock (Fig. 7.913). Taken together these data strongly suggest that the 
carboxy-terminal domain of Lsm4p is not essential for Lsm l-7p localisation to P-
bodies. However, reduced and delayed localisation of Lsm 1-7 complex members to 
P-bodies in an lsm4AC2 strain suggest its importance for efficient accumulation of 
Lsml-7p in P-bodies 
7.3.4 The GFP-tag aggravates the Ism4LtC2 defect 
The almost complete absence of GFP-Lsm4AC2 from P-bodies after osmotic shock 
seems to contradict the only slightly reduced P-body accumulation of GFP-Lsm 1, - 
Lsm2 and Lsm6 in the lsm4AC2 strain. Upon closer inspection, GFP-Lsm4AC2 was 
shown to localise weakly to foci after hypo-osmotic shock in a small fraction of cells 
(< 1%), where it co-localised with Dcp2-RFP (data not shown). In addition, cells 
grown into late stationary phase (0D600 4) displayed accumulation of GFP -
Lsm4AC2 in cytoplasmic foci together with Lsm 1 -RFP in more than 90% of cells 
(data not shown). GFP-Lsm4AC2 must therefore be able to incorporate into the 
Lsml-7 complex and thus localises to P-bodies. Reduced accumulation in P-bodies is 
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Fig. 7.9 GFP-Lsm2 and GFP-Lsm6 localise to P-bodies under stress conditions 
but less efficiently in an 1srn4tC2 strain. (A) GFP-Lsm2 and GFP-Lsm6 localise 
throughout the cell with some nuclear accumulation for Lsm6p. Approximately 
I h after osmotic shock the majority of cells show strong foci in MRY71 (LSM4), 
but only weak foci in MRY73 (lsm4tC); (B) MRY7 1 starts showing P-body 
localisation of GFP-Lsm2 and -Lsm6 in the majority of cells after 5 - 20 mm, 
whereas MRY73 only shows weak foci after 60 min or more. MRY71 and MRY73 
strains were transformed with pGFP-N-Lsm2 and -Lsm6 plasmids. Cells were grown 
in SD-Ura-Met and live cells were examined during log phase growth or at different 
times after osmotic shock. 
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Growth was compared of GFP-1sm44C2 and lsm4AC2 strains. Whereas the lsm4AC2 
strain was only weakly temperature sensitive, the GFP-lsm4AC2 strain grew more 
slowly at all temperatures and was strongly temperature sensitive (Fig. 7.10). It 
therefore seems that the N-terminal GFP tag aggravates a growth defect caused by a 
C-terminal deletion in Lsm4p. It is likely that this is an indication of reduced 
complex formation, suggesting that the carboxy-terminal domain may also play a 
role in stabilising complex formation. In conclusion, the N-terminal GFP-tag in 
addition to the C-terminal deletion may prevent the mutant Lsm4 protein from 
localising efficiently to P-bodies, possibly by interfering with complex formation. 
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Fig. 7.10 Growth phenotypes of Ism4 C-terminal deletion mutants. 
(A) lsm4A strains with plasmid-based LSM4 expression from its native 
promoter, MRY7 I (pUSS I -LSM4), MRY72 (pMC II -1sm4LCI) and 
MRY73 (pMCI2-/sm4AC2) were plated in ten-fold serial dilution on 
YPDA and grown at 30°C, 36°C and 37'C. MRY73 shows slower 
growth at 37°C only; (B) PGIL-LSM4 strain MCY4 with GFP-tagged 
Lsm4p (pMPSLsm4) or Lsm4AC2 (pMPSLsm4DI) was plated on SD 
-Ura-Met and grown at 23°C, 30°C and 37°C. Cells expressing the GFP-
tagged N-terminal domain of Lsm4p display a slow growth phenotype 
at all temperatures and are heat sensitive. 
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7.3.5 The Lsm4p C-terminus may contribute to efficient P-body 
formation 
As the Lsm4 carboxy-terminal domain seems to be important for efficient 
recruitment of Lsm 1-7p to P-bodies, it is possible that Lsm4p is also important for 
aggregation of other P-body components and ultimately efficient P-body formation. 
No significant effect was seen however on Dcplp or Dcp2p localisation to P-bodies 
in an lsm4AC2 strain (data not shown). A minor effect on the speed with which these 
decapping factors accumulate in foci after osmotic shock may exist however. This is 
subject to further investigations. 
7.4 A potential link between Lsm4p and cytokinesis? 
7.4.1 Depletion of Lsm4p leads to abnormal cell morphology 
MCY4 (PGAL-LSM4) cells show increasing numbers of abnormally shaped cells when 
Lsm4p is depleted by growing the cells on glucose (Fig.7.1 1D). Cells are often much 
enlarged and show (emerging) buds that do not separate, but elongate instead. MCY4 
(PGAL-LSM4) cells grown on galactose also show occasional cell shape abnormalities 
(Fig. 7.II13). In addition, nuclear morphology is often abnormal in cells 
overproducing Lsm4p (data not shown). Effects of LSM4 overexpression on cell and 
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Fig. 7.11 MCY4 (PGAL-LSM4) cells depleted of Lsm4p display 
abnormal cell shapes. MCY4 cells growing in YPGaIA largely 
show normal cell morphologies (A) although a small percentage 
does show abnormal cell shapes (B). After 20h of growth in YPDA 
more than half of the cells show abnormal cell shapes (D), whereas 
the majority of those grown in YPGaIA still look normal (C). 
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its cellular concentration. A mechanism behind the effect of Lsm4p depletion on cell 
morphology is unclear, may be indirect and is no doubt complicated. 
7.4.2 Increased Lsm4p production rescues a W2-Ts phenotype 
LSM4 was originally isolated as SDB23 in a high copy-number suppression screen of 
dbf2-Ts (Parkes et al., 1992; Cooper et al., 1995). Dbf2p is a kinase involved in exit 
from mitosis and subsequent cytokinesis (Hwa et al., 2003; Corbett et al., 2006). To 
show that the dbf2 suppression activity lies within the LSM4 ORF a 3.2 kb genomic 
BamHI fragment was re-cloned into YEp24 and this high copy vector (pMR165) was 
transformed into dbJ2-1 (Li 19-713) and dbJ2-2 (Amy1292) strains. The 2-LSM4 
plasmid was able to suppress the temperature-sensitive phenotype of the dbJ2 strains, 
although only at 35°C and not at 37°C as originally described (data not shown). The 
difference in the level of suppression between dbJ2-1 and dbj2-2 described by Parkes 
and Johnston (1992) was not observed here either (data not shown). 
Dbf2p kinase is activated by Cdc 1 5 cell cycle kinase. As Cdc 15p acts upstream of 
Dbf2p Lsm4p may similarly allow suppression of a cdc15 mutation. However, the 
temperature-sensitive phenotype of a cdcl5-2 (Amy1277) strain could not be rescued 
by pMR168 (2g-LSM4; data not shown). The 3.2 kb genomic fragment that rescues 
dbJ2-Ts carries the SWI4 promoter sequence in addition to the LSM4 ORF. The SW74 
gene encodes an essential transcription factor which controls gene expression at the 
GuS transition of the cell cycle. SWI4 transcription itself is cell cycle regulated, and 
this periodicity is crucial for cell cycle regulation (Foster et al., 1993; MacKay et al., 
2001). The SWI4 promoter contains a number of transcription factor binding sites 
that are involved in the cell cycle regulated expression of SWI4 (Horak et al., 2002). 
It would therefore be conceivable that the suppression of the dbJ2-Ts phenotype is 
caused by the presence of additional copies of these promoter elements and not by 
increased levels of Lsm4p. To rule this out, the LSM4 start ATG was mutated by site-
directed mutagenesis of pMR165 to a TAG stop codon, effectively abolishing Lsm4 
protein production. Significantly, the resulting plasmid (pMR168) was unable to 
rescue temperature-sensitive growth of dbJ2-1 and dbJ2-2 strains (data not shown). 
Increased Lsm4p production is therefore critical for dbJ2-T suppression. It should be 
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noted that the level of Lsm4p overproduction from the 2.t vector is unlikely to have 
the same effect as overproduction from the MET25 or GALl promoter (i.e. 
aggregation). Overexpression of LSM4 from these promoters was unable to rescue 
dbJ2 temperature-sensitive growth (data not shown). In contrast, the variable copy 
number of the 2g vector may allow optimal levels of Lsm4p production needed for 
dbJ2 suppression. The mechanism for this suppression is unknown but may be linked 
to a role for Lsm4p in cytokinesis. 
7.5 Discussion 
In this chapter I have shown that Lsm4p forms aggregates when expressed at high 
levels. Aggregation into UFO bodies depends on the asparagine-rich prion-like C-
terminal domain and overproduction of this domain alone leads to formation of 
similar aggregates. Lsm4p but not Lsm4C aggregates cause specific aggregation of 
other Lsm proteins. The resulting effect on U6 snRNA levels is the likely reason for 
toxicity of Lsm4p overproduction and the synthetic phenotypes with U6 snRNP 
mutants. I have shown that the ability of Lsm4p to aggregate is a pre-requisite for 
efficient localisation of Lsml-7p to P-bodies, at least after hypo-osmotic shock. In 
addition, I have shown that depletion of Lsm4p leads to a cell morphology defect 
and, as interactions exist between LSM4 and cell cycle factors, this may be linked to 
a role for Lsm4p in cytokinesis. 
Although the Lsm4p C-terminal domain is poorly conserved between S. cerevisiae 
and higher eukaryotes, a function in recruitment to P-bodies may be conserved. The 
C-terminal extension of human LSm4 has a Q-rich stretch (Fig. 1.8), which may 
allow similar prion-like behaviour. Lsm4 proteins from other Saccharomyces species 
all have N-rich tails, although their exact positions are not conserved. Some of them 
even have extended N-rich stretches, with one (S. bayanus) showing a run of 24 
asparagine residues interrupted by only one serine residue. Intriguingly, others show 
increased levels of glutamine residues, with S. kluyveri additionally showing a low 
level of RG repeats (SGD; data not shown). Lsm4p homologues from other species 
often, but not always, show N- and/or Q-rich C-terminal extensions (data not shown). 
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A function for Lsm4p in Lsml-7p P-body localisation may therefore be conserved, at 
least in some organisms. Other Lsm proteins may have taken over this function by 
increasing the number of aggregation prone amino acid residues. This is a hypothesis 
that needs to be tested by comparing full sets of Lsm proteins from a range of 
species. 
An intriguing question is how Lsm4p aggregation is prevented under normal growth 
conditions. Post-translational modifications, e.g. phosphorylation, of Lsm4p or other 
Lsm proteins, in particular its proposed neighbours Lsmlp, Lsm8p and Lsm7p may 
play a role. Such modifications allow the cell to respond to changes in conditions 
quickly and efficiently, and may allow it to regulate required levels and intracellular 
localisations of Lsml-7p and Lsm2-8p. As Spiller (2005; unpublished results) 
showed that there is competition between these two complexes (e.g. there is a shift in 
localisation from the nucleus to the cytoplasm minutes after glucose starvation) this 
is a distinct possibility. The N-termini of Lsmlp and Lsm8p (see Chapter 9), and the 
C-terminus of Lsm4p itself in particular are likely targets for potential modifications. 
Interestingly, it was shown that a C-terminal deletion mutant of the Kluyveromyces 
lactis Lsm4 protein (K1Lsm4C), which is able to support viability in the MCY4 
(PGAL-LSM4) background (Mazzoni and Falcone, 2001), led to decreased viability in 
the stationary phase (Mazzoni et al., 2003a; Mazzoni et al., 2003b). It was later 
shown that this was caused by increased levels of apoptosis (Mazzoni et al., 2005) 
and that the same happened in deletion mutants of other proteins involved in mRNA 
turnover (LSMJ, DCPJ, DCP2), suggesting a direct connection between increased 
mRNA stability and apoptosis (Mazzoni et al., 2003b). Mazzoni et al. (2003b) also 
suggested that the C-terminus of Lsm4p may have a specific role in mRNA 
decapping, as mRNA degradation, but not pre-mRNA splicing was affected in the 
K!Lsm4zlC mutant strain. My data now provide a possible explanation for the effect 
on mRNA decapping, i.e. reduced localisation of Lsml-7p to P-bodies. Intriguingly, 
abnormal cell shapes, identical to those described here, were observed in stationary 
phase cells prior to apoptosis in the K!Lsm4AC mutant strain. 
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Lsm4p may have a function in cytokinesis as several links between the two exist, not 
the least of which is the genetic interaction between LSM4 and dbJ2, which I have 
now conclusively shown to depend on LSM4 expression. Dbf2p is a kinase involved 
in exit from mitosis and subsequent cytokinesis (Hwa et al., 2003; Corbett et al., 
2006). It was shown that mutations in DBF2 as well as in a number of other late cell 
cycle genes can cause abnormal cell morphologies, some of which are reminiscent of 
those observed for Lsm4p depleted cell (Chun et al., 1996; Jiménez et al., 1998 and 
references therein). It was suggested that this is due to an actin-based morphogenetic 
response to improper septin-ring formation, as some septin mutants show similarly 
elongated buds (Jiménez et al., 1998). In addition, LSM4 was one of three genes 
isolated in a screen looking for essential genes affecting cell morphology (Chun et 
al., 1996) and I have now shown that depletion of Lsm4p also leads to abnormal cell 
morphology. The other two genes found in the Chun & Goebi study were MOB], a 
component of the mitotic exit network (MEN) which associates with and is required 
for the activation and Cdc 1 5p-dependent phosphorylation of the Dbf2p kinase (Luca 
et al., 2001; D'Amours and Amon, 2004; Stoepel et al., 2005) and AMEJ, an 
essential kinetochore protein associated with microtubules and spindle pole bodies 
(Pot et al., 2005). It is possible that the Lsm4p depletion phenotype just like dbJ2 
suppression by LSM4 is caused by an effect on the mitotic exit network or on other 
factors involved in cell division or exit from mitosis. 
Could it be that Lsm4p has other functions apart from those in mRNA decapping and 
splicing as part of the known Lsm complexes? Various yeast two-hybrid interactions 
found for LSM4 suggest possible functional links (Fromont-Racine et al., 2000; Uetz 
et al., 2000). Most interestingly some of the genes that were found encode proteins 
involved in cell growth, proliferation and division. CKB2 encodes a regulatory 
subunit of the CK2 protein kinase with roles in cell growth and proliferation (Glover, 
III, 1998). DSEJ may participate in pathways regulating cell wall metabolism, and its 
deletion affects cell separation after division (Colman-Lerner et al., 2001). SLK19 
encodes a kinetochore-associated protein which is a component of the FEAR 
(Fourteen Early Anaphase Release) regulatory network, which, like MEN, promotes 
Cdcl4p release from the nucleolus during anaphase (Stegmeier et al., 2002; Pflz et 
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al., 2002). Cdc14p is a protein phosphatase required for mitotic exit. After release 
from the nucleolus it acts on key substrates effecting a decrease in CDK/B-cyclin 
(e.g. CLB2) activity necessary for cell cycle progression (Saunders, 2002). Other 
LSM4 yeast two-hybrid interactors affect chromatin remodelling and maintenance. 
SIN3 encodes the DNA binding subunit of the Sin3p-Rpd3p histone deacetylase 
complex involved in chromatin silencing at rDNA and telomeres (Silverstein and 
Ekwall, 2005). STN1 encodes a telomere end-binding and capping protein and plays 
a key role in linking telomerase action with completion of lagging strand synthesis 
(Grossi et al., 2004). An interaction between Lsm4p and any of these factors could 
underlie an as yet unknown function for the Lsml-7 or Lsm2-8 complexes. 
Alternatively, Lsm4p may be part of another Sm-like complex with functions 
relating to cell division and cytokinesis. 
It may be that the role for Lsm4p in Lsm l-'7p recruitment to P-bodies is directly 
linked to cell division. A possible mechanism involves Lsml-7p dependent 
degradation of cell cycle regulated mRNAs. This may be equivalent to the cell cycle 
regulated RNase MRP specific degradation of CLB2 (cyclin) mRNA in TAM bodies 
(Gill et al., 2006). Synthetic lethal interactions of ismiA, lsm6A, 1sm74 and patlA 
with nmel-P6, an MRP-Ts mutant, suggest that there may even be a direct functional 
link between Lsml-7p dependent RNA degradation and TAM bodies. Efficient 
CLB2 mRNA degradation by the exosome and/or Xrnlp after endonucleolytic 
cleavage by RNase MRP may depend on Lsml-7p. However, no abnormal cell 
shapes similar to those of Lsm4p depleted cells were observed for ismiA, lsm5A, 
1sm6A or lsm7A cells, at least not under permissive growth conditions (data not 
shown). It would be interesting to see if depletion of one of the other essential Lsm 
proteins (LSM2, LSM3 or LSM8) leads to abnormal cell morphology. It is possible 
that morphological defects caused by Lsm4p depletion are caused by inefficient 
degradation of cell cycle specific mRNAs through an Lsml -7p dependent pathway. 
However, as a synthetic lethal phenotype exists between LSM4 (Tet switch-off) and 
act J-l2OTs (Davierwala et al., 2005), a more direct effect of Lsm4p depletion on 
actin and cell morphology can not be ruled out. 
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In summary, Lsm4p plays a crucial role in efficient accumulation of Lsm l-'7p in P -
bodies and depletion of Lsm4p affects cell morphology. The two may or may not be 
linked. Regardless, effects on cell morphology may be linked to cytokinesis. 




A functional analysis of Lsm5p 
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8.1 Introduction 
LSM5 encodes a 93 aa (10.4 kDa) polypeptide and does not have significant N- or C-
terminal extensions outside the Sm domain. Various reports show that LSMJ, LSM6 
and LSM7 are not essential for cell viability in S. cerevisiae (Mayes et al., 1999; 
Salgado-Garrido et al., 1999). However, LSM5 was shown by Mayes et al. (1999) to 
be an essential gene, whereas others showed it to be dispensable for growth 
(Salgado-Garrido et al., 1999; Pannone et al., 2001). Also, in a genome-wide screen 
by Giaever et al. (2002) it was reported that LSM5 is needed for cell survival and 
growth. Pannone et al. (2001) stated that, at 25°C, four spores from LSM5I1sm5A 
tetrads grew, whereas only two viable spores (LSM5) per tetrad were recovered after 
incubation at 30°C. Strain backgrounds, which were different for all the above 
studies (BMA64, BSY320, CY1 (YPH501) and BY4743 respectively), may also 
influence viability after lsm5 deletion. In this chapter the effect of the 1sm5 deletion 
on two different strains is investigated, showing that LSM5 is indeed a non-essential 
gene, but that growth is severely affected. In contrast to its relatively severe effect on 
growth rate compared to lsm6 and lsm7 deletions, the lsm5 deletion shows a very 
similar effect on the levels of spliceosomal snRNAs, U6 and U4/U6 in particular. 
8.2 Ism5 deletion strains are viable but show severely 
reduced growth rates 
Mayes et al. (1999) reported that no viable spores carrying an lsm5A::TRPI deletion 
in the BMA64 background were obtained after sporulation. However, when 
AEMY48 which carries a plasmid (pAEM75-CEN-URA3-PGAL-LSM5) in addition to 
the genomic 1sm5 deletion was grown on 5-FOA-Glu at 23°C some very slow 
growing cells survived (data not shown). These lsm5A cells (MRY6) were able to 
grow on solid medium at 14°C and 23°C, grew very poorly at 30°C and died at 37°C 
(Fig. 8.2, MRY7c). When grown in liquid medium they display doubling times of 
approximately 6 h at 18°C, 8 h at 25°C and more than 16 h at 30°C (Fig. 8.1C), 
showing that these cells are extremely sick and heat sensitive. Effects of ism 
deletions on growth of BY474 I and BY4742 strains tend to be less severe than those 
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Fig. 8.1 Creation of an lsmS deletion strain and its growth phenotype. 
(A) Colony PCR was performed on wild-type BY4741 and a Hygroniycin 
resistant colony after transformation with an HpHMX6 deletion cassette 
targetting the LSM5 ORF. Colony PCR with primers mro83 and rpTEF 
only results in a product for the deletion strain (lane 2); PCR with primers 
mro83and mro84 results in a small product (lane 3) covering the LSM5 
ORF in wild type and a large product (lane 4) covering the HpHMX6 
casette inserted at the LSM5 locus in 1srn5. (B) Ten-fold serial dilutions 
of liquid BY4741 and MRY27 cultures were plated on YPDA and incubated 
at 14°C, 23°C, 30°C or 37°C. (C) MRY6 and MRY27 were grown in YPDA 
at 18°C, 25°C, 30°C or 37°C and their doubling times were estimated 
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seen for the same deletions in the BMA64 background. An 1sm5 deletion was made 
by direct insertion of an HpHMX6 cassette replacing the entire LSM5 ORF in 
BY4741 cells and subsequent selection on YPDA-Hyg plates at 23°C. Resulting 
colonies were tested by colony PCR for insertion of the HpHMX6 cassette at the 
correct locus (Fig. 8.IA). The resulting MRY27 strain was shown to grow on solid 
YPDA medium at all temperatures (14°C, 23°C, 30°C and 37°C), but many times 
slower than BY4741 wild-type cells, particularly at higher temperature (Fig. 8.113). 
When grown in liquid medium MRY27 cells displayed doubling times of 
approximately 4 h at both 25°C and 30°C, so considerably faster than MRY6 cells 
(Fig. 8.1C). Similar differences in growth phenotypes were observed between lsm6 
and ism 7 deletion strains in the BMA3 8 background compared to the same deletions 
in the BY4741 background. In the BMA38 background these deletion strains are 
heat-sensitive lethal, whereas in the BY4741 background they are heat-sensitive slow 
growing (compare Fig. 5.2 and 6.3; data not shown). 
8.3 The Arabidopsis sadlllsm5 mutation does not show a 
growth defect in yeast 
A single point mutation in a conserved residue in the N-terminal domain of 
Arabidopsis thaliana Lsm5p, the El 2K sad] (supersensitive to ABA and drought) 
mutation, was shown to make plants hypersensitive to abscisic acid (ABA) and 
osmotic stress (Xiong et al., 2001). The plant hormone abscisic acid plays an 
important role in plant growth and development, including seed maturation, root 
growth and stress tolerance. The promoter of RD29A, a stress-responsive gene, 
contains elements that confer responsiveness to cold/osmotic stress and ABA. In a 
screen, sad] was found to superinduce expression of RD29A by ABA and osmotic 
stress, but not cold stress. It is not known what the mechanism is behind the effects 
the sad] mutation has on stress response and ABA signalling. One possibility 
suggested by Xiong et al. (2001) is that the sad] mutation affects the decay rate of 
mRNA for an early component in ABA signalling, possibly a regulatory component 
that modulates ABA biosynthesis. Interestingly, microarray analysis suggested that 
the sad] mutation does not affect general gene expression (Xiong etal., 2001). 
Although S. cerevisiae obviously does not have an ABA signalling pathway I 
decided to investigate whether a mutation of the equivalent glutamate residue in 
position 10 of Lsm5p to lysine leads to an abnormal phenotype in yeast. LSM5 was 
cloned with its promoter and terminator sequences (327 bp upstream and 127 
downstream of the ORF) into pRS3 13. The resulting pMR9 plasmid was used to 
introduce the El OK mutation by site directed mutagenesis in pMR 10. Both plasmids, 
as well as pRS3 13 were transformed into AEMY48 (lsm5A PGAL-LSM5) and selected 
for on SDGa1-His medium. Subsequent counter-selection against the pAEM75 
(CEN-URA3-PGAL-LSM5) plasmid on 5-FOA-Glu plates resulted in strains MRY7 
(LSM5), MRY8 (1sm5-EJOK) and pMR7c (1sm54 pRS313). Fig. 8.2 shows that there 
was no difference in growth between the wild-type BMA64a and MRY7 strains at 
any of the tested temperatures, indicating that the plasmid-based copy of LSM5 fully 
supplements the genomic deletion. No difference, however, was observed either 
between the LSM5 and ism 5-El OK strains at any of the temperatures tested. 
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Fig. 8.2 1sm5t and lsm5-EIOK growth phenotypes. lsm5z\ strain MRY6 
carrying pRS3 13 (MRY7c), pMR9 (MRY7-LSM5) or pMR 10 (MRY8-
lsm5-EJOK) as well as BMA64a (wild type) were grown in liquid medium, 
and 10-fold serial dilutions were plated on YPDA and grown at 14°C, 23°C, 
30°C or 37C. 
8.4 Effects of IsmM on spliceosomal snRNA levels, a 
comparison with Isml4 IsmM and Ism7A 
It is unclear why some of the Lsm proteins are essential and others are not, with the 
exception of Lsmlp which is assumed to function only as part of the non-essential 
Lsml-7 complex. In contrast, it seems that the function of the Lsm2-8 complex is 
essential. It has been proposed that, of the wide variety of functions the nuclear Lsm 
proteins have in RNA processing, U6 snRNA stabilisation by the Lsm2-8 complex is 
the only one that is essential (Pannone et al., 2001), as essential Lsm proteins 
become non-essential upon overexpression of U6 RNA (Mayes et al., 1999; Pannone 
et al., 2001). However, the Lsm2-8p subunits Lsm6p, Lsm7p and now Lsm5p have 
been shown to be non-essential. It is likely that the Lsm2-8 complex forms an 
alternative heterohexameric ring structure in the absence of one of these proteins, but 
an alternative heteroheptameric complex with one of the Lsm proteins occurring 
twice in one ring or with one of the homologous Sm proteins taking the place of the 
missing subunit cannot be ruled out. It is striking that all non-essential Lsm proteins 
are homologous to the SmE, F and G proteins that have been proposed to form a 
stable trimeric sub-complex (Raker et al., 1996). The significance of this is unclear. 
It is clear however that deletion of non-essential as well as depletion of essential 
components of Lsm2-8p leads to destabilisation of U6 snRNA and reduction of the 
levels of U6 (Mayes et al., 1999) and U4/1J6 snRNAs (Mayes et al., 1999; this 
thesis; Beggs lab unpublished observations). In addition, Verdone et al. (2004) 
suggested a specific role for Lsm6p in U4/U6 di-snRNP and Lsm7p in U4/U6.U5 tn-
snRNP formation, as lsm6A extracts displayed reduced levels of annealing of 
exogenous U6 to U4 RNA, whereas lsm7A extracts displayed reduced U6 RNA 
incorporation into tri-snRNP particles. This suggests that each of the individual Lsm 
proteins may have a specific function in the context of the Lsm complexes. Analysis 
of the lsm54 strain may elucidate what this function is for the Lsm5 polypeptide. 
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8.4.1 Ism5ii, Ism6Lt and Ism7L strains shows similar effects on 
the levels of spliceosomal snRNAs 
The effect of the lsm5 deletion on the levels of spliceosomal snRNAs was examined 
and compared to effects of other non-essential LSM gene deletions. Total RNA was 
extracted under non-denaturing conditions from wild-type BY4741 and isogenic 
lsml4 (Y01301), lsm5.4 (MRY27), 1sm6A (MRYI7) and lsm7A (MRY18) strains 
grown to 0D600 0.5 - 0.8 in YPDA at 30°C. The RNA was separated by denaturing 
and non-denaturing PAGE, Northern blotted and probed for the spliceosomal 
snRNAs (Fig. 8.3A, C and E). This was carried out for biological duplicates and 
quantification was performed on two separate Northern blots for each biological 
replica. The average values (shown in Fig. 8.3B, D and F) were corrected for equal 
loading by comparing the levels of U 1 snRNA in each lane. The assumption that 
there is no effect of the ism deletions on the levels of UI RNA was shown to be 
correct by comparison to an scRl loading control (Fig. 8.5). As expected the level of 
total U6 RNA (Fig. 8.313) was reduced for 1sm5A (39 ± 7% of WT), lsm6A (48 ± 
12%) and Ism 7A (37 ± 7%) compared to wild type. Surprisingly the level of U6 RNA 
was also reduced, but to a lesser extent, for ismiA (66 ± 9%). A slight effect of 
depletion of some of the Lsm proteins on the levels of U5-L and U5-S had previously 
been reported by Mayes et al. (1999). Here a clear effect was seen of ism deletions, 
leading to decreased levels of U5-L (91 ± 17% for IsmiA; 45 ± 17% for 1sm5A; 72 ± 
22% for lsm6zl; 59 ± 22% for lsm7A) and increased levels of US-S snRNA (129 ± 
27% for lsmlA; 153 ± 33% for 1sm5A; 142 ± 33% for 1sm6zl; 100± 24% for lsm7zi). 
Fig. 8.3 Deletions of LSM5, LSM6 and LSM7 lead to reduced levels of U2, 
U6 and U4/U6 snRNA, increased levels of U4 snRNA and a change in the 
ratio of U5-L over U5-S snRNA. RNA was extracted under non-denaturing 
conditions from BY4741 and isogenic lsmIA, ls,n5E, 1sm6A and 1sm7A 
strains. The RNA was separated by denaturing and non-denaturing PAGE, 
Northern blotted and probed for the spliceosomal snRNAs. (A) Northern 
blot after denaturing PAGE and (B) quantification of all spliceosomal 
snRNAs. (C) Northern blot after non-denaturing PAGE probed for U6 RNA 
and (D) quantification of U4/U6 duplex and free U6 snRNA. (E) Northern 
blot after non-denaturing PAGE probed for U4 RNA and (F) quantification 
of U4/U6 duplex and total U4 snRNA. Levels were expressed as a 
percentage of WT and were corrected for equal loading by comparison to the 
amount of UI snRNA present in each lane. Average values of biological 
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Although there seemed to be considerable experimental variation, there was a 
significant effect on the U5-L over U5-S ratio, which changes from approximately 
140% in wild-type to 90% in ismiA, 40% in 1sm5A, 70% in lsm6A and 80% 1sm7A. 
Interestingly, deletions of LSM5, LSM6 and LSM7 also showed a clear effect on 
levels of U2 snRNA (50 ± 9% for 1sm54; 55 ± 12% for lsm5A; 65 ± 18% for 1sm7A), 
whereas there was no significant effect for ismiA. Finally, levels of U4 snRNA 
significantly increased for lsm5A, lsni64 and lsm6A, but not ism iii. Levels of U4 
RNA approximately doubled for lsm6A and 1sm7A (214 ± 75% and 189 ± 86% of 
WT respectively), and on average quadrupled for 1sm5A (419 ± 164%). 
8.4.2 Levels of U6 and U4/U6 snRNA are decreased and U4 
snRNA levels increased in Ism54 Ism6Lt and Ism78 strains 
Quantification of levels of U4 and U6 snRNAs after non-denaturing PAGE (Fig. 
8.3C-F) confirmed effects on the levels of U4 (529 ± 191% for lsm5A; 206 ± 48% for 
lsm6A; 175 ± 32% for lsm7A) and U6 snRNA (77 ± 2% for ismiA; 46 ± 15% for 
1sm5zl; 36 ± 7% for lsm6A; 43 ± 7% for 1sm7A) found by denaturing PAGE (8.4.1). 
Levels of free U4 snRNA were high, in particular for 1sm5A, while there was no 
detectable free U4 RNA in wild-type or ismiA cells. In addition, levels of U4/U6 
RNA were significantly reduced in 1sm5A (55 ± 9%), lsm6A (51% ± 1%) and lsm7A 
(29% ± 2%), but not Ism ]A. 
8.4.3 Changed levels of spliceosomal snRNAs in Ism deletion 
strains are not fully corrected by increased U6 expression 
As increased U6 expression is able to suppress growth defects of ism deletion strains 
(Mayes et al., 1999; Pannone et al., 2001), we investigated whether U6 expression 
from pBSI 191 (CEN-URA3-SNR6) in addition to expression from the SNR6 genomic 
copy would have an effect on the changed levels of spliceosomal snRNAs in the 
same ismiA, lsm5A, 1sm6A and Ism 7.4 strains (8.4.2). Total RNA was extracted under 
non-denaturing conditions from these strains carrying pBS 1191 grown at 30°C in 
SD-Ura to 0D600 0.5 - 0.8; RNA was separated, Northern blotted, probed for 
spliceosomal snRNAs and bands were quantified. This was done for duplicate 
Northern blots of single biological samples. Graphs in Fig. 8.4 display average 
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values of quantifications of these Northern blots. Interestingly, the level of U6 
snRNA, as estimated from Northern analysis after denaturing PAGE (Fig. 8.4A and 
B), did not increase for lsm5A (38 ± 1% of WI), but slightly increased for Ism ]A (82 
± 3%) and lsm7A (56 ± 4%) and even increased to levels above those in wild-type 
cells for lsm6A (149 ± 2%). Levels of U4 snRNA were slightly decreased for 1sm6A 
(81 ± 11%) and 1sm7A (69 ± 14%) compared to wild type, in sharp contrast to the 
doubled levels of U4 in the absence of pBS 1191 (Fig. 8.3). In lsm5A, however, the 
level of U4 RNA was still significantly above that of wild-type cells (230 ± 16%), 
but reduced compared to lsm5A in the absence of pBSI 191 (Fig. 8.3). Similarly, the 
levels of U2 snRNA approached normal levels for 1sm6A (89 ± 15%) and lsm7A (99 
± 46%), but were still down for 1sm5A (49 ± 4% of WI). Finally, the change in the 
ratio of U5-L and US-S snRNAs, due to respective decreased and increased levels in 
Ism deletion strains, was only corrected to a ratio similar to that of wild type (109 + 
3%) for 1sm74 (115 ± 7%), but was still down for lsm5A (24 ± 0%), lsm6A (50 ± 
2%) and Ism iA (58 ± 2%). 
Fig. 8.4 Increased SNR6 expression from pBSI 191 only alleviates some 
effects deletions of LSM5, LSM6 and LSM7 have on the levels of U2, U4, U6 
and U4/1J6 snRNA, and the ratio of U5-L over U5-S snRNA. RNA was 
extracted under non-denaturing conditions from BY4741 and isogenic 
lsmIA, 1sm5A, 1sm6A and lsm7A strains carrying the pBSl 191 (CEN-URA3-
SNR6) plasmid and grown on SD-Ura. The RNA was separated by 
denaturing and non-denaturing PAGE, Northern blotted and probed for the 
spliceosomal snRNAs. (A) Northern blot after denaturing PAGE and (B) 
quantification of all spliceosomal snRNAs. (C) Northern blot after non-
denaturing PAGE probed for U6 RNA and (D) quantification of U4/U6 
duplex and free U6 snRNA. (F) Northern blot after non-denaturing PAGE 
probed for U4 RNA and (F) quantification of U4/U6 duplex and total U4 
snRNA. Levels were expressed as a percentage of WI and were corrected 
for equal loading by comparison to the amount of U  snRNA present in each 
lane. Average values for two Northerns of single biological samples are 
given. 
271 
A 	 B 
180% 
U2 
Ui 	 120% 
100 , 
 
60 1 1 , 
4111111111P 	
0, 






c Ii fl II 
U4/U6 _______________ 






WT 	tsml! 	!sm5\ 	ism6\ 	lsrn7\ 




Ism 1",  
O!sm5! 
E3 Ism6' 




11 12 13 1415 
F 
200% • uu 400% D Li4 
180% 350% I I 
total 
160% II 300% 
120% 
250%  I 	I 
100% 200% 
80% 
140% ! 150% 
60% 
100% 
40% uIun 20% 0% 5 0% 0% 
f fF  
272 
Quantification of the levels of U4, U6 and U4/U6 snRNAs after non-denaturing 
Northern analysis showed a similar trend (Fig. 8.4C-F). Levels of U4/U6 snRNA 
were back to normal or even higher than those for wild type for all ism deletion 
strains carrying pBSI 191 (114 ± 5% for Ism M, 192 ± 23% for lsm5A, 149 ± 15% for 
1sm64 and 121 ± 4% for ism 74). Free U6 snRNA approached the wild type level for 
ismiA (89 ± 3%) and was significantly higher for lsm6A (198 ± 13%), but was still 
reduced in 1sm54 (38 ± 2%) and lsm7A (57 ± 5%). There were still significantly 
increased amounts of free U4 snRNA present in lsm5A, lsm6A and ism 74 compared 
to wild type. The total level of U4 RNA as estimated from this non-denaturing 
Northern analysis, however, was similar between ismiA, lsm6A and 1sm74, but was 
more than tripled in lsm5A (361 ± 4% compared to WT). Although there were some 
inconsistencies, the reasons for which are unclear, the general trend was the same 
between quantification of the denaturing and non-denaturing Northerns. 
8.5 scRi levels are increased in Ism1 
As mentioned above, loading was controlled for by comparing levels of U  snRNA 
in the different lanes under the assumption that ism deletions do not affect this RNA. 
As ism deletions seem to affect levels of all other snRNAs, I wanted to test whether 
this assumption is correct by comparison to another RNA that is not known to be 
affected by the Lsm proteins. scRi is the stable cytoplasmic non-coding RNA 
component of the signal recognition particle, which is involved in co-translational 
targeting of polypeptides with a signal peptide sequence to the endoplasmic 
reticulum. Lsm proteins are not known to be involved in its biogenesis or its 
degradation, although it was shown that depletion of Lsm3p and Lsm5p leads to 
reduced precipitation of scRi by Lhplp (Kufel et al., 2002). The Northern blot after 
denaturing PAGE from Fig. 8.4A was probed for scRi RNA and bands were 
quantified and levels were compared to those of U I snRNA. 
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The results presented in Fig. 8.5 show that there was no significant effect of deletion 
of LSM5, LSM6 or LSM7 on the levels of scRi. This confirms that UI snRNA was 
also not affected by these deletions, as the levels of Ui RNA were also comparable 
between wild type and the ism deletion strains. Interestingly however, the level of 
scRi RNA in ismiA was almost three times (293 ± 32%) that of wild type. 
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Fig.8.5 Levels of scRi RNA are increased in an lsmIA strain, but not in 
1sm5& /smóL\ and Ism 7A strains. The denaturing Northern blot from Fig. 8.4 
was probed for U  and scRi RNA. Bands were quantified and scRI amounts 
were corrected for equal loading by assuming no effect of the LSM deletions 
on U 1 snRNA. Approximately equal relative intensity for scRl in 1sm5A, 
1sm6A and Ism 7A compared to wild type shows that this assumption is correct. 
The amount of scRl in Ism ]A, however, has almost tripled. Average values 
for two Northerns of single biological samples are given. 
8.6 Discussion 
Roles for Lsmlp in mRNA decapping (Tharun el al., 2000; Bouveret el al., 2000) 
and for Lsm6p and Lsm7p in U4/U6 di-snRNP and U4/U6.U5 tri-snRNP formation 
respectively (Verdone et al., 2004) were elucidated using the corresponding deletion 
strains. It seems likely that each of the subunits of the heteroheptameric Lsm 
complexes has a specific function, which it can probably only carry out in the context 
of this complex. The availability of a viable !sm5 deletion strain will allow us to 
study functions associated with Lsm5p more easily. However, care should be taken 
in interpreting the results from analyses using this strain as together with the LSM5 
ORF, another ORF on the opposite strand of the chromosomal DNA is disrupted. 
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This ORF, FTRI (YER145C), nearly fully overlaps the LSM5 ORF (282 bp) with the 
exception of the final 43 bp at the 3' end of LSM5, which presumably means the 
LSM5 terminator sequence and FTR] promoter sequences also overlap. As the 
coding sequence of FTRJ covers 1215 bp the LSM5 promoter must lie within the 
FTRJ open reading frame. Ftrlp is a high affinity iron permease involved in the 
transport of iron across the plasma membrane. It forms a complex with Fet3p and its 
expression is regulated by iron levels (Stearman et al., 1996; Eide, 1998). FTR] is 
non-essential, but its deletion leads to reduced growth rates after several generations 
when grown on galactose, synthetic complete medium or a non-fermentable carbon 
source (Giaever et al., 2002; Steinmetz et al., 2002). Due to extensive overlap 
between these two genes, deletion of LSM5 without affecting FTR] expression 
would require introduction of a non-sense mutation into the LSM5 coding sequence 
that does not alter the Ftrl protein sequence. 
The sad] allele of LSM5 shows a subtle defect in Arabidopsis thaliana that does not 
alter general gene expression, but seems to specifically affect positive feedback 
regulation of ABA biosynthesis genes by ABA and drought stress induction of ABA 
biosynthesis. It was suggested that the sad] mutation affects the decay rate of mRNA 
for an early component in ABA signalling. Negative regulators of ABA signalling, 
including protein phosphatase 2-C-like gene and ABI], were indeed shown to be 
amongst those messages with reduced levels in the sad] mutant (Xiong et al., 2001). 
Initial analysis of the equivalent E1OK mutation in LSM5 in yeast showed no growth 
defects. Since the sad] mutation in Arabidopsis displays only a subtle defect with 
regards to growth, development and stress response, this mutation may have a similar 
subtle effect in yeast. It is possible that this residue plays a role in targeting specific 
transcripts involved in stress response for degradation and that this function is 
conserved between Arabidopsis and yeast. It may therefore be interesting to 
investigate whether the 1sm5-EJOK strain has a growth defect under specific 
conditions, e.g. after osmotic shock, and if so what transcripts are affected under 
these conditions. 
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It is unclear whether the phenotypic effects that are seen for lsm5L\, Ism 6A and ism ?'Li 
strains are due to reduced efficiency of complex formation, reduced RNA-binding 
and/or reduced activity of alternative complexes, or loss of specific functions 
associated with the Lsm5, 6 and 7 proteins. Similar effects of all three deletion 
strains on U2, U5-LJLJ5-S, U4 and U6 snRNA levels suggest that this is due to one of 
the former. Effects on U2, U5 and U4 snRNA levels may be an indirect effect of the 
reduced levels of U6 snRNA. Alternatively, all three ism deletions may have a direct 
effect on degradation and/or processing of these RNAs. Increased expression of U6 
RNA rescues the U41U6 to levels above wild type for all three mutants. The fact that 
U41U6 levels are increased so readily may be due to the increased levels of free U4 
snRNA, explaining why U4/U6 increases the most for lsm5A. Surprisingly however, 
effects of increased U6 snRNA expression on the other snRNAs vary for the three 
Ism mutants, suggesting that it is not a simple knock-on effect of reduced levels of 
U6 and U4/U6 RNA. The fact that effects are different for each of the ism mutants 
may help us to elucidate mechanisms behind the effects on the spliceosomal snRNAs 
and may ultimately teach us more about functions of these individual Lsm proteins. 
Increased levels of total U4 snRNA and reduced levels of U4/U6 suggest that there 
may be a direct link between U4 RNA degradation and U4 release from the 
spliceosome. As a result of inefficient U4/U6 di-snRNP formation U4 incorporation 
into the pre-spliceosome will be reduced, leading to an overall reduction in release of 
U4 RNA prior to activation. It is possible that the Lsm proteins thus indirectly affect 
U4 RNA degradation, as U6 overexpression (partially) alleviates increased U4 RNA 
levels in the ism deletion mutants. Mutations in a number of other U6 snRNP-related 
splicing factors, Prp3p, Prp4p and Prp24 (Lygerou et al., 1999), and a number of 
Prpl9 complex components, including Prpl9p and NTC25 (Lygerou et al., 1999; 
Chen et al., 2006) were shown to have reduced U6 and U4/U6 levels and to 
accumulate free U4 snRNA. However, none of these was shown to lead to increased 
levels of total U4 RNA 3.  It is therefore possible that the Lsm2-8 complex may have a 
more direct function in targeting U4 RNA for degradation after its release from the 
Care should be taken in interpreting levels of free U4 and U6 RNA, as Chen et al. (2006) 
showed that there is a marked difference between these levels in splicing extracts and total 
RNA extractions. 
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spliceosome. U4 snRNA was shown to be degraded by the exosome, as mature U4 
snRNA accumulated in strains depleted of various exosome components (Alimang et 
al., 1999). Lsm2-8p may therefore have a function in exosome-mediated U4 
degradation, and as U4 snRNA levels were increased the most in the 1sm5A strain 
Lsm5p may play a central role in this. Exosome mutations also led to accumulation 
of U5-S, but not U5-L, significantly increasing the U5-LIU5-S ratio (Allmang et al., 
1999). This suggests that the increase in this ratio in ism mutant strains may similarly 
be caused by an effect of Lsm2-8p (and/or Lsml-7p) on exosome-mediated 
degradation of U5-S. 
Surprisingly, deletion of LSMJ also affected the levels of spliceosomal snRNAs 
(except Ui and U4), although the effects were less pronounced than in lsm5A, 1sm6A 
and ism 7A strains. The reason for this remains unclear. Interestingly, however, Kufel 
et al. (2002) also showed similar effects on (nuclear) pre-tRNA processing in lsmlA, 
lsm6E and 1sm7E strains at 37 °C, although these effects were much weaker than 
those observed for strains depleted of essential Lsm proteins. Spiller (2005; 
unpublished results) suggested that there may be competition between formation of 
Lsml-7p and Lsm2-8p and a regulated exchange of shared subunits depending on 
growth conditions. If this is true, it may be expected that levels of Lsm2-8p would be 
higher in an 1sm14 strain, which would have the opposite effect to that observed 
here. On the other hand, the cytoplasmic Lsml-7 complex may act as a source of 
Lsm2-7 proteins for incorporation into the nuclear Lsm2-8p complex if the need for 
this arises. Deletion of LSMJ may disturb this delicate balance reducing the 
flexibility of the cell to quickly respond to changes in conditions. Alternatively, the 
Lsml-7 complex has a function in stabilising or processing these stable small RNAs, 
presumably in the cytoplasm. This suggests a cytoplasmic phase for U6 RNA and 
pre-tRNAs. U6 RNA has indeed been shown to shuttle between nuclei in a yeast 
heterokaryon assay (Olson and Siliciano, 2003) and has been shown to accumulate in 
the cytoplasm in the absence of Lsm2-8 proteins (Spiller et al., 2007). Also, splicing 
of pre-tRNAs has been shown to take place in the cytoplasm (Yoshihisa et al., 2003), 
showing that a role for Lsm i-'7p in processing of these RNAs in the cytoplasm may 
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be possible. Alternatively, Lsm l-'7p is present at low but functional levels in the 
nucleus. 
Increased levels of scRi RNA in ismiA, but not in lsm5A, lsm6A and lsm7zJ seem to 
suggest a direct involvement of Lsmlp, and presumably Lsml-7p, in scRi 
degradation. Why would deletion of LSM1, but not deletion of any of the other three 
non-essential LSM genes affect scRi degradation? In the absence of Lsmlp there is 
presumably no functional cytoplasmic Lsm complex, whereas in the absence of 
Lsm5, 6 or 7p there may be an Lsml-7 complex lacking one of its subunits, which 
could be functionally competent in terms of scRi degradation. It would be interesting 
to investigate whether scRi degradation is carried out by the exosome or by Xrnlp 
and what role Lsml-7p plays in this. Increased scRi levels in an rrp6 deletion strain 
(Alimang et al., 1999) suggest that this exosome component may be involved in 
scRi degradation. Lsml-7p may therefore affect exosome-mediated degradation of 
this cytoplasmic non-coding RNA. 
In summary, I have shown that LSM5 is a non-essential gene. Its deletion has similar 
effects to those seen for lsm6 and lsm7 deletions: decreased U2, U6 and U4/U6 
levels, a change in the U5-L/U5-S ratio and increased U4 snRNA levels. The strong 
increase in U4 snRNA levels for lsm5A suggest that Lsm5p may have a specific 
function in the exosome-mediated decay of U4 RNA. 
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CHAPTER 9 




S. cerevisiae has at least two different Lsm complexes. The exclusively nuclear 
Lsm2-8 complex consists of the Lsm2 to Lsm8 proteins and forms the core of the 
spliceosomal U6 snRNP particle (Mayes et al., 1999; Salgado-Garrido et al., 1999; 
Spiller, 2005). A second complex is formed by the Lsml to Lsm7 proteins and is 
thought to be exclusively cytoplasmic. This Lsml -7 complex has been shown to play 
a role in mRNA decapping by Dcplp/Dcp2p and subsequent 5' to 3' degradation by 
Xrnlp exonuclease (Tharun et al., 2000; Tharun et al., 2001). It has been shown that 
this process occurs at specific cytoplasmic sites termed P- or Processing Bodies 
(Sheth et al., 2003). Under conditions that warrant high levels of mRNA turnover 
such as osmotic shock or glucose starvation P-bodies increase in number and size 
(Teixeira et al., 2005). Complex formation seems to be essential for Lsmlp and 
Lsm8p to localise to P-bodies and to nuclei respectively. This was shown for Lsm2-
8p in yeast where Lsm8p loses its nuclear localisation when cells are depleted of 
Lsm2p or Lsm4p (Spiller, 2005; unpublished results). Human LSm4 was shown to 
lose its localisation to P-bodies when mutations in residues that are predicted to be 
involved in complex formation (G27D or L40N) were introduced (Ingelfinger et al., 
2002). Both complexes contain the Lsm2 to 7 proteins. Completion of the ring-
shaped heteroheptamer by Lsm8p leads to nuclear localisation, whereas a ring 
completed by Lsmlp is (presumably) excluded from the nucleus. In contrast, the 
homologous Sm complex, which forms the core of the non-U6 spliceosomal snRNPs, 
accumulates in the nucleus only. SmB/D3, SmD1/D2 and SmF/E/G subcomplexes 
have been suggested to form as RNA-free particles and to assemble into the 
heptameric complex on the snRNAs (Raker et al., 1996; Raker et al., 1999). The 
basic residues in the C-terminal protuberances of the yeast 5mB and Dl proteins 
have been shown to form separate nuclear localisation signals that are functionally 
redundant (Bordonné, 2000). The human 5mB, Dl and D3 proteins were shown to 
contain similar signals important for nuclear localisation (Girard et al., 2004). 
Nothing is known however about what leads to the nuclear accumulation of Lsm2-8p 
on the one hand and the nuclear exclusion of Lsml-7p on the other. Since Lsm2 to 
7p are shared between both complexes it would seem likely that specific localisation 
signals are present within the Lsml and Lsm8 proteins themselves. Tharun et al. 
ME 
(2005) performed extensive mutational analysis of LSMJ showing the importance of 
residues proposed to be involved in RNA binding and complex formation, and of the 
C-terminal domain for the functional competence of the Lsml-7 complex. However, 
not much attention was given to what domains or residues are essential for specific 
localisation, apart from showing that (surprisingly) mutations in the putative RNA-
binding residues did not significantly affect localisation to P-bodies. To investigate 
the requirement of different domains of the Lsm 1 and Lsm8 proteins for their 
function and localisation in more depth, I created a number of mutant and hybrid 
proteins. These were all tested for their ability to support growth either of an ismiA 
strain at non-permissive temperature or of an lsm8A strain. This showed that essential 
functions of Lsm8p are remarkably resilient to mutations. The cellular localisation of 
GFP-tagged versions of all hybrid and mutant proteins was investigated by 
fluorescence microscopy, uncovering a central role for the N-terminal domains of 
Lsmlp and Lsm8p for specific cellular localisation of the Lsml-7 and Lsm2-8 
complexes. 
9.2 Creation and expression of Lsmlp and Lsm8p hybrids 
and deletion mutants 
To decide where to make deletions and what domains of Lsmlp and Lsm8p to fuse 
together in hybrid polypeptides the two proteins were aligned with ClustaiW (Fig. 
9.1 A). In addition, the 213/3D structures of each of these proteins was predicted using 
the 3D-PSSM server (Fig. 9.1B and C; Kelley et al., 2000b). 
9.2.1 Structure prediction of Lsmlp and Lsm8p 
The most highly conserved part between the Lsml and Lsm8 polypeptides is the part 
that covers the Smi and Sm2 motifs (Fig. 9. 1A). These motifs form the Sm-fold, the 
hallmark of the Sm-like proteins, consisting of a five-stranded anti-parallel j-sheet 
which is involved in inter-subunit and protein-RNA contacts. The Sm 1 motif is 
formed by n-strands 01 to 133  (aa 53-88 for Lsmlp and aa 12-45 for Lsm8p) and the 
Sm2 motif is formed by 134 and 135 (aa 94-113 for Lsmlp and aa 49-65 for Lsm8p; 
Fig. 9.113 and Q. Crystal structures and cross-linking data have shown that RNA 
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binding residues in Sm(-like) proteins are located in loop 3 (between P2 and 33) and 
loop 5 (between 34 and 35). The consensus sequences for these so-called Knuckle 
motifs in eukaryotic Sm and archaeal Sm-like proteins are [His/Tyr]-Met-Asn for 
Knuckle I and Arg-Gly-Asp for Knuckle II (Khusial et al., 2005). It is unknown how.c3 
the Lsm proteins bind RNA, but it is presumed to occur in a similar fashion. The 
Lsm-ring subunits and the Sm rings have similar amino acid sequences in Knuckle 
II, however, most Lsm proteins diverge from the consensus sequence in the Knuckle 
I motif. Asparagine residue 3 is highly conserved but residues at positions 1 and 2 
are often substituted by large hydrophobic residues. This has been suggested to be 
the cause of the broader RNA binding specificity of the Lsm rings (reviewed by 
Khusial et al., 2005). This seems to hold true for yeast Lsmlp (Knuckle I: Tyr-Ala-
Asn; Knuckle II: Arg-Gly-Glu) as well as yeast Lsm8p (Knuckle I: Asn-Thr-Asn; 
Knuckle II: Arg-Gly-Ser). Some of these putative RNA binding residues in Lsmlp 
were mutated and shown to affect both mRNA decay and mRNA 3' end protection, 
but not localisation to P-bodies (Tharun et al., 2005). 
Prediction of secondary structures outside the Sm motifs revealed an a-helical 
structure directly upstream of P 1, another common feature of the Sm-fold (al: aa 43-
49 for Lsmlp and aa 3-8 for Lsm8p; Fig. 9.1B and Q. In addition both proteins show 
potential a-helical structures in their C-terminal extensions (strong prediction for 
Lsmlp aa 135-159; weaker predictions for Lsmlp aa 124-129 and Lsm8p aa 93-
104). Most of the N-terminal extension of Lsmlp is predicted to be unstructured. 
Based on the alignment and structure predictions (Fig. 9.1) fusions and deletions of 
N- and C-terminal domain were made outside the most highly conserved regions of 
the Sm motifs and care was taken to avoid structured regions. The N-terminal 
domain of Lsm 1 p  was taken as aa 1-51 and that of Lsm8p as aa 1-10. The C-terminal 
domain of Lsmlp was taken as aa 122-172 and that of Lsm8p as aa 74-109, with the 
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Fig. 9.1 Lsmlp and Lsm8p alignment (A; ClustaiW; boxview) and 2D/3D 
structure predictions (B,C; 3D-PSSM). Arrowheads indicate the sites at which 
N- and C-terminal deletion mutants and hybrids of Lsm 1 and 8 proteins were 
created. Asterisks indicate the amino acids forming the putative RNA-binding 
Knuckle domains. In (B) and (C) green boxes indicate regions that are predic-
ted to form a-helices (H), blue arrows indicate regions that are predicted to form 
13-strands (E) and lines indicate regions that are predicted to form random coil 
(C). The corresponding numbers give the confidence score of these predictions, 
with 5-9 (in bold) indicating high confidence. al  and 31-5 of the Sm-like fold 
are predicted correctly for both Lsrn I  and Lsm8p. 
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9.2.2 Hybrids and mutant proteins are stably expressed 
To test whether the hybrid and mutant proteins were stably expressed in yeast, I 
expressed GFP-tagged versions of these proteins and performed ct-GFP Western 
analysis on total protein samples. Plasmids with N- or C-terminally tagged proteins 
expressed from the MET25 promoter were transformed into MSP26. Cells were 
grown in SD-Ura-Met (or SD-Ura) to an 0D600 of approximately 3 and harvested. 
Total protein was prepared for each, separated by SDS-PAGE and Western blotted. 
Anti-GFP antibody was used to detect the GFP-tagged proteins and anti-a-Tubulin 
antibody was used to detect a-Tubulin to test for equal loading (Fig. 9.2). All 
proteins, except LsmiN8AC-GFP were expressed at similar levels in the absence of 
methionine, indicating that they are stably expressed. Expression was significantly 
lower, but not absent, in the presence of 1 mM of methionine as can be seen for GFP-
Lsml 18. This reflects incomplete repression of the MET25 promoter, which can be 
seen at the level of mRNA (Fig. 9.10) as well as protein (Fig. 9.2). 
9.3 The N- and C-terminal domains of Lsmlp and Lsm8p do 
not suffice as localisation signals 
To test whether the N- and C-terminal extensions of Lsmlp and Lsm8p contain any 
localisation signals, these domains were fused to the N- and C-termini of GFP 
respectively (in pGFP-N-FUS and pGFP-C-FUS). The resulting plasmids were 
transformed into MPS26, cells were grown in SD-Ura-Met and localisation was 
examined in live cells during log phase growth. To test if the Lsmlp domains would 
allow for GFP localisation to P-bodies under hypo-osmotic stress conditions, cells 
were incubated in water for 10-60 min before examining localisation in live cells. All 
GFP-fusions showed localisation identical to GFP alone, i.e. throughout the cell, 
excluding vacuoles (Fig. 9.3). This indicates that the terminal extensions of Lsm 1 p 
and Lsm8p by themselves do not suffice as localisation signals. This does not rule 
out that they may play a role in localisation, possibly as part of a signal sequence 
together with domains of other Lsm proteins. The human SmB protein is an example 
of this as, deletion of its C-terminal domain leads to reduced nuclear localisation, 
284 
even though it did not suffice as a nuclear localisation signal when fused to GFP 
(Girard el al., 2004). 
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Fig. 9.2 Anti-GFP Western analysis of GFP-tagged Lsml and Lsm8 mutant 
and hybrid proteins. (A) Schematic overview of hybrids and deletion mutants 
of Lsmlp and Lsm8p. (B) MPS26 cells carrying the plasmids expressing the 
hybrid and mutant proteins GFP-tagged at the N- or C-terminus were grown 
into stationary phase in SD-Ura-Met and total protein samples were prepared 
of equal OD600  units. Proteins were separated by SDS-PAGE. Western blotted 
and probed with anti-GFP antibody. Equal loading was tested for by probing 
with anti-a-Tubulin antibody. 
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Fig. 9.3 Neither the N-terminal, nor the C-terminal extension of Lsm I p or 
Lsm8p is sufficient for localisation to P-bodies or nuclei respectively when 
fused to GFP. GFP-Lsm I localises to P-bodies under stress conditions (A), 
whereas LsmIN-GFP (B) and GFP-LsmIC (C) localise throughout the cell, 
like GFP (G) even under stress conditions. GFP-Lsm8 localises to the nucleus 
(D), whereas Lsm8N-GFP (E) and GFP-Lsm8C (F) localise throughout the 
cell. MPS26 was transformed with pGFP-N-Lsml, pMRI44 (IN), pMRl33 
(IC), pGFP-N-Lsm8, pMR 132 (8N), pMR 156 (8C), or pGFP-N-FUS. Cells 
were grown in SD-Ura-Met and localisation was examined during log phase 
growth. Localisation under stress conditions was examined after hypo-osmotic 
shock in water for 10-60 mm. 
9.4 No single domain of Lsm8p is essential for nuclear 
localisation 
Three different strategies were used to investigate the requirement of Lsm8p domains 
for its nuclear localisation. Firstly, mutations were made in the putative RNA binding 
residues to see if RNA binding is a prerequisite for nuclear localisation. Secondly, 
deletions of N- and/or C-terminal domains were made to see if, like for human 
SmBAC (Girard el al., 2004), localisation would be reduced. Thirdly, N-terminal, C-
terminal or Sm domains of Lsm8p were replaced by those of Lsmlp to see if any 
particular domain from Lsmlp would lead to nuclear exclusion. 
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9.4.1 Reduced RNA binding may affect Lsm8p nuclear localisation 
To test the effect of mutations in the putative RNA-binding Knuckle motifs, three 
different ma mutations were made in LSM8. Two of these were made in or near the 
Knuckle I motif: lsm8 ma] carried the mutations N28A and D31A, and lsm8 mna2 
carried the mutations T34A and N35A. A third, lsm8 rna3, was made in the Knuckle 
II motif and carried the mutations R57A, G58W and S59A. Based on analogous 
residues in Lsmlp (Fig. 9.1)(Tharun et al., 2005) these would be expected to form 
the RNA-binding pocket (T34, N35, R57, S59) or be important for positioning of 
these residues (D31, G5 8). Mutations were introduced by site-directed mutagenesis 
using the Quik Change method in pGFP-N-Lsm8. Presence of the correct mutations 
and absence of any others in the LSM8 coding sequence were checked by 
sequencing. The lsm8 mutant genes could then be amplified by PCR and cloned into 
pGFP-C-FUS with or without the GFP fusion. 
MPS26 was transformed with these plasmids expressing N- or C-terminally tagged 
mutant proteins from the MET25 promoter. Cells were grown in SD-Ura or when 
fluorescence proved to be too weak in SD-Ura-Met, and localisation was examined 
in live cells during log phase growth. The ma] and rna2 mutations showed to have 
no significant effect on nuclear accumulation of Lsm8p (Fig. 9.4A). In contrast, the 
rna3 mutation in N-terminally tagged Lsm8p caused this protein to localise 
throughout the cell. However, when the same protein was tagged on the C-terminus it 
accumulated in the nucleus at levels comparable to those of wild-type GFP-Lsm8p 
(Fig. 9.4A). When, in addition to the ma mutations, the C-terminal domain of Lsm8p 
was replaced with that of Lsm 1 p  all proteins failed to accumulate in the nucleus, 
irrespective of what side the GFP tag was on. Fluorescence of these hybrid proteins 
was extremely weak, potentially indicative of problems with correct folding, as 
expression levels were shown to be unaffected (Fig. 9.2). In contrast, replacement of 
the C-terminus of Lsm8p with that of Lsmlp in Lsm881p did not prevent 
accumulation of this hybrid protein in the nucleus, although nuclear levels were 
reduced compared to wild type (Fig. 9.413). 
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Fig. 9.4 Effects of mutations in putative RNA binding residues of Lsm8p on its 
nuclear localisation. MSP26 was transformed with plasmids (A) pGFP-N-Lsm8 
and pMR83 (pGFP-C-Lsm8); pMR70, 71 and 72 (pGFP-N-Lsm8 ma 1, 2 and 3); 
pMR92, 93 and 94 (pGFP-C-Lsm8 ma 1, 2 and 3); (B) pMR70 and 84 (pGFP-N 
and -C-1sm881); pMR73, 74 and 75 (pGFP-N-Lsm881 mat, 2 and 3); and pMR95, 
96 and 97 (pGFP-C-Lsm881 rnal, 2 and 3). Cells were grown in SD-Ura 
(-Met) and localisation was examined in live cells during log phase growth. (A) 
Lsm8p. Lsm8-rnalp and -rna2p accumulate in the nucleus, but Lsm8-rna3p only 
accumulates in the nucleus when tagged on the C-terminus. (B) Mutant Lsm8 
proteins that have their C-terminal domains replaced with that of Lsm I  in 
addition to the ma mutations fail to accumulate in the nucleus altogether and 
show extremely weak fluorescence, whereas Lsm8l I  shows reduced, but 
significant nuclear accumulation. 
9.4.2 Any of the Lsm8p domains can be deleted or replaced 
without complete loss of nuclear accumulation 
I have shown that the Lsm8p N- or C-terminal domains are not sufficient to allow 
GFP to accumulate in the nucleus (9.3). To test if these domains are essential for 
nuclear accumulation of Lsm8p, the termini were deleted or replaced with those of 
Lsmlp. Thus, the following mutant and hybrid proteins were created: Lsm8iCp, 
Lsm88lp, LsmAN88p and Lsml88p. To test if the central Sm-domain is essential for 
nuclear localisation (e.g. by giving Lsm2-8p U6 snRNA specific binding activity) 
this domain was replaced with that of Lsmlp in Lsm8l8p. In addition the Sm domain 
of Lsmlp was replaced with that of Lsm8p in Lsml81p. MPS26 was transformed 
with plasmids expressing these proteins, GFP tagged on the N- or C-terminus, from 
the MET25 promoter. Localisation was examined in live cells during log phase 
growth. 
The C-terminal domain of Lsm8p is not essential for nuclear accumulation as both 
Lsm8ACp and Lsm881p still accumulated in the nucleus (Fig. 9.5A). Both were 
significantly reduced however, particularly GFP-Lsm8ACp, suggesting that the 
Lsm8p carboxy-terminal domain does contribute to efficient nuclear localisation. 
The N-terminal domain is not essential for nuclear accumulation either, as both 
LsmAN88p and Lsm188p still accumulated in the nucleus (Fig. 9.513). Again, 
reduced nuclear localisation, particularly for Lsm l88p, suggests that the N-terminal 
domain plays a significant role in localisation to the nucleus. Finally, failure of 
Lsm 181 p  to accumulate in the nucleus and nuclear localisation of Lsm8 i8p suggests 
that the Sm-domain of Lsm8p is neither essential nor sufficient for nuclear 
















Fig. 9.5 None of the Lsm8p domains is essential for nuclear localisation, 
but the N-terminal domain plays a central role. MSP26 was transformed with 
plasmids (A) pMR70 and 80 (pGFP-N-Lsm881 and Lsm8AC), pMR84 and 104 
(pGFP-C-Lsm881 and Lsm8AC); (B) pMRI 16 and 114 (pGFP-N-Lsm81 8 and 
181), pMRI25 and 123 (pGFP-C-Lsm818 and 181); (C) pMR126 and 140 
(pGFP-N-Lsm188 and lsmiN88), pMRI 17 and 141 (pGFP-C-Lsm188 and 
lsmAN88); (D) pMRI 15 and 129 (pGFP-N-Lsm8l I and Lsm8IAC), pMRI24 
and pMRI3O (pGFP-C-Lsm8l I and Lsm8IAC). Cells were grown in SD 
-Ura(-Met) and localisation was examined in live cells during log phase growth. 
(A) The C-terminal domain is not essential for nuclear localisation, but does 
contribute as N-terminally tagged Lsm8AC fails to accumulate strongly in the 
nucleus; (B) The central Sm-domain is not essential or sufficient for nuclear 
localisation but does contribute as N-terminally tagged Lsm8 18 shows 
significantly reduced nuclear localisation; (C) The N-terminal domain is not 
essential for nuclear localisation as LsmAN88 and Lsm 188 still accumulate in 
the nucleus, although at reduced levels; (D) The N-terminal domain of Lsm8p 
fused to the Sm-domain and C-terminal domain of Lsmlp allows these proteins 
to accumulate in the nucleus, showing that the N-terminal domain of Lsm8p 
as part of a functional Lsm protein is sufficient for nuclear accumulation. 
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9.4.3 The N-terminal ten amino acids of Lsm8p have a function in 
nuclear localisation 
Generally, combining hybrids of Lsm8p and Lsmlp, or other mutations in Lsm8p 
with an N-terminal GFP tag seemed to affect nuclear accumulation more strongly 
than when the same mutations were combined with the C-terminal GFP tag (Fig. 9.4 
and 9.5). This suggests that the N-terminus plays a role in nuclear accumulation, 
although I have already shown it is neither essential (Fig. 9.513) nor sufficient on its 
own (Fig. 9.3E). To see if these ten residues are sufficient for nuclear accumulation 
in the context of the Lsm complex they were fused to the Sm domain and/or C-
terminal domain of Lsmlp in Lsm81iCp and Lsm8l ip. MP526 was transformed 
with plasmids expressing these hybrid proteins, GFP tagged on the N- or C-terminus. 
Localisation was examined in live cells during log phase growth. These hybrid Lsm 
proteins carrying only the N-terminal ten amino acids and no other part of Lsm8p 
accumulated in the nucleus, at least when tagged on the C-terminus (Fig. 9.5D). This 
indicates that these residues play a central role in nuclear localisation of Lsm8p. 
9.5 Lsmlp, Lsmlp mutants and Lsml/8p hybrids localise to 
P-bodies 
It seems likely that Lsmlp has a nuclear exclusion signal as it is generally assumed 
that Lsmlp localises exclusively to the cytoplasm. Tharun et al. (2000) performed 
immuno-staining on cellular Lsmlp (HA-tagged on the genome) and showed it to be 
more prominent in the cytoplasm, whereas others have shown Lsmlp to be excluded 
from the nucleus altogether (Spiller, 2005). The reason for this apparent 
contradiction is unknown. Here, GFP-tagged Lsmlp was shown to localise 
throughout the cell, only excluding vacuoles, making it difficult to look for a nuclear 
exclusion signal. Apart from its presumed cytoplasmic localisation Lsmlp 
concentrates in P-bodies under stress conditions (Sheth et al., 2003; Teixeira et al., 
2005). To investigate whether any of the Lsmlp domains plays a role in localisation 
to these foci a similar approach was taken as for Lsm8p (section 9.4). Deletions of N-
and/or C-terminal domains were made as well as exchanging N-terminal, C-terminal 
or Sm domains for those of Lsm8p. 
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9.5.1 No single domain of Lsmlp is essential for localisation to P-
bodies 
Plasmids expressing N- or C-terminally GFP tagged mutant or hybrid proteins from 
the MET25 promoter were transformed into AEMY25 (ismiA). Cells were grown in 
SD-Ura-Met and localisation was examined in live cells during log phase growth or 
after hypo-osmotic shock (10-60 min incubation in water). The Lsmlp C-terminal 
domain seems not to be essential for localisation to P-bodies as LsmlACp and 
Lsmll8p were shown to localise to P-bodies (Fig. 9.6A). The N-terminal domain 
and central Sm-domain seem not to be essential either, as LsmAN1 ip and Lsm8l ip 
(Fig. 9.613) as well as Lsml8lp (Fig. 9.6C) were shown to accumulate in P-bodies 
under stress conditions. Localisation to P-bodies was however, significantly reduced 
compared to wild type, as only 5-20% of cells expressing these mutant or hybrid 
Lsml proteins showed foci, compared to 90% of cells expressing GFP-Lsml. 
Interestingly, Lsml88p accumulated in the nucleus (Fig. 9.513; Fig. 9.613), but it 
accumulates in cytoplasmic foci under stress conditions. This suggests that the N-
terminal domain of Lsmlp in combination with the Sm- and C-terminal domains of 
Lsm8p is sufficient to allow concentration in P-bodies. 
9.5.2 Lsmlp, Lsmlp mutants and Lsml/8p hybrids co-localise 
with Dcp2-RFP 
To test whether the foci observed for Lsm 1 ACp and Lsm I 18 were indeed P-bodies, 
co-localisation with Dcp2p, another P-body component, was investigated. Dcp2-RFP 
was expressed from its own promoter from pRP1155 (CEN-LEU2-DCP2-RFP) and 
GFP-Lsm 1, GFP-Lsm 1 AC, GFP-Lsm 118 and GFP were expressed from the MET25 
promoter. Localisation was examined in live cells approximately 60 min after 
glucose starvation. For this purpose log phase cells grown in SD-Ura-Leu-Met were 
washed with and resuspended in glucose-free medium and incubated at room 
temperature. Dcp2-RFP was shown to localise to foci in all cells, and co-localised 
with GFP-Lsml, Lsm1AC and Lsmll8 foci (Fig. 9.7), showing that these mutant 
and hybrid proteins accumulate in P-bodies under stress conditions. 
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Fig. 9.6 None of the Lsm I  domains are essential for localisation to P-bodies 
under stress conditions AEMY25 (Ism /A) was transformed with plasmids (A) 
pGFP-N-Lsml, pMR79 (pGFP-N-Lsml 18) and pMR69 (pGFP-N-LsmltsC); 
(B) pMR 124 (pGFP-C-Lsm8 II) and pMR 135 (pGFP-C-LsmN 11); (C) 
pMRI23 (pGFP-C-Lsml8l); and (D) pMRI26 (pGFP-N-Lsm188). Cells were 
grown in SD-Ura(-Met) and localisation was examined in live cells during 
log phase growth or after hypo-osmotic shock (stress). (A) The C-terminal 
domain is not essential for localisation to P-bodies as Lsm 1 z\Cp and Lsm I 18 
still localise to P-bodies (indicated by arrows); (B) The N-terminal domain is 
not essential for P-body localisation as LsmiN lip  and Lsm8l ip still accumu-
late in P-bodies under stress conditions, although this is strongly reduced for 
Lsm8 lIp; (C) The central Sm-domain is not essential for P-body localisation; 
(D) Although Lsm I 88 accumulates in the nucleus (N), the N-terminal domain 
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Fig. 9.7 Lsm lp, Lsm I ACp and Lsm ll8p co-localise with Dcp2p in 
cytoplasmic foci. AEMY25 (lsmIA) was transformed with pGFP-N-
Lsrn 1, pMR69 (pGFP-N-Lsrn I AC), pMR79 (pGFP-N-Lsm 118) and 
pGFP-N-FUS together with pRPI 155 (DCP2-RFP). Cells were grown 
in SD-Ura-Leu-Met and localisation was examined in live cells 60 mm 
after glucose starvation. 
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9.6 The Lsmlp and Lsm8p N-terminal domains are required 
for distinct cellular localisation 
It seems that the N-terminal domains of Lsm I  and Lsm8p play a central role in their 
localisation. To test what happens to localisation of mutant and hybrid proteins in 
their absence MPS26 was transformed with plasmids expressing N- or C-terminally 
GFP-tagged LsmANI 1, LsmAN88, Lsm81AC, Lsm18AC, LsmANI8, LsmAN81, 
LsmAN I AC and LsmAN8AC mutant proteins from the MET25 promoter. Cells were 
grown in SD-Ura-Met and localisation was examined in live cells during log phase 
growth and after hypo-osmotic shock. In the absence of the N-terminal domain both 
Lsmlp (LsmANlIp) and Lsm8p (LsmAN88p) accumulated in the nucleus as well as 
in foci (Fig. 9.8A). As Lsm8lACp accumulated in the nucleus and Lsml8ACp 
accumulated in P-bodies (Fig. 9.813), it seems that in the absence of the C-terminal 
domain the N-terminal domain, not the Sm domain, determines the sub-cellular 
localisation. These data suggest that the N-terminal domains do indeed play a central 
role in determining the sub-cellular localisation of the Lsm I and Lsm8 proteins, and 
presumably Lsm 1-7 and Lsm2-8 complexes. The carboxy-terminal domains seem to 
have a function in localisation as well. LsmAN18 mainly accumulated in the nucleus, 
whereas LsmAN8I mainly accumulated in P-bodies (Fig. 9.8C). Although in the 
absence of the N-terminal domain these mutant and hybrid proteins do not have one 
distinct sub-cellular localisation, the carboxy-terminal domain, not the Sm domain, 
seems to determine the preferred site of accumulation. The Sm domain of Lsmlp 
alone accumulated both in nuclei and P-bodies, whereas the Sm domain of Lsm8p 
alone showed extremely weak fluorescence, but in some cells accumulated in foci 
(Fig. 9.813). It therefore appears that in the absence of both N- and C-terminal 
extensions, the Sm domains of Lsm Ip and Lsm8p do not have a strongly preferred 
localisation site. Their potential for P-body localisation (and nuclear localisation in 
case of LsmAN1AC) does suggest that they incorporate into the Lsm complexes. 
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Fig. 9.8 The Lsrn I  and Lsm8p N-terminal domains are required for distinct 
localisation. MPS26 was transformed with plasmids: (A) pMR 134 and 140 (pGFP-
N-LsmANl I and LsmAN88), pMR 135 and 141 (pGFP-C-LsmANI I and LsmAN88); 
(B) pMRI29 and 137 (pGFP-N-Lsm8IAC and LsmI8AC), pMRI3O and 138 (pGFP-
C-Lsm8 I AC and Lsm I 8AC); (C) pMR 143 and 147 (pGFP-N-LsmAN 18 and Lsm 
AN8I). pMRI45 and 148 (pGFP-C-LsmANI8 and LsmAN8I); (D) pMRI5O and 
153 (pGFP-N-LsmANIAC and LsmAN8AC), and pMRI5I and 154 (pGFP-C-Lsm 
ANIAC and LsmAN8AC). Cells were grown in SD-Ura-Met and localisation 
was examined in live cells during log phase growth and after hypo-osmotic shock. 
(A) In the absence of the N-terminal domain both Lsrnlp and Lsm8p accumulate 
in the nucleus (N) as well as in foci (P) after osmotic shock; (B) Lsm8 I AC accumu-
lates in the nucleus, whereas Lsm I 8AC accumulates in P-bodies; (C) LsmAN 18 
and LsmAN 18 localise to both, but LsmAN 18 mainly accumulates in the nucleus, 
whereas LsmAN8lmainly accumulates in P-bodies; (D) The Sm domain of Lsmlp 
accumulates in both nuclei and P-bodies, whereas the Sm domain of Lsm8p shows 
extremely weak fluorescence, but may also accumulate in foci. 
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In summary, the N-terminal domains of Lsmlp and Lsm8p seem to most strongly 
confer preference for localisation to P-bodies or nuclei and seem to prevent 
localisation of Lsm8p to P-bodies and of Lsmlp to the nucleus. The C-terminal 
domains seem to play a secondary role as they determine the preferred site of 
accumulation in the absence of the N-termini. Finally, the central Sm domains do not 
seem to have a significant effect on localisation, although exchanging these domains 
between Lsmlp and Lsm8p does lead to reduced localisation to P-bodies and nuclei 
respectively. 
9.7 A correlation between viability and correct localisation 
All mutant and hybrid proteins, either GFP-tagged on the N- or C-terminus (pGFP-
N-FUS or pGFP-C-FUS respectively) or without a tag (pMET25), were tested for 
their ability to support viability. Plasmids were transformed into AEMY25 (lsmM) 
and MPS 11 (lsm8A PGAL-HA-LSM8) and tested for growth at a range of temperatures 
by streaking on SD-Ura (low level of expression) and SD-Ura-Met (high level of 
expression). Growth in MPSI 1 was tested at 18, 23, 30, 36 and 37°C, whereas 
growth in AEMY25 was tested at permissive (30°C) and non-permissive 
temperatures (36 and 37°C). The amount and rate of growth was compared to a 
positive control (pGFP-N-Lsm8 for MPS I 1; pGFP-N-Lsml for AEMY25) and a 
negative control (pGFP-N-FUS) and given a score: i I I I for growth like the positive 
control, - for background growth like the negative control and +++, ++ or + for 
anything in between. 
There seemed to be a clear correlation between viability in 1sm8A and accumulation 
in the nucleus (Fig. 9.9A; Table 9.1). All mutant and hybrid proteins that 
accumulated in the nucleus only were able to support viability to some extent. Even 
some of the proteins that accumulated in the nucleus as well as in P-bodies supported 
growth. There was a tendency for mutants and hybrids to support growth better at 
lower (18 and 23°C) than at higher temperatures (230°C). Mutant and hybrid Lsm8 
proteins with a GFP-tag on the Lsm8p N-terminus generally showed less growth than 
the same proteins with a C-terminal tag or no tag, emphasising the importance of a 
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Fig. 9.9 Summary of localisation and viability of Lsm I and Lsm8 hybrid 
and mutant proteins. (A) Mutant proteins that accumulate in the nucleus. 
Most proteins that accumulate in the nucleus are also able to support growth 
of an lsm8A strain; (B) Mutant proteins that accumulate in P-bodies. Most, 
but not all proteins that accumulate in P-bodies are also able to support 
growth of an IsmM strain at non-permissive temperature. Lsmlp domains 
are indicated in red; Lsm8p domains are indicated in green. Viability was 
scored by comparison to the wild-type plasmid (++++) and the GFP only 
negative control (-). * Proteins that accumulate both in nuclei and P-bodies. 
Viable in lm,9 P-HA-LSM8 LSM7-MYC 'UPS1 1) background 
atl8CinSD 	I at23CinSD at3OCinSD at36CinSt) at3TCinSO 
olasmud -Ura -Urn-Met I -(ira -(ira-Met -Urn -(ira-Met -tire -tire-Met -Ura -(ira-Met 
pGFP-N-L&nB +4+4 *44 ** ***** * 
pGFP-C-LsmO 
*4+ **** 
*  *++ 
oMET25-Lsm8 +*.+ ***** + *** ***** 4* +++t 
pGFP-N-Lsrn881 - - + - - o t. ni n i n  
pGFP-C-Lsn1881 +4* .... 
QMET25-Lsm881 *-+. +.*-.  
pGEP-M-LsrnB trial *.+* .... 4*4+ +4*4  
pGFP-C-LsmB mal 4+4* ++-t+ -t*+ 
* 
++t+ +.$ +++ +++* +•*. * .t* 
oMET25-Lsm8 foal +4*4 *..*.+ ++*+ +t ***+ +*+ ++++ •+++ ++++ +44* 
pGFP-N-Lsm8 rna2 +.s-t+ *s-++ 4-44+ 4+4+ +44 +4+4  
pGFP-C-LsmS rna2 +44* +*  +**t +4*4 *44 * 
oMET25-isrn6 rna2 +4*4 *4+4 
**+*** 
*  4 4*4 +*++ **t* *44+ +44+ *44+ 
pGFP-N-LsmS ma3 + . + - - n t n t n t. nt. 
pGFP-C-LsrnB ma3 + +4 *4 +4+ - 4 - - n t nt. 
oMET25-Lsni8 rna3 +. + +++ - +. - - , 	t. nt 
pGFP-N-Lsm881 rnal n t n t n t 0 t - - fl,t fl t. fl t n.t 
pGFP-C-Lsm881 inal - - n t - - - - itt n.j 
MET25-Lsm881 trial - - n t - - - - nt. nt. 
pGFP-N-Lsm881 ma2 n t n t n.j 0 t - - n.j. nt. 0.t. n.j 
pGFP-C-Lsm681 rna2 - - ni - - - - - nt. nt 
MET25-Lsm881 rna2 - - n t. - - - - - nt nt. 
pGFP-N-LsmSBl ma3 it t n.j n t. n - - n.j. nt. n.j. nt. 
pGFPC-Lsm881 rna3 - - n t. - - - - - itt. nt. 
.,MET25-Lsm881 rna3 - n t - . - - - fl.j n.j 
%C - . - 4- - - n.j itt. n.j. n.i 
pGEP-C-Lsm8\C *** 4*4+ +4 4*4+ - +++ - - n.j nt. 
pMET25-Lsrn8.\C **-* ++*+ -i-+ +-*.. ..- +++. - - n.j. n.j. 
pGFP-N-Lsm118 n t - n.t - nt. - n.j, ni nt. nt. 
pGFP-C-Lamll8 n  - n t. - n I - n.j nt. nt. n.t 
ME125.Lsml 18 n t - n t - n j. - n.j n.j. I 	n.t. n.t 
pGFP-N-Lsml8l n I - n t - n t - n I n I. n.t n.j 
pGFP-C-Lsnil8l n - n t. - fit. - n t. n.j n I n.t 
MET25-Lsm181 fit - n - fit. - n.t. n  n.t. n.j 
pGFP-N-Lsm811 - *-. - 4 - - fit. n.j. n t n.j 
pGFP-C-LsmBll - 4--i- - - - - n.t. nt. n 	. n.j. 
MET25-Lsm811 - +-.-+ . .i-+ - - - - - 
pGFP-N-LsmBlB - + - - - n  n.j n.t ni 
pGFP-C-Lsm818 - *+.  
MET25-Lsm818 - •' - .'-.'-- - - - 
pGFP.N-LsmlBS * ++ + + *-+ - - - 
pGFP-C-LsmlSB *4 *+ ++ *1 4+ +4i- - + - - 
MET25-Lsrn188 + *4+ *4 ++ - + - + 
pGFP-N-Lsm18.0 n-t. - n.j. - nt. - nt. - nt. n.t. 
2GFP-C--Lsrnl8f.0 n.j - nt. - n.j. - n.j. - n-t. n1. 
pMET25-LsmlB.SC n j - n.j. - n - nt. - n.j. n.t 
pGFP-N-Lsm81.0 n.t - ni - n.j. - nt. - n.j. n.j. 
pGFP-C-Lsm81.0 n.j - n t. - n.t. - nt. - n.t. nt. 
pMET2-Lsm81C - - - + nt - n.j. n.j 
pGFP-N-Lsm..\N11 + t - nt - n t. - n.j - nt. n.j. 
pGFP-C-Lsm.%N1 1 n t - nt. - nt. - ni - n t. n t. 
pMET25-Lsm.\N11 - +. - + - - n.j. - n-t. nt. 
pGFP-N-Lsm.\N88 4* ++-i- 4*4 + +++ - n.j. n.j. 
pGFP.C-AN88 4+ +' i- *' - - nt. + t. 
nMET25-Lsm-\N88 *4 **-i- *4 .i. ++ .4+ n.j. • n-t. - 
pGFP-N-LsrnNl.'.0 n.j. - nt. - n.j. - n.j - n.j. n-t. 
pGFP-C-Lsm \N1.0 n t n.j - n.j. - n - n.j. n.j 
pMET25-Lsn0N1.\C n itt. - n 	. - n 	. - n.j. n.j 
pGFPN-Lsrn.\N8.\C n t - n.j. - n.j. - n.j. - n-t. n.j. 
pGFP-C-Lsm.\N8\C n t - n t. - it t - n.i - n.j. n.j. 
pMET25-Lsm.N8.\C it 	I - n.j - n I - n.j. n t ,  n.j 
pGFP-N-Lsrn.N18 n - n.j - fit - n.j. - n.t. n.j. 
pGFP-C-Lsni.N18 n - n - fit. - n.j - n.j n.j. 
pMET25-Lsm.N18 + t - n . itt. - n j - n.j. n.1. 
pGFP-N-Lsm.N81 n t - n I - n.j. - n t. . n.t. n.j. 
pGFP-C-Lsm.N81 n t . fl t - fl t. - fl.t . fit. n 
oMET25-Lsmi.N81 itt - n - n.j. - n.j. - n.j. n.j. 
pGFP-N-Lsm8..0 NLS . . - 4+ . 4 - - fl.t 
pGFP-C-Lsm8\C NLS + 4+4+ *4 *44* * +4+ - +4 Ii 
pMET25-Lsm8 \C NLS + *+* * **++ * *•+ - 4+ nt. 
r,MET25-Ism8 rna3 NLS I 	+ .*+ .i-*. • - - n.t - 
Table 9.1 Viability of an lsm8E strain expressing mutant and hybrid Lsm8 proteins. Indicated 
plasmids were transformed into MPS 11 and tested for growth on SD-Urn and SD-Ura-Met at 
18, 23, 30, 36 and 37'C. Amount and rate of growth were compared to that for pGFP-N-Lsm8 
and pGFP-N-FUS and given a score: +-+--H- for growth like the positive control, — for background 
growth and +++, -H- or ± for anything in between. n.t. = not tested 
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Viable in lsrn1\ (AEMY25) background 
at 36°C in SD 	at 37°C in SD 
ølasmid -Ura 	-Ura-Met 	-Ura 	-Ura-Met 
pGFP-N-Lsml •+++ 	++++ +44+ 
pGFP-C-Lsml ++ 	 +4+ - 	 ++ 
pMET25-Lsml ++++ 	++++ +4+ 	++++ 
pGFP-N-Lsm881 - 	 - - 	 - 
pGFP-C-Lsm881 - - - - 
oMET25-Lsm881 - 	 - - 	 - 
pGFP-N-Lsmll8 + +4+ - + 
pGFP-C-Lsmll8 - 	 +++ - 	 + 
pMET25-Lsm118 + +4+ - ++ 
pGFP-N-Lsm1C - 	 ++ - 	 + 
pGFP-C-Lsm1\C - 	 - - 	 - 
pMET25-Lsm1\C n.t n.t nt. nt. 
pGFP-N-Lsml8l nt. 	- - 	 - 
pGFP-C-Lsm181 - - - - 
oMET25-Lsml8l +4 	 +4 - 	 + 
pGFP-N-Lsm811 - 	 - - 
pGFP-C-Lsrn811 +4  
pMET25-1-srn8l 1 - 	 - - 	 - 
pGFP-N-Lsm818 - 	 - - 	 - 
pGFP-C-Lsm618 - - - - 
MET25-Lsm818 - 	 - - 	 - 
pGFP-N-Lsm188 - 	 - - 	 - 
pGFP-C-Lsm188 - - - - 
MET25-1-srn188 - 	 - - 	 - 
pGFP-N-Lsml&\C - - - - 
pGFP-C-Lsml8.\C - 	 - - 	 - 
pMET25-Lsml8\C - - 
pGFP-N-Lsm81\C - 	 - - 	 - 
pGFP-C-Lsm81\C - - - - 
pMET25-1-sm8l\C + 
pGFP-N-LsmN11 - 	 - - 	 - 
pGFP-C-Lsm\N11 - - - - 
pMET25-LsmAN11 + 	 + - 	 - 
pGFP-N-Lsm.\N88 - 	 - - 
pGFP-C-LsmN88 - - - 	 - 
pMET25-LsmSN88 - 	 - - 
pGFP-N-Lsm\N18 - - 	 - 
pGFP-C-LsmN18 - 	 - - - 
pMET25-Lsm\N18 + + - 	 - 
pGFP-N-Lsm\N81 - 	 - - 	 - 
pGFP-C-LsmN81 - - - - 
pMET25-Lsm\N81 - 	 - - 	 - 
pGFP-N-Lsm\N1\C - 	 - - 	 - 
pGFP-C-Lsm-\N1\C - - - - 
pMET25-Lsm\N1\C + 
pGFP-N-Lsm\N8\C - 	 - - 	 - 
pGFP-C-Lsm\N8\C - - - - 
pMET25-LsmN8L\C - - 	 - 
Table 9.2 Viability of an Ism 1A strain expressing mutant and hybrid Lsml 
proteins at non-permissive temperature. Indicated plasmids were transformed 
into AEMY25 and tested for growth on SD-Ura and SD-Ura-Met at 36 and 
37CC. Amount and rate of growth were compared to pGFP-N-Lsrn I and 
pGFP-N-FUS and given a score: +±-H- for growth like the positive control, 
- for background growth and +±+, -H- or + for anything in between. n.t. 
not tested 
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freely available Lsm8p N-terminal domain. Although the two correlate, reduced 
viability of Lsm8p mutants and hybrids may not necessarily be caused by reduced 
nuclear localisation in all cases. Instead they may both have the same cause, e.g. 
reduced complex formation. To test if increased nuclear localisation would allow 
increased levels of growth, the nuclear localisation signal (NLS) of simian virus 40 
(SV40) large T antigen was added to Lsm8ACp and Lsm8-rna3p. However, neither 
showed increased nuclear accumulation or increased viability (Table 9.2; data not 
shown), although the fusions were stably expressed (Fig. 9.2). The reason for the 
failure of the SV40 NLS to localise these Lsm8 mutant proteins to the nucleus is 
unknown. It should be noted however, that the SV40 NLS could not efficiently 
replace the NLS-like motif of SmB either, whereas the same SV40 NLS fused to 
GFP was shown to allow for its nuclear accumulation (Bordonné, 2000). This may 
suggest that the SV40 NLS is not accessible due to association of the NLS-tagged 
proteins with other (L)Sm proteins. 
The stringency for growth at non-permissive temperature for mutants and hybrids in 
the ismiA background seemed to be higher. Only few mutants and hybrids showed 
some growth at 36°C, and even fewer at 37°C (Fig. 9.913; Table 9.2). Although not 
all mutant and hybrid proteins that were able to accumulate in P-bodies supported 
growth at non-permissive temperatures, there was still a correlation between P-body 
localisation and viability, as all proteins that did support growth also accumulated in 
foci. 
9.8 Levels of mutant and hybrid protein expression affect 
viability 
As results in Table 9.1 and 9.2 show, the level of expression of mutant and hybrid 
proteins has a significant effect on their ability to support growth. Whereas 
expression of wild-type Lsmlp and Lsm8p in the presence of 1mM methionine (i.e. 
the MET25 promoter is repressed) still allowed growth at all temperatures, most 
mutants and hybrids showed a reduction in the amount of growth. Indeed, increased 
expression of ism 118 from the GAL] promoter (pMR71) showed still more growth in 
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ismiA at non-permissive temperature than when this hybrid protein was expressed 
from the MET25 promoter (pMR89) in the absence of methionine (data not shown). 
Expression from the MET25 promoter is significantly lower than from the GALl 
promoter (Mumberg et al., 1994; Niedenthal et al., 1996). To estimate how much 
higher the level of expression is from the MET25 promoter compared to natively 
expressed LSM8, Northern analysis was performed on total RNA from BMA38a 
(with pGFP-N-FUS) and MPS 11 (lsm8A PGAL-LSM8)  transformed with pGFP-C-
LSM8. Cells were grown in SD-Ura with or without 1 mM methionine to an 0D6 00 
of 0.5. Total RNA was extracted and used for Northern analysis. The Northern blot 






mRNA •( 	16 z 
ac 
E 	14 
L 12 _.1 . .s 	10 8 ow 6 
LSMBmRNA 4 C 
2 
lBS rRNA = 0 - 
LSW LS-GFP LSJ-GFP 
TSA1 mRNA 
	
SET-OFF MET ON 
46P 4W 10 
Fig. 9.10 LSM8 probed Northern comparing the levels of native LSM8 
expression to those of LSM8-GFP from the pGFP-C-FUS MET25 promoter 
under growth conditions in which the promoter is switched OFF (+Met) or 
ON (-Met). BMA38u (WT) was transformed with pGFP-C-FUS; MPS II 
(PG4/ -LSM8) was transformed with pGFP-C-LSM8. Cells were grown in 
SD-Ura with or without 1 mM methionine to OD 500 of 0.5. Total RNA was 
extracted and used for Northern analysis (A). The Northern was probed with 
a single stranded DNA probe covering the full LSM8 coding sequence. 
Loading was controlled for by probing the same Northern with oligonucleo-
tide probes against 18S rRNA and TSA 1 mRNA. (B) Quantification of bands 
shows that under MET-OFF conditions the level of LSIvI8 expression is 
approximately 3.5 times higher than expression from the native promoter. 
Under MET-ON conditions the expression is approximately 4.5 times higher 
than under MET-OFF conditions, making expression of LSM8-GFP under 
MET-ON conditions 16 times that of native LSM8. 
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sequence. Quantification of bands showed that in the presence of 1mM methionine 
the level of LSM8-GFP mRNA was approximately 3.5 times that of natively 
expressed LSM8 mRNA. In the absence of methionine the expression was 
approximately 4.5 times higher than in the presence of methionine, making 
expression of LSM8-GFP from the activated MET25 promoter approximately 16 
times that of native LSM8. It is likely that many of the mutant and hybrid proteins 
would not support growth when expressed at normal levels. Higher levels of 
expression may be needed to make up for reduced half lives of mutant and hybrid 
proteins. Weak fluorescence for some of the mutant and hybrid proteins (particularly 
some of the deletion mutants) may be indicative of this. Alternatively, increased 
protein levels increase the chance of at least a fraction of the population to form 
functional complexes with the other Lsm proteins. 
9.9 Effects of Lsm8 mutant and hybrid proteins on levels of 
spliceosomal snRNAs 
To investigate whether Lsm8 mutant and hybrid proteins which are able to support 
viability also bind and stabilise U6 snRNA, total RNA was extracted from strains 
expressing these proteins and used for Northern analysis. MSPI 1, an lsm8 deletion 
strain which depends on a CEN-HIS3 plasmid expressing HA-Lsm8p from the GAL] 
promoter, was transformed with pGFP-N-FUS and pGFP-C-FUS based plasmids 
expressing the mutant and hybrid proteins from the MET25 promoter. Cells were 
grown in SDGaI-Ura at 30°C into mid-log phase before shifting them to SD-Ura-Met 
and growing them for an additional lOh at 30°C. To test if cells were depleted from 
HA-Lsm8p, total protein from cells before and 10 h after the shift to glucose was 
separated by SDS-PAGE. Western analysis showed an almost complete loss of HA-
Lsm8p after 10 h (Fig. 9.1 1D). After 10 h equal numbers of cells (10 0D600 units) 
were harvested at 0D600 0.6-0.8 and total RNA was extracted under non-denaturing 
conditions. Total RNA was separated by native or denaturing PAGE. Northern 
analysis of U6 (Fig. 9.11 A) and U4 snRNAs (Fig. 9.11 B) after non-denaturing 
PAGE showed decreased levels of U4/U6 RNA for all mutants and hybrids except 
lsm8 rnal and rna2. Levels of free U6 snRNA were similarly decreased for all 
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Fig. 9.11 Levels of snRNAs in lsm8 mutants and hybrids. (A) Northern 
probed for U6 RNA after non-denaturing PAGE of total RNA shows a 
decrease in the levels of U6 and U4/U6 RNA for most lsm8 mutant and 
hybrids; (B) Same Northern probed for U4 RNA confirms the decrease in 
U4/U6 levels and shows an increase in the levels of total U4 RNA for most 
lsm8 mutants and hybrids; (C) Northern probed for all five spliceosomal 
snRNAs after denaturing PAGE; (D) Western blot on total protein probed 
with a-HA antibody shows cells are almost entirely depleted of HA-Lsm8p 
after 10h of growth on glucose; similar levels of a-Tubulin confirm equal 
loading. MSP1 1 (1sm8A PGAL-HA-LSM8) was transformed with CEN-
URA3 plasmids expressing the mutant and hybrid proteins from the MET25 
promoter. Cells were grown in SDGa1-Ura into mid-log phase before 
shifting them to SD-Ura-Met and growing them for an additional 10h at 
30°C. Equal numbers of cells (10 0D60 0 units) were harvested at 0D600 0.6-
0.8 and total RNA was extracted under non-denaturing conditions. Equal 
amounts were separated by native (A/B) or denaturing (C) PAGE. Bands 
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mutant and hybrids, including lsm8 rnal and rna2, but surprisingly, levels were only 
decreased by approximately 30-40% for most strains including the GFP only control. 
In contrast, levels of total U4 snRNA were significantly increased for all mutants and 
hybrids to levels two to six times that of wild type. The increase was the least for the 
rnal and rna2 mutants (128% and 177% of wild type respectively) suggesting that 
the increase may be (partially) related to decreased levels of U4/U6 RNA (see also 
Chapter 8). Northern analysis of all snRNAs after denaturing PAGE generally 
confirmed the above findings (Fig. 9.11 C; data not shown). Problems with proper 
separation of the RNA from lsm8 I 8-GFP (Fig. 9.11 C) suggests that quantification 
data (Fig. 9.1 IA and B) for this hybrid may not be meaningful. In addition to 
reduced levels of U6 RNA and increased levels of U4 snRNA, a change in the levels 
of U5-L and U5-S snRNA was observed. Levels of U5-L RNA were reduced for all 
lsm8 mutant and hybrid strains, whereas levels of U5-S RNA were increased 
compared to wild type, leading to a decrease in the U5-L over U5-S ratio for all 
mutants by 20-70% (compared to WT set at 100%). This was also observed for 
lsm5zl, lsm6A and lsm7zJ strains (see Chapter 8), suggesting that this is a general 
phenomenon in ism mutants, although the mechanism behind this is still unknown. 
9.10 Discussion 
In this chapter I have shown that the N-terminal domains of Lsm I  and Lsm8p play 
a central role in their localisation to P-bodies and nuclei respectively. They 
contribute to targeting these polypeptides to the correct sub-cellular sites as well as 
preventing accumulation of Lsm8p in P-bodies and of Lsmlp in the nucleus. The C-
terminal domains play a secondary role as they determine the preferred site of 
accumulation in the absence of the N-termini. Finally, the central Sm domains have 
only a minor effect on localisation, as exchange of these domains between Lsmlp 
and Lsm8p leads to reduced localisation to P-bodies and nuclei respectively. In the 
absence of the N- and C-terminal domains however, the Sm domains do not show a 
preferred site of accumulation, and in hybrids of Sm domains of one protein with 
terminal extensions of the other it is the terminal domains that determine localisation 
specificity. RNA binding specificity of the Lsm 1-7 and Lsm2-8 complexes may be a 
contributing factor to their specific localisation. Limited effects of mutations in 
putative RNA binding residues of Lsm 1 p  (Tharun et al., 2005) and Lsm8p, and 
exchange of the Sm domains argue against this, unless the terminal extensions affect 
RNA binding specificity, e.g. by interacting with nearby stem-loop structures. Lsm2-
8p has been shown to be instrumental in nuclear accumulation of the U6 snRNA 
(Spiller et al., 2007), but my results, particularly those for lsm8 rna3, suggest that 
binding of Lsm2-8p to U6 snRNA may not be essential for nuclear accumulation of 
the Lsm proteins. However, residues outside the Sm-fold may contribute to RNA 
binding specificity. The RNA binding pockets formed by residues within the Sm-fold 
give the Lsm complexes specificity for a U-rich single stranded RNA sequence, but 
the presence of an adjacent stem-loop structure was proposed to stabilise the RNA-
protein interaction (Vidal et al., 1999; this thesis). It is the latter interaction to which 
other residues, for example those in the N-terminal domains, could contribute. 
In terms of functionality Lsm8p seems to be more resistant to mutations than Lsmlp, 
as N- or C-terminal domains can be removed or replaced with those of Lsmlp and 
still support growth. Also, a mutant strain in which the central Sm domain is replaced 
with that of Lsmlp is still viable. Emphasising the functional flexibility of Lsm8p 
and the importance of the N-terminal ten amino acids of Lsm8p is the fact that 
Lsm8l Ip, a hybrid with these ten residues fused to the Sm and C-terminal domains 
of Lsmlp, allows some growth of an 1sm8A strain. Mutations in Lsmlp more readily 
affect viability, as deletion or replacement of any of the Lsm 1 p  domains strongly 
affects viability at non-permissive temperature. A mutant strain expressing Lsml 18p, 
in which the Lsm lp C-terminus is replaced with that of Lsm8p, shows most growth 
at 1sml4 non-permissive temperatures. This is surprising as the C-terminal domain 
was suggested to be functionally important (Tharun et al., 2005). Similarly affected 
growth for C-terminally tagged Lsmlp does indeed suggest that the C-terminal 
domain may have an essential function which is affected by addition of a tag. 
However, strongly reduced growth for Lsm1Cp suggests that part of this function 
may be to contribute to complex formation and/or protein stability which may be 
reduced in the absence of a C-terminal domain. There is a correlation between 
correct localisation of the mutant and hybrid proteins and their ability to support 
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growth. However, not all proteins that accumulate at the correct sites support 
viability. Obviously correct localisation is not sufficient if the mutant protein does 
not support essential functions of the corresponding complex. In addition, it has been 
suggested that temperature sensitivity of the ismizi strain is related to Lsml-7p 
function in protection of shortened 3' mRNA termini and not to Lsm l-7p function in 
decapping in P-bodies (He et al., 2001; Tharun et al., 2005). The difference in 
apparent resistance to effects of mutagenesis between Lsmlp and Lsm8p may be 
partially explained by the fact that Lsm8p is an essential protein and Lsmlp is not. 
Most of the mutant and hybrid Lsm8 proteins displayed heat-sensitive growth, but 
allowed growth at lower temperatures. Heat-sensitivity of some of the mutants and 
hybrids may be caused by reduced thermodynamic stability of these proteins or of 
the complex they are part of. This reduces the chance of the Lsm Ip mutants and 
hybrids supporting growth at ismiA non-permissive temperatures (36 or 37°C). 
As stabilisation of U6 snRNA has been suggested to be the only essential function of 
the Lsm2-8 proteins (Pannone et al., 2001), the Lsm8p mutants and hybrids that 
support viability presumably bind and stabilise U6 snRNA sufficiently. It was shown 
however, that there was only a weak correlation between levels of U6 and U4/U6 
RNA and viability of the corresponding strain, suggesting that additional functions of 
Lsm8p may contribute to the growth phenotypes of the mutant strains. The U4/U6 
levels were affected more strongly for most mutants than what was observed for 
lsm5A, 1sm64 and 1sm7A strains (see Chapter 8), whereas, surprisingly, free U6 
levels were affected less for most. The reason for this is unclear, but may reflect 
early effects of Lsm8p depletion on U4/U6 levels with U6 RNA levels decreasing 
more slowly over time. In contrast, virtually unaffected U4/U6 levels for the rnal 
and rna2 mutants suggest that Lsm2-8p function in U4/U6 di-snRNP formation is 
not affected for these mutants. Significantly reduced U6 RNA levels on the other 
hand, suggest that their ability to bind and stabilise free U6 RNA is affected. This 
seems slightly contradictory as RNA binding is thought to be essential for Lsm2-8p 
in promoting U41U6 annealing. The reason for this is unclear, but may indicate that 
protein-RNA contacts outside the single-stranded U-rich tail are more important for 
U4/U6 annealing whereas loss of the interaction with the U6 3' end is important in 
protecting U6 snRNA from degradation. 
Effects of the Lsm8 mutant and hybrid proteins on U4 snRNA levels and U5-L/U5-S 
ratios suggest that the nuclear Lsm2-8p complex may be required for efficient 
exosome-mediated degradation of U4 snRNA as well as U5-S RNA (see also section 
8.6). 
Dissection of the Lsmlp and Lsm8p proteins has proved useful in determining 
domains important for localisation of these polypeptides. Further examination of the 
specific effects some of these mutants and hybrids may have on particular processes 





10.1 Sm-like proteins are RNA chaperones 
Studies in the budding yeast S. cerevisiae have implicated the Lsm proteins in a wide 
range of RNA metabolic processes. The nuclear Lsm2 to 8 proteins, that form the 
Lsm2-8 complex and possibly alternative nuclear complexes, are required for 
efficient processing of pre-rRNAs, pre-tRNAs and pre-snoRNAs. In addition, Lsm2-
8p is required for nuclear pre-mRNA decapping and subsequent 5' to 3' degradation. 
Arguably the most important function of Lsm2-8p is stabilisation of the spliceosomal 
U6 snRNA. The Lsm2 to 8 proteins form the core of the U6 snRNP; they are stably 
associated with the 3' end of U6 snRNA, protecting it from degradation, and are 
important for efficient association of the U4 and U6 snRNAs in the U4/U6 di-
snRNP. Fernandez et al. (2004) argued that defects in the processing of other stable 
RNAs are indirect effects of reduced U6 RNA levels in the absence of a fully 
functional Lsm2-8 complex, as overexpression of SNR6 suppressed some of them. 
This issue is unresolved. 
Although depletion of Lsm proteins affects many different RNA processing events, 
the exact mechanism behind these effects still remains elusive. The eukaryotic Lsm 
proteins were suggested to function as RNA chaperones, modulating RNA-RNA and 
RNA-protein interactions. Later, the bacterial Hfq protein, which has limited 
sequence homology to the (L)Sm proteins, was shown to form a similar ring-like 
structure. This Sm-like protein functions as an RNA chaperone: e.g. it promotes 
interactions between small regulatory RNAs and their target mRNAs. This, together 
with the ability of the native human LSm2-8 complex to promote U4/U6 di-snRNP 
formation has led to the widely accepted view that all Sm-like proteins function as 
RNA chaperones. One definition of an RNA chaperone is a protein that assists in 
RNA folding by preventing misfolding or by resolving misfolded RNA structures 
(Herschlag, 1995). RNA chaperones have also been described as proteins that 
stimulate intermolecular annealing events between complementary nucleic acids 
(Tsuchihashi and Brown, 1994). As no direct evidence existed that eukaryotic Lsm 
proteins have either of these abilities, their RNA chaperone activity was still open for 
debate. 
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I have now shown that H. sapiens Lsml-7p and Lsm2-8p, as well as E. coli Hfq are 
able to promote annealing between U4 and U6 RNAs in vitro, providing the first 
direct evidence that eukaryotic Lsm complexes are indeed RNA chaperones 4, just 
like their bacterial counterparts. Failure to show the same activity for the yeast Lsm 
complexes is attributed to technical difficulties in assembling functional complexes 
from purified recombinant proteins in vitro. Two models have been proposed for the 
way in which Hfq promotes annealing between two different RNA molecules. In the 
first, Hfq binds the two RNAs simultaneously, thus increasing their chances to 
interact. In the second, Hfq destabilises secondary structures in one of the RNAs, that 
would otherwise inhibit intermolecular basepairing interactions (reviewed by 
Valentin-Hansen et al., 2004; see Fig. 5.1). Evidence exists for both models, 
suggesting that Hfq is able to employ either mechanism. To investigate the mode of 
action of the human and yeast Lsm complexes a strand displacement assay was 
developed. A stable secondary structure in the 3' half of U6 snRNA has been 
proposed to inhibit association with U4 snRNA (Fortner et al., 1994; Brow et al., 
1995). The substrate in the strand displacement assay was therefore based on the 3' 
stem-loop, to test if Lsm2-8p is able to destabilise this structure. Hfq as well as 
human and yeast Lsml-7p and Lsm2-8p displayed strand displacement activity, 
suggesting that each of these Sm-like complexes is able to destabilise RNA structure. 
I propose that this is a passive process in which binding of single stranded RNA 
along the inner pore of the ring-shaped complex bends the RNA, which in turn 
affects nearby RNA structures (Fig. 5.10). This model is supported by absence of 
strand displacement activity for an Hfq mutant that is impaired in RNA binding. 
However, strand displacement by the yeast Lsm complexes, but their failure to 
promote U4/U6 annealing suggests that RNA binding alone may not be sufficient. As 
human L5m4 was required and sufficient for both annealing and unwinding activities 
this protein may play a crucial role in the RNA chaperone function of the Lsm 
complexes. Recombinant yeast Lsm4p was also shown to promote U4/U6 annealing 
(it was not tested for strand displacement), suggesting that inactivation of this 
The definition of a molecular chaperone includes the condition that the chaperone does not form part 
of the final, folded structure. As Lsm2-8p forms part of the U41U6 di-snRNP, it does not conform to 
the strictest definition of a chaperone. On the other hand, the U41LJ6 duplex is stable once formed, 
even in the absence of the Lsm proteins. 
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polypeptide under denaturing conditions may be the reason for the absence of 
annealing activity for the in vitro assembled yeast Lsm complexes. Lsm4p may be 
involved in additional contacts with the U6 RNA, possibly the 3' stem-loop structure 
which I (and others) have shown stabilises the protein-RNA interaction. 
Interestingly, Vidal et al. (1999) showed that yeast Lsm4p crosslinks directly to U6 
snRNA in yeast extracts and that it co-immunoprecipitates the U6 snRNA 3' half (nt 
50-112) efficiently, but not U6(93-112). A central function for Lsm4p in the RNA 
chaperone activity of Lsm complexes awaits confirmation. Lsm4p mutants with point 
mutations in putative RNA-binding residues or residues involved in inter-subunit 
contacts may aid in this. 
Lsm2-8p and Prp24p are both essential for efficient U4/U6 annealing in vivo. Lsm2-
8p has been proposed to promote Prp24p-U6 RNA interactions (Rader et al., 2002; 
Ryan et al., 2002). Based on genetic interactions with mutations in U4 and U6 
snRNA, that either promote or inhibit their annealing, each of the four Prp24p RRMs 
was previously proposed to function in either U4/U6 association or dissociation. I 
have now shown that mutations in conserved residues of each of the RRMs confer 
synthetic lethality with deletions of LSM6 or LSM7. I therefore propose that all four 
Prp24p RRMs work together with Lsm2-8p to anneal U4 and U6 RNA (Fig. 6.5). 
Recent work by Karaduman et al. (2006) shows that binding of these proteins 
together leads to a U6 structure that is more favourable for annealing to U4 than 
when one or both of them are absent. The U4/U6 duplex in a Prp24p-U4/1J6 complex 
formed in vitro was shown to be incomplete (Ghetti et al., 1995; Jandrositz et al., 
1995). This suggests that Lsm2-8p, in addition to direct effects on the U6 structure, 
may promote complete U4/U6 annealing by destabilising the Prp24p-U4/LJ6 
interaction. 
Both Lsml-7p and Lsm2-8p were able to promote strand displacement as well as 
U4/U6 annealing. This indicates that both complexes can function as RNA 
chaperones and that this activity may have only limited specificity. The latter is in 
line with the wide range of substrates these complexes have. Destabilisation of RNA 
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secondary structures in mRNA by Lsm i-7p may affect binding of proteins that are 
involved in decapping and decay. 
10.2 Lsm protein promiscuity 
The above shows that the Lsm complexes are promiscuous in their interactions with 
RNA, at least more so than the homologous Sm complexes. This was proposed to be 
due to different residues involved in formation of the nucleotide binding pockets 
(Khusial et al., 2005) and emphasises the functional diversity of the Lsm proteins 
compared to the Sm proteins. Inter-subunit interactions of the Lsm proteins also 
seem to be more promiscuous than those of the Sm proteins. Formation of stable 
yeast Lsm3p homomultimers (Collins et al., 2003; this thesis) and formation of 
various ring-like structures by different combinations of human LSm proteins (Zaric 
et al., 2005) are but two examples. This underscores the considerable technical 
difficulties in assembling functional heteroheptameric complexes from recombinant 
subunits in vitro. Co-expression of seven Lsm proteins from a heptacistronic 
construct may overcome some of these problems, and may be helpful in allowing 
more detailed functional and structural examinations of the Lsm complexes. 
Higher eukaryotes have the SMN complex which assists in proper snRNP assembly 
in vivo, thus preventing unwanted protein-protein and protein-RNA interactions. As 
S. cerevisiae is not known to have an equivalent RNP chaperone, this begs the 
question how budding yeast prevents undesirable interactions. The only proteins that 
have been implicated in snRNP assembly in yeast are Lhplp (Xue et al., 2000) and 
Brrlp (Noble et al., 1996b). Their precise role in snRNP assembly is however, 
poorly understood and may not be related to that of the SMN complex in higher 
eukaryotes. 
10.3 Potential new functions of Lsm proteins 
Sm-like proteins occur in all three kingdoms of life. Most, but not all, bacterial 
genomes encode one Hfq or Hfq-like protein, whereas a few have been found to have 
two copies (reviewed by Valentin-Hansen et al., 2004). Most archaeal genomes have 
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similarly been found to encode one or two Sm-like proteins that form 
homomultimeric complexes containing six or seven subunits (reviewed by Beggs, 
2005). In contrast, upwards of 15 (L)Sm proteins have been found in eukaryotes. S. 
cerevisiae contains 15 known (L)Sm proteins and has at least 5 other proteins that, 
by sequence homology, are thought to form an Sm-like fold. Trypanosomes on the 
other hand have 17 (L)Sm proteins (Liu et al., 2004; Tkacz et al., 2006), with one 
Lsm ring apparently performing functions in both pre-mRNA splicing and mRNA 
decapping, and various Sm rings, with U snRNP-specific compositions. Finally, 
metazoa have 17 or more (L)Sm proteins, with complexes equivalent to those in 
budding yeast and at least one additional (L)Sm complex specific to the U7 snRNP 
The increasing number of (L)Sm proteins up the evolutionary ladder suggests 
multiple gene and possibly genome duplication events that allowed their functional 
diversification. The presumed advantage of having multiple (L)Sm proteins is the 
increase in the number of different functions that can be carried out. Intriguingly 
however, a wide (if not wider) variety of functions is similarly carried out by the 
single homohexameric Hfq protein. It seems nonetheless likely that each of the 
(L)Sm subunits has a specific function to play within the context of the complexes 
they are part of. One of the most striking examples is that of the Lsm 1-7 and Lsm2-8 
complexes, in which exchange of a single subunit leads to different localisations and 
functions. Interesting questions that remain include: Are there alternative complexes 
apart from the two that are known in yeast? If so, are they hexamers (e.g. Lsm2-7p), 
do they contain different combinations of Sm and Lsm proteins or do they even 
contain some of the other putative Lsm proteins? 
With regards to the question of subunit specific contributions to Lsm complex 
functions our lab has made some progress over the past few years. Lsm6p and Lsm7p 
were shown to be required for efficient U4/1J6 di-snRNP and U4/U6-U5 tri-snRNP 
assembly respectively (Verdone et al., 2004). The underlying mechanism for this is 
unknown, but may involve protein-protein interactions of Lsm6p with di-snRNP and 
Lsm7p with tri-snRNP specific proteins. I have now uncovered specific functions for 
the Lsm4 polypeptide. As discussed above, it may be essential for the RNA 
chaperone function of the Lsm complexes. Additionally, I have shown that the 
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unusual C-terminal extension of Lsm4p shows prion-like behaviour and that this 
quality is important for fast and efficient accumulation of Lsml -'7p in P-bodies. 
Finally, a cell morphology defect observed in cells depleted of Lsm4p alludes to an 
unknown role for this protein in cytokinesis. As I have confirmed the non-essential 
nature of the Lsm5 protein, studying its specific functions is now more feasible. A 
dramatic increase in the level of U4 snRNA in the lsm5A strain suggests that Lsm5p 
may have a task in degradation of this small stable RNA. A similar effect of Lsm8p 
depletion suggests the involvement of the nuclear Lsm2-8 complex, and a smaller but 
consistent effect on U5-S indicates this snRNA may also be degraded in an Lsm2-8p 
dependent fashion. As these RNAs were shown to be degraded by the nuclear 
exosome, Lsm2-8p may act to stimulate and/or recruit exonuclease activity, possibly 
by affecting TRAMP activity. As the level of scRi was significantly increased in an 
ismiA strain, the Lsml-7 complex may play a comparable role in promoting 
degradation of stable RNAs in the cytoplasm. 
With this in mind, it is interesting to note that a strong yeast two-hybrid interaction 
was detected between Lsm2p and Air2p, which is a subunit of the TRAMP complex 
(Fromont-Racine et al., 2000). This interaction could however, not be confirmed by 
co-immunoprecipitation (LaCava et al., 2005), suggesting that a potential interaction 
may be transient. Defects in pre-tRNA, -rRNA and -snoRNA processing in ism 
mutant strains are also consistent with a role for Lsm proteins in TRAMP/exosome 
mediated processing and/or degradation of these RNAs. Intriguingly, E. coli Hfq 
stimulates polyadenylation of mRNA by PAP 1 (Hajnsdorf et al., 2000; Le Derout et 
al., 2003; Folichon et al., 2005) and promotes degradation by PNPase, and can even 
be found in a complex with these two enzymes (Mohanty et al., 2004). The 
polyadenylation and degradation of nuclear RNAs in eukaryotes by the TRAMP and 
exosome complexes may be an analogous mechanism preserved throughout 
evolution (Houseley et al., 2006). Could Lsm2-8p have taken on the role of Hfq in 
promoting polyadenylation, in this case by the TRAMP complex? 
Other parallels exist between Hfq and the Lsm proteins (reviewed by Wilusz and 
Wilusz, 2005), emphasising that we may learn more about the eukaryotic Lsm 
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proteins by looking at functions and mechanisms of their bacterial counterparts. One 
area of considerable interest is that of small regulatory RNAs. As Hfq is essential for 
the function of many of these sRNAs it is a real possibility that the eukaryotic Lsm 
complexes play a similar role in the function of miRNAs. As budding yeast does not 
have RNAi machinery, it may instead employ ncRNAs for post-transcriptional 
regulation in a manner equivalent to the Hfq-sRNA system in bacteria. This is 
subject to ongoing investigations in our lab. 
10.4 Localisation of Lsml-7p versus Lsm2-8p 
It is not known what determines the different cellular localisations and functions of 
the Lsml-7 and Lsm2-8 complexes. Involvement of the different domains of Lsmlp 
and Lsm8p in localisation of these proteins to the cytoplasm (to P-bodies under stress 
conditions) and nucleus respectively was investigated by creating (deletion) mutants 
and hybrids of various domains of these proteins. Their localisations suggest that the 
N-termini of both proteins play a central role in targeting them to their respective 
cellular locations. Surprisingly, exchange of the central Sm-domains, that contain the 
putative RNA-binding residues, had limited effects on localisation and functional 
competence of the resulting hybrid proteins. This suggests that protein-RNA 
interactions outside the Sm-domain may play a crucial role in the possible RNA-
binding specificity of these complexes. The C-terminal extensions of both 
polypeptides were shown to be non-essential and to play a secondary role in 
determining localisation. In spite of the central role of the N-terminal extensions in 
localisation of the Lsm complexes, they do not function as localisation signals, as 
neither was sufficient for localisation of GFP to nuclei or P-bodies. This suggests 
that other Lsm polypeptides have a task in localisation. I have shown that at least one 
of these is Lsm4p. It is as yet unclear how functions of the N-termini of Lsmlp and 
Lsm8p are connected to a role for the Lsm4p C-terminus in localisation to P-bodies. 
One could imagine Lsm8p masking the aggregation-prone residues and exposing 
residues that could function as a nuclear localisation signal instead. The Lsm4p C-
terminus was shown to be non-essential for Lsm8p nuclear localisation, but its 
deletion did lead to reduced accumulation in the nucleus (data not shown). Lsmlp on 
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the other hand may, together with Lsm4p, form a nuclear exclusion signal. The 
aggregation-prone residues may be similarly masked in Lsm l-7p, and, conceivably, a 
conformational change triggered by post-translational modifications under stress 
conditions may expose these, leading to fast accumulation in P-bodies. However, as 
the Lsm4p C-terminus is not essential for P-body localisation and Hfq was even seen 
to accumulate in foci together with Dcp2p (see appendix A3), the ability to bind 
RNA may be sufficient to allow P-body localisation of cytoplasmic Lsm complexes. 
10.5 Final conclusions 
The in vitro studies reveal that the RNA chaperone activities of Sm-like proteins 
appear to have been conserved from bacteria to eukaryotes. The in vivo results begin 
to distinguish functions specific to individual Lsm polypeptides and protein domains, 
however, undoubtedly others remain to be found. One of the difficulties is that 
complex formation is thought to be essential for all Lsm functions. The successful 
approach with Lsmlp and Lsm8p hybrids and deletion mutants suggests that a 
similar approach involving extensions of the other Lsm proteins (in particular the 




A.1 Effects of Hfq co-purification on RNA binding, annealing 
and strand displacement by yeast Lsm proteins 
I performed a large number of RNA bandshift, annealing and strand displacement 
experiments with purified recombinant yeast Lsm proteins without realising that 
some of them, Lsm8p in particular, also contained co-purified E. coli Hfq. Some 
discrepancies between results of these experiments lead me to investigate the 
additional protein band in the His-HA-Lsm8p preparation as discussed under 3.6.1. 
Results obtained for the Lsm-Hfq mixtures are difficult to interpret as it is, in most 
cases, impossible to distinguish between activities from Lsm, Hfq and possibly even 
mixed complexes. Later experiments, discussed in Chapters 4 and 5, allowed some 
distinction between these activities by comparing Lsm complexes purified from hfq 
deletion strains and recombinant Hfq. To put these later experiments in perspective 
results of earlier experiments with the Lsm-Hfq mixtures are presented and discussed 
here. 
A.1.1 Effects of Hfq co-purification on RNA binding of yeast Lsm 
proteins 
Recombinant His-tagged yeast Lsm proteins 1 to 8 were expressed in BL21(DE3) 
cells and purified by Ni-NTA affinity chromatography as described in Chapters 2 
and 3. These purified proteins were used together with in vitro transcribed gel-
purified U6 RNA in RNA bandshift assays to examine the ability of each of the Lsm 
polypeptides to interact with U6 snRNA. At protein concentrations in large excess 
over RNA Lsm5p, Lsm6p and Lsm8p seem to bind U6 RNA efficiently, with some 
others showing minor shifts (Fig. Al .1A). A comparison of the shift in mobility in 
the presence of these proteins to that observed for Prp24p (data not shown) suggested 
that Lsm multimers rather than Lsm monomers bind U6 RNA. Some, or maybe all, 
of the Lsm proteins may form homo-multimeric complexes some of which may bind 
RNA. Lsm3p was reported to form stable homo-multimeric rings (Collins et al., 
2003; this thesis, Fig. 3.4C) and additional bands after SDS-PAGE (and Coomassie 
staining or Western analysis) were at times observed for a number of the other Lsm 
proteins (data not shown) suggesting that some of these interactions are also 
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sufficiently stable to withstand heating in the presence of SDS. The observed absence 
of significant levels of U6 RNA binding by Lsm3p (Fig. Al. I A) is in agreement with 
the observation of Collins et al. (2003) that Lsm3p does not have high affinity for U-
rich RNA. When lower, equimolar amounts of each of the recombinant Lsm 
polypeptides were used in a U6 RNA bandshift experiment only Lsm8p showed 
significant RNA binding (Fig. A1.1B). A mix of Lsm2 to 8 proteins showed a shift 
similar to that observed for a mix of Lsm5, 6 and 8p only (data not shown), 
indicating that an Lsm2-8p complex may not form under these conditions as 
discussed in Chapter 3. A similar shift was also observed with in vitro assembled 
Lsm2-8p (Fig. Al .2A), but not with Lsm l-'7p (data not shown). The shift for Lsm2-
8p occurred at a relatively low protein concentration, suggesting that a functional 
complex had formed. At higher protein concentrations multiple bands with decreased 
mobility were observed in RNA bandshift experiments (e.g. compare Lsm8p 
bandshift in Fig. Al .1A and B). This may be indicative of aggregation of complexes 
as discussed in 3.5.3, or may indicate multiple complexes interacting separately with 
one RNA molecule. Aggregation seems to be a common feature of Sm-like 
complexes as multimers of ring-shaped complexes were observed for yeast Lsm3p 
(Collins et al., 2003), a number of archaeal Sm-like proteins (Mura et al., 2003a; 
Mura et al., 2003b) and E. coli Hfq (Arluison et al., 2006). 
Similar bandshifts by the in vitro assembled Lsm2-8 complex were observed for U4 
RNA, U6rc RNA (reverse complement of U6 RNA) and U2A 107 RNA (a shortened 
version of U2 snRNA, see Table 2.1.7.5; Fig. ALIC-E), suggesting that RNA 
binding was not specific to U6 RNA. The RNA binding activities of the Lsm5p, 
Lsm6p and Lsm8p protein preparations were shown to be due to the presence of Hfq 
(Fig. 4.lA). It is unclear whether co-purified Hfq homohexamers were responsible 
for RNA binding or whether heteromultimeric complex containing both Hfq and Lsm 
proteins may have been present. Slight differences in U6-protein complex mobility 
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Fig. A1.1 RNA binding by recombinant yeast Lsrn proteins purified by 
affinity chromatography from BL21(DE3) hfq+  strain. (A) Bandshift with 
1.3 pmol (50 ng) of U6 RNA and excess amounts of purified recombinant 
Lsm proteins: 9 pmol of Lsm 1, 160 pmol of Lsm2, 730 pmol of Lsrn3, 26 
pmol of Lsm4, 535 prnol of Lsm5, 540 pmol of Lsm6, 64 pmol of Lsm7 and 
200 pmol of Lsm8: (B) Bandshift with 1.3 pmol of U6 snRNA and 25 pmol 
of each of the individual recombinant Lsm proteins; (C) Bandshift assay with 
1.8 pmol of U4 RNA and individual Lsm proteins as under (A); (D) Bandshift 
assay with 1.3 pmol of U6 reverse complement RNA and individual Lsm 
proteins as under (A); (E) Bandshift assay with 1.3 pmol of U2A 107 RNA 
and individual Lsm proteins as under (A). 
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Fig. A1.2 RNA binding by in vitro assembled Lsm2-8p from purified 
recombinant components expressed in BL21(DE3) hfq+ strain. (A) 
Bandshift with 1.3 pmol of U4 or U6 RNA and 15 pmol of Lsm2-8p 
and 2-fold serial dilutions thereof, (B) Bandshifl with 1.3 pmol of 
U2A 107 RNA with same concentration range of Lsm2-8p and with 
excess tRNA or 1.3 pmol of U6 RNA: (C) Bandshift with 1.3 pmo! 
of U6A3' RNA; (D) Bandshift assay with 1.3 pniol of U6, U6A3' or 
U4 RNA and 15 pmol of Lsm2-8p with and without excess competitor 
tRNA (75 [tg). 
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In vitro assembled Lsm2-8p with natively purified His-HA-Lsm8 and 8 M urea 
purified His-Lsm2 to 7 (3.5.1) presumably contained approximately one seventh of 
the concentration of Hfq that was present in the His-HA-Lsm8 preparation. I assume 
that Hfq homohexamers and Lsm heteromultimers formed during renaturation, 
although formation of Hfq-Lsm heteromultimers cannot be ruled out. This mixture 
was used in RNA bandshift assays with U4, U6, U2t107 and U6i3' RNA (Fig. 
Al .2A-C) and protein was shown to bind all these RNAs. There seemed to be a 
slightly higher affinity for U6 RNA than for the other RNAs tested. Addition of 
1500x excess competitor tRNA showed that there was a level of specificity for 
binding to U4 and U6 RNA, but slightly less for U6L3' RNA (Fig. AIM), 
suggesting that a U-rich sequence, in this case an Sm or Lsm binding site, may be 
favoured. 
A.1.2 Effects of Hfq co-purification on U4/U6 annealing activity of 
yeast Lsm proteins 
Recombinant yeast Lsm proteins purified from BL2 1 (DE3) cells were used in a 
U4/U6 annealing assay (Fig. Al .3A). A small amount of U4/U6 duplex was formed 
in the absence of any protein. Lsm5p and Lsm8p (hfq+) preparations promoted 
formation of U4/U6 duplex most efficiently. Interestingly, the mobility of this duplex 
was slightly faster than that of the duplex formed in the absence of protein. This 
seems to be caused by Hfq and is discussed in more detail in Chapter 4. The fact that 
a small amount of the "faster" duplex was formed in the presence of Lsml, Lsm3 
and Lsm6p suggests that these proteins contained small amounts of co-purified Hfq 
as well. Lsm8p (hfq+) was also shown to promote annealing between U4 and U63' 
RNA (data not shown) indicating that the uridine-rich single stranded tail at the 3' 
end of U6 snRNA is not essential for annealing by this protein preparation. Neither a 
mixture of natively purified Lsm2 to 8p (hfq+) nor in vitro assembled Lsm2-8p 
(hfq+) displayed significantly higher annealing activities than the Lsm8p (hfq+) 
preparation alone, suggesting that all annealing activity is caused by co-purified Hfq. 
Absence of any annealing activity in Lsm8p purified from a hfq deletion strain and 
similar formation of a "fast" U4/U6 duplex with recombinant Hfq and Lsm8p from a 






















Fig. AI.3 U4/U6 annealing by individual yeast recombinant Lsni proteins 
and in vitro assembled Lsm2-8p from a BL2I(DE3)hfq+ strain is due to 
co-purification with E. co/i i-Ifq. (A) U4/U6 annealing with 0.2 pmoi of U6 
RNA, 0.3 pmol of U4 RNA and 17 pmol of LsmI, 21 pmol of Lsrn2, 97 pmol 
of Lsm3, 4.5 pmol of Lsm4, 71 pmol of Lsm5, 72 pmol of Lsm6, 8.5 pmol of 
Lsm7, 26 pmol of Lsm8, a mixture of Lsm2 to 8 (containing 1/7 of each of 
the above concentrations) and 3.5 pmol of in vitro assembled Lsm2-8; (B) 
U4/U6 annealing with 26 pmol Lsm8p purified from a hfq+ strain, 5 pmol 
of recombinant Hfq (monomers) and 49 pmol of Lsm8p purified from a A/zfq 
strain; (C) U4/U6 annealing with 7.5 prnol of recombinant Prp24p and 2.25 
prnol of Lsm2-8p (Hfq+) or 2-fold dilutions thereof. 
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recombinant Prp24p, which migrates like spontaneously formed duplex, was 
converted to the more mobile duplex when Hfq (co-purified with Lsm8p) was added 
(Fig. Al .3C). These data strongly suggests that Hfq affects the structure of the 
U4/U6 duplex (discussed in 4.3.2.2). 
A.1.3 Effects of Hfq co-purification on strand displacement activity 
of yeast Lsm proteins 
A potential mechanism for the annealing activity of Sm-like proteins is 
destabilisation of intramolecular structures that inhibit intermolecular basepairing 
interactions. Experiments investigating this mechanism are discussed in detail in 
Chapter 5. Initial strand displacement experiments with the Lsm-Hfq protein 
mixtures showed that either Hfq or Lsm complexes or both are able to "unwind" a 
RNA/DNA duplex resembling the U6 3' stem-loop structure. Increasing amounts of 
in vitro assembled Lsm2-8p (hfq+) lead to increasing amounts of strand 
displacement. Addition of 1 mM ATP to these reactions did not increase strand 
displacement activity (Fig. Al .4A). Surprisingly, Lsm8p (hfq+) only displayed very 
little activity although more Hfq was present in these reactions. The 
denaturing/renaturing steps of in vitro Lsm2-8p assembly therefore seem to lead to 
increased strand displacement activity. It is unclear whether this is due to formation 
of (more) Hfq homohexamers or formation of active Lsm2-8p complex or both. 
Strand displacement activity for Lsm2-8p (hfq+) was shown not to be caused by 
RNA degradation (Fig. A1.413). Both in vitro assembled Lsml-7p (hfq+) and Lsm2-
8p (hfq+) were shown to "unwind" the duplex over time (Fig. Al.4C). Lsm2-8p 
seems to initially bind the substrate and subsequently displaces the DNA 
oligonucleotide. Strand displacement by Lsml -7p (hfq+) and Lsm2-8p (hfq+) was 
shown not to be entirely specific for the U6-like substrate (Fig. Al .5). However, both 
complexes (or co-purified Hfq) did seem to have a preference for substrates with the 
U-rich single-stranded tail, particularly when the sequence in the stem-loop was 
replaced with a non-U6 sequence (Fig. Al .5A). Results of strand displacement 
assays to which competitor RNA (tRNA, U4, U6E3' or U6 RNA) was added indicate 
that binding and "unwinding" of the substrate depends at least in part on specific 



























Fig. A 1.4 Strand displacement activity of in vitro assembled Lsm I -7p and 
Lsm2-8p from a BL2I(DE3) hfij± strain may be due to co-purification with 
E. co/i Hfq. (A) Strand displacement of 250 nM of U6(77-I 12)/(77-92)rc 
substrate with 7.2 .tM of Lsm8 (monomers; Hfq+) and 2.4 jtM of Lsm2-8 (Hfq+) 
and 2-fold dilutions thereof, after 10 min of incubation with and without 
1 mM ATP; (B) Strand displacement by Lsm2-8 (l-lfq+) is not due to RNA 
degradation. Duplicates of samples from (A) were separated by denaturing 
PAGE and U6(77-112) RNA was detected by Northern blot analysis; (C) 
Both in vitro assembled Lsml-7p (Hfq±; 600 nM) and Lsrn2-8p (l-lfq+; 600 
nM) display strand displacement of 250 nM of substrate over time. 
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Fig. A1.5 Strand displacement activity of in vitro assembled LsmI-7p and 
Lsm2-8p (Hfq+) shows a low level of specificity. (A) Quantification of strand 
displacement of various substrates at 250 nM by 600 nM of recombinant 
Lsm8p (hexamers, Hfq+), Lsml-7p, Lsm2-8p or Prp24p after 60 min of 
incubation. Corrected for background unwinding in the absence of protein; 
(B) Various in vitro transcribed RNA fragments and RNA/DNA duplexes 
(separated by denaturing and native PAGE respectively) that were used as 
substrates in the strand displacement assays; (C) Relative strand displace-
ment of U6(77-1 12)/(77-92)rc by Lsml-7p and Lsm2-8p in the presence of 
various competitor RNAs. Unwinding in absence of competitor RNA was 
set to 100%. 
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Lsm2-8p complex that was assembled in vitro from recombinant Lsm2 to 8 proteins 
all purified under denaturing conditions displayed strand displacement, but no U4/U6 
annealing activity (data not shown). This was one of the main reasons to investigate 
the additional band in the native Lsm8p purification, which turned out to be Hfq, as 
this band was absent in Lsm8p purified under denaturing conditions. This also 
suggested that Hfq was responsible for the annealing activity, but not for all strand 
displacement activity, which was later confirmed (Chapters 4 and 5). 
A.2 Hfq interaction with Lsm8p 
Hfq co-purifies with recombinant Lsm8p. What is the nature of this interaction? Do 
Hfq and Lsm8p form a heteromultimeric ring or other structure or do both proteins 
interact independently and simultaneously with the same RNA? Purified recombinant 
His-Myc-Hfq and His-HA-Lsm8p do not interact in vitro under immunoprecipitation 
conditions (Fig. A2. 1). This may mean that stable homomultimeric complexes 
formed by purified Hfq and Lsm8p do not allow heteromultimeric complexes to form 
or that there is no RNA present to bridge the interaction. Purified recombinant His-
HA-Lsm8p with co-purified Hfq shifts U6 RNA in a bandshift assay, whereas His-
HA-Lsm8p from an hfq deletion strain does not (Fig. 4.1A). If this is due to a 
heteromultimeric Hfq-Lsm8p complex it would be expected that U6 RNA should co-
immunoprecipitate with this complex. Anti-HA or a-His antibody was used to 
immunoprecipitate His-HA-Hfq or His-HA-Lsm8p purified from a wild-type or a 
4hfq strain in the presence of in vitro transcribed U6 RNA (Fig. A2.2). Hfq 
immunoprecipitated with either antibody efficiently pulls down U6 RNA, whereas 
Lsm8p with co-purified Hfq only pulls down a small amount of U6 when 
immunoprecipitated with a-His antibody. This may mean that the tags are partially 
masked in a potential Lsm8p-Hfq heteromultimer or that the Hfq-U6 interaction is 
stronger than that of Lsm8p-Hfq-U6. In contrast, Lsm8p alone does not pull down 
any U6 RNA confirming the U6 bandshift data. In summary, Lsm8p and Hfq may 
form a heteromultimeric complex that binds U6 RNA. 
329 
a-HA C0IP 	u-Myc C0IP 
	
Myc-Hfq 	+ + + + 	+ - + - 
HA-Lsm8 	+ - +  
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Fig. A2.1 Recombinant Hfq and Lsm8p do not interact in vitro. 
Approximately 0.5 ig of His-N4yc-l-Ifq and His-HA-Lsm8p were 
mixed and immunoprecipitated with u-Myc or a-HA-conjugated 
agarose beads. Resulting pellets and supernates were separated by 
SDS-PAGE and Western blots were hybridised with a-Myc or a-HA 
antibodies. His-HA-Lsm8p and His-Myc-Hfq are efficiently and 
completely pulled down by the corresponding antibodies, but no 
Hfq or Lsm8p is co-iimunoprecipitated. Pull downs are even 







Fig. A2.2 His-HA-Lsm8p and native Hfq may form heteromultimeric 
complexes. Approximately 0.5 .ig of purified recombinant protein (from 
hfq+ or /fq- strains) was imniuno-precipitated with a-HA or a-His anti-
bodies in the presence of 7.5 ng of U6 RNA. RNA from pellets and super-
nates was separated by denaturing PAGE and visualised by hybridising the 
Northern blot with labelled U6-specific probe. 
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A.3 Effects of hfq expression in yeast 
The interaction between yeast Lsm8p and Hfq (A2) as well as structural and 
functional similarities between Hfq and the Lsm complexes raises the question what 
effect hfq overexpression may have on yeast and what effect LSM overexpression 
may have on E. coli. In particular, can Hfq rescue isin deletion phenotypes by 
carrying out some of functions of the Lsm complexes or does it interfere with these 
functions by interacting with Lsm8p and/or other Lsm proteins? GFP-Hfq (pMRI 28) 
was overexpressed in BY4741 cells and localisation was examined during log phase 
growth and after hypo-osmotic shock (Fig. A3.1). GFP-Hfq localised throughout the 
cytoplasm and was excluded from the nucleus (Fig. A1IA). After hypo-osmotic 
shock GFP-Hfq aggregated strongly in cytoplasmic foci and co-localised to these 
foci with Dcp2-RFP, suggesting that Hfq localises to P-bodies under stress 
conditions. This presumably means Hfq interacts with poly(A) tails of mRNAs that 
aggregate in P-bodies and suggests that there may not be an essential P-body 
localisation signal in Lsm l-7p, unless Hfq is associated with the yeast Lsm proteins. 
GFP-Hfq overexpression from the MET25 promoter did not have any significant 
effects on growth of wild-type yeast or ism deletion strains. The exception was ism 74 
in which GFP-Hfq overproduction partially alleviated temperature-sensitive growth 
(data not shown). Overexpression of Hfq from the MET25 promoter from a high 
copy 2t plasmid (pMRI27) however, was toxic in BY4741 (Fig. A3.213) and 
BMA38a wild-type cells (data not shown). Surprisingly this effect was not as strong 
in ismI, 6 or 7 deletion strains (Fig. A3.2A). Hfq expression had the least effect on 
ism 74 and even had a slightly positive effect under some conditions. In summary, 
Hfq seems to interfere with essential processes in wild-type cells, but may be able to 
partially functionally replace Lsml-7p. Hfq may bind to shortened poly(A) tails and 
protect them from degradation. 
Overexpression of individual Lsm proteins in E. coli did not have any discernible 
negative effects on its growth, nor was it able to suppress effects of an hfq deletion 
(data not shown). 
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MET-ON 





GFP-Hfq 	Dcp2-RFP 	 merge 
Fig. A3.1 GFP-Hfq localises to the cytoplasm in yeast and localises to 
P-bodies under stress conditions. (A) GFP-Hfq overexpressed from the 
MET25 promoter (pMR128) localises throughout the cytoplasm and 
is excluded from the nucleus as can be seen in live cells and fixed cells 
in which nuclear DNA is DAPI-stained; (B) GFP-l-lfq co-localises with 
Dcp2-RFP after hypo-osmotic shock. Under growth conditions in which 
P1ET2 is repressed (MET-OFF) GFP-Hfq localises weakly to foci 
that contain Dcp2-RFP; under MET-ON conditions GFP-Hk1 accumulates 
strongly in foci together with Dcp2-RFP. BY474 1 was transformed with 
pMR 128 (GFP-Hfq) and pRPI 155 (Dcp2-RFP). Cells were grown in 
SD-Ura-(-Leu)(-Met) and localisation was examined in live (B) or fixed 
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pRS423-MET25 +1- Hfq 
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pRS423-MET25 +1- Hfq 
	 BY4741 
Fig. A3.2 l-lfq overexpression has a detrimental effect on wild-type yeast growth, 
but less so on isni deletion mutant strains. AEMY25 (ismiA), MRY27 (ls,n5A), 
MRYI7 (lsrn6A), MRYI8 (Ism 7A) and BY4741 (WT) were transformed with 
pRS4123-MET25 (2ji, 1-11S3) with (+) or without (-) I-Ifq. Cells were grown in SD 
-His and spotted in 10-fold serial dilutions on SD-His (MET-OFF) or SD-His-Met 
(MET-ON) and incubated at 30 or 37C. (A) Hfq overexpression aggravates 
slow growth in ls,n/A and lsm6A, is synthetic lethal with 1sm5A, does not affect 
lsm7A at 30°C, but aggravates all temperature-sensitive phenotypes. A low level 
of Hfq expression (MET-OFF) even leads to slighlty better growth of Ism7A at 
30°C; (B) Hfq overexpression has a strong negative effect on growth of wild-type 
yeast at 30 and 37°C. 
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